Technological Approaches for Investigating Mechanotransductive Enterogenesis. by Utter, Brent Allen
  
 
 
 
 
Technological Approaches for Investigating 
Mechanotransductive Enterogenesis 
by 
Brent Allen Utter 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Mechanical Engineering) 
in the University of Michigan 
2014 
Doctoral Committee: 
Professor Diann Erbschloe Brei, Co-Chair 
Associate Research Scientist Jonathan E Luntz, Co-Chair 
Associate Professor Brent Gillespie 
Associate Professor Andrew James Putnam 
Professor of Surgery Daniel H. Teitelbaum 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Brent Utter 
All Rights Reserved 
2014 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my family 
  
iii 
 
 
 
 
Acknowledgements 
From day one, I have been surrounded and supported by exceptional individuals. I wish to 
thank my research advisors, Diann Brei, Jonathan Luntz, and Dr. Teitelbaum. Diann has been 
instrumental in guiding the high-level vision of this research, Jonathan has been an outstanding 
source of clever ideas and technical knowledge, and Dr. Teitelbaum’s expertise on short bowel 
syndrome and pediatric surgery has been invaluable. Without their mentorship, this dissertation 
could not have happened. I am also thankful for my committee members, Andrew Putnam and 
Brent Gillespie, and grateful for their service on my committee. 
For fostering an amazing environment to research in, I would like to thank my former and 
current lab mates: Anupam Pathak, Jon Redmond, Jim Otten, Brian Barnes, Julie Abel, Monica 
Toma, Shishira Nagesh, Poorna Mane, Joe Shaktman, Suhant Ranga, WonHee Kim, Clover 
Aguayo, and Isabel Czarnocki, who deserves special mention for her important contributions to 
this research. In addition to my lab mates, I have been fortunate to collaborate with accomplished 
researchers and surgeons from Dr. Teitelbaum’s group: Manabu Okawada, Eiichi Miyasaka, 
Haytham Mustafa-Maria, Bhani Chawla, Richard Herman, Matthew Ralls, Ryo Sueyoshi, Jennifer 
Freeman, Yumi Fukatsu, and Farokh Demehri. 
I have my family to thank for my drive to conduct meaningful research and my love of 
engineering. My parents sparked my curiosity of the world around me, gifted me countless science 
toys, and were generally okay with me taking apart everything in the house. I wish to thank my 
sister for encouraging me to pursue my dreams and leading by example. For her emotional support, 
guidance through personal challenges, and unconditional love, I thank my girlfriend, Nancy 
Pinnell.  
Lastly, I would like to acknowledge and thank the sponsors of this research: The National 
Institute of Health, The Hartwell Foundation, The Food and Drug Administration, and General 
Motors. Without their support, this research would not have been possible.  
iv 
 
 
 
 
Table of Contents 
DEDICATION ii 
ACKNOWLEDGMENTS iii 
LIST OF FIGURES xi 
LIST OF TABLES xiv 
ABSTRACT xv 
CHAPTER ONE. INTRODUCTION 1 
1.1. SHORT BOWEL SYNDROME 2 
1.1.1. Etiology 2 
1.1.2. Effects of Short Bowel Syndrome 4 
1.1.3. Treatment and Management Methods 5 
1.1.3.1. Non-Surgical Approach 6 
1.1.3.2. Surgical Approach 7 
1.1.3.2.1. Bianchi Procedure 8 
1.1.3.2.2. Serial Transverse Enteroplasty 10 
1.1.3.2.3. Bowel Transplant 12 
1.1.4. Treatment Outcomes 12 
1.2. MECHANOTRANSDUCTIVE TREATMENT APPROACH 13 
1.2.1. Prior Mechanotransduction Based Enterogenesis Research 14 
1.2.1.1. Experimental Study Growth Results 17 
1.2.1.2. Comparison of Medical Results in Rabbit and Rat Studies 19 
1.2.2. Potential Advantages of the Mechanotransductive Approach 20 
1.3. RESEARCH ISSUES 21 
1.3.1. Treatment Feasibility and Potential 22 
1.3.2. Treatment Development 22 
1.3.3. Device Technologies for Studying Mechanotransductive Enterogenesis 23 
1.3.3.1. Scalability for Enabling Feasibility Studies with Porcine Animals Models 24 
1.3.3.2. Suitability for Enabling Studies to Develop Treatment Approach Guidelines 25 
1.3.3.2.1. Displacement Measurement and Control 26 
1.3.3.2.2. Tensile Load Measurement and Control 26 
1.3.3.3. Summary Evaluation of Research Enterogenesis Devices 26 
1.3.4. Attachment Methods 27 
1.3.5. Clinical Device Development 28 
v 
 
1.4. RESEARCH GOALS AND OBJECTIVES 29 
1.5. SUMMARY OF RESEARCH APPROACH 30 
1.5.1. Objective One: Treatment Approach Feasibility and Potential 30 
1.5.1.1. Design Considerations 31 
1.5.1.2. Prototype 31 
1.5.1.3. Validation and Characterization 32 
1.5.1.4. In Vivo Studies 32 
1.5.2. Objective Two: Treatment Development 32 
1.5.2.1. Design 33 
1.5.2.2. Prototype 34 
1.5.2.3. Characterization and Validation 34 
1.5.2.4. In Vivo Studies 35 
1.5.3. Objective Three: Tissue Attachment 35 
1.5.3.1. Conceptualization and Initial Downselection 36 
1.5.3.2. Experimental Studies 36 
1.5.4. Objective Four: Clinically Relevant Device 37 
1.5.4.1. Design 37 
1.5.4.2. Prototype 38 
1.5.4.3. In Vivo Studies 38 
1.6. SUMMARY OF CONTRIBUTIONS 38 
1.6.1. Medical Treatment 39 
1.6.2. Device Innovation 39 
1.6.3. Experimental Methodologies 40 
1.6.4. Mechanical Device / Tissue Interaction 40 
1.6.5. Impact 41 
REFERENCES 41 
CHAPTER TWO. TREATMENT FEASIBILITY STUDIES WITH A 
CURVED HYDRAULIC DEVICE 46 
2.1. CURVED HYDRAULIC DEVICE DESIGN 49 
2.2. PROTOTYPE 52 
2.2.1. Curved Housing and Stages 53 
2.2.2. Sealing 56 
2.2.3. Attachment to Tissue 57 
2.3. VALIDATION AND CHARACTERIZATION 58 
2.4. IN VIVO EXPERIMENTAL STUDIES 59 
2.4.1. Experimental Procedure 60 
vi 
 
2.4.2. In Vivo Results and Discussion 62 
2.4.2.1. Tissue Growth 62 
2.4.2.1.1. Transepithelial Electrical Resistance 63 
2.4.2.1.2. Cell Proliferation 64 
2.4.2.1.3. Morphology 66 
2.4.2.2. Vascular Adaptation 68 
2.4.2.3. Challenge of Tissue Attachment 70 
2.5. CONCLUSION 70 
REFERENCES 71 
CHAPTER THREE. TREATMENT DEVELOPMENT STUDIES WITH AN 
INSTRUMENTED AND DISPLACEMENT CONTROLLED SMA DRIVEN 
RATCHETING DEVICE 73 
3.1. DEVICE CONCEPT 76 
3.1.1. Ratcheting Mechanism 77 
3.1.1.1. Ratcheting Mechanism Architecture 78 
3.1.1.2. Ratcheting Mechanism Operation 79 
3.1.2. Data Acquisition and Control System 81 
3.1.2.1. Data Acquisition and Control System Architecture 81 
3.1.2.2. Data Acquisition and Control System Operation 82 
3.2. RATCHETING MECHANISM DESIGN 84 
3.2.1. Reset View Design Methodology 84 
3.2.1.1. Transformation from Material Stress-Strain to Engineering Force-Displacement 86 
3.2.1.2. Transformation from Engineering Force-Displacement to Reset View 88 
3.2.1.3. Reset Spring Selection 89 
3.2.2. Analytical Ratchet Model 90 
3.2.2.1. Tooth and Pawl Geometry 91 
3.2.2.1.1. Packaging Constraint 92 
3.2.2.1.2. Load Bearing Capacity 92 
3.2.2.1.3. Self-Locking Condition 92 
3.2.2.1.4. Pawl Reengagement Slide / Skip Mode 93 
3.2.2.2. Ratchet Force Model 94 
3.2.2.2.1. Ratchet Disengagement Kinematics 94 
3.2.2.2.2. Ratchet Disengagement Kinetics 97 
3.3. PROTOTYPE 98 
3.3.1. Determination of Safe Applied Bowel Tension Range 99 
3.3.1.1. Acute In Vivo Testing of Ischemic Failure Limit 99 
3.3.1.2. Ex Vivo Testing of Mechanical Failure Limit 100 
3.3.2. Application of Reset View Design Methodology 101 
3.3.3. Ratcheting Mechanism Prototype 105 
vii 
 
3.3.4. Data Acquisition and Control System Prototype 107 
3.4. BENCHTOP VALIDATION 109 
3.4.1. Ratchet Model Validation 109 
3.4.1.1. Ratcheting Force Model Validation Setup 109 
3.4.1.2. Ratcheting Force Model Validation Procedure 110 
3.4.1.3. Ratcheting Force Model Validation Results 110 
3.4.2. Ratcheting Mechanism Performance Demonstration 113 
3.4.3. Data Acquisition and Control System Performance Demonstration 115 
3.4.4. Benchtop Environmental Validation 115 
3.5. IN VIVO EXPERIMENTAL STUDIES 116 
3.5.1. Experimental Procedure 116 
3.5.1.1. Surgical Implantation and Tissue Analyses 117 
3.5.1.2. Expansion Approaches 118 
3.5.1.3. Tissue Evaluation Plan 118 
3.5.2. In Vivo Results 119 
3.5.2.1. Constant Rate Impulsive Displacement Control Trial 119 
3.5.2.2. Displacement Rate Limited Load Control Trial 121 
3.5.2.3. Constant Load Control Trial 122 
3.5.2.4. Medical Results 123 
3.6. CONCLUSION 126 
REFERENCES 128 
CHAPTER FOUR. EXPERIMENTAL STUDY OF SOFT TISSUE 
ATTACHMENT METHODS 130 
4.1. ATTACHMENT APPROACHES 134 
4.1.1. End Abutment 135 
4.1.2. Dilation 136 
4.1.3. Impingement 137 
4.1.4. Binding / Kinking 138 
4.1.5. Adhesion 138 
4.1.6. Clamping 139 
4.1.7. Tissue Piercing 139 
4.2. EXPERIMENTAL EVALUATION OF ATTACHMENTS 139 
4.2.1. Ex Vivo and Acute In Vivo Experiments 140 
4.2.1.1. Dilation Approach – Smooth and Textured Balloons 141 
4.2.1.1.1. Dilation Prototypes 141 
4.2.1.1.2. Dilation Approach Experimental Procedure 141 
4.2.1.1.3. Dilation Approach Results 142 
4.2.1.2. Adhesion Approach – Suction 143 
viii 
 
4.2.1.2.1. Suction Prototype 143 
4.2.1.2.2. Suction Approach Experimental Procedure 144 
4.2.1.2.3. Suction Approach Results 144 
4.2.1.3. Impingement Approach – Bristles and Petals 145 
4.2.1.3.1. Impingement Approach Ex Vivo Experimental Procedure 146 
4.2.1.3.2. Impingement Approach Ex Vivo Experimental Results 146 
4.2.1.3.3. Impingement Approach Acute In Vivo Experimental Procedure 147 
4.2.1.3.4. Impingement Approach Acute In Vivo Experimental Results 148 
4.2.2. One to Two Week In Vivo Experiments 150 
4.2.2.1. Binding / Kinking Approach – Surgically Enforced 150 
4.2.2.2. Clamping Approach – Extraluminal Ring 151 
4.2.2.3. Tissue Piercing Approach – Sutures and Reinforced Sutures 155 
4.2.2.4. Dilation Approach – Dilating Fenestrated Mesh 158 
4.3. COMPARISON OF ATTACHMENT APPROACHES 160 
4.4. CONCLUSION 162 
REFERENCES 163 
CHAPTER FIVE. DEVELOPMENT OF A CLINICAL DEVICE FOR 
TREATING SHORT BOWEL SYNDROME 165 
5.1. DESIGN OF EXPANSION APPROACH 167 
5.1.1. Development of Selection Criteria 168 
5.1.2. Conceptualization of Expansion Mechanisms 172 
5.1.2.1. Extension 173 
5.1.2.2. Payout 174 
5.1.2.3. Track 174 
5.1.2.4. Feed-In 175 
5.1.2.5. Motility 175 
5.1.2.6. Secondary Growth 176 
5.1.2.7. Field Induced 176 
5.1.3. Downselection 176 
5.1.4. Payout Expansion Mechanism 180 
5.1.4.1. Architecture 181 
5.1.4.2. Operation 182 
5.2. RECIPROCATING LINEAR HYDRAULIC DEVICE PROTOTYPE 183 
5.2.1. Expansion Mechanism 183 
5.2.2. Expansion Mechanism Integration with Attachments 185 
5.2.3. Benchtop Prototype Characterization 188 
5.3. IN VIVO EXPERIMENTAL GROWTH STUDY 190 
5.3.1. In Vivo Experiment Procedure 190 
ix 
 
5.3.1.1. Surgical Implantation Procedure 191 
5.3.1.2. Device Expansion Procedure 193 
5.3.1.3. Tissue Measurement Plan 193 
5.3.1.4. In Vivo Performance of Device Validation Procedure 193 
5.3.2. In Vivo Experiment Results 194 
5.3.2.1. Performance of Reciprocating Linear Hydraulic Device 194 
5.3.2.2. Tissue Growth Analysis 194 
5.3.2.3. Grown Tissue Health 196 
5.3.2.3.1. Histology 196 
5.3.2.3.2. Morphology 197 
5.3.2.3.3. Cell Proliferation 197 
5.4. CONCLUSION 198 
REFERENCES 200 
CHAPTER SIX. CONCLUSION 201 
6.1. GOAL AND OBJECTIVES 201 
6.2. RESEARCH SUMMARY 202 
6.3. MEDICAL TREATMENT CONTRIBUTIONS 205 
6.3.1. Feasibility of Mechanotransduction Approach 205 
6.3.2. Profile Comparison 206 
6.3.3. Payout Approach 207 
6.4. DEVICE INNOVATION CONTRIBUTIONS 207 
6.4.1. Novel Technologies 208 
6.4.1.1. Curved Hydraulic Device 208 
6.4.1.2. Instrumented SMA Driven Ratchet 209 
6.4.1.3. Reciprocating Linear Hydraulic Device 209 
6.4.2. Design Methodologies 209 
6.4.2.1. Reset View Design Methodology 210 
6.4.2.2. Ratcheting Rack-Pawl Force Interaction Model 210 
6.5. EXPERIMENTAL METHODOLOGY CONTRIBUTIONS 211 
6.5.1. Bowel Tension Measurement 211 
6.5.2. Tissue Health and Growth Analyses 213 
6.5.2.1. Tissue Length Measurement 213 
6.5.2.2. Measurement of Neovascularization 213 
6.5.2.3. Measurement of Cell Proliferation 214 
6.6. MECHANICAL DEVICE/TISSUE INTERACTION CONTRIBUTIONS 214 
6.6.1. Safe Load Determination 214 
x 
 
6.6.2. Tissue Attachment 215 
6.6.2.1. Dilating Fenestrated Mesh 215 
6.6.2.2. Unreliable and/or Unsafe Tissue Attachment Approaches 216 
6.6.2.2.1. Ill-Suited Permanent Attachment Approaches 216 
6.6.2.2.2. Ill-Suited Non-Permanent Attachment Approaches 216 
6.6.3. Device Form 217 
6.6.3.1. Length, Rigidity and Curvature 217 
6.6.3.2. Diameter 217 
6.6.3.3. Proximal and Distal Bowel Tissue Interface 218 
6.6.3.4. Local Feature Contours 218 
6.7. IMPACT 218 
6.8. FUTURE RESEARCH 219 
6.8.1. Medical and Surgical Challenges 220 
6.8.1.1. Improving the Measurement of Small Bowel Growth 220 
6.8.1.2. Addressing the Formation of Adhesions 221 
6.8.1.2.1. Adhesion Preventing Film and Gels 221 
6.8.1.2.2. Delaying the Distraction Period 221 
6.8.1.2.3. Minimally Invasive Surgical Techniques 222 
6.8.2. Engineering Challenges 222 
6.8.2.1. Expansion Mechanism Improvements 222 
6.8.2.1.1. Flexible Expansion Mechanism 223 
6.8.2.1.2. Allowing Flow Through or Around the Device 223 
6.8.2.2. Instrumentation and Control 224 
6.9. CLOSING 224 
REFERENCES 225 
 
  
xi 
 
 
 
 
List of Figures 
Figure 1.1. Basic Gross Anatomy of Small Bowel and Supporting Vasculature. 3 
Figure 1.2. Conventional Approach to Surgical Treatment. 5 
Figure 1.3. Surgical Structuring Approaches. 7 
Figure 1.4. The Bianchi Procedure. 9 
Figure 1.5. Serial Transverse Enteroplasty Procedure Schematic. 10 
Figure 1.6. Internal Screw Device. 15 
Figure 1.7. External Screw Device. 15 
Figure 1.8. Intraluminal Spring. 16 
Figure 2.1. Linear Hydraulic Device (shown extended). 47 
Figure 2.2. Porcine Small Bowel Loop with Mesentery. 48 
Figure 2.3. Architecture of Curved Hydraulic Device. 50 
Figure 2.4. Prototype of Curved Hydraulic Device. 53 
Figure 2.5. Exploded Schematic View of the Curved Hydraulic Device. 56 
Figure 2.6. Curved Hydraulic Device Displacement Versus Input Volume. 59 
Figure 2.7. Schematic of Surgical Implantation Procedure. 61 
Figure 2.8. Transepithelial Electrical Resistance of Small Bowel Samples. 64 
Figure 2.9. Percentage of Proliferating Cells in Small Bowel Samples. 65 
Figure 2.10. Total Muscle Height. 67 
Figure 2.11. Mesentery of Distracted Segment at Implant (left) and Explant (right). 69 
Figure 2.12. 3D Reconstructions of Control and Distracted Mesentery Samples. 69 
Figure 3.1. Bowel Lengthening System. 76 
Figure 3.2. Operation of Ratcheting Mechanism. 80 
Figure 3.3. Data Acquisition and Control System Architecture. 82 
Figure 3.4. Data Acquisition and Control System Operation. 83 
Figure 3.5. Reset View Design Process. 90 
Figure 3.6. Geometry of Ratchet Model. 91 
Figure 3.7. The Self Locking Criterion. 93 
Figure 3.8. Geometric Definitions of Disengagement Kinematics. 95 
xii 
 
Figure 3.8. In Vivo Tensile Loading Setup. 100 
Figure 3.10. Ex Vivo Experimentation Setup. 101 
Figure 3.11. Reset View Design of Actuator with 8 and 10 mil SMA Wire. 105 
Figure 3.12. Prototype of Instrumented SMA Driven Ratchet. 106 
Figure 3.13. Data Acquisition and Control System Prototype. 108 
Figure 3.14. Experimental Setup. 110 
Figure 3.15. Experimental Force-Displacement Results. 111 
Figure 3.16. Path Followed by Tip of Pawl. 111 
Figure 3.16. Surgical Implantation Schematic. 117 
Figure 3.17. Load and Displacement Data Captured During Distraction Period of Displacement-
Based Expansion Trial. 119 
Figure 3.18. Effect of Actuation Close Up and the Measurement of Peristalsis. 120 
Figure 3.19. Load and Displacement Data Captured During Distraction Period of Displacement 
Rate Limited Load Control Trial. 121 
Figure 3.20. Load and Displacement Data Captured During Distraction Period of Load-Based 
Expansion Trial. 123 
Figure 3.21. Circular Muscle Layer of Distracted Tissue Segments. 124 
Figure 3.22. Percentage of Cell Proliferation in Crypt/Villus Complexes of Distracted Tissue 
Segments. 125 
Figure 3.23. Transepithelial Electrical Resistance of Sample Bowel Tissue from Constant Rate 
Impulsive Displacement Control Trial. 126 
Figure 4.1. Small Bowel Attachment Approaches 134 
Figure 4.2. Bristle and Petal Based Impingement Approaches 137 
Figure 4.3. Dilation Prototypes. 142 
Figure 4.4. Slipping Force of Dilation-Based Attachments. 143 
Figure 4.5. Prototype of Suction Attachment. 144 
Figure 4.6. Slipping Force of Suction Approach. 145 
Figure 4.7. Ex Vivo Gripping Performance of the Bristle Approach. 147 
Figure 4.8. Bristle and Petal Based Attachment Implanted in Live Porcine Tissue. 148 
Figure 4.9. Balloon-Actuated Petal Approach. 149 
Figure 4.10. Surgically Enforced Tissue Kinking Approach. 151 
Figure 4.11. Clamping Approach with Single Stage Linear Hydraulic. 152 
Figure 4.12. Curved Hydraulic Device with Ring Attachments. 154 
Figure 4.13. Schematic of Suture Attachment Outcomes. 155 
xiii 
 
Figure 4.14. Outcomes of the Sutured Attachment Approach. 156 
Figure 4.15. Tissue Piercing Approach Results – Normalized Expansion Vs. Distraction Period.
 157 
Figure 4.16. Dilating Fenestrated Mesh Attachment, Prior to Implant. 158 
Figure 4.17. Effect of Attachment on Tissue Health. 160 
Figure 4.18. Comparison of Evaluated Attachment Approaches. 161 
Figure 5.1. Conceptualization Tree. 173 
Figure 5.2. Pugh Chart of Expansion Mechanisms. 177 
Figure 5.3. Concept Score Difference from Mean. 180 
Figure 5.4. Architecture and Operation of Reciprocating Linear Hydraulic Device. 181 
Figure 5.5. Section Views of Expansion Mechanism Prototype. 184 
Figure 5.6. Expansion Mechanism. 185 
Figure 5.7. Prototype Integrated with Attachments. 186 
Figure 5.8. Compliant Tissue Guide. 187 
Figure 5.9. Detailed View of Attachment. 188 
Figure 5.10. Benchtop Characterization of Reciprocating Linear Hydraulic Device. 190 
Figure 5.11. Surgical Implantation Procedure. 192 
Figure 5.12. Growth Measurement. 195 
Figure 5.13. Tissue Histology. 196 
Figure 5.14. Tissue Morphology. 197 
Figure 5.15. Cell Proliferation. 198 
 
 
 
 
 
 
 
 
 
xiv 
 
 
 
 
List of Tables 
Table 1.1. Conditions Leading to Massive Resection in Pediatric Patients. 4 
Table 1.2. Conditions Leading to Massive Resection in Adult Patients. 4 
Table 1.3. Reported Enterogenesis Results with Current Devices. 18 
Table 1.4. Statistically Significant Medical Results of Rabbit and Rat Enterogenesis Studies. 20 
Table 1.5. Advantages and Disadvantages of Prior Enterogenesis Devices. 24 
Table 2.1. FEA Results of Stainless Steel and Delrin Tubing for Curved Hydraulic Device 55 
Table 2.2. Dimension of Housing and Three Stages of Curved Hydraulic Device. 55 
Table 2.3. Tissue Growth Results with Curved Hydraulic Device 63 
Table 3.1. Geometric Parameters of Pawl and Pushrod 102 
Table 3.2. Data Acquisition and Control System Components. 108 
  
xv 
 
 
 
 
Abstract 
Short bowel syndrome (SBS) is a devastating condition characterized by insufficient small 
bowel length which leads to malnutrition and high rates of mortality. The treatment and 
management of SBS is difficult, and current approaches suffer from low success rates, lethal 
complications, and high costs. To improve the quality of care for SBS patients, of which there are 
approximately 40,000 in the USA, this research investigated technological approaches for a 
promising and novel treatment approach based on mechanotransductive enterogenesis, a process 
in which longitudinal small bowel tissue growth is induced by the application of tensile loading. 
Three enterogenesis device technologies were designed to attach to segments of small bowel tissue 
and extend, thereby placing the tissue under tension and inducing growth. Each device was used 
in experimental in vivo studies with clinically relevant porcine animal models to advance the 
knowledge of mechanotransductive enterogenesis for correcting SBS. The Curved Hydraulic 
Device was used to induce high expansion bowel lengthening, establishing the clinical feasibility 
of the mechanotransduction-based approach. The Instrumented Shape Memory Alloy Driven 
Ratchet, designed with the new Reset View Design Methodology and rack/pawl force interaction 
model, was used to develop the treatment approach by determining the limit of safely applied 
bowel tension, comparing the effect of applying different tissue expansion profiles on tissue 
growth, and exploring the limits of the maximum tissue expansion rate. Lessons from these studies 
led to the Reciprocating Linear Hydraulic Device, which was used to successfully demonstrate the 
viability of a high-expansion cyclical bowel lengthening approach by lengthening a segment of 
small bowel tissue by more than the device stroke. The success of this approach depended on the 
development of a clinically relevant tissue attachment approach, the Dilating Fenestrated Mesh, 
which was developed through the in vivo evaluation of a broad range of attachment approaches 
that characterized their attachment performance, ease of implantation/removal, and risk of causing 
surgical complications. This dissertation has made important contributions toward the 
advancement of this vital new treatment approach for SBS through the innovation of enterogenesis 
device technologies, the development of experimental methodologies, and an understanding of the 
mechanical device/tissue interaction. 
1 
 
CHAPTER ONE. INTRODUCTION 
Short bowel syndrome is a serious medical condition characterized by insufficient small bowel 
length which leads to malabsorption, poor quality of life, and high rates of mortality. The treatment 
and management of short bowel syndrome is difficult, and current approaches suffer from low 
rates of success, lethal complications, and high costs. The clinical feasibility of lengthening small 
bowel by inducing its growth through the application of tensile load (mechanotransductive1 
enterogenesis2) was hinted at in studies with rat and rabbit animal models, but there is a large gap 
between these studies and the clinical realization of the approach. To improve the quality of care 
of short bowel syndrome patients, the goal of this dissertation is to narrow this gap by exploring 
technological approaches for a promising and novel treatment method of short bowel syndrome 
based on mechanotransductive enterogenesis in clinically relevant porcine animal models. The 
objectives include establishing the clinical feasibility of the mechanotransductive approach, 
developing the treatment approach by exploring displacement and tension-based tissue expansion 
strategies, investigating clinically relevant small bowel attachment approaches, and developing 
clinically relevant enterogenesis device technologies and tissue lengthening approaches. To 
explore these objectives, a series of novel enterogenesis devices were designed, fabricated, and 
used to enable in vivo3 experimental studies of mechanotransductive enterogenesis in porcine 
animal models. Attachment approaches for transferring load from enterogenesis devices to bowel 
tissue were investigated in a series of acute and longer-term in vivo studies. This dissertation makes 
important contributions to the disciplines of surgery and engineering, which together constitute the 
                                                     
1 Mechanotransductive: Relating to the process through which mechanical stimuli elicit a biochemical response in living cells 
2 Enterogenesis: Growth of bowel tissue 
3 In vivo: Occurring within live animal 
2 
complete foundation supporting the design and usage of enterogenesis technologies for correcting 
short bowel syndrome. 
1.1. Short Bowel Syndrome 
Short bowel syndrome (SBS), or short gut syndrome, is a devastating medical condition 
characterized by the malabsorptive state of a patients, primarily infants and children, who have 
undergone massive small bowel resection4 to treat intestinal pathologies. Although less common, 
SBS may also be caused by congenital5 small bowel atresia6. The length of small bowel removed 
that results in malabsorption varies greatly from patient to patient as a result of differences in age, 
the part of small bowel resected, and the health of other organs in the digestive system [1]. Thus, 
definitions of SBS vary greatly in the literature. Rickham, who coined the name “short bowel 
syndrome” in 1967, stated that patients having less than 30% of small intestine remaining (75cm 
for neonates and 150-200 cm for adults) would develop SBS [2]. Recent definitions state that SBS 
develops when less than 200 cm of small intestine remains following resection in adults [3,4], 
and/or the long-term requirement of Parenteral Nutrition (PN) following bowel resection [5,6]. A 
consensus definition has been proposed to aid patient diagnosis and treatment [7]: “Short-bowel 
syndrome – intestinal failure results from surgical resection, congenital defect or disease-
associated loss of absorption and is characterized by the inability to maintain protein-energy, 
fluid, electrolyte or micronutrient balance when on a conventionally accepted, normal diet.” 
1.1.1. Etiology 
The etiology, or cause, of massive small bowel resection leading to SBS varies between 
infants and adults. The small bowel is fed blood almost entirely by the superior mesenteric artery, 
which connects to the small bowel via the mesentery, a thin membrane suspending blood vessels 
(Figure 1.1). Not surprisingly then, the health of the small bowel is strongly coupled to that of the 
superior mesenteric artery and its companion vein, which drains blood away from the small bowel. 
Injury to either vessel related to trauma and or abnormal intestinal pathologies may lead to small 
bowel resection and subsequent SBS. Among infants, necrotizing enterocolitis, the death of small 
bowel tissue, and midgut volvulus, the abnormal looping of small bowel upon itself, are leading 
                                                     
4 Resection: Surgical removal 
5 Congenital: Present at or before birth 
6 Atresia: Absence or closure of orifice or bodily passage 
3 
causes of the requirement for massive resection leading to SBS [1]. In both pathologies, a reduction 
of blood to the small bowel tissue plays an important role in the deterioration of its health and 
functionality. Intestinal atresia, a condition where an underdeveloped portion of small bowel 
causes obstruction, requires resection to restore the flow of enteric contents. Gastroschisis, a 
prenatal condition where small bowel exits the body through a defect in the umbilical cord, is also 
a cause of significant bowel resection. Additional causes in infant populations include genetically 
inherited motility disorders such as total aganglionosis7, chronic intestinal pseudo-obstruction8, 
and congenital short bowel [8]. Among adults, common indications for massive bowel resection 
are radiation enteritis9, cancer, mesenteric vascular disease, and severe Crohn’s disease10 [1,6]. 
Tables 1.1 and 1.2 document the conditions causing massive bowel resection in adult and pediatric 
                                                     
7 Total aganglionosis: Absence of ganglion cells in entire colon that causes inability of tissue to relax, creating an obstruction 
8 Intestinal pseudo-obstruction: A condition characterized by constipation, colicky pain, and vomiting, but without evidence of organic 
obstruction apparent at laparotomy 
9 Enteritis:  Inflammation of small bowel 
10 Crohn’s disease:  A type of inflammatory bowel tissue that can affect any portion of the GI tract  
 
Figure 1.1. Basic Gross Anatomy of Small Bowel and Supporting Vasculature. 
The small bowel consists of three major segments: the duodenum, which connects to 
the stomach, the jejunum, the middle portion, and the ileum, which connects to the 
large bowel through the ileocecal valve. The small bowel is supported by vasculature 
embedded in the mesentery, the thin membrane connecting the small bowel to the 
superior mesentery artery and its companion vein. 
Mesenteric Vasculature
(fed by superior mesenteric artery, not shown)
Mesentery
Small Bowel
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patients, respectively, from a single-institution retrospective review [6]. However, the relative rates 
of etiologies are typical and highlight the contrast between causes in infants and adults. 
1.1.2. Effects of Short Bowel Syndrome 
For the estimated 40,000 [9] patients in the United States with SBS, the symptoms of the 
condition are devastating. Ingested food is malabsorbed, leading to diarrhea and the subsequent 
excessive loss of nutrients, fluids, and electrolytes. In infants, the lack of nutrition results in an 
inability to thrive and develop. When left untreated, the development of symptoms similar to 
chronic dehydration may also occur. Furthermore, massively dilated portions of small bowel are 
common in SBS patients, leading to a motility disorder where the flow rate of enteral contents is 
reduced. The reduction of enteral content flow begins a cascade of events: bacterial overgrowth, 
translocation of bacteria and toxins, recurrent sepsis11, cholestasis12, and eventually liver failure. 
As a result, SBS is a highly lethal condition, particularly for infants and children, with mortality 
rates exceeding 30% [1,4,5,7,10–13]. The cost of care is high, with the average first year single 
patient total exceeding half of a million USD and subsequent years steadily costing 250,000 to 
300,000 USD/year on average [14]. Therefore, the burden of SBS is severe both financially and 
medically. 
                                                     
11 Sepsis:  A bacterial infection in the bloodstream or body tissues. 
12 Cholestasis:  A condition caused by rapidly developing or long-term interruption in the excretion of bile (a digestive fluid 
that helps the body process fat). 
Table 1.1. Conditions leading to massive 
resection in pediatric patients. 
Table adapted from [6]. The leading causes of 
massive resection in pediatric populations are 
necrotizing enterocolitis and midgut volvulus. 
 
Table 1.2. Conditions leading to massive 
resection in adult patients. 
Table adapted from [6]. The leading causes of massive 
resection in are populations are cancer secondary to 
irradiation and mesenteric vascular disease. 
 
Condition resulting in massive resection, 
pediatric patients.
Condition No. %
Necrotizing enterocolitis 37 33
Midgut volvulus 36 32
Intestinal atresia 23 21
Other benign disease 16 14
Total 112 100
Condition resulting in massive resection, adult 
patients.
Condition No. %
Irradiation/cancer 17 35
Mesenteric vascular disease 10 21
Crohn's disease 5 10
Other benign disease 16 33
Total 48 100
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1.1.3. Treatment and Management Methods 
The approach to the management and treatment of SBS can vary greatly from patient to 
patient, and is dependent on many factors including the presence of the colon, the presence of the 
ileocecal valve13, the health of other organs in the digestive system, patient age, the extent of 
remnant bowel dilation, and importantly, the length and location of remnant bowel. Although the 
approach to treatment and indications for surgery will vary from institution to institution, Figure 
1.2 illustrates a typical treatment plan, which is simplified to account mainly for two factors: extent 
of bowel dilation and remnant small bowel length. Non-surgical approaches to the treatment of 
SBS include administering Total Parenteral Nutrition to sustain patients while the bowel 
undertakes adaptive processes to increase enteral nutrient absorption, and the use of growth 
hormones to hasten the adaptation. If patients cannot wean from Total Parenteral Nutrition, 
                                                     
13 Ileocecal valve:  Valve at junction separating the small intestine from the large intestine 
 
Figure 1.2. Conventional Approach to Surgical Treatment. 
Figure adapted from [6]. Based the length of remnant small bowel following resection and the extent of 
remnant bowel dilation, different approaches to treating SBS are commonly indicated. When the 
segment is sufficient in length but dilated, surgical tapering to reduce the dilation is considered. If bowel 
dilation is proximal to a stricture, a small narrowing of the bowel, stricturoplasty may also be considered. 
In the best case, the remnant bowel is not dilated and a fully enteral diet is accepted. Thus, no surgical 
treatment is necessary. Regardless of the dilation extent, if Total Parenteral Nutrition (TPN) is required 
long-term and leads to complications, surgical bowel lengthening procedures may be considered such 
as the Bianchi Procedure, Serial Transverse Enteroplasty (STEP), and transplants. 
Surgical Approach to SBS
Remnant Length 
Dilated
Length > 120cm, 
Stasis, Bacterial 
Overgrowth
Restructuring 
Surgery (Tapering) 
or Stricturoplasty
Length 60-90cm, 
Dependent on 
TPN
Lengthening 
Surgery (Bianchi 
Procedure, STEP 
Procedure)
Remnant Length Normal 
Diameter
Fully Enteral 
Diet 
Accepted
No 
Surgical 
Treatment
TPN 
Required
Length >90cm, 
Rapid Transit
Consider Valve or 
Segment Reversal
Length <60cm, 
TPN 
complications
Transplantation
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surgical options are considered to restructure and lengthen bowel, and bowel transplant is also 
considered. 
1.1.3.1. Non-Surgical Approach 
The mainstay of treatment for SBS is Total Parenteral Nutrition (TPN), a high caloric and 
nutrient rich solution that is feed intravenously into patients [15]. TPN manages the symptoms of 
SBS stemming from the malabsorption of nutrients, but does not treat the cause of SBS. Due to 
the potentially lethal complications and high costs associated with long-term reliance on TPN, 
ideally patients on TPN are able to gradually wean to a normal diet. From Medicare data, the yearly 
cost of TPN exceeds 150,000 USD, and that figure does not include additional costs due to frequent 
hospitalization, medical equipment, and nursing care [16]. High calorie TPN solutions required by 
neonates and infants may cause a reduction of bile flow, known as Parenteral Nutrition Associated 
Cholestasis (PNAC), which can lead to cholestatic liver injury, irreversible cirrhosis14, and 
eventually death. Furthermore, long-term reliance on TPN may also lead to recurrent sepsis and 
thrombosis15 from bacterial contamination of the feeding catheter. 
The acceptance and absorption of EN depends on the extent to which the remnant small bowel 
adapts following a major resection. The adaptation process is characterized by an increase of villus 
height and crypt depth16, mucosal hyperplasia17, and bowel dilation [12,17], all of which 
effectively increase the absorptive area in an attempt to compensate for a loss of length. However, 
bowel dilation can negatively affect motility, potentially resulting in bacterial overgrowth, and 
require bowel restructuring surgeries. Factors that affect small bowel adaptation include the length 
and location of the remnant bowel, age, underlying cause of requirement for massive resection, 
health of other organs in the digestive system, and the presence of the ileocecal junction [6]. To 
hasten the adaptive process, the use of growth hormones, growth factors, and nutrients have been 
explored with mixed results [4,18–22]. Although an increase in absorption of nutrients has been 
clinically observed [18,21], a major problem associated with this approach has been a reversal of 
the absorptive gains at the end of the treatment period [22]. 
                                                     
14 Cirrhosis:  Cirrhosis is scarring of the liver and poor liver function. It is the final phase of chronic liver disease 
15 Thrombosis:  The formation of blood clots  
16 Villi and Crypts:  The features of the innermost layer of small bowel (mucosa). Villi are outward projections of the mucosa, while 
crypts are inward 
17 Mucosal hyperplasia:  An increase in the number of cells of the mucosa  
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Both TPN and natural bowel adaptation play an important role following major small bowel 
resection, but not all patients wean from TPN. It is possible to achieve long-term success with TPN 
in cases where small bowel adaption does not fully wean patients to EN, but the high complication 
rate, poor quality of life, and expense of TPN has encouraged the development of surgical options 
[23]. 
1.1.3.2. Surgical Approach 
In cases where lengthening of the bowel is not necessary but the transit of enteral contents is 
abnormally slow or fast, surgical restructuring techniques are considered. When the flow of enteral 
content is abnormally slow, bacterial overgrowth can occur, whereas abnormally fast enteral 
content flow can lead to malabsorption. Dilated bowel segments slow the flow of enteral contents, 
and may be surgically tapered, as shown in Figure 1.3. A bowel stricture also slows the flow of 
enteral content and causes proximal18 bowel dilation, resulting in the consideration of a 
stricturoplasty (Figure 1.3). In cases where the transit of enteral contents is too rapid, the 
introduction of a valve or a reversed segment of bowel may be considered. 
                                                     
18 Proximal:  Upstream 
 
Figure 1.3. Surgical Structuring Approaches. 
Image taken from [6]. Surgical techniques for increasing or reducing the rate of enteral content transit 
through the small bowel are shown. In cases where the transit of enteral content is slow, bacterial 
overgrowth can occur and lead to sepsis. To increase the rate, strictures in the bowel are removed by 
stricturoplasty and dilated portions of bowel are tapered. In cases where the flow is too rapid, the bowel 
cannot properly absorb nutrients. To decrease the rate, valves can be surgically implement as well as 
reversed segments of bowel. Reversing a segment of bowel works because naturally occurring 
peristalsis in the reversed segment will work to move enteral content opposite the normal flow. 
Stricturoplasty Tapering Valve Reversed Segment
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After significant small bowel resection, naturally adaptive processes may not completely wean 
SBS patients from TPN. For these cases, two surgical lengthening techniques, known as the 
Bianchi Procedure and the Serial Transverse Enteroplasty (STEP), may be considered to lengthen 
the small bowel and improve its absorptive capacity. Additionally, bowel transplantation is another 
surgical bowel lengthening approach. For the Bianchi and STEP procedures, a dilated portion of 
bowel is required to be tapered and lengthened. The surface area for nutrient absorption is not 
increased by either technique initially. However, both surgeries significantly reduce the inner 
diameter of the bowel, which then adapts by increasing it inner diameter following the surgery and 
leading to a greater area of absorption. Additionally, tapering dilated bowel segments in this 
manner has the additional benefit of decreasing the risk of bacterial overgrowth secondary to the 
slow transit of enteral contents. 
1.1.3.2.1. Bianchi Procedure 
The first surgical small bowel lengthening technique was developed by Bianchi and results 
with porcine models were reported in 1980 [24]. The Bianchi procedure, also known as 
Longitudinal Intestinal Lengthening and Tailoring (LILT), is shown in Figure 1.4 as a five step 
procedure consisting of A, splitting the mesentery lengthwise along the bowel, B, further 
separating mesentery from bowel to make room for a staple line, C, applying a line of staples, D, 
separating the two new segments of bowel, and E, anastomosing19 the ends of the two new 
segments such that the direction of peristalsis is not reversed. The procedure doubles the length of 
the typically dilated bowel that it is performed on while simultaneously reducing the diameter, a 
result that quickens the flow of enteral contents and prevents bacterial overgrowth. 
The clinical application of the Bianchi procedure has been associated with serious 
complications and the need for further surgical lengthening procedures and bowel transplant. In a 
20-year single institution (St. Mary’s Hospital, Manchester, UK) study consisting of 20 patients, 
an increase in nutrient absorption was observed, but at a mean follow up period of 6.4 years, the 
mortality rate of the patients was 55%. The most prominent complication was hepatic20 failure (10 
out of the 11 patients that died). Of the 9 surviving patients, 7 weaned completely from TPN 
[25,26]. Another more recent retrospective study of a 20-year single institution experience 
                                                     
19 Anastomosis:  A surgically made connection between tissues, usually between tubular structures. 
20 Hepatic:  Relating to the liver 
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(Children’s Hospital of Pittsburgh) was reported with 19 patients, 7 of which weaned from TPN, 
9 of which required bowel transplants, and 3 of which were still on TPN [27]. In another single 
institution (Mannheim University Hospital, Heidelberg University, Germany) series, 49 patients 
from 1982 to 2004 underwent a modified (no stapler used, manual suture lines) Bianchi procedure 
[28]. Of the 49 patients, 19 weaned off of TPN, 5 were still on TPN at follow up, 16 patients were 
not followed up, and 9 died from complications including liver failure (n = 4) and sepsis (n = 3). 
The most prominent long-term complication reported was bowel re-dilation leading to reduced 
motility, stasis, bacterial overgrowth and malabsorption. 
 
Figure 1.4. The Bianchi Procedure. 
Taken from [24]. The Bianchi Procedure is illustrated in five steps. A, the mesentery is split 
into two halves and disconnected from the mesenteric side of the bowel (B). C, a staple line 
is introduced into the bowel such that neither half of the mesentery is cut, creating to segment 
of bowel from one (D). Lastly, the two segments of small bowel are reconnected, such that 
the peristaltic action of both segments does not opposed the natural flow of the GI tract. 
A B
C D
E
a
b
a
b
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1.1.3.2.2. Serial Transverse Enteroplasty 
The Serial Transverse Enteroplasty Procedure, or STEP, was developed by Kim et al. [29] 
and results with 6 porcine models were reported in 2003. The STEP procedure is sometimes 
preferred to the Bianchi procedure, because it is easier to perform and doesn’t require anastomoses 
[30]. However, the Bianchi procedure cannot be performed to a bowel segment where a STEP 
procedure was previously performed, while a STEP procedure can follow a Bianchi procedure. 
Thus, the Bianchi procedure is sometimes preferred as the first bowel restructuring technique. The 
STEP procedure consists of creating a zigzag path by creating staple lines on alternating sides of 
the small bowel, as shown in Figure 1.5. In the initial study, the 6 porcine models gained weight, 
had no bowel obstruction, no dilation at six weeks post operation, and on average, the STEP 
segment of bowel was lengthened from 49.2 to 82.8 cm. Like the Bianchi procedure, the STEP 
procedure narrows the diameter of the small bowel, helping to prevent stasis and bacterial 
overgrowth. 
The first clinical case report [31] was a two-year-old boy with a prior Bianchi procedure at 
the Children’s Hospital in Boston, MA. The STEP procedure successfully lengthened 83 cm of 
 
Figure 1.5. Serial Transverse Enteroplasty Procedure Schematic. 
Image taken from [29].The Serial Transverse Enteroplasty (STEP) lengthening 
segments of dilated small bowel by introducing zigzagging staple lines into the small 
bowel which subsequently straighten out. For each staple line, a small mesenteric 
defect is created to position the stapling tool. 
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previously dilated bowel to 147 cm, making the entire length of the small bowel 200 cm. The 
patient tolerated the procedure well and had a significant increase in absorptive capacity. Recent 
reports of STEP procedures at the Children’s Hospital in Boston documented the outcome of 16 
surgeries from February 2002 to February 2008 [32,33]. Of the 16 patients, 6 have weaned 
completely from TPN, 2 patients required transplants, and complications included catheter-related 
bacteria (n = 5), GI bleeding (n = 1), and bowel obstruction (n = 1). An average length increase of 
the STEP segment of 91% and no deaths were reported. 
The outcome of 14 patients who underwent the STEP procedure from May 2003 to May 2006 
at the Hospital for Sick Children, Toronto, CA is reported in a retrospective study [30]. Of the 14 
patients, 8 were followed up at more than 1 year post operation, 7 of which were able to wean off 
TPN. Complications included GI bleeding (n = 1), staple line leakage (n = 2), and 3 patients died 
from liver failure (n = 2) and a combination of sepsis and heart failure (n = 1). In addition to the 
STEP procedure, 2 patients required liver/bowel transplants. An average increase of the STEP 
segment length of 94% was reported. 
Another single-institution retrospective chart review of 119 patients seen from January 1995 
to December 2009 at the University of Michigan reported the results of 14 patients receiving the 
Bianchi procedure (n = 5) and the STEP procedure (n = 9). Within this cohort, two patients who 
received the STEP procedure required an additional STEP procedure to eliminate bowel re-dilation 
that was causing bacterial overgrowth and malabsorption [34]. Two patients who received the 
Bianchi procedure required a subsequent STEP procedure. Of the 9 patients who underwent the 
STEP procedure, 3 patients were able to wean completely off of TPN, an additional 3 patients 
continued to decrease their requirement for TPN for greater than one year post operation, and there 
was one death from the combination of a bleeding stress ulcer and parenteral nutrition associated 
liver disease. Complications associated with the STEP procedure included bowel re-dilation, 
bacterial overgrowth, GI bleeding, the requirement for reoperation, adhesive small bowel 
obstruction, and strictures. Of the eight patients who experienced bowel re-dilation, 7 required re-
operation and only one patient weaned off of TPN, whereas no patient in the un-dilated group 
required an additional operation. 
An International STEP Data Registry was formed to acquire sufficient data for facilitating 
analysis [35]. From September 2004 to April 2006, 38 patients from 19 centers and 3 countries 
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have enrolled in the registry. Reported complications include leakage along staple lines (n = 2), 
bacterial overgrowth (n = 2), abscesses (n = 3), the necessity of reoperation (n = 3), and death (n 
= 3). The average percentage of enteral nutrition accepted increased from 31% to 67%, and the 
average length of the STEP segment increased from 68 cm to 115 cm. 
While both procedures increase the length of the small bowel and facilitate weaning from 
parenteral nutrition, many of the complications associated with the Bianchi and STEP procedures 
are not uncommon and necessitate the requirement for further surgical intervention. In particular, 
bowel re-dilation and enteral content leakage are common complications that can lead to a 
cascading set of worsening complications. Therefore, other treatment modalities, such as bowel 
transplant, are sometimes preferred to surgical lengthening with either the Bianchi or STEP 
procedures. 
1.1.3.2.3. Bowel Transplant 
Bowel transplants may be considered for patients who have undergone extreme bowel 
resection, aren’t weaning from TPN, or do not have the dilated lengths of small bowel that make 
surgical lengthening practical. The motivation for transplants stem from the technical and 
immunologic problems associated with TPN, which lead to high costs and mortality rates. If 
performed early, bowel transplant may prevent parenteral nutrition associated liver disease [6]. 
Bowel transplants are surgically challenging, and compared to other organ transplants, have 
lower survival rates [36]. Furthermore, patients require long-term immunosuppressive medication, 
and the surgery can cost in excess of 210,000 USD [16]. Although the short-term patient and graft 
survival rates have seen improvement, the most recent results on an estimated 95% of bowel 
transplants performed from 1999 to 2009 have a 50% patient mortality rate at five years post 
operation [37]. 
1.1.4. Treatment Outcomes 
Despite the improvements made in the last decade with the administration of TPN, new 
surgical lengthening and tapering options such as STEP, and improved short-term patient/graft 
survival rates with transplants, SBS remains one of the most lethal conditions for infants and 
children [38]. TPN is costly, and long-term reliance on TPN continues to be associated with lethal 
complications. Surgical lengthening techniques such as the Bianchi Procedure and STEP lengthen 
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bowel and can improve bowel motility short-term, but both procedures are invasive and suffer 
from complications including bowel re-dilation and leakage along the lengthy staple lines. Bowel 
transplants can dramatically increase the length of small bowel in patients, but continue to suffer 
from dismal long-term graft rejection rates. The severity of complications associated with the 
traditional treatment methods has led to high rates of mortality and morbidity. Overall rates of 
mortality vary greatly in literature, but large intestinal failure centers have recently reported 
mortality rates exceeding approximately 30 percent [1,4,7,13–15] with some reaching as high as 
37.5% [5,16]. To improve on these outcomes, a new approach to lengthening small bowel based 
on mechanotransduction has been evaluated in experimental studies with small animal models. 
1.2. Mechanotransductive Treatment Approach 
To improve the survival rate of SBS patients, a new approach for treating patients based on 
mechanotransductive enterogenesis, the induction of small bowel tissue growth by the application 
of mechanical loading, appears very promising. Mechanotransduction is the process through which 
a mechanical stimulus excites a biochemical response at the cellular level. All biological tissues 
respond to shear and or normal forces by growing, changing compliance, and a wide range of other 
physiological changes [39]. The migration, proliferation, differentiation, and apoptosis of living 
mechanosensitive cells are modulated by force [39], the cumulative effect of which can profoundly 
affect the development and function of organs and tissues. However, the mechanisms by which 
the transduction occurs within living cells are not fully understood [40–42]. Examples of 
mechanotransduction in the regulation of normal processes are widespread and diverse, as a result 
of the universal nature of cellular mechanosensitivity. 
Due to the vast number of possible congenital and acquired bone, tooth and soft tissue 
deformities and injuries, there are a plethora of medical treatments based on mechanotransduction 
where the correction of these conditions is achieved. Bone growth, or osteogenesis, is achieved by 
the application of tensile, or distractive, loading on the fibrocartilage callus that forms in the gap 
created between the segments a broken bone [43]. Distraction osteogenesis is used both in pediatric 
and adult populations for correcting mismatched leg lengths, congenital or acquired bone 
malformation, and for growing bone to replace segments surgically removed because of tumors. 
Favorable outcomes are reported for numerous distraction osteogenesis based treatments including 
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cranial vault expansion [44], mandibular distraction [45–47], brachymetatarsia21 [48], and failed 
pollicization22 [49]. Like bone, the ability to induce the growth of soft tissues by gradual expansion 
and loading provides a wide range of medical treatments [50]. Following a mastectomy, 
reconstruction of the breast(s) may be achieved by the gradual expansion of a bladder implanted 
within a subpectoral pocket [51,52]. Many congenital conditions are treated by the load induced 
growth of soft tissues such as the management of giant omphaloceles23 and melanocytic naevi24 
[53,54], abdominal wall defects [55], hypospadism25 [56], anophthalmos26 [57], and long-gap 
esophageal atresia27 [58,59]. The breadth of soft tissues that may be grown by the application of 
external force suggests the potential for the tension-induced growth of small bowel in the treatment 
of short bowel syndrome.  
1.2.1. Prior Mechanotransduction Based Enterogenesis Research 
There has been very promising yet limited research studies conducted on the process of 
tension-induced enterogenesis. The underlying process of mechanotransduction, defined as the 
biological response of a cell to a mechanical stimulus, has resulted in the growth of small bowel 
segments as demonstrated in previous in vivo studies with rat [60–67] and rabbit [68] animal 
models28, but not in larger more clinically relevant animal models such as pigs. In these 
experiments, three enterogenesis devices were used to apply tensile load: the Internal Screw, the 
External Screw, and the Intraluminal Spring. 
The Internal Screw Device [68] (Figure 1.6) is an extraluminal device and is unique in that it 
was designed for tensioning continuous, or non-isolated, segments of rabbit small bowel. The 
device is composed of two perforated semicircular tissue couplers that attach to the antimesenteric 
side of the small bowel with sutures, and two lead screws that drive the attachments along the 
length of the slotted housing. The attachments are initially close to the center of the housing at the 
start of the implantation period. While implanted, the attachments are separated gradually by 
                                                     
21 Brachymetatarsia: Condition where one or more metatarsals are abnormally short 
22 Pollicization: Surgical construction of thumb using a finger 
23 Omphalocele: Birth defect where the bowel, liver, or other abdominal organs protrude through a defect in the abdominal wall 
24 Melanocytic naevi: Moles 
25 Hypospadism: Male birth defect where urethral orifice is misplaced along the underside of the penis rather that at the tip of the 
glans 
26 Anophthalmos: Absence of ocular tissue 
27 Esophageal atresia:  Absence or gap of length of esophagus 
28 Animal model: A living non-human animal used to conduct medical experiments for studying human diseases and medical 
conditions 
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turning the screws protruding from the rabbits’ abdomen. The tissue couplers displace as the 
screws are turned because they have threaded holes at their base, through which the screw is 
placed, and are prevented from rotating by interference from a slot running lengthwise the device. 
Designed for rats, the External Screw Device [64] (Figure 1.7) works by feeding a screw 
through a threaded hole on an externally mounted structure affixed to the animal model’s abdomen 
with sutures. Unlike the internal screw, the external screw applies tension to the blind end of an 
isolated segment of small intestine that is sutured to an ostomy through which the screw is inserted. 
 
Figure 1.6. Internal Screw Device. 
Figure adapted from [68]. The first enterogenesis device was the internal 
screw, which was device for studying the load-induced growth of small 
bowel tissue in rabbit models. The device was extraluminal, and attached 
to the rabbit small bowel with sutured semicircular rings. To apply 
tensile load, the ring attachments were separated by turning the screw, 
which extended out of the rabbit abdomen. 
 
Figure 1.7. External Screw Device. 
Figure adapted from [64]. The external screw device was designed for 
studies with rats. To apply load, the end of the screw abuts a blind-ended 
segment of isolated small bowel tissue as the screw is turned. 
b). External Screw
a). Internal Screw
c). Nickel Titanium Spring
b). External Screw
a). Internal Screw
c). Nickel Titanium Spring
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While the screw is feed through the external structure and ostomy, the end of the screw abuts a 
suture line at the end of the small bowel segment, thus applying tension and inducing growth. 
Designed for rats, the most recently reported enterogenesis device is a superelastic nickel 
titanium (NiTi) Intraluminal Spring [65] that is initially held compressed by dissolvable sutures 
and implanted in an isolated small bowel segment (Figure 1.8). With the NiTi spring, the tensioned 
segment of bowel is isolated so that the ends of the spring can transfer load to the tissue by end 
abutment and to prevent bowel obstruction. When the sutures break down, the spring expands and 
abuts the surgically closed ends of the isolated bowel segment in which it is implanted. This 
process continues until the spring is fully extended, as determined by tracking its extension with 
radiographs. 
Different tissue evaluation approaches and control segment choices were used in the prior 
studies with small animal models. In the rabbit study, the Internal Screw Device expanded a 
segment of bowel that was part of the continuous GI tract and a non-tensioned portion of normal 
small bowel was used as a control. For the rat studies, which used the External Screw Device and 
Intraluminal Spring, the lengthened bowel segments were isolated from the continuity of the GI 
tract and not exposed to enteral nutrition. Therefore, the control segments for the rat studies were 
similarly isolated and unfed segments of bowel tissue. Although each research group has 
approached the evaluation of the tissue segments differently, the tissue health analyses listed below 
were the most common. 
 
Figure 1.8. Intraluminal Spring. 
Figure adapted from [65]. The intraluminal spring was designed for 
studies with rats. To apply load, the spring is implanted in an isolated 
segment of small bowel with the spring compressed by a dissolving 
suture. Once dissolved, the spring abuts the ends of the isolated tissue 
segment. 
b). External Screw
a). Internal Screw
c). Nickel Titanium Spring
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1. Morphological Changes 
Morphological features of the distracted small bowel were measured and compared 
with controls to evaluate changes in the longitudinal and circular muscle layer 
thickness, serosal thickness, mucosal thickness, villus height and width, and crypt 
depth. The preservation of these structures’ dimensions is a positive indicator of bowel 
growth and health. Purely stretching bowel would lead to decreased thicknesses of the 
layers of the bowel and wider villi. Studying the morphological features also reveals 
the extent of tissue inflammation, tearing within the muscle layers, and mucosal 
disruption. 
2. Enzyme Activity 
Measuring the enzyme activity of small bowel indicates the absorptive capacity of the 
tissue. Increases of total enzyme activity within the distracted segments is a positive 
indicator of true bowel growth versus stretching, as merely stretched bowel would 
maintain or experience a reduction of total enzyme activity. In addition, the reduction 
of total enzyme activity may be caused by physical disruption of the mucosa. 
3. DNA, RNA, and Protein Concentrations 
DNA, RNA, and protein concentrations are measured to evaluate whether or not there 
is a tissue cellularity difference with control segments. The preservation or increase of 
tissue cellularity indicates true small bowel growth. 
4. Cell Proliferation 
The percentage of proliferating cells was measured to indicate the health of the grown 
small bowel tissue. Healthy normal bowel mucosa is constantly sloughing off and 
producing new cells. However, in segments where bowel growth is occurring, the 
percentage of proliferation cells will be equal to or higher than that of control 
segments. 
1.2.1.1. Experimental Study Growth Results 
The growth results of the rabbit and rat studies are summarized in Table 1.3. Using the Internal 
Screw Device, the mechanotransductive response of small bowel tissue was first demonstrated in 
healthy (normal bowel length) rabbit models (n = 27) by Printz et al. in 1997 [68]. Segments of 1 
cm in length were doubled to 2 cm by the application of distractive force over the course of 3 
weeks. Using the External Screw Device, Park et al. [62] doubled the length of small bowel 
segments, from 1.5 cm to 3 cm, in healthy rat models (n = 10) during a three week distraction 
period. Also using the External Screw Device, Safford et al. [64] increased the length of small 
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bowel segments by a factor of 2.5, from 0.76 cm to 1.9 cm, in healthy rat models (n = 50) during 
a 30 day distraction period. Chang et al. [60] sought specifically to evaluate the stability of the 
distracted segments of small bowel in rats (n = 20) in the absence of distractive forces following 
bowel tensioning. During a one-week distraction period, small bowel segments were 
approximately doubled in length from 1.5 cm to 3.1 cm using the External Screw Device. After 
waiting 3 weeks with the distracted segment under no further applied tension, the distracted small 
bowel lengths were measured again as 3.2 cm (p > 0.05) for rats in the waited group, demonstrating 
the stability of the grown tissue segments. Using the Intraluminal Spring, Shekherdimian et al. 
[65] increased the length of small bowel segments in rats (n = 5) by a factor of 3.40, from 1.3 cm 
to 4.4 cm. Stark et al. modified that Intraluminal Spring, replacing the dissolving sutures with a 
dissolvable gel coating to hold the spring compression, and conducted two studies where rat small 
bowel (n not reported) was expanded by factors of 3.6 in two weeks [66], and 3.3 [67] in 18 days. 
Table 1.3. Reported Enterogenesis Results with Current Devices. 
Bowel growth results using the Internal Screw Device, External Screw Device 
and Intraluminal Spring are listed in chronological order. The growth, or 
expansion, ratio of tissue using the Internal Screw Device and External Screw 
Device ranged from 2 to 2.5, while the Intraluminal Spring ranged from 3.3 to 
3.6. 
 
Device 
Animal 
Model, n 
Initial 
Segment 
Length 
(cm) 
Final 
Segment 
Length 
(cm) 
Net 
Growth 
(cm) 
Growth 
Ratio 
Author and 
Citation 
Internal 
Screw 
Rabbits 
n = 27 
1 1.99 0.99 1.99 
Printz et al. 
[68] 
External 
Screw 
Rats 
n = 10 
1.5 3 1.5 2.00 
Park et al. 
[62] 
External 
Screw 
Rats 
n = 50 
0.76 1.9 1.14 2.50 
Safford et al. 
[64] 
External 
Screw 
Rats 
n = 20 
1.5 3 1.5 2.00 
Chang et al. 
[60] 
Intraluminal 
Spring 
Rats 
n = 5 
1.3 4.4 3.1 3.38 
Shekherdimian 
et al. 
[65] 
Intraluminal 
Spring 
Rats 
(n not reported) 
1.0 3.6 2.6 3.60 
Stark et al. 
[66] 
Intraluminal 
Spring 
Rats 
(n not reported) 
1.0 3.3 2.3 3.30 
Stark et al. 
[67] 
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Several non-device based studies of mechanotransductive enterogenesis in rat models are 
reported in which the infusion of saline [63] and polyethylene glycol (PEG) [61] into isolated 
bowel segments induced longitudinal and radial loads. Puapong et al. [63] reported lengthening 
the small bowel of rats (n = 7) by a factor of 1.32, from 3.1 cm to 4.1 cm. Okawada et al. [61] 
infused PEG into isolated segments of small bowel in mice (n = 8), which created an osmotic 
gradient that drew fluid into the bowel, leading to increase in bowel segment length by 17.9%. 
Radial bowel growth due to the application of pressure (rather than pure bowel tension) induced 
an increase of bowel diameter by 74.3%. 
1.2.1.2. Comparison of Medical Results in Rabbit and Rat Studies 
Table 1.4 summarizes the statistically significant morphological differences, differences in 
total enzyme activity, differences in the concentration of DNA, RNA, and protein, and differences 
in cell proliferation, all when comparing the lengthened tissue segments to appropriate control 
segments. 
The morphology of the rabbit and rat segments were largely preserved. However, almost all 
studies reported statistically significant thickened muscle layers due to cell hypertrophy 
(enlargement). Okawada et al. also reported an increase in muscle layer thickness, but it was not 
statistically significant. The significance of this commonality across enterogenesis studies and 
animal models is not known. However, the overall preservation of other morphological features is 
a positive indicator of true growth. Where reported, total enzyme activities were mostly increased, 
which also suggests the true growth of bowel tissue because of the associated increase in total 
absorptive capacity of the tissue. No statistically significant changes in the concentration of DNA, 
RNA, or protein were recorded, which suggests the preservation of tissue cellularity - meaning the 
density of cells was not different and therefore the tissue was not merely stretched. Lastly, the 
measurement of cell proliferation was reported in two studies, one of which described a large 
increase in the number of proliferating cells, another indication that true tissue growth occurred. 
Ultimately, the culminating conclusion to these studies is that the small bowel of rat and rabbit 
models is mechanosensitive and that the application of tension induces the true growth of healthy 
bowel tissue. More importantly, these results hint at the feasibility of the mechanotransduction 
approach for clinical application in humans. However, there is a large gap between these initial 
studies with small animal models and the development of a clinical treatment. 
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1.2.2. Potential Advantages of the Mechanotransductive Approach 
The mechanotransductive approach to small bowel lengthening, if proven feasible for treating 
SBS in clinical trials, has important advantages compared to surgically lengthening procedures 
and transplants. Both the Bianchi Procedure and STEP require dilated segments of small bowel to 
be present in the patient. Although dilated bowel segments are common with SBS patients, the 
extent of dilation and length of the dilated portion limit the net increase in length resulting from 
the reconstruction. The net increase in length induced by tensile loading will be limited only by 
the extension capability of the bowel extender or possibly by physiological limitations, if they 
Table 1.4. Statistically Significant Medical Results of Rabbit and Rat Enterogenesis Studies. 
Common tissue evaluation metrics included morphological changes, enzyme activity, cell proliferation, and 
RNA, DNA, and protein concentrations. In all studies using a mechanical lengthening device (excludes 
Okawada et al.), an increase of muscle layer thickness due to hypertrophy was reported. Where reported, 
total enzyme activity increased, cell proliferation stayed the same or increased, and the concentrations of 
DNA and protein did not change. Although the medical significance of the increased muscle layer thickness 
is not known, these results support the feasibility of a mechanotransductive treatment to SBS in small 
animal models. (+), (-), and (NC) denote an increase, a decrease, and no significant change, respectively. 
 
Author Morphological
Changes
Total
Enzyme Activity
DNA, RNA,
and Protein 
Concentration
Cell
Proliferation
Printz et al.
Muscle Thickness (+)
Villus Width (+)
Not Reported
DNA (NC)
Protein (NC)
No Change
Park et al. Muscle Thickness (+)
Lactase (NC)
Alkaline Phosphatase (+)
Not Reported Not Reported
Safford et al. Muscle Thickness (+)
Lactase (NC)
Sucrase (+)
Maltase (+)
Palatinase (+)
Not Reported Not Reported
Shekherdimian 
et al.
Muscle Thickness (+)
Villus Height (-)
Not Reported Not Reported Not Reported
Stark et al.
Muscle Thickness (+)
Crypt Depth (+)
Not Reported Not Reported Not Reported
Stark et al.
Muscle Thickness (+)
Crypt Depth (+)
Not Reported Not Reported Not Reported
Puapong et al. Muscle Thickness (+)
Lactase (+)
Alkaline Phosphatase (+)
Protein (NC) Not Reported
Okawada et al. Crypt Depth (+) Not Reported Not Reported Increase
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exist. Thus, greater bowel lengthening may be possible with the mechanotransductive approach. 
Both the Bianchi Procedure and STEP are invasive and require lengthy sutures lines, from which 
enteral contents may leak, causing a cascade of complications. These complications are not 
fundamentally associated with the mechanotransduction approach, because given the right 
technology, a bowel extending device may be implanted through the upper GI tract and not require 
piercing the bowel to apply tension. Compared to transplants, the main advantage of the 
mechanotransduction approach is that the increased length of small bowel is the patient’s own 
tissue, so there is no risk of tissue rejection and no need for long-term immunosuppressive 
medication.  
1.3. Research Issues 
Despite encouraging experimental results with small animal models, there remains a long path 
to clinical trials of the mechanotransductive approach from both a technological and a medical 
standpoint. The prior results suggest that the large growth increases were not the result of 
stretching/yielding small bowel tissue, but rather that actual tissue growth was induced. 
Furthermore, the health and functionality of the tensioned tissue segments remained consistent or 
increased compared to appropriate controls. However, these studies were completed with small 
animal models. Thus, the applicability of their results to humans is limited. Several key medical 
studies are necessary to begin considering clinical trials based on the mechanotransductive 
approach. 
The selection of an appropriate animal model with relevant physiological and anatomical 
similarities to humans must be made to conduct studies bearing greater clinical relevance. 
Anatomically, the GI tract components of large animals such as pigs, goats, sheep, and cows are 
closer in size to humans than rats and rabbits. However, goats, sheep, and cows are ruminants - 
animals with considerably different digestive components within their stomach that enable them 
to process plant-based food. Unlike ruminants, the digestive physiology of pigs is very similar to 
that of humans [69]. The gut microbiome of pigs also shows great similarity to that of humans, 
making pigs and humans susceptible to many of the same enteric pathogens [70]. Most 
importantly, in the context of this dissertation, preterm pigs are an important clinical model for 
studying the natural growth of the GI tract in preterm infants [71]. Even with these advantages, 
studies of mechanotransductive enterogenesis have not be reported with porcine animal models.  
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The gap between prior research studies of enterogenesis with small animal models and clinical 
trials spans five key areas of research requiring the use of clinically relevant porcine animal 
models: one, establishing the clinical feasibility and potential of the treatment approach; two, 
developing the treatment approach; three, designing and creating enterogenesis devices for 
studying mechanotransductive enterogenesis; four, investigating safe and reliable small bowel 
tissue attachment approaches; and five, developing a clinically relevant device technology and 
tissue expansion approach.  
1.3.1. Treatment Feasibility and Potential 
The mechanotransductive response of small bowel tissue in clinically relevant animal models, 
such as pigs, must be demonstrated by inducing healthy bowel growth via the application of tensile 
force. The clinical potential for the treatment will depend on the ability to lengthen tissue by large 
expansion factors of growth, because many patients with SBS have very little remnant bowel. 
Furthermore, as the bowel lengthens by large expansion factors, the mesentery must increase its 
vascularity to support the growing tissue with blood. Angiogenesis, or blood vessel growth, within 
the mesentery of the tensioned segments has not been reported in prior studies, but it is certainly 
important for the health of the small bowel because if the blood supply becomes insufficient as the 
bowel lengthens, ischemia29 and necrosis30 may develop. Thus, the demonstration of large 
expansion factor growth and mesenteric adaptation with porcine models is a key step to the 
development of mechanotransduction-based treatment approaches. 
1.3.2. Treatment Development  
To develop the treatment, it is important to understand how much load can safely be applied 
to the tissue, how quickly the tissue can grow, and the effect of different tissue expansion strategies 
on the growth rate and health of porcine small bowel tissue. Prior research studies have not 
explored these important aspects of small bowel growth in small animals or more clinically 
relevant animal models. However, exploring these issues is key to uncovering effective methods 
of exploiting mechanotransduction safely and providing guidelines for how to quickly induce the 
                                                     
29 Ischemia:  Reduction of blood flow to tissue 
30 Necrosis:  Tissue death 
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growth of healthy bowel, leading to shortened implantation periods, lower risks of complication, 
lower costs, and better outcomes. 
Examples of tissue expansion profiles include constant displacement rate, constant load, and 
ramping displacement rate, to name a few. In the rabbit study with the Internal Screw Device and 
the rat studies with the External Screw Device, the tissue expansion profile used was a constant 
impulsive daily displacement rate profile, where the net expansion of the tissue was increased by 
the same amount each day. Although simple to execute, this expansion profile may not be well-
suited for efficiently inducing small bowel growth because the displacement rate must be set 
conservatively to prevent the application of injurious loads on the bowel. In the rat studies with 
the Intraluminal Spring, the tissue expansion profile was based on the application of a linearly 
decreasing tensile load generated by a NiTi spring. However, other displacement profiles may be 
more effective, such as a ramping profile, where the tissue is expanded by greater daily 
displacements as the implantation progresses, or a constant profile, where small expansions are 
spaced evenly during the distraction period. Furthermore, constant, ramping, and impulsive load 
profiles may be applied to achieve healthy and functional porcine small bowel growth rapidly. 
1.3.3. Device Technologies for Studying Mechanotransductive Enterogenesis 
To conduct experiments establishing the feasibility of the mechanotransductive approach and 
further developing the treatment in porcine animal models, the current state of the art in 
enterogenesis devices is not sufficient. The advantages and disadvantages of the Internal Screw 
Device, External Screw Device, and Intraluminal Spring are shown in Table 1.5. The reason these 
devices cannot be used to conduct feasibility studies in porcine animal models is that they cannot 
be simply scaled up for porcine models due to safety concerns. To develop treatment approach 
guidelines and explore methods of efficiently exploiting mechanotransductive growth, a more 
sophisticated enterogenesis device is needed with displacement control, displacement 
measurement, and bowel tension measurement.   
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1.3.3.1. Scalability for Enabling Feasibility Studies with Porcine Animals Models 
The Internal Screw Device, External Screw Device, and Intraluminal Spring designs were 
considered for demonstrating the feasibility and potential of the mechanotransductive treatment 
approach in porcine models, but safety concerns for the health of the animal model have arisen 
due to the strength and activity level of porcine models. The Internal Screw cannot simply be 
scaled up for feasibility studies with porcine models because the screws are required to protrude 
through the abdomen. The risk of the animal model injuring itself with rigid structures extending 
Table 1.5. Advantages and Disadvantages of Prior Enterogenesis Devices. 
The prior enterogenesis devices, designed for rabbits and rats, have several important features in 
common. Although they all promote high expansion factor growth, they cannot be scaled up for 
large animal studies, do not measure the applied tensile load, and do have load control (although 
the loads applied by the Intraluminal Spring can be limited by the spring design). For these reasons, 
new enterogenesis devices were developed to enable studies with porcine animal models, which 
are clinically relevant. 
 
Feature Internal
Screw
Device
External 
Screw 
Device
Intraluminal 
Spring
Animal model designed for Rabbits Rats Rats
Can be scaled up for large
animal studies
No No No
Displacement measurement
(without imaging technology)
Yes Yes No
Displacement control Yes Yes No
Load measurement No No No
Load control No No
Somewhat
Yes
Fully implantable No No Yes
Implantable in continuous 
bowel
No No No
High Expansion Factor Yes Yes Yes
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from the body is high because the animal likely to catch the structure on a feature of the pen, thrust 
its body against a wall of the pen in an attempt to scratch, or kick the structure with its hind legs. 
These actions would not only potentially harm the animal, but also lead to poor experimental 
outcomes because the bowel tissue may tear as a result of the impulsive external loading. To 
overcome this challenge, the porcine animal models cannot be immobilized because it is 
impractical and against regulations set by the University Committee on the Use and Care of 
Animals to stantion pigs. Like the Internal Screw Device, the External Screw Device cannot be 
safely scaled up for feasibility studies with porcine models because the device fundamentally has 
rigid external features that pose health risks and would not be tolerated by porcine animal models. 
Although the intraluminal spring has no extracorporeal structures, there are concerns with scaling 
it up for large animals. The initial studies reported that the springs could sometimes buckle, which 
later studies fixed by placing a concentric guide wire down the center of the spring. The guide wire 
must be stiff enough to prevent spring buckling and long enough to support the fully extended 
spring. Thus, the guide wire poses unacceptable health risks, such as bowel perforation, for strong, 
large, and physically active porcine animal models. Also, the uncontrolled nature in which the 
spring expands is a cause for concern, because it could potentially damage the tissue. Additionally, 
the intraluminal spring would be implanted in an isolated segment of small bowel with both ends 
surgically closed, requiring the implantation of mucous drainage catheters that can lead to surgical 
complications. As a result, none of the current enterogenesis device designs are suitable for 
studying feasibility in large animal models. 
1.3.3.2. Suitability for Enabling Studies to Develop Treatment Approach Guidelines 
The prior enterogenesis devices have both significant advantages and disadvantages in the 
context of further developing the mechanotransductive based treatment approach in clinically 
relevant porcine models. To understand how much load can safely be applied to the tissue, how 
quickly the can tissue grow, and what is the effect of different tissue expansion strategies on the 
health and growth rate of the tissue, an enterogenesis device for porcine models with displacement 
control, displacement measurement, load control, load measurement and full implantability is 
required. None of the current enterogenesis devices have these capabilities and cannot be scaled 
up for porcine models. Therefore, new enterogenesis device technologies designed to explore these 
issues is required. 
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1.3.3.2.1. Displacement Measurement and Control 
The measurement and control of displacement is an important capability for enterogenesis 
devices from a safety standpoint (to prevent injurious increases of tissue expansion), but also for 
enabling experiments where differing displacement rates and profiles are investigated. The Internal 
Screw Device and External Screw Device allow for simple displacement measurement and control 
by recording the numbers of screw turns made by medical personnel. Displacement measurement 
with the Intraluminal Spring is not possible without the use of radiographs, which can be difficult 
to interpret because of device orientation and the lack of a scale, and there is no control of 
displacement. This lack of displacement control limits the scope of research studies that can be 
undertaken with the Intraluminal Spring, because the effect of varying displacement rates and 
profiles cannot be rigorously explored. 
1.3.3.2.2. Tensile Load Measurement and Control 
The measurement and control of bowel tension is another important enterogenesis device 
capability for further developing the treatment approach. However, none of the devices are 
instrumented to enable load measurement, which is important for avoiding the application of 
injurious loads and for enabling experiments that explore the effect of the load profile on the rate 
and health of tissue growth. The Internal Screw Device and External Screw Device could both 
instrumented to monitor force, but this approach was not considered because they cannot be safely 
scaled up for porcine studies. The Intraluminal Spring can be designed to produce a nearly constant 
load as a result of the super-elasticity property of NiTi. Thus, there is the potential to apply 
different constant tensile loads to small bowel by carefully designing the spring. However, this is 
not true load control, because the application of different load profiles is not possible. 
1.3.3.3. Summary Evaluation of Research Enterogenesis Devices 
Although important for studying the mechanotransductive enterogenesis of small bowel in 
small animal models, prior enterogenesis devices do not enable studies critical for supporting the 
clinical application of mechanotransductive enterogenesis in large animal models. As shown by 
Table 1.5, none of the prior art are scalable for studies with porcine animal models to address 
clinical feasibility. Furthermore, although the internal and external screw device have 
displacement control and measurability, none of the devices are able to record the applied bowel 
tension in real-time. Load measurement, displacement measurement, and displacement control are 
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necessary features for enterogenesis devices that enable studies to development treatment approach 
guidelines. As a result, new enterogenesis devices designed for porcine animal models are required 
to conduct studies of small bowel growth bearing clinical relevance. 
1.3.4. Attachment Methods 
The safe transfer of load from the extending mechanism to the bowel lumen remains a 
challenge. In prior research studies on mechanotransductive enterogenesis, two primary tissue 
attachment approaches have been used: end abutting attachments, and attaching through the lumen 
with sutures. Although these attachment methods were suitable for research, there are significant 
disadvantages that limit their extension to clinical applications. Thus, new approaches for attaching 
to small bowel are needed for clinical applications. 
To induce longitudinal small bowel growth, an expansion mechanism must be coupled with 
attachments that can safely and reliably transfer load from the device to the tissue. Prior research 
with the External Screw and Intraluminal Spring relied on attachment by end-abutment, an 
approach where the ends of the device push on one or two blinded ends of an isolated small bowel 
segment. Although shown to be reliable, this approach is not clinically acceptable because it 
requires the removal and reinstatement of the grown bowel segment into GI tract – operations that 
require significant portions of bowel to be discarded to create and take down the surgical 
connections of the bowel. Additionally, attachment by end-abutment precludes the ability to 
implant and remove enterogenesis devices by non-invasive surgical procedures. 
Sutures were used to transfer load from the Internal Screw Device to rabbit small bowel in the 
first studies of mechanotransductive enterogenesis with small animal models. The authors reported 
that the sutures cut through the bowel wall without causing perforation, disconnecting the Internal 
Screw Device from the rabbit small bowel. Similarly, traction sutures are placed in the proximal 
and distal esophageal pouches and pulled on to create tension in the tissue and induce growth for 
the treatment of long-gap esophageal atresia. The difficulty of this technique, known as the Foker 
Method, is that the traction sutures cut through the esophageal wall, causing esophageal leakage 
and requiring an additionally thoracotomy to replace the sutures [72]. As a result, the reliability 
and safety of the suture-based attachments for tensioning soft tissue has been demonstrably poor. 
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Thus, a better attachment approach is required for the clinical application of 
mechanotransductive enterogenesis. However, there are significant challenges that make the 
development of safe and reliable intraluminal attachments non-trivial:  
1. the bowel lumen is very slippery and lined with cells that continuously slough off, 
2. the attachments must be easily maneuvered through the bowel for implantability, but 
simultaneously be able to grip the bowel lumen, 
3. bowel obstruction must be avoided, 
4. the attachments should be robust to peristalsis and radial bowel adaptation, and 
5. safe attachment to the bowel lumen is difficult due to the delicate nature of the tissue 
and the risks of tissue ischemia and perforation.  
Because of the compliance of small bowel tissue, attachment by the application of pressure to 
an area of the bowel lumen can potentially stop blood from perfusing that area, leading to ischemia 
and subsequent necrosis and/or perforation. Thus, attachments have a tradeoff between their ability 
to transfer load and the health risks their use poses. However, this tradeoff must be overcome to 
realize clinically applicable attachments, because both tissue health and attachment performance 
are critical. In addition to the need of the attachments to reliably and safety grip bowel tissue, they 
must also be able switch between attached and detached states to facilitate their implantation, 
removal, and purposeful repositioning. 
1.3.5. Clinical Device Development 
Lastly, current enterogenesis devices were designed for researching mechanotransductive 
growth in small animal models and they cannot be safely scaled up for research with large animals 
or for clinical trials. With respect to clinically applicable enterogenesis devices, there is no prior 
art. Thus, technologies for correcting short bowel syndrome designed for clinical applicability are 
needed. 
For a clinically applicable device, greater designs constraints are present compared to 
research-orientated devices. The most important differences are the need to be able to implant the 
device in a continuous portion of the small bowel (by non-invasive surgical techniques) rather than 
within an isolated segment, the greater constraints on the form of the device, greater lengthening 
capabilities to enable the treatment of severe cases of SBS, and the enhanced emphasis on device 
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safety features including applied tensile load measurement, displacement control, and 
displacement measurement. 
None of the current enterogenesis device technologies can be implanted in a continuous 
segment of small bowel by non-invasive surgical techniques. The External Screw Device and the 
Intraluminal Spring cannot be implanted in continuous bowel because they attach to the small 
bowel by end-abutment, an approach that requires the isolation of the distracted tissue segment. 
The Internal Screw Device was designed to apply tension to a segment of continuous small bowel, 
but the device cannot be implanted with non-invasive surgical techniques because its implantation 
requires a laparotomy. Constraints and guidelines concerning clinical enterogenesis device form 
have not been explored in prior studies. Device form encompasses coupled parameters including 
device length, rigidity and curvature; device diameter; the proximal and distal device/tissue 
interface; and the local feature contours of the device. Prior studies have also not described 
required tissue lengthening capabilities to treat severe cases of short bowel syndrome. However, 
this is likely because every patient with SBS is different and will thus respond to small bowel 
tissue lengthening to a different extent. Lastly, because prior enterogenesis device were designed 
primarily for research purposes, they to do reflect an emphasis on device safety features such as 
the capability to monitor the applied small bowel tension. 
1.4. Research Goals and Objectives 
The goal of this research is to explore technological approaches for a promising and novel 
treatment method of short bowel syndrome based on mechanotransduction. Four key research 
objectives have been identified toward to the achievement of this goal: 
1. Treatment Approach Feasibility and Potential. Investigate the potential for inducing large 
net growth, large expansion factor growth, and inspect the mesentery for an increase in the 
vascularity to evaluate the feasibility of mechanotransduction for correcting short bowel 
syndrome and to support further research into the technologies for and the development of 
mechanotransduction-based treatment approaches.  
2. Treatment Development. Create technologies and perform studies to determine the upper 
bound of safely applied bowel tension, compare the effect of applying different tissue expansion 
profiles on tissue growth and explore the limits of the maximum small bowel expansion rate to 
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develop the best practices and methods for safely and effectively exploiting 
mechanotransduction. 
3. Tissue Attachment. Develop clinically relevant tissue attachments for the safe attachment and 
detachment of an expansion mechanism to the small bowel. Identify the risk of surgical 
complications associated with a range of attachment approaches, including perforation and 
ischemia, and measure their attachment and detachment performance.  
4. Clinically Relevant Device. Develop and demonstrate a clinically relevant enterogenesis 
device and treatment method for pediatric and adult SBS by demonstrating very high net bowel 
growth. The in vivo validation of the device with porcine models must produce medical results 
for promoting clinical trials by achieving high expansion factor growth backed by analysis of 
the tissue to demonstrate its health and functionality. 
1.5. Summary of Research Approach 
To meet the goal of this dissertation, a similar research approach was taken for objectives one, 
two, and four. The approach taken was as follows: based on the objective, design an enterogenesis 
devices with pertinent functionality, fabricate the device, validate and/or characterize the device 
performance on the benchtop, and conduct in vivo medical studies to further validate the 
performance of the device and answer objective-specific questions about mechanotransductive 
small bowel growth. To meet the third objective on tissue attachment approaches, a large set of 
attachment approaches were downselected through a series of in vivo studies that evaluated their 
attachment performance, detachment performance (where applicable), and the health risk they 
impose with respect to bowel ischemia and perforation.  
1.5.1. Objective One: Treatment Approach Feasibility and Potential 
To establish the feasibility of the mechanotransductive approach and demonstrate its potential 
for correcting short bowel syndrome, the tasks of this objective were to explore the potential for 
high net growth, large expansion factor growth, and to observe the adaptation of vasculature in the 
mesentery. To achieve this, a three-stage telescoping curvilinear hydraulic device was developed 
and used to induce bowel growth in a series of in vivo studies. The housing and three telescoping 
stages of the Curved Hydraulic Device were curved to reduce stress on the mesentery, which is a 
thin membrane supplying the support structure for the vasculature feeding the bowel. Additionally, 
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the curved design also reduced the end-to-end length of the device, allowing it to fit more readily 
in the limited peritoneal cavity. Small bowel naturally loops as a result of radial mesenteric forces. 
Thus, a linear enterogenesis device causes more stress on the mesentery than a curved device. 
Because the Curved Hydraulic Device has greater extension capabilities compared to other 
enterogenesis devices, its curvilinearity was especially important to reduce stress on the mesentery. 
The goal, however, was not to completely eliminate stress on the mesentery, as it must adapt and 
grow along with the small bowel tissue it supports.  
During experimental studies, the Curved Hydraulic Device was implanted in an isolated (from 
the continuous GI tract) segment of small bowel known as a Roux limb. Therefore, the device 
posed no risk of bowel obstruction because enteral contents do not pass through the Roux limb. 
The device was actuated by the injection of water from an external syringe, via a transdermal 
hydraulic line passing through an ostomy formed at the proximal end of the Roux limb. Fluid was 
gradually forced into the Curved Hydraulic Device from the external syringe, making the stages 
of the device extend, which in turn applied growth inducing tension to the small bowel. At the end 
of the implantation period, tissue samples were taken to demonstrate the true growth of small 
bowel tissue by evaluating the morphology, histology, cell proliferation, and the 
neovascularization of the mesentery supporting the growth segment. 
1.5.1.1. Design Considerations 
Several considerations were important for the design of the Curved Hydraulic Device, 
including specifying an expansion factor target, designing the components to not yield due to 
external loading, and determining the dimensional constraints imposed by the size of the porcine 
abdominal cavity, bowel lumen diameter, and the height of the mesentery (for determining the 
curvature of the device). 
1.5.1.2. Prototype 
To prototype the Curved Hydraulic Device, three main tasks were identified: fabricate the 
housing and three telescoping stages, develop a sliding sealing method, and develop an attachment 
method for transferring load from the device to the tissue. The resulting prototype was composed 
of a housing and three stages that were made from 316 stainless steel and manually curved around 
a 9 cm radius mandrel. The housing and stages were sealed with soft butyl rubber seals from 
medical syringes, because curving the stages and housing caused the components to have an 
32 
elliptical cross section that could not be sealed with conventional O-rings. To transfer load to the 
small bowel, two circumferential rings of sutures were placed at both ends of the device during 
the implantation procedure. In some trials, the sutures were reinforced with denatured pig skin or 
denatured human skin to improve the reliability of the attachments. 
1.5.1.3. Validation and Characterization 
To prepare for in vivo studies, the performance of the Curved Hydraulic Device was 
characterized by experimentally finding the relationship between the input fluid volume and the 
resulting device displacement. The three telescoping stages of the device have decreasing cross-
sectional areas. Thus, for a fixed volume of injected fluid, the stages displaced different amounts. 
Additionally, the order in which the stages extend was not consistent. Therefore, there was not a 
one-to-one relationship between amount of fluid injected and the device displacement. However, 
the range of possible displacements as a function of the injected fluid volume was found. 
1.5.1.4. In Vivo Studies 
A series of in vivo studies have been completed with the Curved Hydraulic Device that 
produced promising small bowel growth results that were corroborated by analyses of the tissue 
morphology, cell proliferation, barrier function, and evidence of increased vascularity with the 
mesentery. This series of studies was the first to quantitatively identify an increase in the 
vasculature of the mesentery resulting for bowel growth, which is an important finding because 
large increases of the bowel length must be supported by the vasculature of the mesentery. This, 
along with the healthy and functional growth of porcine small bowel, demonstrated the clinical 
feasibility of the mechanotransduction treatment method and its potential for inducing significant 
lengths of small bowel growth. 
1.5.2. Objective Two: Treatment Development 
To go beyond the demonstration of feasibility and begin discovering the knowledge needed 
to effectively design a clinical device and guide its usage, a new enterogenesis device with different 
functionality and capabilities than the Curved Hydraulic Device was developed. Further in vivo 
experiments were conducted that compared different tissue expansion strategies, explored how 
rapidly small bowel can be safely grown, and explored the maximum safe tension that can be 
applied to the tissue. To enable these experiments, a considerably more sophisticated enterogenesis 
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device with force instrumentation and displacement control was required. Although the Curved 
Hydraulic Device could be instrumented with a force sensor, the Instrumented SMA Driven 
Ratchet was developed because the accurate control of displacement could not be achieved with 
the hydraulic device due to stiction, the compliance of the hydraulic lines, and the unpredictable 
order in which the stages extended. In contrast, the expansion of the Instrumented SMA Driven 
Ratchet was gradual (each actuation extended the device by 1.2 mm), repeatable, and controlled.  
Like the Curved Hydraulic Device, similar post experiment tissue analyses were performed, 
and the Instrumented SMA Driven Ratchet was implanted in a Roux limb during in vivo 
experiments to eliminate the risk of device-related bowel obstruction. During experiments, a 
wireless communication link between the Instrumented SMA Driven Ratchet and the operator 
enabled concurrent control of the device expansion and gave immediate feedback on the applied 
bowel tension and tissue displacement. When commanded from a PC running the user interface, 
the device completes one operation cycle of its ratcheting mechanism, applying tension to the 
small bowel segment and inducing growth. The measurement of the applied bowel tension was 
used to avoid the application of injurious loads as well as to enable experiments where the 
expansion of the device was guided by displacement rate and/or applied bowel tension based 
strategies. 
1.5.2.1. Design 
The Instrumented SMA Driven Ratchet is composed of two main subsystems: the ratcheting 
mechanism, and the data acquisition and control system. To design the SMA driven ratcheting 
mechanism, design guidelines for defining the ratchet pawl and rack geometries were developed 
to take packaging constraints, load bearing capacity, self-locking behavior, and the pawl 
reengagement kinematics into account. Additionally, a novel adaptation of the traditional graphical 
design method for SMA actuated devices called the Reset View Design Methodology was 
developed. In short, the design methodology visually enables the designer to understand and 
specify the reset, or bias, spring common to SMA actuated devices. To use the Reset View Design 
Methodology, the system loads on the SMA actuator needed to be predicated or experimentally 
determined. To achieve this, an analytical model of the force required to drive the ratcheting 
mechanism was developed, the safe range of applied load on the bowel was experimental 
characterized, and external forces due to friction were conservatively estimated.  
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To design the data acquisition and control system, the desired subsystem functionality was 
specified and the physical embodiment of the subsystem was separated into three separated 
components: the Bowel Extender Circuit, the Pack Circuit, and the Base Station Circuit. The 
Bowel Extender Circuit, which mounted directly on the device, drove the SMA wire, digitized the 
outputs of the force and displacement sensors, and relayed data/commands through a wired serial 
communication link with the Pack Circuit. The Pack Circuit, which was mounted subcutaneously 
or on the animal model’s back, acted as the main control unit of the subsystem and communicated 
wirelessly with Base Station circuit, which acted as a relay between the medical operator and the 
Pack Circuit. 
1.5.2.2. Prototype 
Utilizing the Reset View Design Methodology and the design guidelines for the ratchet pawl 
and rack geometries, the ratcheting mechanism was designed and then fabricated mostly from 
rapid prototyped (SLA) components. To seal the body of the device, it was encapsulated in RTV 
silicone adhesive, and the rack/body interface was sealed with a Viton gasket. The components of 
the Bowel Extender Circuit were selected to minimize the footprint and power consumption, and 
the operating frequency of the wireless communication link was chosen as 433 MHz because 
experimental studies showed that the 433 MHz frequency had reduced signal attenuation through 
the tissue compared to 2.4 GHz. 
1.5.2.3. Characterization and Validation 
The analytical ratcheting force model, the performance of the ratcheting mechanism, and the 
performance of the data acquisition and control system were validated successfully on the 
benchtop. To verify the analytical ratcheting force model, a custom load and displacement 
measuring system was created that allowed for the direct measurement of force applied by the 
actuator as a function of stroke. The magnitude and form of the experimental data matched well 
(within measurement noise) with predicted values, thus validating the model. The performance of 
the ratcheting mechanism was validated by ratcheting against increasing static loads until the 
ratcheting operation cycle could not complete. The results of this experiment demonstrated the 
mechanism’s ability to operate against up to 850 gf, well above the required specification. The 
data acquisition and control system was characterized and validated by calibrating the load and 
displacement sensors, determining the range of the wireless link, demonstrating the sufficient 
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capacity of the onboard battery, and by testing the stability and functionality of the subsystem in a 
two-week benchtop experiment where the Instrumented SMA Driven Ratchet was submerged in a 
saline bath held at the average internal temperature of a pig. 
1.5.2.4. In Vivo Studies 
The Instrumented SMA Driven Ratchet has been used in a series of in vivo studies to evaluate 
the performance of the device and to examine the force and growth response of the bowel to 
different tissue expansion strategies based on the tissue displacement rate and/or the applied tensile 
load. In total, three tissue expansion strategies were performed in separate experiments: Constant 
Rate Impulsive Displacement Control (wherein the tissue expansion was 8.4 to 9.6 mm per day 
and not based on the applied tension), Displacement Rate Limited Load Control (wherein the 
device automatically expanded every time the measured load was below 60 gf, but no faster than 
1.2 mm, one actuation, per hour), and Constant Load Control (wherein the device automatically 
expanded every time the measured load was below 45 gf without a displacement rate limitation). 
In this series of studies, the rate of small bowel expansion increased significantly as the 
determination of when to expand the tissue was based on the applied bowel tension. 
Across studies, analyses of tissue samples taken from the distracted segments indicted little 
evidence of serosal or muscle layer tearing, the gross preservation of morphology, maintenance of 
the barrier function, and similar percentages of proliferating cells (compared to relevant controls). 
These promising medical results indicated that the small bowel tissue underwent true growth rather 
than experiencing permanent yielding, and that basing the expansion of the tissue on the measured 
tensile load is a safe approach to rapidly growing small bowel tissue. 
1.5.3. Objective Three: Tissue Attachment 
Current attachment approaches for transferring load to the small bowel in research studies 
include end-abutment and sutures, both of which are not extendable to the clinical application of 
the mechanotransduction approach to correcting SBS. To safely and effectively couple the 
expansion mechanism to the bowel lumen in a clinical context, it is important to have attachments 
that are implantable in continuous bowel without causing bowel obstruction, the attachments 
should grip the bowel lumen during the distraction period, operate in a detached state to facilitate 
device implantation, removal, and purposeful repositioning, and the attachments should be 
designed such that they do not cause bowel perforation or ischemia. The approach to developing 
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a reliable and safe tissue attachment was to conceptualize a broad range of approaches, fabricate 
them, and evaluate their performance in a series of in vivo experiments.  
1.5.3.1. Conceptualization and Initial Downselection  
The design process was to develop and categorize a wide range of conceptual attachment 
approaches including End Abutment, Dilation, Impingement, Binding/Kinking, Adhesion, 
Clamping, and Tissue Piercing. For each approach, concepts were generated and a qualitative 
assessment of safety and feasible was made to reduce the number of conceptual embodiments to 
be designed, prototyped and experimentally evaluated. The initial downselection of the concepts 
was based on an assessment of manufacturability, feasibility, safety, availability, and cost, while 
further downselection was based on experiment studies. 
1.5.3.2. Experimental Studies 
The goal of the ex vivo31, acute in vivo, and one-to-two week in vivo studies was to evaluate 
the range of attachments approaches based on attachment performance and the risk of surgical 
complications associated with their use. The attachment performance metrics included their ability 
to transfer high loads (greater than 200 gf) without slipping, their attachment reliability in vivo in 
experiments up to and exceeding one week, and their ability to facilitate surgical implantation and 
removal by sliding easily though the tissue lumen it their detached state. The metrics related to 
preventing surgical complications included the risk of bowel obstruction by enteral content 
blockage, the risk of tissue ischemia, and the mechanical risks of tissue perforation and tearing. 
Acute in vivo experiments were conducted on a range of the attachment concepts to determine 
how well they attach, detach, and if they pose the risk of health complications like ischemia and 
bowel perforations and/or tears. Because ex vivo experiments cannot be used to determine the risk 
of ischemia, most attachments were evaluated in acute (less than 1-2 hour) in vivo experiments. 
Longer in vivo experiments were conducted to evaluate the attachment performance and potential 
surgical complications with a series of attachment approaches that demonstrated promise in the ex 
vivo and/or acute in vivo experiments. These approaches included the binding/kinking approach, 
the clamping approach, the tissue piercing approach with sutures, and the dilation approach with 
textured balloons. At the conclusion of these studies, the Dilating Fenestrated Mesh was the most 
                                                     
31 Ex Vivo: Occurring outside of animal (within tissue removed from animal) 
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promising attachment for small bowel because of its ability to attach and detach from the bowel 
lumen in weeklong in vivo experiments without causing bowel ischemia or perforation. 
1.5.4. Objective Four: Clinically Relevant Device 
The first two objectives established the need for enterogenesis devices to conduct research on 
treatment feasibility and the methods by which the growth process and be safely exploited to 
quickly grow small bowel tissue in clinically relevant animal models. Thus, the design an 
enterogenesis device for clinical applications was a new design problem and prompted the 
reexamination of customer needs and design goals. Because the third objective concerned the 
development of clinically relevant tissue attachment approaches, the design of the clinically 
relevent device focused on the tissue expansion mechanism. The development of the clinically 
relevant device expansion mechanism followed the formal design process of understanding the 
goals of the device, developing metrics to compare different conceptual approaches, concept 
development, downselection, refinement, fabrication, and validation both on the benchtop and in 
a one week in vivo experiment. 
The culminating final tasks of this dissertation were to integrate the expansion mechanism 
with the intraluminal attachments and demonstrate the performance of the device through in vivo 
experimental studies. The in vivo experiments were used to validate the performance of the device 
and to determine if the payout approach to growing small bowel is feasible. As with prior in vivo 
experiments, tissue analyses were performed to evaluate the health and functionality of the grown 
tissue segments. 
1.5.4.1. Design 
A conceptual approach based on “paying out” tissue was identified as the most advantageous 
approach based on a Pugh chart analysis. A key defining advantage of the payout approach is that 
the net growth of bowel is not limited by the length or the stroke of the device, unlike current 
enterogenesis device technologies. In the payout operation, tension is applied the small bowel 
tissue in a continuous or incremental fashion by attachments that rotate or translate lengthwise, 
respectively. In the continuous approach, rotating attachments continuously apply tension to the 
small bowel growth segment which pays out small bowel tissue from one or both ends of the 
device. In the incremental payout approach, bowel tension is supplied by an attachment that 
translates back and forth along the length of the device with each cycle paying out an incremental 
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length of small bowel from one or both ends of the device. An embodiment of the incremental 
payout approach was developed because of its compatibility with the downselected attachment. 
The refined concept was a compact single-stage reciprocating linear hydraulic device with the 
unique capability to extend and retract without requiring two hydraulic lines. 
1.5.4.2. Prototype 
To create an environmentally robust prototype, the Reciprocating Linear Hydraulic Device 
was fabricated by traditional machining techniques from a variety of non-corrosive biocompatible 
materials including 316 stainless steel, natural Delrin, and nylon. The stainless steel body of the 
device extends by 3.4 cm with driven by the hydraulic line with approximately 2cc of water. When 
the pressure on the hydraulic line is released, a compression spring within the device retracts the 
housing back to its original position. Because the prototype could reciprocate and the attachments 
could actively switch between attached and detached states, the integrated prototype enabled the 
experimental evaluation of the payout approach’s viability. 
1.5.4.3. In Vivo Studies 
In Vivo studies were conducted to validate the performance of the device and to demonstrate 
the payout approach to small bowel lengthening. Both results hinged of the accurate measurement 
of tissue growth significantly exceeding the stroke of the device and on the medical tissue analyses. 
To measure the macro-scale tissue growth, evenly spaced tissue marking sutures placed during the 
implantation were measured at the explant and compared. However, to use tissue marking sutures, 
the length of the experiment had to be limited because sutures become difficult to recover in 
experiments exceeding one week (they slip out of the tissue). The tissue analyses included an 
examination of tissue histology, morphology, and epithelial cell proliferation, all of which 
indicated the true growth of healthy small bowel tissue exceeding the 3.4 cm stroke of the 
Reciprocating Linear Hydraulic Device. 
1.6. Summary of Contributions 
This research has made important contributions to the disciplines of medical science, surgery, 
and engineering. The major medical and surgical contributions include establishing the clinical 
feasibility of the mechanotransductive treatment approach, the determination of the maximum safe 
tensile small bowel tissue load, the comparison of displacement and tension-based tissue expansion 
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profiles, and the viability demonstration of the payout approach to growing small bowel tissue. 
The medical studies leading to those contributions were enabled in large part by concurrently made 
engineering contributions, which include the three novel enterogenesis device architectures, the 
Reset View Design Methodology for designing shape memory alloy driven devices, the ratchet-
pawl force interaction model, the in vivo tissue tension measurement system, and the Dilating 
Fenestrated Mesh intraluminal tissue attachment. All contributions and findings have been 
organized into four themes: medical treatment, device innovation, experimental methodologies, 
and mechanical device/tissue interaction.  
1.6.1. Medical Treatment 
This dissertation makes critical contributions toward the development of the 
mechanotransduction-based treatment for correcting short bowel syndrome. Most importantly, this 
dissertation establishes the feasibility of the treatment approach in clinically relevant porcine 
animal models. Additionally, experimental studies comparing tissue expansion strategies based on 
tissue displacement rates or/and applied tensile load were conducted with the Instrumented SMA 
Driven Ratchet. These studies showed that basing the expansion of bowel tissue on the applied 
tensile load results in much higher rates of expansion, which can clinically lead to a shorter 
duration of treatment, reduced complication risks, lower costs, and an overall better quality of 
patient care. Lastly, the medical viability of tensioning and relaxing the same segment of bowel 
tissue multiple times to induce high fold growth is demonstrated, supporting the design of ultra-
compact enterogenesis devices that can enable non-invasive surgical techniques. 
1.6.2. Device Innovation 
Three actuation architectures with unique features and functionality have been developed to 
enable studies of mechanotransductive growth with porcine animal models, the Curved Hydraulic 
Device, the Instrumented SMA Driven Ratchet, and the Reciprocating Linear Hydraulic Device. 
Although these enterogenesis were designed to be compact and apply loads suitable for inducing 
bowel growth, their designs can be scaled to develop actuators for applications requiring higher 
force and stroke capabilities. 
To design the Instrumented SMA Driven Ratchet, the Reset View Design Methodology and 
an analytical model of the ratchet rack and pawl force interaction were developed. Although 
created for the design of a compact SMA driven ratcheting mechanism, the Reset View Design 
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Methodology is a general graphical approach for designing SMA actuators biased by a reset 
element that greatly facilitates the selection of the reset element. Similarly, the ratchet rack and 
pawl force interaction model is scalable, making the model useful for designing a large range of 
actuated linear ratcheting mechanisms. 
1.6.3. Experimental Methodologies 
This dissertation makes contributions and findings that improve experimental methodologies 
for studying mechanotransductive enterogenesis. Contributions include the development of 
techniques for measuring net small bowel growth with marking sutures and quantifying mesenteric 
neovascularization using 3D reconstructions of the tissue, both important metrics for establishing 
the feasibility of mechanotransductive bowel lengthening approaches. 
1.6.4. Mechanical Device / Tissue Interaction 
This dissertation makes important contributions and findings regarding the mechanical 
device/tissue interaction, including the determination of the maximum safely applied bowel 
tension, methods for attaching to bowel tissue, and important considerations for designing the form 
of enterogenesis devices. The determination of the maximum safely applied bowel tension was 
critical for safely conducting experiments exploring high rates of healthy bowel growth. 
Furthermore, the methods used to determinate the upper limit can be repeated for clinical 
applications and used to prevent over tensioning the remnant bowel of SBS patients. A novel 
attachment approach for transferring load to small bowel for the correction of SBS is a significant 
contribution because its use can be extended to a number other medical applications such as 
improving endoscopic maneuverability, anchoring an instrument within large blood vessels to 
accurately place stents or perform endovascular coiling, and applying tensile load to the esophagus 
for the treatment of long-gap esophageal atresia. Many of the findings of this dissertation relate to 
the importance of the device form. The considerations for and relationships between length, 
rigidity, curvature, diameter, tissue interfaces, the local feature contours are important to 
understand in order to design safe enterogenesis devices. The findings here were developed over 
the course of this dissertation through many experiences in the operating room with porcine animal 
models. 
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1.6.5. Impact 
In sum, the contributions of this dissertation lay the complete engineering and medical 
foundation for the design and usage of technologies for correcting short bowel syndrome by 
mechanotransductive enterogenesis. The mechanotransductive approach to lengthening remnant 
small bowel has significant advantages compared to surgical restructuring approaches and 
transplants. Thus, realizing the clinical potential for this novel and promising treatment approach 
promises to improve the quality of care for SBS patients and ultimately save lives.  
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CHAPTER TWO. TREATMENT 
FEASIBILITY STUDIES WITH A CURVED 
HYDRAULIC DEVICE 
Unfortunately, the current management and treatment methods for short bowel syndrome are 
associated with high rates of complication, morbidity, and mortality. A potential new treatment 
approach based on mechanotransductive small bowel growth is a promising alternative to surgical 
bowel lengthening and bowel transplant, but its clinical feasibility is yet undemonstrated in 
clinically relevant animal models. To establish the feasibility of the treatment approach, it is 
important to complete studies with clinically relevant animal models where large amounts of 
functional and healthy small bowel tissue are grown. Large net growth and large expansion factors 
of growth are important to demonstrate with clinically relevant animal models, such as pigs, 
because SBS patients may have very little remnant bowel following major small bowel resection. 
In addition, observing adaptation of the mesenteric vasculature is important because it is needed 
support the greater lengths of small bowel tissue. 
Research-oriented devices for studying tension induced small bowel growth in rabbits and rats 
have been successful, but the devices were designed for small animal models and could not be 
scaled up for studies with larger and more clinically relevant animal models such as pigs. The 
external [3–5] and internal [6] screw devices are not fully implantable and have rigid 
extracorporeal features that pose health risks for stronger, more active, and larger animal models. 
While the intraluminal spring [7–9] is fully implantable, its use in porcine models poses risks as 
well due to the requirement of draining the isolated bowel growth segment of mucous, and the 
uncontrolled nature of the spring’s expansion. 
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Recently at the University of Michigan, an initial study [2] was conducted on the clinical 
feasibility of mechanotransductive enterogenesis with porcine models that used a simple linear 
two stage hydraulic device (Figure 2.1). The device is composed of a housing and two telescoping 
stages that extend as working fluid is injected via a transdermal hydraulic line with a syringe. As 
the linear hydraulic device extends, its ends abut the suture lines of the isolated bowel segment 
within which it is placed, applying tension to the tissue and inducing growth. As with the rabbits 
and rats, the porcine small bowel was proven mechanotransductive, achieving an extension ratio 
of 1.45 with only eight days of applied distractive forces in an initial study [2], as well as 
demonstrating the maintenance of bowel length and function upon restoring distracted segments 
back into the continuity of the GI tract in a subsequent study where the expansion factor was 2.03 
[1]. These studies investigated a variety of functionality and health metrics of the distracted tissue 
segments including the tissue morphology, enzyme activity, barrier and transport function, the 
percentage of proliferating cells, and bowel motility. The results of these evaluations suggested 
that the distracted segments preserved tissue function and health, as well as increased the 
percentage of proliferating cells. Thus, the initial studies with clinically relevant models were very 
promising because true growth of small bowel was achieved without a loss of function. 
Although these studies are very encouraging, an even greater lengthening of the small bowel 
is needed to demonstrate the potential efficacy of this treatment approach for treating extreme 
cases of SBS. Furthermore, small bowel growth experiments to demonstrate high expansion ratio 
growth and mesenteric adaptation are important for the clinical application of the 
mechanotransduction based approach. Prior bowel growth studies have not reported any 
observations of mesenteric growth and adaptation, but the growth and remodeling of blood vessels 
 
Figure 2.1. Linear Hydraulic Device (shown extended). 
Used in early studies [1,2] of mechanotransduction at the University of Michigan, a two-stage linear 
hydraulic device made of medical syringes is shown. 
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within the mesentery is critical for supporting the increased length of bowel tissue, particularly as 
greater expansion factors are sought to demonstrate the potential of the treatment approach. To 
increase the lengthening capability of the previously used Linear Hydraulic Device, perform 
experiments with high growth ratios, and observe how the mesentery adapts when high growth 
ratios are achieved, the Curved Hydraulic Device has been developed. Two important reasons 
allow for greater lengthening of the Curved Hydraulic Device as compared with the linear 
hydraulic device. First, the space of the abdominal cavity is limited. Thus, extending along curved 
path increases the potential net growth of small bowel. Second, a curved device reduces mesenteric 
stress, allowing for greater displacement due to the decreased chance of complications such as 
mesenteric tears and/or ischemia. As shown in Figure 2.2, the mesenteric forces on the bowel are 
radially inward, causing the tissue to curve. By developing a curved hydraulic device, extraneous 
forces on the mesentery can be minimized during the implantation and expansion of the device. 
The objectives of this chapter are to evaluate if large net bowel growth is possible without loss 
of bowel health and function, if unprecedented high expansion factors of growth are possible, and 
if the mesentery adapts to meet increasing demands for blood flow by the growth and remodeling 
of blood vessels that support the increasing length of the small bowel. To enable experiments 
exploring these objectives, a new Curved Hydraulic Device was developed to better fit within the 
porcine abdominal cavity, reduce extraneous mesenteric stress, and provide greater expansion 
performance compared to the Linear Hydraulic Device. This chapter describes the architecture and 
 
Figure 2.2. Porcine Small Bowel Loop with Mesentery. 
The influence of the mesenteric load on the small bowel causes it 
to bend naturally. 
Mesentery
Small Bowel
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operation of the Curved Hydraulic Device, the design and fabrication of the prototype, its benchtop 
performance validation, and its in vivo use for experimental bowel growth studies in porcine 
models. The Curved Hydraulic Device has been used in a series of in vivo experiments to determine 
the feasibility of mechanotransductive growth in clinically relevant animal models, where the 
tissue of the distracted segments was evaluated for indications of true growth rather than stretching. 
To guide these studies, experimental plans were developed for surgically implanting, expanding, 
and surgically removing the Curved Hydraulic Device after one to three weeks of tissue distraction. 
In the series of experiments, the expansion rate was set to impose an impulsive displacement 
prolife, expanding the device twice a day. The medical evaluations included examining the tissue 
morphology, percentage of proliferating cells, barrier function, and observing the mesentery for 
increased vascularization. Despite challenges related to securely attaching the device to the bowel 
wall, strong growth results and the observation of mesenteric adaptation have suggested the 
feasibility and potential of the mechanotransductive treatment approach for correcting SBS. 
In addition to demonstrating the feasibility of the mechanotransduction-based treatment 
approach and laying the foundation for further research, these studies have also made more general 
engineering, medical analysis, and surgical contributions. The multistage, telescoping, curved 
hydraulic device architecture is a unique and novel actuator with potentially wide ranging 
applications. To record the adaptation of mesenteric vasculature, a new method of visualizing the 
vasculature and quantifying the volume of blood vessels within the tissue was utilized for the first 
time with porcine mesentery. And furthermore, insights have been made toward solving the 
general surgical challenge of reliably securing sutures under tension to soft tubular tissues like the 
esophagus and small intestine. 
2.1. Curved Hydraulic Device Design 
To investigate the potential for inducing large net growth and large extension ratio growth, 
the Curved Hydraulic Device concept was designed and developed for in vivo studies with porcine 
animal models. The choice of animal model greatly affects the design of the Curved Hydraulic 
Device and the clinical applicability of experimental results. While no animal model will 
completely mimic a human, porcine models have been chosen for studying mechanotransductive 
small bowel growth because the internal anatomy of a pig is very similar to that of a human, they 
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have similar nutritional requirements [10], similar digestive physiology [11], similar susceptibility 
to enteric pathogens [12], and they are an important model of natural GI tract growth in preterm 
infants [13]. The Curved Hydraulic Device is composed of an external syringe which is used to 
push the working fluid into a set of concentric telescoping curved cylinders equipped with seals. 
The largest cylinder, or housing (Figure 2.3), is fitted with a device-to-tissue attachment and a 
connection for the hydraulic line. Opposite the hydraulic line, another device-to-tissue attachment 
is fixed to the last (smallest diameter) stage. The extension of the curved hydraulic device is driven 
by the input of fluid from and external syringe through a transdermal hydraulic line. The device is 
initially collapsed when implanted. As the external syringe is depressed, the stages of the hydraulic 
device extend due to the conservation of the fluid volume provided by the seals. For a fixed input 
volume, the expansion of the device is not known because it depends on which stage or stages 
have extended. Tension on the small bowel tissue is applied by the device-to-tissue attachments 
which are sutured into the tissue, and through the process of mechanotransduction, the tissue 
grows, thus reducing tension. The process of loading the tissue and allowing time for growth is 
repeated at a regular interval for the duration of the one to three week implantation period. 
 
Figure 2.3. Architecture of Curved Hydraulic Device. 
The architecture of the Curved Hydraulic Device is composed of a housing and three stages, which 
extend (as fluid is injected from an external syringe) to place tension on the tissue and induce 
mechanotransductive small bowel growth. 
Initial position
Small Bowel
After injection of working fluid
2nd Stage
Housing
1st Stage 3
rd Stage
Syringe
Hydraulic Line Mesentery
Pig
Vasculature
Sutures (4x)
Attachments (2x)
Curved Hydraulic Device
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The design of the Curved Hydraulic Device was dependent on and guided by the net expansion 
target. However, clinical tissue lengthening goals have not been previously set and must be 
determined based on the experience of pediatric surgeons in the care of SBS patients. The goal of 
the Curved Hydraulic Device in vivo studies is to generate large net growth and exceed previously 
achieved expansion factors of growth with clinically relevant models. To treat many cases of 
pediatric SBS with the mechanotransduction approach, where success is measured by the patient’s 
ability to wean from TPN, greater net and expansion ratio growth of the small bowel is required 
than that produced in the Linear Hydraulic Device studies [1,2,14]. Recently, the remaining small 
bowel length after resection was found to be a poor predictor of a patient’s ability to wean off of 
TPN, while the percentage of expected length, which changes rapidly in utero, was found to be a 
strong predictor [15]. In a retrospective study of 80 neonates, 83.1% of the patients’ whose small 
bowel length was greater than or equal to 10% of their expected small bowel length were able to 
wean from TPN, while only 10.5% could do the same with less than 10% of their expected small 
bowel length. However, the percent of expected small bowel length varies widely from patient to 
patient following major resection, leading to a large range of required net increases, 1 cm to 25 cm 
(based on the study), to achieve greater than or equal to 10% of the expected small bowel length 
in neonates. To improve on the expansion capability of the Linear Hydraulic Device, the net 
expansion target was set to greater than 10 cm, whereas the Linear Hydraulic Device studies 
reported an average of 5.5 cm of net expansion in the first study [2] and 10.3 cm in the second [1]. 
To achieve greater net expansion and expansion ratio than the Linear Hydraulic Device, which had 
two stages, the Curved Hydraulic Device was designed with an additional third stage. The 
expansion ratio target of the device was set to at least 2X to improve on the capability of the Linear 
Hydraulic Device. Additionally, the Bianchi and STEP surgical small bowel lengthening 
procedures have reported expansion amounts in the range of 1.9 to 2X [16–18]. Although the 
device expansion target is 2X, because the attachments were designed to connect circumferentially 
rather than by end abutment, the tissue expansion ratio can be set much greater than 2X by 
modifying the initial position of the attachments relative to the housing of the device. 
In addition to the goals for the net extension and expansion factor of the device, the geometric 
size constraints on the Curved Hydraulic Device were severely constrained by the peritoneal cavity 
length and bowel lumen diameter of the porcine models. To define these constraints, measurements 
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were made directly of porcine anatomy to determine the peritoneal cavity length, height of 
mesentery, and relaxed bowel diameter. The abdominal cavity length was measured to determine 
the maximum length of the device, defined as the greatest linear distance between the two ends of 
the device when fully extended. Radiographs of young (~6 months) porcine models from previous 
in vivo studies indicated that approximately 30 cm is the upper limit on the maximum length of 
the device. The mesenteric height is defined as the length of mesentery between the bowel and the 
superior mesenteric artery. This dimension is relevant for specifying the radius of curvature of the 
Curved Hydraulic Device to minimize mesenteric tension at the time of the implantation and 
during the expansion. Based on measurements taken during previous in vivo studies, a mesenteric 
height of 9 cm was found and thus set as the target for the radius of curvature of the Curved 
Hydraulic Device. To determine the maximum outer diameter of the intraluminally placed device, 
estimates of the bowel inner diameter were determined by removing short lengths of small bowel 
and cutting them into strips such that their circumference could be directly measured. Assuming 
the shape of the bowel to be circular, the inner diameter was found by dividing the circumference 
by π. Using this method, the relaxed inner bowel diameter of the porcine models (4 to 6 month 
old) was estimated at 1.7 cm.  
The architecture of a Curved Hydraulic Device is unique, and the non-linear actuator has a 
range of other potential applications beyond studying enterogenesis in porcine models, such as 
enabling studies of esophageal or intestinal growth with differently sized animal models. The 
general design approach and considerations addressed herein serves as foundation for developing 
this class of actuators for other applications. 
2.2. Curved Hydraulic Device Prototype 
To enable the in vivo studies, a prototype of the Curved Hydraulic Device was designed and 
built as shown in Figure 2.4. The three main elements of the design are presented in the following 
section which include material selection based on biocompatibility and yield strength, the 
fabrication of the curved housing and stages, the sealing of the device, and the device-to-tissue 
attachments.  
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2.2.1. Curved Housing and Stages 
The fabrication of the housing and stages was challenging because the chosen material had to 
be biocompatible, the housing and stages had to be curved with approximately identical radii of 
curvature, and the inner and outer diameters of the housing and stages had to be such that they fit 
concentrically while simultaneously fitting available seals. Custom made housing and stages from 
material suppliers were considered but disregarded due to their high cost and lengthy lead time 
compared to off-the-shelf options. Rapid prototyping the housing and stages was also considered, 
but was also disregarded due to limitations on material choice. Specifically, the SLA method uses 
epoxy resins that can lose dimensional stability in fluids, and while the FDM method uses more 
 
Figure 2.4. Prototype of Curved Hydraulic Device. 
The Curved Hydraulic Device was composed of Delrin seals and attachments and 316 stainless 
steel housing and stages. The housing and stages were curved by manually bending the tubing 
around a mandrel. An external medical grade syringe was used to drive the working fluid into the 
device. 
Housing
(316 Stainless Steel)
Luer Lock Connection
Medical Grade Silicone Tubing
1st, 2nd, and 3rd Stage 
(316 Stainless Steel)
Medical Grade Syringe (10cc)
2.15 cm
Circular Attachment
(Delrin)
15.5 cm (collapsed attachment to 
attachment arc length)
Circular Attachment
(Delrin)
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robust materials like ABS, the resolution of parts created with this technique is not conducive to 
make sliding and sealable components. 
Using the CES Selector software package (Granta Design), biocompatible materials were 
identified for the housing and stages to prevent health complications during implantations and to 
protect the Curved Hydraulic Device from the in vivo environment. Two material choices were 
specified for further down-selection: 316 stainless steel, and Delrin 150, a biocompatible [19] 
thermoplastic polymer that is readily available and easily machinable. 
To form the curved cylinders, stainless steel may be cold formed, and Delrin, which is a 
thermoplastic, may be formed at high temperature. To choose between the materials, an FEA 
analysis of the housing and three stages was performed for stainless steel 316 and Delrin using a 
set of dimensions from an initial design for the length, inner diameter, and thickness of the material 
for the housing and each stage. To develop a conservative design, an assumed end load of 15 lbf 
(6.8 kgf) was applied at 45 degrees relative to the faces of each stage while the opposite face was 
rigidly fixed. The magnitude of the assumed end load was not specified based on the expected 
applied tensile loading on the distracted bowel segment. Rather, it was chosen based on the 
possibility that the weight of the animal could apply a bending moment to the extended device or 
that adhesions connecting the distracted segment to the peritoneal wall could transfer large loads 
to the device. The initial design (inner and outer diameters) of the housing and stages was based 
on matching commercially available stainless steel tubing with compatible O-Ring seals while 
keeping the outer diameter of the housing less than 1.7 cm to fit within the small bowel. 
Results from the numerical study are shown in Table 2.1. As expected, the stainless steel 
components had higher safety factors against yielding than the Delrin components. The 
simulations for the second and third Delrin stages did not complete due to post-yield numerical 
instabilities arising from large displacement. However, the first Delrin stage yielded during the 
simulation. Therefore, stainless steel was the chosen housing and stage material for the Curved 
Hydraulic Device prototype. Because none of the stainless steel components yielded in the FEA 
analysis, the initial housing and stages were not redesigned. 
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Dimensions for the housing and three stages are shown in Table 2.2. The curvature of the 
stainless steel tubes was developed by manually bending them around a mandrel with a diameter 
of 9 cm to match the radius of bowel curvature measured in porcine models. To prevent kinks in 
the tubes while bending, wet sand was compacted inside the tubing and the ends were sealed. The 
wet sand packed tubes were fixed tightly between a clamp and a mandrel, and the free end of the 
tube was manually pulled around the mandrel until it conformed to the desired radius. Due to the 
tubing springing back in the absence of the applied external load, the actual radius of curvature 
increased to approximately 10.6 cm. The less compliant stages had a greater spring-back effect 
and thus required mandrels with less than a 9 cm diameter for bending. Bending the tubing in this 
manner also introduced an ellipticity into the cross-section that made the minor and major 
Table 2.1. FEA Results of Stainless Steel and Delrin Tubing for Curved Hydraulic Device 
FEA results showed that the original design of the Curved Hydraulic Device will not yield if made with 
316 stainless steel. If made of Delrin, all stages of the model yield. The 2nd and 3rd stages of the Delrin 
model failed due to numerical instabilities arising from large displacement secondary to yielding. 
 
Table 2.2. Dimension of Housing and Three Stages of Curved Hydraulic Device. 
The dimensions of the original Curved Hydraulic Device are shown. The design was based on 
keeping the outer diameter of the housing less than 1.7 cm to fit within the bowel lumen, while 
finding commercially available 316 stainless steel tubing with compatible dimensions for use with 
standard O-rings. 
 
Material Component Max Stress 
(Mpa)
Safety Factor
Stainless Steel Housing 18 9.44
(Yield Stress: 170 MPa) 1st Stage 63 2.7
2nd Stage 143 1.19
3rd Stage 102 1.67
Delrin Housing 20 3.15
(Yield Stress: 63 MPa) 1st Stage 66 0.95
2nd Stage Fail- N/A Fail- N/A
3rd Stage Fail- N/A Fail- N/A
Component Outer Diameter Inner Diameter
(in) (cm) (in) (cm)
Housing 0.625 1.588 0.555 1.41
1st Stage 0.5 1.27 0.43 1.092
2nd Stage 0.375 0.953 0.305 0.775
3rd Stage 0.25 0.635 N/A (Solid Rod)
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diameters vary on the order of ten to fifteen thousands of an inch. This ellipticity made the design 
of the seal and seal mounts challenging. 
2.2.2. Sealing 
The ellipticity of the housing and stages made sealing a challenge, because radial gland seals 
are designed for circular cross-sections and the curved cylinders were slightly elliptical. Instead of 
using traditional O-Ring seals, the sealing of Curved Hydraulic Device was achieved with a series 
of six seals taken from medical grade syringes. Compared to traditional O-Ring seals, the butyl 
rubber syringe seals conformed more securely to the slightly elliptical cross-section of the stainless 
steel tubing. As shown in Figure 2.5, two 10 cc syringe seals were used to seal between the 
proximal attachment/housing interface and the housing/1st stage interface. Two 5 cc syringe seals 
were used between the seal holder/1st stage interface and the 1st/2nd stage interface, and two 3 cc 
 
Figure 2.5. Exploded Schematic View of the Curved Hydraulic Device. 
The assembly and materials or the Curved Hydraulic Device are shown. Overlapping components 
were fixed together by epoxy (bushing/housing, bushings/stages), set screws (proximal 
attachment/housing, seal holders/stages), and with mounts (seals/seal holders). The distal attachment 
screws onto the final stage. 
1st Stage
(316 Stainless Steel)
3cc Medical 
Syringe Seal
(Butyl Rubber)
Proximal Attachment (Delrin)
Housing (316 Stainless Steel)
10cc Medical 
Syringe Seal
(Butyl Rubber)
Seal Holder
(Delrin)
5cc Medical 
Syringe Seal
(Butyl Rubber)
5cc Medical 
Syringe Seal
(Butyl Rubber)
Seal Holder
(Delrin)
10cc Medical 
Syringe Seal
(Butyl Rubber)
Bushing
(Delrin)
Bushing
(Delrin)
Distal Attachment
(Delrin)
2nd Stage
(316 Stainless Steel)
3rd Stage
(316 Stainless Steel)
6-32 Button Head 
Screw, 3/8 in long
(316 Stainless Steel)
3cc Medical Syringe Seal
(Butyl Rubber)
Bushing
(Delrin)
3cc Medical Syringe Seal
(Butyl Rubber)
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syringe seals were used between the seal holder/2nd stage interface and the 2nd/3rd stage interface. 
The seals were held in place by two seal holders machined from Delrin and one stainless steel 6-
32 button head screw fixed to the third stage. To prevent the complete separation of the stages and 
housing during operation, the seal holders and 6-32 screw interfere with the three approximately 
0.020 inch thick Delrin bearings fixed to the end of housing, the first stage, and the second stage 
by stainless steel 2-56 set screws. The bearings, seals, seal holders, and 6-32 button head screw 
are shown in an exploded schematic view of the Curved Hydraulic Device in Figure 2.5. 
2.2.3. Attachment to Tissue 
The safe and reliable transfer of load from the device to the small bowel is possibly one of the 
greatest challenges to demonstrating the clinical potential of mechanotransductive tissue growth. 
There are safety issues related to ischemia (reduced blood flow) and tearing of the bowel. There 
are also practical issues; the bowel lumen is smooth, slippery, and lined with a mucosal layer which 
continuously and naturally sloughs away. Prior enterogenesis devices have successfully 
transferred load to isolated segments of bowel with a single surgical closed end, like the external 
screw, or with both ends closed, like the Intraluminal Spring [7–9] and the linear hydraulic device 
[1]. However this attachment method, which will be referred to as end abutment, is clinically very 
undesirable because significantly long segments of bowel are lost in the process of creating 
multiple anastomoses and restoring the distracted segment back into the continuity of the GI tract. 
Furthermore, in a study where both ends of the isolated segment were surgically closed, the buildup 
of mucous within the segment proved to be a lethal complication [14]. To overcome this 
complication, transdermal drainage catheters were placed in the isolated segment in subsequent 
experiments, but they had to be flushed regularly to prevent clogging, and they increased the risk 
of infection and bowel leakage. 
To transfer load from the Curved Hydraulic Device to the segment of bowel in which it is 
implanted, two Delrin attachments are fixed on the opposing ends of the device. Rather than the 
end abutment attachment method, the attachments transferred load through rings of sutures to the 
bowel wall. The attachments supported six evenly placed sutures each, and were filleted to prevent 
ischemic injury to the bowel wall. Designing the number of holes for the sutures was not trivial; 
too many holes would lead to bowel tearing (like perforated paper), but too few holes would lead 
to higher loads applied to the tissue by each suture. Based on these considerations and some brief 
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ex vivo evaluations of prototyped attachments, the choice of six holes was made, which placed 
each suture approximately 1 cm apart along the circumference of the bowel lumen. The innermost 
layer of the bowel, or mucosa, produces mucous and continuously sloughs off cells. To prevent 
the buildup the mucous and other enteral contents between the attachments, the distal, or 
downstream, attachment was machined to have six 0.16 inch diameter holes. The hole size was 
chosen by maximizing the diameter without comprising the structural integrity of the attachment, 
although no formal design optimization technique was applied. Based on a prior experimental 
study [20] that explored the minimum flow-through area to allow the safe passage of enteral 
contents, the six 0.16 diameter provide more than enough flow-through area. Thus, the need for 
drainage catheters was eliminated. The proximal, or upstream, attachment was fitted with a female 
luer lock adaptor to connect the medical grade silicone hydraulic line. 
2.3. Validation and Characterization 
To prepare for in vivo experiments, the Curved Hydraulic Device performance was evaluated 
on the benchtop. Experiments were performed to detect if there were leaks, to evaluate the force 
output, and to measure the relationship between the input fluid volume and the displacement of 
the three devices stages. To detect leaks, the displacement of the stages was blocked with the 
device collapsed as well as with the device fully extended, and fluid pressure within the device 
was elevated by manually attempting to force fluid through the hydraulic line with an external 
syringe. For both the collapsed and extended configurations, the seals of the Curved Hydraulic 
Device held with minimal (less than approximately 5% of the full expansion volume) leakage. To 
evaluate the force output, the Curved Hydraulic Device was successfully extended against an 
external load of 1kg. The performance of the Curved Hydraulic Device was characterized by 
measuring the device expansion versus volume of injected water to determine fluid injection rates 
during in vivo experiments, where the motion of the device cannot be monitored save for the use 
of radiographs. To collect the data shown the Figure 2.6, the displacement arc length was measured 
with a ruler for even increments of injected water volume. Because the housing, 1st stage, and 2nd 
stage have different inner diameters, they expand at different rates with respect to the volume of 
injected water. The first stage (largest) displaces 0.8 cm/ml, the second stage displaces 1.0 cm/ml, 
and third stage (smallest) displaces 1.8 cm/ml of inputted volume. Additionally, the order in which 
the stages extended varied between trials and was therefore an unknown during implantation. Thus, 
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Figure 2.6 shows the lower displacement bound, were the stages extend one at a time in ascending 
order: 1st, 2nd, and then 3rd. If the stages extend one at a time in descending order, the expansion of 
the devices follows upper displacement bound. While implanted, the total displacement of the 
device may vary as much as the difference of the upper and lower bound, giving a maximum 
uncertainty of approximately 4.5 cm at half the total volume capacity of the device (assuming no 
hydraulic fluid has leaked). If no hydraulic fluid has leaked, this uncertainty in the device 
displacement goes to zero as the inputted volume reaches full capacity. This variation is 
problematic for studies where the effect of displacement rate on growth characteristics is sought, 
and it may also be too unsafe for clinical applications, but this result is suitable for the large growth 
and expansion ratio goals of this chapter. The final displacement and inputted volume are 15.5 cm 
and 15.3 mL, respectively, giving the Curved Hydraulic Device an average displacement per 
volume rate of 1.01 cm/mL and an extension ratio of 2.1X. 
2.4. In Vivo Experimental Studies 
To demonstrate the feasibility and potential of the mechanotransductive approach to treating 
short bowel syndrome, a series of medical experiments were completed that used the expansion 
 
Figure 2.6. Curved Hydraulic Device Displacement Versus Input Volume. 
The upper bound, lower bound, and the uncertainty (upper minus lower bound) of the Curved Hydraulic 
Device displacement is shown. The uncertainty arises because each stage of the device extends a different 
amount per fixed fluid injection and the order in which the stages extend was not repeatable. 
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capabilities of the Curved Hydraulic Device. The goal of the series of experiments was to evaluate 
the feasibility and potential of the mechanotransductive approach to correcting SBS by 
investigating the potential for inducing large net growth, large expansion factor growth, and 
observing the mesentery supporting the distracted segment for an increase in vascularity. To 
promote large net growth, the Curved Hydraulic Device was implanted intraluminally in porcine 
animal models and extended by impulsively increasing the displacement of the hydraulic device 
twice daily over the course of approximately two weeks. To distinguish between actual growth 
and the permanent deformation of the tissue, samples of the grown tissue were compared with 
controls to determine if there were morphological differences, increased proliferation of cells, 
preserved barrier function, and to evaluate adaptation of the mesenteric vasculature. 
2.4.1. Experimental Procedure 
Three procedures have been developed to guide the experimental studies: the surgical 
implantation procedure, the device expansion protocol during the distraction period, and the 
surgical device removal and post experiment tissue analysis plan. All animal experiments were 
conducted at the University of Michigan with approval from the University Committee on the Use 
and Care of Animals (protocol number 09026).  
A surgical implantation procedure was developed to implant the Curved Hydraulic Device 
intraluminally, but not within the continuous GI tract. Rather, the device was implanted within a 
Roux limb connecting the continuous GI tract to a stoma located on the underside of the porcine 
model. The surgery began with a 15 cm midline incision to open the abdominal cavity of the 
porcine model. The small bowel was manipulated to determine the flow direction of enteral 
contents and to locate the Ligament of Treitz, which marks the start of the small intestine. 
Approximately 60 cm along the length of small bowel from the Ligament of Treitz the small bowel 
was cut, creating two open ends of bowel labeled (a) and (b), as shown in Figure 2.7. 
Approximately 60 to 75 cm along the length of bowel from (b), an end-to-side anastomosis was 
created, connecting (a) to (c) and restoring the continuity of the GI tract. The segment of small 
bowel from (b) to (c), or Roux limb, was no longer in the continuity of the GI tract and would not 
pass ingested contents, however, the health of the Roux limb was maintained by the blood supply 
from the intact mesentery. During the creation of the Roux limb, the Curved Hydraulic Device was 
sterilized by soaking it in a liquid sterilant (Metrix, Metricide®) for the manufacturer recommend 
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time of 40 minutes. After sterilization, the device was thoroughly rinsed with sterile saline to 
prevent any sterilant from getting into the surgical field. The Curved Hydraulic Device was 
inserted, 3rd stage end first, into the open end of the Roux limb, and was sutured in place with the 
device-to-tissue attachments. Laser Doppler images, which captured the rate of blood flow, of the 
bowel and mesentery were acquired to confirm the absence of device-induced ischemia. A stoma, 
or surgically created opening, was made in the skin and fascia of the abdomen, and the Roux limb 
was secured to the stoma at the fascia and skin. The final steps of the surgery were to route the 
hydraulic line through the Roux limb, connect the external injection syringe to the hydraulic line, 
and secure the external injection syringe and hydraulic line to the center of the porcine model’s 
back. 
The planned length of the implantations was approximately two weeks long, during which the 
full expansion is device was evenly distributed (as much as possible) by injecting the same amount 
of working fluid each day. Two injections of fluid, approximately 0.6 ml each, were given each 
day – one in the morning, and one in the evening. At the time of each injection, the health of the 
pig was observed and recorded. To monitor the displacement progress of the device, radiographs 
were taken during some experiments. 
 
Figure 2.7. Schematic of Surgical Implantation Procedure. 
The Curved Hydraulic Device was implanted in a Roux limb created by cutting the small bowel and 
creating two open ends, (a) and (b), creating an anastomosis at (a) and (c), and connecting (b) to a 
stoma on the abdomen of the porcine model. 
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At the device removal and tissue harvest surgery, tissue samples were taken from the non-
distracted Roux Limb as the control samples, from the distracted Roux limb, and from normal 
small bowel for comparison. During the distraction period, the Roux limb is not exposed to what 
the animal models ingest, except for cases of reflux into the Roux limb. The lack of nutrient rich 
contents flowing though the lumen of the Roux limb has an effect on its physiology, making the 
non-distracted Roux limb tissue sample the most appropriate control for evaluating the distracted 
tissue segment. The analyses for evaluating the tissue health and function included evaluating the 
barrier function by measuring the tissue’s transepithelial electrical resistance, evaluating growth 
by counting the percentage of proliferating cells marked by PCNA, and examining the general 
health by observing the tissue morphology from histologic slides. The extent of vasculature 
adaptation within the mesentery supporting the distracted segment was also captured by taking 
high resolution photographs, and by injecting a radiopaque dye (Microfil® injection compound) 
into the vasculature, taking CT scans of the tissue, and creating three-dimensional reconstructions. 
2.4.2. In Vivo Results and Discussion 
Four trials have been successfully conducted over the course of several years with the Curved 
Hydraulic Device. Reliable attachment to the bowel wall has proven to be challenging. However, 
strong results concerning tissue growth, mesenteric adaptation, and important design insights for 
clinically-relevant enterogenesis devices have been achieved.  
2.4.2.1. Tissue Growth 
The growth of healthy porcine small bowel tissue has been successfully induced by the 
application of distractive loads with the Curved Hydraulic Device in a series of four experiments 
as shown in Table 2.3. The amount of net tissue growth was in the range of 4.9 cm to 8.9 cm, while 
the ratio of tissue expansion varied from 1.6 to 2.2X. Many other experiments with the Curved 
Hydraulic Device were conducted than what is presented here, but due to challenges related to the 
poor reliability of tissue attachment sutures and tissue marking sutures, the amount of tissue length 
grown could only be determined for the four experiments presented here. 
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To investigate if the grown tissue was as healthy and functionally similar to normal small 
bowel, the transepithelial electrical resistance (TER) of the tissue was measured, the percentage of 
proliferation cells was determined, and the morphology of the tissue was observed with histologic 
slides. 
2.4.2.1.1. Transepithelial Electrical Resistance 
Small bowel tissue transports nutrients across the epithelium while simultaneously 
maintaining a barrier that prevents the passage of harmful bacteria, viruses, and organisms. One 
method to measure the strength of the tissue barrier function is to evaluate the TER using a Ussing 
Chamber. Measurements of TER were taken for the Curved Hydraulic Device experiment ending 
in December of 2011. Tissue samples were taken from the normal fed bowel, the unfed Roux limb 
control, and two sections of the distracted tissue segment labeled device middle and device end 
(Figure 2.8). The results suggested that, relative to the Roux Y Control, the TER of the distracted 
tissue segments was preserved. This is a positive indicator that true small bowel growth occurred 
without resulting in microscopic tearing or perforations. If the small bowel was stretched or 
permanently deformed rather than grown, the expected TER would be significantly lower than the 
Roux limb control segment, which was not the case. If a microscopic tear or perforation of the 
tissue was present, the measured TER would decrease to near zero because there would be no 
tissue to prevent the flow of ions across the Ussing Chamber. 
Table 2.3. Tissue Growth Results with Curved Hydraulic Device 
Net tissue lengthening and expansion ratios of tissue growth ranged from 5.4 to 8.9 cm and 1.6 to 
2.2X, respectively. Variation in the initial segment length was achieved by changing the mounting 
locations of the tissue attachments. 
 
Trial Experiment 
Explant Date
Initial 
Segment 
Length (cm)
Net Tissue 
Lengthening 
(cm)
Expansion 
Ratio of 
Tissue
1 12/21/2011 15.0 8.9 1.6
2 6/13/2012 13.2 7.5 1.6
3 2/19/2013 4.5 4.9 2.1
4 4/26/2013 4.5 5.4 2.2
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2.4.2.1.2. Cell Proliferation 
The small bowel has a high turnover rate of cells that form in the crypt villus complex and 
subsequently slough off into the bowel lumen. If small bowel growth is occurring, the rate at which 
cells are proliferating should be at least greater than that of tissue that is not growing. To measure 
the percentage of proliferating cells, tissue samples were stained to test for the presence of 
Proliferating Cell Nuclear Antigen, or PCNA. The percentage of proliferating, or PCNA positive, 
cells were measured for all of the experiments except for the one ending on 12/21/2011, where the 
histology could not be used due to difficulties associated with slide preparation. Similarly, the data 
from the “Normal Bowel” for the experiment ending on 4/26/2013 could not be used. Otherwise, 
PCNA data were taken from normal (or fed) bowel, the roux limb control, and two sections of the 
distracted tissue segment. The plotted data indicate the average ratio of proliferating cells to all 
cells counted along each crypt/villus complex per high power field. 
The results (Figure 2.9) show that across all samples, the range of proliferating cells is in the 
range of approximately 30 to 70 percent of the total cells. The data for the distracted portion (End 
Device and Mid Device) are compared most accurately with the Roux Y Control for several 
reasons. First, like the Roux Y Control, the End Device and Mid Device tissue samples were not 
 
Figure 2.8. Transepithelial Electrical Resistance of Small Bowel Samples. 
Compared to the Roux Y Control, tissue samples from the end and middle of the 
device did not have significantly different transepithelial electrical resistance. This 
result suggests that the grown bowel tissue was not perforated on a microscopic 
level and that the barrier function of the grown tissue segment was maintained. 
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exposed to enteral contents during the two week experimentation period, whereas the Normal 
Bowel was in the continuous GI tract and exposed to enteral contents. The lack of enteral content 
exposure may lead to disuse atrophy in the tissue and other physiological changes. Thus, the 
Normal Bowel samples are not appropriate controls. Secondly, the tissue for the End Device, Mid 
Device, and Roux Y Control are all surgically manipulated at the implantation surgery, unlike the 
Normal Bowel. The surgical manipulation of the tissue may lead to physiological changes, again 
making the Roux Y Control more appropriate. 
There were statistically significant results for the experiments ending on 6/13/12 and 
4/26/2013, where the percentage of proliferation cells on the End Device and Mid Device were 
 
Figure 2.9. Percentage of Proliferating Cells in Small Bowel Samples. 
Relative to the Roux limb control, the percentage of proliferating cells decreased in the End and 
Mid Device for the experiments ending on 6/13/2012 and 4/26/2013. However, the medical 
significance of this result is minimal, as the overall maintenance of cell proliferation was observed 
across trials, and the End and Mid Device were not significantly different from the Normal Bowel 
in the experiment ending on 6/13/2012. This result indicates that true bowel growth was induced. 
Pairwise t-Tests were taken only for End Device against the Roux Y Control, and the Mid Device 
against the Roux Y Control. *Brackets indicate statistically significant differences (p < 0.05). 
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less than that of the Roux Y Control (t-test: two-sample assuming unequal variances, p < 0.05). 
Although the results are mathematically significant, the medical significance of these results is not 
necessarily important. Especially considering that there was no statistically significant difference 
between the Normal Bowel and the distracted segments for the experiment ending on 6/13/2012. 
Although the percentage of proliferating cells was less than the Roux Y Control in two of the 
experiments, the percentage of proliferating cells was not low enough to cause concern. For the 
experiment ending on 2/19/2013, there were no statistically significant differences found for any 
pairing of tissue sample locations. The results suggest that inducing small bowel growth by the 
application of tension does not lead to medically significant changes in the percentage of 
proliferating cells in the epithelium. However, the importance of timing the fixation of the tissue 
for histology was not explored. Because of the high turnover rate of cells in the epithelium [21], 
the captured change of the rate of cell proliferation secondary to applied tissue tension may be 
highly dependent on how quickly the tissue can be fixated after distraction. Nonetheless, the results 
presented here do not suggest any negative health effect on tissue as a result of the applied load. 
The general maintenance of cell proliferation also indicates that actual bowel growth occurred, 
rather than stretching.  
2.4.2.1.3. Morphology 
The morphology of the small bowel tissue was also observed to determine the health of the 
tissue. In the distracted tissue segments, there was no evidence of gross tearing, minimal disruption 
of the mucosa, and minimal swelling of the tissue, which indicated that the distraction process did 
not physically harm the tissue. The lack of mucosal disruption further strengthens the result that 
the TER of the distracted segment was maintained. Relevant morphologic features of the tissue, 
which included crypt depth, villus height, and muscle layer thickness were measured. 
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Results for the total muscle thickness (longitudinal muscle thickness plus circular muscle 
thickness) are shown in Figure 2.10. For all experiments excluding the one ending on 4/26/2013, 
the total muscle thickness for the End Device and Mid Device were greater than that of the Roux 
Y Control with statistical significance (t-test: two-sample assuming unequal variances, p < 0.05). 
The increase of muscle layer thickness was largely attributed to hypertrophy, an enlargement of 
cell size, rather than hyperplasia, an increase in the number of cells. Although the medical 
significance of this result is not clear, increased muscle layer thickness due to hypertrophy has 
been observed in all but one prior study of enterogenesis [3,4,6–9,22], as indicated by Table 1.4 in 
Chapter One concerning the statistically significant medical results of rabbit and rat enterogenesis 
 
Figure 2.10. Total Muscle Height. 
Relative to the Roux limb control, statistically significant increases in the Circular Muscle Thickness were 
measured for the experiments ending on 12/21/2011, 6/13/2012, and 2/19/2013. Pairwise t-Tests were taken only 
for End Device against Roux Y Control, and Mid Device against Roux Y Control. *Brackets indicate 
statistically significant differences (p < 0.05) 
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studies. In the single study that did not report muscle layer thickening [23], fluidic pressure was 
applied to segments of rat small bowel rather than device-enabled pure tension. 
The villus height and crypt depth were also measured, and ranged from 100 to 350 m for the 
villus height, and from 150 to 350 m for the crypt depth. Unlike muscle layer thickness, both the 
villus height and crypt depth were not significantly different compared to the Roux Y Control and 
Normal Bowel (t-test: two-sample assuming unequal variances, p < 0.05). The preservation of 
these structures is important to the maintenance of tissue health and function. A reduction of villus 
height greatly decreases the absorptive surface area, and crypt depth is related to the rate at which 
new epithelial cells are formed and their absorptive capacity [24]. Thus, the measured lack of 
change in these structure was a positive indication of health bowel growth.  
Taken together, the medical analyses of the tissue samples strongly suggested that the true 
growth of healthy and functional small bowel can be induced the by application of distractive 
loading. However, to support greater lengths of small bowel tissue, the vasculature of the 
mesentery must adapt to continue distributing blood to the tissue. 
2.4.2.2. Vascular Adaptation  
The adaptation of the mesenteric vasculature has been successfully observed, suggesting the 
long-term health of distracted tissue segments will be sustained [25]. Figure 2.11 shows two high 
resolution photographs of the mesentery before (left) and after (right) tissue distraction. The 
images illustrate how the vasculature of the mesentery adapts by neovascularization, the formation 
of small blood vessels branching off of the main vessels. Qualitatively, the figure shows that the 
density of blood vessels is increased in the distracted segment. To quantify these results, a novel 
method for measuring the volume of blood vessels within samples of porcine mesentery was 
developed wherein a radiopaque agent (Microfil ®) is injected into the arterial vessels of the 
mesentery, the mesentery is then scanned using the CT imaging technique, and three-dimensional 
reconstructions are created by and analyzed with GE Healthcare’s Microviewer software. The 
resulting three-dimensional reconstructions are shown in Figure 2.12. Approximately, a four-fold 
increase of neovascularization occurred in the mesentery supporting the distracted segment 
compared to the control. Thus, not only can healthy and functional small bowel growth be induced, 
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but the supporting mesentery adapts to supply the greater lengths of tissue by creating small arterial 
vessels to redistribute oxygen rich blood to the tissue. 
 
 
 
Figure 2.11. Mesentery of Distracted Segment at Implant (left) and Explant (right). 
High resolution photographs showing the increase in mesenteric neovascularization. The increase is 
best observed by comparing the extent of small vessel growth between the major blood vessels. 
 
Figure 2.12. 3D Reconstructions of Control and Distracted Mesentery Samples. 
Three-dimensional reconstructions were created by injecting a contrast agent into the blood vessels 
of the mesentery and taking CT scans of the tissue. This allowed the extent of neovascularization 
to be quantified. A 4X increase in neovascularization was measured, suggesting the sustainability 
of the grown bowel segment by increased blood perfusion within the tissue. 
Neovascularization
b. Distracted segment of 
mesentery: 8.3% volume of 
neovascular vessels
a. Control segment of 
mesentery: 2.0% volume of 
neovascular vessels
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2.4.2.3. Challenge of Tissue Attachment 
Attaching reliably to the small intestine to transfer loads from the Curved Hydraulic Device 
has proven very difficult. At the device removal surgeries of several trials, the sutures connecting 
the circular attachments to the small bowel could not initially been found on the outside of the 
bowel. However, the sutures were still tied to the holes of the circular attachment. Unfortunately, 
they unexpectedly slipped through the full thickness of the small bowel tissue and could no longer 
transfer load from the device. Interestingly, the sutures’ passage through the tissue did not cause 
enteral content leakage, because it appeared that the tissue healed around the sutures during the 
process. The lack of peritonitis provided further evidence that bowel leakage did not occur. To 
reinforce the attachments in the later trials, the sutures were reinforced with thick pieces of Strattice 
(denatured pig skin) or Alloderm (denatured human skin). Although the reinforcements improved 
the reliability of the tissue attachments, the material has also traveled through the bowel wall when 
the combination of applied bowel tension and the length of implantation were too great in several 
trials. Despite this challenge, very promising small growth and mesenteric adaptation results have 
been achieved with the Curved Hydraulic Device. 
2.5. Conclusion 
Short bowel syndrome treatments continue to suffer from high cost, lethal complications, and 
low rates of long-term success. To investigate the feasibility and potential of a new treatment 
approach based on mechanotransductive enterogenesis in clinically relevant animal models, the 
Curved Hydraulic Device was created and developed to enable experimental in vivo bowel growth 
studies with porcine animal models. 
The Curved Hydraulic Device is a unique telescoping, three-stage, curvilinear hydraulic 
actuator which can be scaled for potential wide ranging applications. To design the device, 
measurements of the porcine small bowel diameter, mesenteric height, and length of the peritoneal 
cavity were made. The targeted expansion ratio of the device was set to 2X, which is similar to the 
expansion ratios achieved by the Bianchi and STEP procedures for surgically lengthening small 
bowel. The fabricated prototype had an expansion ratio of 2.1X and an expansion capacity of 15.5 
cm, as determined by an experimental benchtop characterization of the device. 
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A series of four in vivo enterogenesis experiments with porcine animal models have 
successfully demonstrated healthy small bowel growth and have shown that the vasculature within 
the mesentery adapts to support the bowel as it grows. To quantify the adaptation of mesenteric 
vasculature, a method of visualizing the vasculature and determining the volume of blood vessels 
within the tissue was developed for porcine mesentery. Furthermore, insights have been made 
toward solving the general surgical challenge of reliably securing sutures under tension to soft 
tubular tissues like the esophagus and small intestine. Despite challenges related to the attachment 
of the device to the small bowel tissue, these studies have established the clinical relevance of the 
mechanotransductive approach to correcting short bowel syndrome and support further research 
into mechanotransductive enterogenesis. 
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CHAPTER THREE. TREATMENT 
DEVELOPMENT STUDIES WITH AN 
INSTRUMENTED AND DISPLACEMENT 
CONTROLLED SMA DRIVEN 
RATCHETING DEVICE 
Several important advantages of researching beyond feasibility have motivated a more 
detailed study of mechanotransductive small bowel growth. One important advantage of 
developing a better understanding of mechanotransductive bowel growth is exploration of the 
upper limit on how quickly small bowel can safely grow, which clinically leads to shorter 
implantations, reduced risk of complications such as bowel injury, obstruction, and bacterial 
overgrowth, and reduced costs. Furthermore, understanding limits on the maximum safe load and 
the nature of the small bowel tension over the length of an implantation can lead to better informed 
decisions of the expansion regimen of the future clinically oriented device. 
Currently, the only enterogenesis device designed for porcine models are the Linear [1–3] and 
Curved Hydraulic Devices. Although these devices could be instrumented for monitoring the 
applied tension, they cannot fundamentally be used for repeatable displacement control because 
of the stick/slip nature of their expansion, uncertainty of the stage extension order, and the 
compliance of their hydraulic lines. Prior enterogenesis devices used in the rat and rabbit studies 
cannot be scaled up to enable these studies with porcine models due to practical safety concerns. 
The external [4] and internal screw devices [5] are not fully implantable and have rigid 
extracorporeal features that pose health risks for more active and larger animal models. The 
intraluminal spring [6–8] is fully implantable, but its use in porcine models poses risks as well due 
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to the requirement of draining the isolated bowel growth segment of mucous and the uncontrolled 
nature of the spring’s expansion. 
The objectives of this chapter are to enable and conduct bowel growth studies that explore the 
upper limit of safely applied tensile loads, explore the upper limit on how quickly small bowel 
tissue can be grown, and compare different strategies for expanding the tissue, such as applying a 
constant displacement rate, maintaining constant tension, and applying other displacement or force 
based profiles. To achieve these objectives in porcine models, an enterogenesis device with force 
instrumentation, displacement monitoring, and repeatable displacement control is needed. It is 
necessary to also have a wireless communication link to eliminate the need to tether the porcine 
models to a data acquisition system with electrical wires, because the porcine models would very 
likely injure themselves or the wired connection. 
To enable more rigorous small bowel growth experiments, a fully implantable, wirelessly 
controlled, force sensing, and displacement sensing enterogenesis device with a Shape Memory 
Alloy (SMA) driven ratcheting mechanism (for reliable and repeatable expansion) was developed. 
The device is composed of two integrated subsystems: the ratcheting mechanism, and the data 
acquisition and control system. To design the SMA wire and reset spring of the ratcheting 
mechanism, an alternative graphical design method is outlined in which the stress/strain material 
curves are scaled and translated into shifted austenite and martensite actuation curves (Reset View) 
that aid the visualization and selection of the reset spring. These transformations are based on the 
geometry of the ratcheting mechanism and actuation system as well as the system forces 
experienced by the spring including the force imposed by the ratcheting mechanism, the external 
force from the bowel, friction in the device, and a seal through which the mechanism extends. To 
predict these forces and apply the Reset View design methodology, an analytical kinematic and 
kinetic model of the ratcheting mechanism was developed, the safe loading range of bowel tissue 
was experimental measured, the force from the seal was experimental measured, and friction 
within the device was conservatively estimated. The design of the data acquisition and control 
system was guided by considerations of the implanted circuit footprint, power consumption, and 
wireless range. The embedded electronics programing was developed to reduce power 
consumption, yet enable control of the device communication parameters and a range of other 
device settings to make adjustments during implantations possible if needed. The integrated device 
has been fabricated, and both the ratcheting model and reset view design process has been validated 
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on the benchtop. The full device performance was validated on the benchtop and in an initial in 
vivo experiment. 
Three in vivo experimental studies enabled by the Instrumented SMA Driven Ratchet explored 
the response of the bowel different tissue expansion approaches. In the constant rate impulsive 
displacement control study, two sets of expansions were commanded each day of the one week 
distraction period. In the displacement rate limited load control study, the expansions were 
automatically commanded if the measured load was less than 60 gf but limited to one expansion 
per hour. And in constant load control trial, the expansions were automatically commanded if the 
measured load dropped below 45 gf with no limitation on expansions per hour. For each study, the 
Instrumented SMA Driven Ratchet was implanted in a Roux limb segment of small bowel isolated 
from the continuous gastrointestinal tract to eliminate the risk of device induced bowel obstruction. 
During the distraction period, the health of the animal model was observed, the applied load and 
displacement of the device were monitored remotely, and the device was commanded based on the 
tissue expansion approach. Following the distraction period, tissue samples of the distracted 
segment, Roux limb control, and normal bowel were taken to evaluate the health and functionality 
of the tissue by evaluating its morphology, transepithelial electrical resistance, and percentage of 
proliferating epithelial cells. Results from the tissue evaluations suggest that the distracted 
segments underwent true growth rather than stretching, and that the health and functionality of the 
tissues were preserved. The load data collected during the constant rate impulsive displacement 
control study suggested two interesting results: the maximum rate at which bowel is safely be 
grown may be much higher than previously thought and the rate at which the tissue grows and 
responds to expansion changes during the distraction period. As suggested by the constant rate 
impulsive displacement control study, when the tissue expansion approach was based on the 
measured load, the rate of tissue growth increased dramatically without affecting tissue health. 
The development and experimental studies with the Instrumented SMA Driven Ratchet has 
led to medical, surgical and engineering contributions. Although intraluminal bowel pressure 
sensors exist in prior art, the Instrumented SMA Driven Ratchet is the first system to make in vivo 
measurements of the longitudinal load within living porcine bowel tissue. The design of the SMA 
driven ratcheting mechanism, an important external leveraging architecture for SMA, was 
developed such that it may be scaled for a wide range of applications. Furthermore, the Reset 
Design View Methodology, a novel design approach for directly selecting the bias element of 
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general SMA actuators reset with a bias element, was established. Results from in vivo experiments 
suggest that higher rates of bowel growth are achievable than previously thought, which is an 
important finding toward developing the mechanotransduction based treatment for correcting short 
bowel syndrome. 
3.1. Device Concept 
To compare the unique methods of exploiting mechanotransduction, it is important to have a 
versatile device that can apply relevant load or displacement profiles such as constant, ramping, 
and impulsive loads or displacements. To eliminate the risk of the device causing a bowel 
obstruction, it is implanted in a segment of small bowel tissue that is isolated from the continuity 
of the gastrointestinal (GI) tract as shown in Figure 3.1. The mesentery, or vasculature, of the 
isolated bowel segment is left intact to prevent the small bowel tissue from becoming ischemic, 
and the continuity of the GI tract is restored through a surgical reconnection. Within the isolated 
bowel segment, the Instrumented SMA Driven Ratchet is sutured to the tissue at both ends with a 
circular attachment. The expansion of the device can be controlled manually or automatically. In 
either mode, the command to actuate is transmitted wirelessly from the base station to the 
embedded electronics on the device which trigger the actuation of the SMA driven ratcheting 
mechanism. As the device expands and tensions the isolated small bowel segment, the applied load 
is transferred from the circular attachment to a force sensor mounted in the device. A series of 
electronic circuits wirelessly transmit the output of the force and displacement sensors to a PC user 
interface, enabling medical personnel to make informed decisions during the implantation with 
 
Figure 3.1. Bowel Lengthening System. 
The bowel extender, which is wirelessly controlled by a user at a PC, is implanted in an isolated segment 
of the pig’s small bowel. Bowel growth is induced by mechanotransduction as the bowel extender 
lengthens. Bowel tension and displacement data are wirelessly transmitted to the PC operating the user 
interface. 
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regard to changing device parameters or the expansion protocol. The expansion of the device may 
be commanded manually or automatically to conduct displacement based studies. For load based 
studies, the living tissue reacts and grows in response to the device; thus, the application of load 
profiles is achieved by actively monitoring the load and actuating the device automatically to 
modify the load when necessary. For example, to maintain a constant load during the implantation 
period, the Instrumented SMA Driven Ratchet is actuated automatically each time the measured 
load decreases below the specified load as the bowel grows. This capability allows medical 
researchers to explore and compare different growth strategies for exploiting 
mechanotransduction. 
The Bowel Lengthening System is composed of two major subsystems: the ratcheting 
mechanism, and the data acquisition and control system. The design of the two subsystems was 
largely decoupled due to the uncomplicated nature in which the subsystems interact. In the 
following section, a detailed description of each subsystem’s architecture and operation is 
presented. 
3.1.1. Ratcheting Mechanism 
A key technical challenge to the bowel lengthening system is the expansion mechanism, 
whose function is to increase the length of the Instrumented SMA Driven Ratchet in a gradual and 
controlled manner, thus safely applying tension to the attached small bowel segment. Because of 
the desired versatility of the Instrumented SMA Driven Ratchet, passive solutions such as springs 
cannot be used because they do not give medical personnel the ability to conduct experiments 
where either the load or displacement is controlled. Thus, an actuated mechanism that can be 
controlled externally is required. A primary constraint on the design of the expansion mechanism 
is the available length and diameter of the tissue lumen, which for a pig’s small bowel limits the 
outer diameter of the device to approximately 0.75 inches and the initial length to approximately 
6.50 inches (to limit the initial stress on the mesentery). This constraint excludes bulky electrical 
motors along with considerations of the power required to drive them. While hydraulics can fit 
into this constrained space, safe and reliable displacement control is difficult to achieve due to 
friction between the piston and cylinder, and the compliance of the hydraulic line. The need for a 
compact and energy dense actuator that can fit within the slender form factor of the Instrumented 
SMA Driven Ratchet is met exceptionally well by SMA wire, which can produce strains of 2 to 
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8% against moderate loads, with lower strains advised for high cycle applications. To reduce the 
length of the actuator/device, the SMA strain can be leveraged through the use of a ratcheting 
mechanism, which accumulates the small displacements generated by the SMA wire during 
operation. The ratcheting mechanism maintains the expansion of the Instrumented SMA Driven 
Ratchet against external loads without requiring any power, which is advantageous because the 
power drawn by the device is supplied by a battery rather than a power supply. Another feature of 
the ratcheting mechanism is that the expansion of the device at each SMA actuation is inherently 
predictable and repeatable, as it is defined by the pitch of the grooved pushrod. 
3.1.1.1. Ratcheting Mechanism Architecture 
The ratcheting mechanism, whose architecture and operation is shown in Figure 3.2, 
accumulates small displacements given by the SMA wire into a much greater net expansion of the 
device. The ratcheting mechanism consists of two front pawls, hinged within the front housing 
which slides axially relative to the rear housing, two rear pawls, hinged within the rear housing, a 
grooved pushrod (rack), which slides through the housings and engages with the pawls, and an 
SMA wire actuator and its reset spring, which induces relative motion between the housings and 
therefore the pawl sets.  The SMA wire actuator is attached to and routed through the front housing, 
around a semicircular bend in the rear housing, and back through and attached to the front housing. 
This routing path is mirror symmetric about the axis of the device, enabling the SMA actuator to 
pull on the front housing without creating a moment that could cause the front and rear housing to 
bind. In this routing configuration, the SMA wire actuator essentially acts like two parallel wires 
fixed to the front and rear housing; thus, in the model-based design of the ratcheting mechanism 
described in this paper, the single SMA wire actuator will be treated as two separate parallel wires. 
A screw passed through a clearance hole on the rear housing and threaded into the front housing 
provides an adjustable hard stop, which limits the martensitic strain of the SMA actuator and sets 
the displacement of the front housing relative to the rear housing when the SMA is cool. A Hall 
Effect sensor, which measures magnetic field strength, is fixed to the rear housing, and a permanent 
magnet is fixed to the front housing. Because of this, the output of the Hall Effect sensor varies 
with the displacement of the front housing relative to the rear housing and can be used to measure 
the strain of the SMA wire during operation. 
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3.1.1.2. Ratcheting Mechanism Operation 
The cyclic linear ratcheting motion is shown in five labeled stages in Figure 3.2. In Stage 1, 
which is the nominal stage of the device, the front housing (a) is held in place by an adjustable 
hard stop (b) against the force produced by the reset spring (c), which strains the SMA wire by the 
distance set with the adjustable hard stop. The SMA wire is mounted between the rear housing (e) 
and the front housing such that as the SMA contracts, the front housing moves toward the rear 
housing. In the nominal position, the rear ratchet pawls (f) hold the pushrod (g) rigidly in place 
against external loads. Stage 2 begins when the command to actuate is received by the electronics 
that drive the SMA wire. In this stage, the SMA wire is actuated via joule heating, which causes 
the material to transform from martensite to austenite. During the transformation the actuator 
contracts, which causes the front ratchet pawls to disengage, opening outward against the force 
from a set of pawl bias springs (h), and causes the reset spring to compress as the front housing 
moves toward the rear housing. The relative motion between the front and rear housing is measured 
by a permanent magnet (i) and a Hall Effect sensor (j) whose output is linear with respect to the 
measured magnetic field strength. During Stage 3, the motion of the front housing relative to the 
rear housing continues until the measured displacement exceeds a user defined limit set to ensure 
the stroke of the actuator is enough for the pawl bias springs to force the pawls to reengage in the 
adjacent groove of the pushrod. When this event occurs, the power to the SMA is automatically 
stopped by the driving circuitry and the SMA is allowed to cool. In Stage 4, the SMA cools and 
transforms back to martensite from austenite. During this transformation, the reset spring pushes 
the front housing away from the rear housing, causing the pushrod to move forward due to its 
engagement with the front pawls, which in turn causes the rear pawls to disengage and the force 
of the bowel tissue to increase as it is strained. As the pushrod moves forward, its motion is 
opposed by friction within an annular seal (not shown) through which the pushrod moves. The 
relative motion continues in Stage 5 until the rear pawls have been reengaged by the pawl bias 
springs into the next groove on the pushrod, and the front housing is once again held in place 
against the adjustable hard stop, thus displacing the pushrod by the pitch of its grooves and 
resetting the mechanism to its nominal stage. During operation, the applied tensile force on the 
small bowel tissue is measured by a compression load cell mounted on the end of the device 
opposite the pushrod. The displacement of the device is found by multiplying the number of 
successful steps, as verified by the output of the Hall Effect sensor, by the pitch of the grooved  
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Figure 3.2. Operation of Ratcheting Mechanism. 
The operation of the ratcheting mechanism is shown in five stages, which are 
repeated to accumulate a displacement,   , at each step against the external load 
from the small bowel, 𝐹𝑏𝑜𝑤𝑒𝑙. 
Stage 1: The nominal position. SMA is martensitic, and the
return spring holds the front housing against the hard stop.
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Stage 2: The SMA is heated, begins transforming to austenite,
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Stage 3: The pawls reengage the pushrod, the displacement
sensor reads the stroke required to ratchet, and the SMA is
automatically turned off by embedded electronics system.
Stage 4: As the SMA cools, the return spring pushes the front
housing, and the pushrod displaces as the rear pawls
disengage. The labeled forces are acting on the front housing.
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Stage 5: The rear pawls reengage, returning the mechanism to
its nominal position. The pushrod has displaced by the pitch of
its grooves,    
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pushrod. To follow an experimental lengthening profile based on the applied displacement or load, 
multiple actuations may be automatically or manually commanded from the user interface. For 
example, to automatically maintain an applied load, the device may be lengthened each time the 
measured load decreases below a specified tension threshold. As the Instrumented SMA Driven 
Ratchet is lengthened, the isolated small bowel segment enclosing the device is tensioned and thus 
grown via mechanotransduction. 
3.1.2. Data Acquisition and Control System 
The data acquisition and control system enables the measurement of the applied bowel tension 
and displacement, drives the SMA wire in the ratcheting mechanism, and creates a wireless link 
between the medical personal and the implanted Instrumented SMA Driven Ratchet that enables 
continuous monitoring and control of the experiment. 
3.1.2.1. Data Acquisition and Control System Architecture 
The data acquisition and control system is a set of three circuits: the Bowel Extender Circuit, 
the Pack Circuit, and the Base Station Circuit, as shown in Figure 3.3. The Bowel Extender Circuit 
is composed of a microcontroller that samples the output of the Hall Effect sensor and the amplified 
output of the load sensor, drives the SMA actuator with a MOSFET, and communicates with the 
wireless Pack Circuit with a wired serial connection. The amplification of the load sensor output 
is achieved by an instrumentation amplifier whose gain is controlled by a digital potentiometer 
interfaced with the microcontroller. The Pack Circuit is made up of a microcontroller that 
interfaces with a wireless transceiver for communication with the Base Station, and is embedded 
in a housing containing the battery powering both implanted circuits. The base station, which is 
not implanted, acts as a two-way communication relay between the PC interface and the implanted 
electronics, and is composed of a microcontroller that interfaces with a wireless transceiver for 
communication with the implanted electronics, and a line driver/receiver for communication with 
the PC. 
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3.1.2.2. Data Acquisition and Control System Operation 
The operation of the electronics was developed to establish the flow of sensor data and user 
input commands between the three circuits and the PC interface while simultaneously conserving 
battery power. Nominally, the Instrumented SMA Driven Ratchet is not actuating and the 
operation of the electronics follows the sequence diagram shown in Figure 3.4. To conserve the 
battery, the Bowel Extender Circuit is turned off by a digital signal from the Pack Circuit that 
enables and disables the voltage regulator of the Bowel Extender Circuit. At the start of the 
operation sequence, the Pack Circuit turns the Bowel Extender Circuit on and sends the following 
user defined parameters: the command to run the SMA actuation sequence (true or false), the 
displacement sensor threshold used during an actuation (integer), and the gain of the 
instrumentation amplifier (integer). The Bowel Extender Circuit then samples the displacement 
sensor and the amplified load sensor and sends the data to the Pack Circuit. Upon receiving the 
sensor data, the Pack Circuit immediately turns the Bowel Extender Circuit off. The sensor data 
are then concatenated with the measured battery voltage and if a parameter of the Pack Circuit has 
been altered, the new value of that parameter for verification. The augmented set of data is then 
sent from the Pack Circuit to the Base Station Circuit wirelessly, where it is relayed to the PC user 
 
Figure 3.3. Data Acquisition and Control System Architecture. 
The data acquisition and control system architecture is composed of three separate but interfaced 
circuits: the Bowel Extender Circuit, which drives the SMA wire actuator and conditions the outputs of 
the load and displacement sensors, the Pack Circuit, which houses the battery and wirelessly 
communicates with the Base Station Circuit, and the Base Station Circuit, which relays data and 
commands between the Pack Circuit and a PC running the user interface. 
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interface. The data are displayed immediately to enable informed decision making by the medical 
personal. From the user interface, the medical personal may queue commands to the Pack Circuit 
via the Base Station Circuit to actuate the Instrumented SMA Driven Ratchet (true or false) or to 
change a parameter including the displacement sensor threshold, the instrumentation amplifier 
gain, the SMA power timeout, and the rate of data acquisition. Upon receiving new parameters 
from the Base Station Circuit, the Pack Circuit “sleeps” to conserve battery power for an amount 
 
Figure 3.4. Data Acquisition and Control System Operation. 
The operation of the data acquisition and control system consists of two separate modes, the Nominal 
Repeating Sequence, in which data/commands are sent/received by the Bowel Extender Circuit and the 
SMA actuator is not powered, and the Repeating Actuation Sequence, in which commands are not sent 
to the Bowel Extender Circuit to increase the data rate and the SMA actuator is powered. The operation 
was developed to maximize the time in which the implanted electronics are off or in a low power 
consumption mode to conserve battery capacity and enable experiments up to two weeks in length. 
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of time specified by the desired rate of data acquisition. Any user commanded change to the set of 
parameters is applied in the operation sequence shown in Figure 3.4. The operation of the 
electronics is different while the SMA wire is being actuated to drive the ratcheting mechanism in 
that the flow of data is one-way rather than two-way (to increase the data acquisition rate), and the 
power of the Bowel Extender Circuit is not cycled by the Pack Circuit between data points. The 
power to the SMA wire and Bowel Extender Circuit is supplied until one of two conditions is met: 
1) the measured output of the displacement sensor exceeds the user defined threshold, or 2) the 
user defined SMA timeout occurs. The SMA timeout prevents unsafe overheating of the SMA 
wire in the event that the Hall Effect sensor fails or the Ratcheting Mechanism is blocked. When 
either condition is met, the actuation sequence is exited and electronic subsystem returns to the 
nominal operating sequence. Although not shown (for clarity) in Figure 3.4, the Pack Circuit and 
Base Station Circuit are programmed with timeouts to prevent them from hanging when the Base 
Station Circuit transceiver is out of wireless range with the Pack Circuit. These timeouts also 
ensure that the Pack Circuit does not needlessly consume battery power when it is out of range 
from the Base Station Circuit. 
3.2. Ratcheting Mechanism Design 
The analytical design of the SMA driven ratcheting mechanism was completed by developing 
the Reset View Design Methodology, an alternative to the traditional graphical design method for 
SMA actuators; by developing a model to guide the design of a parameterized ratchet pawl and 
rack geometry; and by deriving a model of the force interaction between the pawls and rack. 
Although used in this dissertation to design an SMA driven ratcheting mechanism, the Reset View 
Design Methodology is a general approach for designing SMA actuators that are re-strained by a 
bias element or reset spring. Additionally, the ratchet models presented herein are scalable and 
may be applied to the design of ratcheting mechanisms for automotive, aerospace, and other 
medical applications. 
3.2.1. Reset View Design Methodology 
Constitutive models describing the behavior of SMA wire continue to be an active research 
topic, and as such, most SMA driven mechanisms are designed with a graphical approach using 
austenite and martensite stress/strain relations acquired experimentally. Although the common 
graphical approach is used to specify the SMA wire parameters (diameter and length) given 
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knowledge of the system loads that act on the actuator and its desired stroke, practically, designers 
have many fewer SMA wire design options to choose from than they have system parameters such 
as the stiffness of the reset spring. This is especially true for the Instrumented SMA Driven Ratchet, 
where the size of the device strongly constrains the length of the SMA wire and the general 
constraint of the limited number of commercially available SMA wire diameters.  
To overcome the limited design space of the SMA actuator within the Instrumented SMA 
Driven Ratchet, the traditional graphical method was adapted such that the SMA wire parameters 
are specified first, and then the parameters of a reset spring are determined to allow the actuator to 
produce the desired stroke. To formulate this new graphical process, the experimentally acquired 
SMA stress/strain material curves are transformed into force/displacement SMA curves by scaling 
the stress and strain curves by the cross-sectional area of the SMA wire and the SMA wire length, 
respectively. To acquire the Reset View, the force/displacement SMA curves are further 
transformed by the shifting them by the system loads. After completing these transformations, the 
resulting view enables the designer to quickly determine the maximum stiffness of a reset spring 
that will produce the desired stroke. This process may be repeated to identify appropriate springs 
for each SMA wire diameter considered for the ratcheting mechanism.  
This section formulates the Reset View graphical method with details on the transformations 
and spring selection process. For the Instrumented SMA Driven Ratchet, the system loads that 
must be determined include the axial components of the external load provided by the tension of 
the isolated small bowel segment, 𝐹𝑏𝑜𝑤𝑒𝑙, the load due to the ratcheting mechanism, 𝐹     𝑒 , the 
friction force from the annular seal on the pushrod, 𝐹 𝑒 𝑙, and the force of friction in the sliding 
components of the device, 𝐹      𝑜 . To predict the loads associated with the ratcheting mechanism, 
a general ratcheting model is derived in Section 3.2.2. The range of safe loads that can be applied 
to pig small bowel tissue is evaluated experimentally, as described in Section 3.3.1. The seal force, 
𝐹 𝑒 𝑙, was identified experimentally, as described in Section 3.3.2. The axial component of the 
force of friction, 𝐹      𝑜 , is highly dependent on the physical prototypes and is not typically 
known prior to design, so it was conservatively estimated. The entire process is performed for the 
design of the Instrumented SMA Driven Ratchet in Section 3.3. 
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3.2.1.1. Transformation from Material Stress-Strain to Engineering Force-Displacement 
The Reset View design process begins with the experimentally measured austenite and 
martensite stress/strain material curves. To transform the material curves into load/displacement 
curves, the SMA wire parameters of length and diameter must be defined. A lower bound on the 
diameter of the SMA wire is determined by finding a lower bound on the maximum force subjected 
to the SMA wire in its austenite state and selecting the smallest wire diameter that keeps the 
corresponding stress below the manufacturer’s recommended maximum stress. For an SMA driven 
ratcheting mechanism, like the device described herein, that expands while the SMA is re-strained 
by the reset spring, the loads acting on the actuator differ in the martensite and austenite phases.  
As the SMA is heated, as shown in operation stages 2 and 3 of Figure 3.2, the external axial 
load is not transmitted through the SMA. Rather, that load is transmitted through the rear ratchet 
pawls, which rigidly hold the pushrod in place. Thus, the pair of austenitic SMA wires are 
subjected only to a load, 𝐹   
 , given by the sum of the reset spring force, 𝐹      , the axial 
component of the sliding friction force within the device, 𝐹      𝑜 , and the axial component of the 
forces generated by the interaction of the pushrod with the front ratchet pawls, 𝐹     𝑒 , such that 
 𝐹   
 = 
 
𝐹      +
 
 
𝐹      𝑜 + 𝐹     𝑒 
 ⏟            
𝐹𝑠𝑦𝑠
𝐴
, 
(1) 
where 𝐹 𝑦 
  represents the sum of the system loads experienced by the austenitic SMA wires 
excluding the spring load. 
As the SMA is allowed to cool, as shown in operation stages 4 and 5 of Figure 3.2, the external 
axial load from the bowel, 𝐹𝑏𝑜𝑤𝑒𝑙, is transmitted to the SMA through the front ratchet pawls. In 
these operational stages, the load subjected to the pair of martensitic SMA wires, 𝐹   
 , is the 
spring load minus the sum of the axial components of the force of friction, the force generated by 
the interaction of the pushrod with the rear ratchet pawls, the force produced by the seal, and the 
external load from the bowel such that  
 𝐹   
 = 𝐹      − 
                  (𝐹     𝑒 + 𝐹      𝑜 + 𝐹 𝑒 𝑙 + 𝐹𝑏𝑜𝑤𝑒𝑙)
 ⏟                        
𝐹𝑠𝑦𝑠
𝑀
, 
(2) 
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where 𝐹 𝑦 
  represents the sum of the system loads subjected to the martensitic SMA wires, 
excluding the spring force.  
To bound the SMA wire diameter required to transform stress into force, the maximum value 
of the austenitic SMA load is predicted using Equation 1, but the force from the spring is not 
known. A minimum SMA wire diameter is determined by assuming that the spring provides just 
enough force to reset the mechanism without needing to reset the martensitic SMA. This allows 
the generation of a bound without knowing the bounding SMA wire diameter a priori. The spring 
force that meets this requirement is found by setting the force from the pair of martensitic SMA 
wires, 𝐹   
 , to zero in Equation 2 and solving for the spring force, 𝐹      . The resulting 
minimum spring force substituted into Equation 1 provides a lower bound of the maximum value 
of the force, 𝐹 𝑚 
 , provided by the pair of austenitic SMA wires as 
 𝐹 𝑚 
 |
𝑚 𝑥
= 𝐹 𝑦 
 + 𝐹 𝑦 
  
                     = 𝐹𝑏𝑜𝑤𝑒𝑙 + 𝐹 𝑒 𝑙 + 2 (𝐹      𝑜 + 𝐹     𝑒 )  
(3) 
The maximum available force from the pair of austenitic SMA wires depends on their total cross-
sectional area and the maximum allowed stress, 𝜎𝑚 𝑥, in the austenite state, generally specified by 
the SMA wire manufacture to provide a long lifetime of the wire and to minimize performance 
degradation due to shakedown [9],  
 𝐹 𝑚 
 |
𝑚 𝑥
= 2𝜎𝑚 𝑥
𝜋
4
𝑑𝑚  
2, (4) 
where 𝑑𝑚   is the minimum allowable diameter which maintains the stress below the specified 
maximum. This minimum diameter can be solved by equating Equations 3 and 4 as 
 
𝑑𝑚  = √
2
𝜋
(
𝐹𝑏𝑜𝑤𝑒𝑙 + 𝐹 𝑒 𝑙 +  2 (𝐹      𝑜 + 𝐹     𝑒 )
𝜎𝑚 𝑥
)  
(5) 
The minimum value of the SMA diameter is rounded up to next commercially available SMA wire 
diameter to select the first candidate wire diameter. One or more larger wire diameters may be 
selected as candidates in addition since 𝑑𝑚   provides a lower bound only and may not be sufficient 
to actuate against available reset springs.  
In the design of compact SMA driven mechanisms, the maximum possible length of the SMA 
wire is often used to reduce the strain of the actuator, given a desired stroke, to maintain a long 
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lifetime of the wire [9]. Thus, the length of the SMA wire may be determined by the physical 
constraints of the device. If physical constraints are not an issue, the length of the SMA wire may 
be determined conservatively by dividing the desired stroke,  , by the operating strain of the SMA 
wire.  
With the values of the SMA wire parameters identified, the stress/strain material curves are 
transformed to engineering force/displacement by multiplying the stress by the total cross sectional 
area of the two wires to obtain force, and multiplying the strain by the length of each wire to obtain 
displacement. This engineering view is commonly used in actuator design as it provides a useful 
visualization in cases with a simple system load, and where the specific contributions of various 
system loads and the SMA wire parameters are subject to design changes [10]. In the Instrumented 
SMA Driven Ratchet, however, the SMA wire dimensions are fixed due to the particularly tight 
packaging constraints within the device, leaving the reset spring as the primary component subject 
to design. Also, the system loading in the Instrumented SMA Driven Ratchet is different in the 
heating and cooling portions of the actuation cycle. In the engineering view, the coupled 
relationship between the two parts of the cycle is unclear, and a new view is required which allows 
for visualization of these varying loads with respect to the reset spring.  
3.2.1.2. Transformation from Engineering Force-Displacement to Reset View 
In the design of the Instrumented SMA Driven Ratchet, the various system loads can be 
predicted prior to design. This allows these loads to be decoupled and grouped with the two 
material curves, shifting them into a different coordinate frame, thus creating a unique view which 
isolates the reset spring. To isolate the load on the spring, the system forces in Equations 1 and 2 
may be recast as  
 𝐹      
 = 𝐹   
 − 𝐹 𝑦 
  
                 = 𝐹   
 − (𝐹      𝑜 + 𝐹     𝑒 ) 
(6) 
 𝐹      
 = 𝐹   
 + 𝐹 𝑦 
  
= 𝐹   
 + (𝐹     𝑒 + 𝐹      𝑜 + 𝐹𝑏𝑜𝑤𝑒𝑙) 
(7) 
The right hand side of Equations 5 and 6 are graphically depicted as a downward shift of the 
austenite curve by 𝐹 𝑦 
  and an upward shift of the martensite curve by 𝐹 𝑦 
 , as shown in Figure 
3.5c. This final transformation leads to the Reset View, where the shifted austenite and martensite 
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curves, ?̂? 𝑚 
 
= 𝐹   
 − 𝐹 𝑦 
  and ?̂? 𝑚 
 
= 𝐹   
 + 𝐹 𝑦 
 , are plotted. Since this 
transformation is into the force-deflection space of the reset spring, the parameters of an 
appropriate reset spring can be directly found from the Reset View. 
3.2.1.3. Reset Spring Selection  
To determine the maximum reset spring stiffness that will produce the desired stroke, the hard 
stop location, 𝑑  , and desired stroke,  , must be determined by the designer. An important 
element of the device’s ratcheting mechanism is its adjustable hard stop, which is used to limit the 
martensite strain of the device, limit the expansion of the device to one groove of the pushrod, and 
mitigate the effect of SMA performance degradation [9]. For the ratcheting mechanism, a small 
incremental expansion of the device can be specified to enable fine adjustments to the load or 
displacement applied to the bowel. This desired stroke,  , is usually selected conservatively as 
some amount greater than the groove pitch,   , of the pushrod, and determines the appropriate 
position of the hard stop. The hard stop is separated by the stroke length from the point A on the 
transformed austenite SMA curve, which intersects the horizontal line defined by the maximum 
allowable SMA force 𝐹 𝑚 
 |
𝑚 𝑥
 transformed into the reset view (i.e. shifted downward by 𝐹 𝑦 
 ). 
Therefore, the maximum spring stiffness equals the slope of the line connecting two points: 1) the 
point A, where the transformed maximum force line intersects the transformed austenite curve (at 
position 𝑑  −  ) , and 2) the point B, where the vertical line at the hard stop position intersects 
the transformed martensite curve (at position 𝑑  ) as shown in Figure 3.5d,  
 
𝑘𝑚 𝑥 =
?̂? 𝑚 
 
|
𝑑ℎ𝑠−𝛿
− ?̂? 𝑚 
 
|
𝑑ℎ𝑠
 
  
(8) 
This is the maximum feasible spring stiffness that gives the desired stroke, since a larger 
stiffness line will intersect the transformed austenite and martensite curves at points horizontally 
closer together than the desired stroke. By using a more compliant reset spring, the design becomes 
robust to unexpected increases of the external load, ratcheting load, or friction load by intersecting 
the vertical hard stop line at a larger value of force. If a reset spring with a stiffness below the 
maximum value cannot be found, the SMA wire diameter should be increased to the next largest 
available diameter, the SMA curves re-transformed, and Equation 8 reapplied. The Reset View 
allows the direct visualization of the impacts of changes in reset spring selection and is useful to 
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guide the selection when considering issues such as robustness to unexpected external loads and 
additional safety factors in stroke. 
 To apply the Reset View design methodology, the values of 𝐹 𝑦 
 and 𝐹 𝑦 
  must be 
determined. For the Instrumented SMA Driven Ratchet, the forces that contribute to 𝐹 𝑦 
 and 
𝐹 𝑦 
  are the ratcheting force, predicted by an analytic model developed in the next section, the 
maximum expected external force from the tension of the small bowel tissue, experimentally 
characterized in Section 3.3.1, the seal force on the pushrod, which was measured with a rod 
similar in size to the pushrod and the seal material, and the force of friction, which is conservatively 
estimated. 
3.2.2. Analytical Ratchet Model 
The Reset View requires a prediction of the force, 𝐹     𝑒 ,  within the ratchet mechanism to 
define the transformations of the SMA material curves. Predicting this force requires the selection 
of the rack tooth and pawl geometry which is selected based on packaging constraints, load bearing 
capacity, self-locking condition, and a slide/skip mode reengagement requirement. For a given 
tooth and pawl geometry, an analytical kinematic model of the ratchet is developed which provides 
the relationship between the rack displacement and pawl angle as the pawls are disengaged. This 
kinematic model is used in an analytical quasi-static kinetics model to predict the force required 
 
Figure 3.5. Reset View Design Process. 
The austenite and martensite curves (a) are scaled from stress/strain to load/displacement (b) based on 
the SMA diameter and length, adding in a max SMA load line from the maximum recommended SMA 
stress. The Reset View (c) is created from this engineering view by shifting the martensite curve up 
by 𝐹 𝑦 
 , and shifting the max SMA load and austenite curves down by 𝐹 𝑦 
 . In this view, an 
appropriate reset spring is easily specified (d). 
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to displace the rack while disengaging the pawls against their bias springs. This force is used as 
one component of the shifting transformation in the Reset View methodology. 
3.2.2.1. Tooth and Pawl Geometry 
Five length parameters define the pawl and profile of the pushrod referenced in the fully 
engaged position shown in Figure 3.6a: the 𝑥 (normal to the pushrod) and 𝑦 (along the pushrod) 
components of the distance from the pivot to the tip of the pawl, 𝑡𝑥 and 𝑡𝑦,  the depth of the pawl 
and pushrod teeth, 𝑙𝑥, and the pitch of the teeth   =𝑙𝑦𝑑 + 𝑙𝑦 , where asymmetric profiles are 
allowed (𝑙𝑦𝑑 ≠ 𝑙𝑦 ). These parameters define the geometry of the mechanism while the pawls are 
engaged, supporting a load, and while the pushrod is displaced by the actuation system a distance, 
𝑦   𝑘, measured relative to the fully engaged position, causing the pawls to disengage, rotating by 
an angle 𝜃  𝑤𝑙 (Figure 3.6b). The design of the geometric parameters that define the pawl and rack 
must balance requirements governed by several factors: physical space constraints of the small 
bowel lumen, the load bearing capacity of the rack and pawl teeth, the self-locking condition, and 
the desired slide/skip reengagement behavior of the ratcheting mechanism. 
 
Figure 3.6. Geometry of Ratchet Model. 
Five geometric parameters are introduced to develop the kinematics of the rack and pawl: 𝑡𝑥, 𝑡𝑦, 𝑙𝑦𝑑, 
𝑙𝑦 , and 𝑙𝑥. The length and width of the pawl are defined by 𝑡𝑦 and 𝑡𝑥, respectively, and 𝑙𝑦𝑑, 𝑙𝑥, and 
𝑙𝑦  define the profile of the rack. The kinematics define the angle of the pawl, 𝜃  𝑤𝑙, as function of the 
rack displacement, 𝑦   𝑘. 
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3.2.2.1.1. Packaging Constraint 
These five geometric parameters must be selected such that throughout the rack displacement, 
𝑦   𝑘, the entire mechanism fits within the lumen of the bowel defined by its inner diameter, 
𝑑𝑏𝑜𝑤𝑒𝑙, which restricts the dimensions of the pushrod and pawls as illustrated in Figure 3.6b. For 
the mechanism and its casing to fit within the bowel, the largest width of the ratchet components 
when the pawls are disengaged to their maximum angle, 𝜃   = max𝜃  𝑤𝑙, must be less than the 
inner diameter of the bowel minus twice the thickness of the outer casing, such that 
 
2 (   (𝜃   ) (
 
2
 𝑥 + 𝑡𝑥) +    (𝜃   )(𝑡𝑥 + 𝑙𝑦𝑑) + 𝑙𝑥) + 𝑑 𝑜𝑑 < 𝑑𝑏𝑜𝑤𝑒𝑙 − 2 𝑡   𝑒   (9) 
3.2.2.1.2. Load Bearing Capacity 
In addition to meeting this packaging constraint, the dimensions of the pushrod grooves and 
pawl teeth must be designed to bear the external load on the mechanism without yielding. This 
requirement may be met analytically using approximation equations such as those appearing in 
textbooks for the design of gear teeth and power screws [11], or numerically using standard FEM 
analysis. The pushrod diameter is designed to satisfy the Euler buckling criterion, and its length is 
guided by the desired net expansion of the device. 
3.2.2.1.3. Self-Locking Condition 
When bearing a load, the pawls must remain engaged and not be forced outward, allowing the 
ratchet to be back-driven. The geometry of the pawls and teeth determine whether the mechanism 
is self-locking without help from friction or the bias springs. The self-locking condition is derived 
geometrically by ensuring that the line of action of the force from the rack on the pawl, 
perpendicular to the pawl contact face and defined by the angle 𝛽1, induces an inward moment 
about the pawl hinge, as shown in Figure 3.7. This angle must be less than the angle 𝛽2 which 
defines the line connecting the center of this contact face to the hinge center. In terms of the tooth 
and pawl geometric parameters, this criterion can be expressed as 
 
𝑙𝑦 
𝑙𝑥
<
𝑡𝑥 −
 
2 𝑙𝑥
𝑡𝑦 +
 
2 𝑙𝑦 
  (10) 
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3.2.2.1.4. Pawl Reengagement Slide / Skip Mode 
 There are three possible configurations for the interaction between the pawl and rack as the 
pushrod is actuated forward depending on the tooth and pawl geometry: slide, skip, and slide/skip. 
In the skip configuration, the pawl does not contact this surface at all, but immediately skips to the 
front face of the next tooth on the rack under the action of the pawl bias springs. In the slide/skip 
configuration, the tip of the pawl contacts the back surface of the rack tooth during only the first 
part of the reengagement, and skips to the next tooth after sliding a portion of the distance down 
the tooth. In the slide configuration, the tip of the pawl contacts the back surface of the rack tooth 
for the entire reengagement. Sliding during reengagement needs to be avoided since sliding friction 
can cause extra wear, and can cause the pawls to bind and not properly reengage. To avoid the full 
slide configuration, the tooth and pawl geometry must be designed such that the arc traced by the 
pawl tooth tip around its hinge is at least tangent to the back face of the tooth when the pawl is 
fully engaged,  
 𝑙𝑦 
𝑙𝑥
<
𝑡𝑥
𝑡𝑦
  (11) 
 
Figure 3.7. The Self Locking Criterion. 
If the net moment on the pawl tends to rotate the pawl 
toward the pushrod, the mechanism is self-locking (without 
the aid of friction) and cannot be back-driven unless the 
teeth on the pawl or pushrod are sheared. 
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A more restrictive condition is that the tooth and pawl geometry completely avoid sliding, 
where the skip configuration requires that the tangency condition be satisfied at the tooth tip such 
that  
 
𝑙𝑦 
𝑙𝑥
<
𝑡𝑥
𝑡𝑦
+
2𝑡𝑦
2𝑡𝑥 − 𝑙𝑥
− 2√
𝑡𝑦
2 + (2𝑡𝑥 − 𝑙𝑥)𝑙𝑥
𝑙𝑥 − 2𝑡𝑥
  (12) 
The self-locking criterion (Equation 10) is closely related to these two conditions, as both are 
derived based on the direction of the tooth/pawl contact normal and the pawl hinge tangent line 
relative to the hinge point. Requiring the skip configuration (Equation 12) implies that the self-
locking criterion is met, while the self-locking criterion implies that the full slide configuration is 
avoided (Equation 11). Therefore, the skip configuration, the most restrictive condition of these 
three, provides the design criterion which, in combination with the packaging constraint (Equation 
9) and the requirement that the teeth bear the axial pushrod loads without yielding provides the 
basis for selecting the geometry of the rack teeth and pawls. 
3.2.2.2. Ratchet Force Model 
Given the tooth and rack geometry, the force required by the actuation system to disengage 
the ratchet, 𝐹     𝑒 , is computed. To calculate this force, the kinematics are defined which relate 
the angle of the pawl, 𝜃  𝑤𝑙, as the rack is displaced 𝑦   𝑘 by the actuator, disengaging the pawls. 
From this relationship, the corresponding force required by the actuator is derived from the ratchet 
disengagement kinetics as a function of the pawl angle and rack displacement from which the peak 
value may be computed. 
3.2.2.2.1. Ratchet Disengagement Kinematics 
The ratchet disengagement kinematics model provides the pawl angle, 𝜃  𝑤𝑙, as a function of 
the rack displacement, 𝑦   𝑘, while the pawl disengages (rotates away from the rack). The 
kinematics are derived by defining the vector  as the relative position of the contact point between 
the pawl face and the tip of the rack tooth relative to the pawl pivot as shown in Figure 3.8. Since 
the displacement of the rack under the influence of the actuation system is only vertical, the 𝑥 
component of this vector remains constant while the 𝑦 component changes with the vertical 
displacement of the rack, 𝑦   𝑘, such that 
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 = [
𝑙𝑥 − 𝑡𝑥
𝑦   𝑘 + 𝑡𝑦 − 𝑙𝑦𝑑
]. (13) 
Relating this vector to the angle of the pawl requires the definition of two fixed geometric 
parameters which are properties of the rack and pawl geometry, the tooth angle, 𝜃 , and the pawl 
base length, 𝑡𝑦 . The tooth angle, 𝜃 , is the angle relative to the 𝑦 axis of the contact face between 
the pawl and the rack when the pawl is fully engaged and is expressed in terms of the rack 
geometric parameters as 
 
𝜃 = ata 
𝑙𝑥
𝑙𝑦𝑑
  (14) 
The pawl base length, 𝑡𝑦 , is the length of the line along the 𝑦 axis connecting the pawl pivot point 
to the intersection of the extension of the pawl contact face and the 𝑦 axis. Referencing the fully 
engaged position, the pawl base length is 
 
𝑡𝑦 = 𝑡𝑦 − 𝑙𝑦𝑑 −
𝑡𝑥 − 𝑙𝑥
ta 𝜃 
  (15) 
The pawl angle, 𝜃  𝑤𝑙, is the difference between the tooth angle, 𝜃 , and the sum of two 
additional angles, 𝜃  and 𝛼, which vary with 𝑦   𝑘 as shown in Figure 3.7. The first of these angles, 
𝜃 , is defined between the vector   and the 𝑦 axis. 
 
Figure 3.8. Geometric Definitions of Disengagement Kinematics. 
The geometric definitions concerning the disengagement kinematics of the 
pawls are shown. The contact vector,  , relates the rack displacement, 𝑦   𝑘, 
to the angle of the pawl, 𝜃 . 
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𝜃 = ata 
𝑡𝑥 − 𝑙𝑥
𝑦   𝑘 + 𝑡𝑦 − 𝑙𝑦𝑑
  (16) 
The second of these angles, 𝛼, is defined between the vector   and the contact face of the pawl. 
This angle is computed using the law of sines for the triangle defined by the pawl pivot, O, the 
contact point at the head of  , and the intersection point B between the extension of the pawl 
contact face and the centerline of the pawl rotated an angle 𝜃  𝑤𝑙 from the 𝑦 axis (which lies at a 
distance 𝑡𝑦  from the pivot). The law of sines for this triangle states that  
 𝑡𝑦 
   𝛼
=
‖ ‖
   (𝜋 − 𝜃 )
  (17) 
Substituting the definition of   (Equation 13) and solving for the angle 𝛼 yields 
 
𝛼 = a   
𝑡𝑦    𝜃 
√(𝑡𝑥 − 𝑙𝑥)2 + (𝑦   𝑘 + 𝑡𝑦 − 𝑙𝑦𝑑)
2
  
(18) 
Using these definitions of the angles 𝜃  and 𝛼, the pawl angle, 𝜃  𝑤𝑙, can be expressed in terms of 
the rack displacement as 
 𝜃  𝑤𝑙 = 𝜃 − (𝜃 + 𝛼), (19) 
where 𝜃  is constant and 𝜃  and 𝛼 are functions of the rack displacement, 𝑦   𝑘, according to 
Equations 16 and 18. This equation for 𝜃  𝑤𝑙 provides the kinematic relationship which is used to 
compute the forces within the ratchet mechanism that are later used in the design process of the 
actuation system. 
This kinematic expression for the pawl angle in terms of the rack displacement is valid as the 
rack displaces until the tip of the pawl contacts the tip of the rack tooth at a critical displacement, 
𝑦   . In the skip mode of the ratchet, this displacement is larger than the tooth pitch since after the 
tip configuration is reached the pawl skips down to contact the next rack tooth, passing the next 
fully engaged position. To find this displacement, the length of the vector   is set equal to the 
distance from the pawl pivot to the pawl tooth such that  
 
‖ ‖𝑦𝑟𝑎𝑐𝑘=𝑦𝑡𝑖𝑝 = √𝑡𝑥
2 + 𝑡𝑦
2  (20) 
Substituting the definition of   (Equation 13) and solving for 𝑦    yields 
97 
 
𝑦   = 𝑙𝑦𝑑 − 𝑡𝑦 +√𝑡𝑦
2 + 2𝑙𝑥𝑡𝑥 − 𝑙𝑥
2  (21) 
This displacement provides the maximum pawl angle, 𝜃   , by substituting into the kinematics 
expression for 𝜃  𝑤𝑙 (Equation 19), thus determining the maximum pawl angle used in the 
packaging constraint in Equation 9 when designing the geometry of the teeth and pawls. 
3.2.2.2.2. Ratchet Disengagement Kinetics 
The force, 𝐹     𝑒 , applied by the actuation system as the pushrod is advanced while forcing 
the pawls outward against the pawl bias springs is found in two steps: 1, summing the moments 
acting on the pawl about the pawl pivot to find the contact forces between the pawl and the rack, 
and 2, projecting the resulting normal and frictional contact forces onto the 𝑦-axis of the 
mechanism, along the direction of actuation. The forces and moments acting on the pawl are shown 
in right-side pawl of Figure 3.6b. The moment,  , from the pawl bias spring forces the pawl against 
the rack tooth creating a contact force,   , normal to the pawl contact surface. A corresponding 
friction force,   , acts along the pawl contact surface as the rack slides forward along the surface 
forcing it outward. Resultant forces ( 𝑥 and  𝑦) create no moment about the pawl pivot such that 
the moment balance about the pivot, assuming quasi-static motion, is 
  × (  +   ) +  =  , (22) 
where the vector   from the pawl pivot to the contact point is a function of the displacement of the 
rack from the pawl disengagement kinematics (Equation 19), and the pawl bias spring moment,  , 
is in general, a function of the pawl angle, 𝜃  𝑤𝑙.  
 The normal force,   , on the pawl is a scalar force, 𝐹 , in the direction of unit normal,  ̂𝟎, 
to the contact surface in the fully engaged position (𝑦   𝑘 =  ) rotated by the pawl angle, 𝜃  𝑤𝑙. 
Using a standard planar rotation matrix, the normal force is 
 
  = [
   𝜃  𝑤𝑙    𝜃  𝑤𝑙
−   𝜃  𝑤𝑙    𝜃  𝑤𝑙
]  ̂𝟎𝐹 , (23) 
where the initial unit normal,  ̂𝟎, is a function of the tooth and pawl geometry expressed as  
 
 ̂𝟎 =
 
√𝑙𝑦𝑑
2+𝑙𝑥
2
[
𝑙𝑦𝑑
𝑙𝑥
]  
(24) 
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The friction force,   , is found by rotating    by 90 degrees counter-clockwise and scaling by a 
Coulomb friction coefficient, 𝜇, yielding 
 
  = [
 − 
  
] [
   𝜃  𝑤𝑙    𝜃  𝑤𝑙
−   𝜃  𝑤𝑙    𝜃  𝑤𝑙
]  ̂𝟎𝐹 𝜇  (25) 
These normal and friction forces are determined by substituting their expressions (Equations 23 
and 25) into the moment balance (Equation 22). Using the pawl disengagement kinematics 
(Equation 19) for the pawl angle, 𝜃  𝑤𝑙, in terms of the rack displacement, 𝑦   𝑘 , and solving the 
moment balance for the scalar normal force, 𝐹 , yields 
 𝐹 =
− 
   (𝛾) (𝐶𝑥0𝜇 − 𝑦   𝑘 − 𝐶𝑦0) +    
(𝛾) (𝜇 (𝑦   𝑘 + 𝐶𝑦0) + 𝐶𝑥0)
 (26) 
where, 
 
𝛾 = 𝜃  𝑤𝑙 + ta 
−1 (
𝑙𝑦𝑑
𝑙𝑥
), (27) 
 𝐶𝑥0 = 𝑙𝑥 − 𝑡𝑥 , (28) 
and 
 𝐶𝑦0 = 𝑡𝑦 − 𝑙𝑦   (29) 
The force applied by the actuation system to displace the rack while disengaging the 
pawls, 𝐹     𝑒 , is computed from this resulting expression for the normal force and the 
corresponding friction force by projecting sum of the friction and normal force vectors,    and   , 
onto the positive y-axis where  
 𝐹     𝑒 = [  ](  +   )  (30) 
This expression provides the required ratchet force which is used in the design of the actuation 
system following the Reset View methodology. 
3.3. Prototype 
The specified components, fabrication, and assembly of the ratcheting mechanism and data 
acquisition and control system are presented here. To realize a design for the SMA actuator and 
reset spring of the ratcheting mechanism, the Reset View Design Methodology developed in 
section 3.2.1 was applied. However, prior to applying the Reset View Design Methodology, the 
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experimental determination of a safe range of applied tensile loads was conducted to determine 
the value of 𝐹𝑏𝑜𝑤𝑒𝑙. The ratcheting mechanism and other components were fabricated both by 
traditional milling and by rapid prototyping with a Stereolithography machine. The electronics of 
the data acquisition and control system were manually soldered onto custom printed circuit boards 
manufactured by a commercial board house. 
3.3.1. Determination of Safe Applied Bowel Tension Range 
The specification of 𝐹𝑏𝑜𝑤𝑒𝑙, the operating load against which the ratcheting mechanism should 
extend, is governed by the range of tensile loads that may safely be applied to porcine small bowel 
tissue to induce its growth. Although important for the design of the ratcheting mechanism, the 
knowledge of the safe range of tensile loads is also important to maintain the health of the pigs in 
which the devices are implanted. The two main health risks involved in the application of tensile 
load on the small bowel are 1) damage due to tissue ischemia caused by the constriction of blood 
vessels of the tensioned bowel tissue or mesentery, and 2) damage due to tissue tearing or severe 
tissue disruption. To establish the upper bound of the safe loading range, in vivo and ex vivo tensile 
loading experiments were performed and are summarized in this section. For greater detail, please 
refer to Miyasaka, et al [12]. 
3.3.1.1. Acute In Vivo Testing of Ischemic Failure Limit 
To evaluate the tensile loads that lead to bowel and mesentery ischemia, segments of bowel 
tissue were tensioned in vivo by an early design iteration of the Instrumented SMA Driven Ratchet. 
The experiments were conducted in vivo because their goal was to evaluate the change in blood 
flow within the bowel and mesentery as the applied tension to the bowel was increased. The 
segments of bowel were tensioned to approximately 30, 60, 90, 120, 160 and 200 gf by a previous 
bowel extending device. The velocity of the blood flow was evaluated using a laser Doppler 
imaging system, shown in Figure 3.8, which scanned the tensioned tissue at each of the 
aforementioned magnitudes of tension. 
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Results from the experiment indicate that blood flow was present within the mesentery for all 
of the applied loads, but the blood flow within the bowel tissue was partially restricted at 
approximately 90 gf, and completely stopped at 120 gf. The area of tissue which became acutely 
ischemic during the experiments is where the end of the pushrod abutted the tissue, compressing 
it. The risk of bowel ischemia is that the tissue may become necrotic, or dead, which could cause 
the weakened bowel tissue to rupture, allowing the enteral contents of the isolated bowel segment 
into the abdomen. Thus, the study recommended an upper limit on the applied load of 90 gf. 
3.3.1.2. Ex Vivo Testing of Mechanical Failure Limit 
To evaluate the tensile loads that lead to bowel tearing and/or the onset of severe tissue 
disruption, a series of ex vivo tensile load experiments were performed. With the experimental 
setup shown in Figure 3.10, tensile load was applied to segments of small bowel tissue (with the 
mesentery intact) excised from a pig. Load was transferred to the tissue, which was submerged in 
a 40°C 0.9% saline bath to best mimic physiological conditions, by a string passing through two 
pulleys with a weight attached to one end. The bowel segments ranged from 10 to 15 cm in length, 
and were attached to the edge of the saline bath and to the string by plastic adaptors on which the 
bowel was sutured. The applied load was increased from 0 gf to 1 kgf, or until tissue failure, by 
 
Figure 3.9. In Vivo Tensile Loading Setup. 
Small bowel segments were tensioned by the Instrumented SMA 
Driven Ratchet. As the applied tension was increased, a laser 
Doppler imaging system was used to determine the velocity of 
blood flow in the mesentery and small bowel. 
Scanning Head of Laser 
Doppler Imaging System
Bowel Segment with 
Implanted Extender
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increments of 20-40 gf every two minutes. After each segment of bowel tissue was tensioned, 
tissue samples were taken for histological review. 
Over the six trials of the experiment, the results had significant variation. Three segments of 
bowel tissue withstood up to 1 kgf, the upper limit specified by the experimental protocol, without 
tearing. In one segment, the mesentery of the bowel tore at 235 gf. In the remaining two segments, 
the bowel wall failed at 515 gf and 595 gf. While the maximum load that the bowel and mesentery 
could withstand without damage varied from 235gf to 1kgf, all of these tests resulted in applied 
loads which significantly exceeded the recommend load of 90gf from the in vivo experiments. 
Thus, it is clear that risk of bowel ischemia is the limiting factor on the range of loads that may 
safely be applied to the bowel tissue. To reduce the chance of health complications associated with 
loading the bowel, an upper limit on the applied load of 90 gf was determined. 
3.3.2. Application of Reset View Design Methodology 
Using the Reset View methodology outlined in Section 3.2.1 to design the actuation of the 
Instrumented SMA Driven Ratchet involves the transformation of the SMA stress-strain curves 
into the force-displacement space of the reset spring using the diameter and length of the SMA 
 
Figure 3.10. Ex Vivo Experimentation Setup. 
Small bowel segments were submerged in 40°C saline, and tensioned 
with dead weights attached to a string through a system of two pulleys 
to determine the applied bowel tensions associated with mechanical 
tissue damage. 
Pulleys
Small Bowel Segment
40 C Saline Bath
Plastic Adapters
String (drawn for visibility)
Applied Weight
(not shown, is attached to string)
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wires as well as the system forces 𝐹 𝑦 
  and 𝐹 𝑦 
 . The system forces are composed of the ratchet 
force, 𝐹     𝑒 , derived from the model in Section 3.2.2.2, the force to be applied to the bowel, 
𝐹𝑏𝑜𝑤𝑒𝑙, bounded in Section 3.3.1, the friction force, 𝐹      𝑜 , between the sliding components 
within the device that was conservatively estimated, and the force required to slide the pushrod 
through the seal, 𝐹 𝑒 𝑙, which was measured experimentally. The design process is presented in 
five steps: 1) define the geometric parameters of the pawl and rack, 2) predict the loads, excluding 
the contribution of the reset spring, experienced by the SMA wire in its austenite and martensite 
phases to specify the shifting transformations of the material curves into the Reset View, 3) 
determine candidate SMA wire diameters and length based on these forces and the device package 
size, 4) select the maximum operating stress of the wire and desired stroke, and 5) use the resulting 
motion limits with the transformed SMA curves in the Reset View to determine the feasibility of 
each SMA wire diameter and the corresponding maximum reset spring stiffness. 
The first step of the Instrumented SMA Driven Ratchet design was to select ratchet pawl and 
rack parameters which are driven by the packaging, stepping, and load bearing constraints 
presented in the tooth and pawl geometric model in Section 3.2.2. In this porcine case study, the 
ratcheting mechanism of the device was constrained to fit within a case with a wall thickness, 
𝑡   𝑒, of 0.03 inches and an 11/16 inch outer diameter sized to fit within the 0.75 inch diameter 
bowel lumen, 𝑑𝑏𝑜𝑤𝑒𝑙. The tooth and pawl geometries were limited by the packaging constraint 
from Equation 9. To safely regulate the extension and force applied to the bowel, a small step size, 
  = 𝑙𝑦 + 𝑙𝑦𝑑, of 0.05 inches was selected. The design of the tooth and pawl geometries was 
guided by this step size, the requirement of full-skip reengagement (Equation 12), which implies 
the self-locking condition (Equation 10), and an FEM-based stress analysis to ensure that the 
ratchet can safely bear a 5 lb load (well above the forces required by the application). The resulting 
geometric parameters are listed in Table 3.1. 
Table 3.1. Geometric Parameters of Pawl and Pushrod 
 
tx 0.1027 in
ty 0.0834 in
lyd 0.0234 in
lyr 0.0234 in
lx 0.0261 in
wx 0.0757 in
drod 0.1200 in
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The second step of the design process was to predict the forces which define the shifting 
transformations into the Reset View. A maximum bowel force, 𝐹𝑏𝑜𝑤𝑒𝑙, of 90 gf was obtained from 
the ex vivo and in vivo bowel tension tests described in Section 6, which was doubled for robustness 
purposes in the design. The friction force from the sliding components of the device, 𝐹      𝑜 , was 
conservatively estimated as 100 gf. The seal force, 𝐹 𝑒 𝑙, was measured to be approximately 150 
gf by pushing a 0.14 inch diameter threaded rod of a similar diameter and tooth pitch to the 
designed pushrod through a 1/16 inch hole punched in a 3/16 inch thick sheet of Viton® foam seal 
material. To compute the peak force to disengage the ratchet, 𝐹     𝑒 , the pawl bias spring torque, 
 , was measured as 0.00285 lbf-inch/deg with a pre-load of 0.0064 lbf-inch in the fully engaged 
position by bending the superelastic SMA wire springs through small angles with a load cell. Using 
the rack and pawl geometric parameters given in Table 3.1, Equation 30 of the ratcheting model 
described in Section 3.2.2 was used to calculate the peak force experienced by the SMA wire due 
to the interaction of the rack and pawls as 120 gf (60 gf per disengaging pawl). These forces define 
the scaling transformations for the Reset View, where the austenite curve is shifted downward by 
𝐹 𝑌 
 =220 gf (0.49 lbf), and the martensite curve is shifted upward by 𝐹 𝑌 
 =550 gf (1.21 lbf).  
The third step was to use these forces along with the packaging constraints of the device to 
compute the lower bound of the SMA wire diameter, 𝑑𝑚  , and its length. The dimensions provide 
the scaling transformations from stress and strain to force and displacement in the Reset View. A 
minimum wire diameter of 6.4 mil was determined from Equation 5 from which the next two larger 
commercially available candidate wire diameters were selected as 8 mil and 10 mil. Stress-strain 
curves for 8 mil diameter 70°C Flexinol® wire were determined experimentally by heating and 
cooling a segment of wire tensioned by an increasingly heavy dead load, the results of which were 
applied to both the 8 mil and 10 mil cases. While the maximum initial length of the device was 
specified as 6.5 inches, the length of the two parallel segments of SMA actuator wires was limited 
to 3.63 inches because of the space required for the sensing, the circular bowel attachment, and 
sealing components. This length and the candidate SMA wire diameters (8 and 10 mil) define the 
scaling from stress-strain to force-displacement, which combined with the previously determined 
system load shifts, 𝐹 𝑦 
  and 𝐹 𝑦 
 , fully define the transformation into Reset View which is 
plotted in Figure 9 for each candidate wire diameter. 
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The fourth step of the design process was to select the maximum operating stress and desired 
stroke of the SMA wire which defines the hard stop location. A maximum stress on the wire of 
180 MPa was selected from the manufacturer’s specifications, which translates to a net maximum 
SMA force of 2.62 lbf and 4.10 lbf for the 8 and 10 mil cases which are transformed and plotted 
as horizontal lines on the Reset View plots (Figure 3.11). A desired stroke,  , was conservatively 
set as 0.145 inches, which is just over three times the 3/64 inch tooth pitch,   . This sets the hard 
stop location at 0.155 inches, which is defined by the location of the intersection between the 
transformed austenite curve and the transformed maximum SMA force line shifted by the 0.145 
inch desired stroke (point labeled A and marked with a vertical line in Figures 9a and 9b at 0.01 
inches). 
The fifth design step is to use these stroke limits and the transformed SMA curves to determine 
the maximum allowable reset spring stiffness, 𝑘𝑚 𝑥. The intersection between the hard stop 
vertical line and the transformed martensite curve (point labeled B in Figures 9a and b), along with 
the maximum SMA force intersection at A, define the maximum allowable spring constant, 𝑘𝑚 𝑥, 
as described by Equation 7. For the wire diameters of 8 and 10 mil, the maximum values of the 
reset spring constants were 0.7 lbf/in and 7.5 lbf/in, respectively. The 8 mil wire is capable of 
providing the desired force and stroke, but with very little force available for design adjustment 
and robustness. In addition, compression springs capable of producing the required forces are 
generally not available with such a low stiffness. Therefore, the 10 mil wire diameter was chosen 
to allow a range of design adjustments, and for which a wide variety of rest springs is available 
that satisfy the 7.5 lbf/in maximum spring stiffness limit. Softer springs are also feasible depending 
on the variety of commercially available springs and the packaging limits of the device, and the 
Reset View enables the visualization of the performance and robustness implications for alternate 
(more compliant) spring selections. 
105 
3.3.3. Ratcheting Mechanism Prototype 
The ratcheting mechanism was assembled mostly of components fabricated by the Viper™ 
SLA® rapid prototyping system from 3D systems, from a propriety material called Accura 60. 
The rapid prototyped components, which are the translucent parts shown in Figure 3.12d, include 
the ratchet pawls (4x), the outer casing, the end cap, the circular attachment, and the rear and front 
housing. The pawl bias springs (4x), are 0.175 in long segments of 15 mil diameter superelastic 
SMA mounted to the rear and front housing with epoxy. The pushrod is a circular rack machined 
from a 0.1875 diameter stainless steel rod using a 60 degree angle cutting drill-mill to create the 
angular grooves. The pushrod attachment was machined from Delrin, and given holes for allowing 
the passage of enteral contents. To seal the device from enteral contents, the outer casing, circular 
 
Figure 3.11. Reset View Design of Actuator with 8 and 10 mil SMA Wire. 
The Reset View Design Methodology is applied to the design of the bowel extender for two SMA 
diameters. In the 8 mil design, a spring constant less than or equal to 0.7 lbf/in (0.12 N/mm) was required 
to achieve the desired stroke. A commercially available spring with a lower or equal spring stiffness 
designed for the operating loads (approximately 2 lbf) could not be specified. In the 10 mil design, the 
spring constant must be equal to or less than 7.5 lbf/in (1.3 N/mm) to achieve to same desired stroke. In 
the final design, the 10 mil SMA wire was chosen because many commercially available springs could 
be selected to meet the design, and a spring with a stiffness of 5.1 lbf/in (0.9 N/mm) was specified. 
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attachment, and end cap are coated with room temperature vulcanizing silicone adhesive, and the 
pushrod/outer casing interface was sealed with a laser cut annular Viton® seal affixed to the outer 
casing. The only materials exposed to the enteral contents directly are Delrin (pushrod attachment), 
stainless steel (pushrod), Viton (pushrod seal), and silicone (encapsulates device body), all of 
 
Figure 3.12. Prototype of Instrumented SMA Driven Ratchet. 
Schematic section views and photographs display the designed and fabricated Instrumented SMA 
Driven Ratchet (a). A detailed view (b) shows small components of the ratcheting mechanism, and a 
diagram of the ratchet pawl and rack (c) defines the important geometric design parameters. Translucent 
components were fabricated using an SLA printer and all other components were manually fabricated. 
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which are sufficiently biocompatible for short-term (< 1 month) intraluminal small bowel 
implantation. 
The SMA wire (10 mil Flexinol® wire, Dynalloy) was mounted through two stainless steel 
vented screws with brass crimps, and routed around a stainless steel SMA guide machined from 
3/8 inch outer diameter tubing. The vented screws allowed the SMA wire to be tensioned 
accurately after installation. To reduce the chance of the SMA wire melting the Accura 60 material, 
1/16 inch outer diameter PEEK tubing lines the path taken by the SMA within the device. The 
SMA is symmetrically routed to eliminate binding between the front flaps and rear housing. The 
electrical connections to the actuator were made at the stainless steel guide and the two brass 
crimps, which are electrically connected at the front housing. The reset spring (P/N 70812, from 
Century Spring) was placed between the front and rear housing and pushes the front housing 
forward until the Martensite hard stop is engaged, resetting the SMA to the desired Martensite 
strain. 
3.3.4. Data Acquisition and Control System Prototype 
The data acquisition and control system comprises the load sensor, displacement sensor, and 
the three electronic circuits that sample the load and displacement sensors, transmit/receive data 
to/from the PC interface, and drive the SMA wire actuator. The displacement and force sensors 
are mounted on the rear housing, as shown in Figure 3.12a. The Hall Effect sensor (SS495, 
Honeywell) was mounted such that as the front housing is drawn closer to the rear housing, a 
permanent magnet mounted on the front housing causes an increase in the output of the Hall Effect 
sensor. The load cell (LPM-510b, Cooper Instruments) is mounted on the end of the rear housing, 
and its wires are routed through the rear housing to reach the Bowel Extender Circuit. Load is 
transferred from the circular bowel attachment, which is not rigidly fixed to the rear housing or 
end cap, to the load cell. The load path to the sensor is not direct due to the presence of the silicone 
seal, but it was accounted for in the sensor calibration which was performed with the seal in place 
at a typical internal temperature for a pig (39° C) in a saline bath. External loads on the device that 
are not caused by the small bowel tissue tension are not measured by the load sensor, because the 
end cap is rigidly attached to the rear housing with 0-80 stainless steel screws. Thus, the effect on 
the load sensor output caused by the pig’s position and activity is minimized. 
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To create the Bowel Extender, Pack, and Base Station Circuits, electronic components were 
selected for each, the layout of each board was designed, custom printed circuit boards were 
fabricated by a commercial board house, and the components were manually soldered. The 
components selected for the Instrumented SMA Driven Ratchet electronics are shown in Table 3.2 
The choice of specific components was driven largely by the need to minimize power consumption 
Table 3.2. Data Acquisition and Control System Components. 
Component selection for the Pack and Bowel Extender Circuits was driven by the need to minimize power 
consumption and circuit size. The Base Station circuit is not designed for implantation and thus through-
hole components were selected for their ease of soldering. Furthermore, because the Base Station Circuit is 
battery powered, the power consumption of its components was not a design driver. 
 
Circuit Component Manufacturer Model Package Label in Fig. 6
Base Station and 
Pack Circuit
433 MHz Wireless Transceiver Nordic Semiconductor nRF905 32 Pin QFN 1
Bowel Extender
and Pack Circuit
Voltage Regulator (2.7 Volts) Analog Devices ADP3300 6 Pin SOT 23 2
Microcontroller Microchip PIC16F886 28 Pin DIP 3b
Base Station Circuit
Microcontroller Microchip PIC16F886 28 Pin SSOP 3a
Voltage Regulator (3.6 Volts) Linear Technology LT1086 3 Pin TO-220 4
Voltage Regulator (5 Volts) Texas Instruments TL750L 3 Pin TO-220 5
Line Driver/Receiver Texas Instruments MAX232N 16 Pin DIP 6
Optical Isolators TT Electronics OPI1264 ~ 7
Bowel Extender 
Circuit
Power MOSFET ON Semiconductor NTHD3100C 6 Pin TSOP 8
Digital Potentiometer Analog Devices 8400ARZ1 8 Pin SOIC 9
Instrumentation Amplifier Burr Brown INA 122 8 Pin SOIC 10
 
Figure 3.13. Data Acquisition and Control System Prototype. 
The tan printed circuit boards of the three circuits comprising the data acquisition and control system 
prototype were manufactured at a commercial board house and all components were manually soldered. 
Surface mount components were used to minimize the size of the implanted electronic circuits. 
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and footprint size for both the Bowel Extender Circuit and Pack Circuit. Because the Base Station 
Circuit is not implanted, size and power considerations were not important and those components 
were selected based solely on their functionality. Photographs of each circuit (Figure 3.13) show 
the layout of components and the overall circuit dimension. The Bowel Extender Circuit and Pack 
Circuit are powered by a lithium battery (Tadiran, TLM-1530MP) with a 340 mAh capacity and 
the ability to source a current pulse of up 5 amps, which is more than sufficient to drive the 1.05 
Amps (Dynalloy specification) required to heat the SMA wire. 
3.4. Benchtop Validation 
The ratcheting force model developed in 3.2.2.2 was evaluated to determine its accuracy and 
to make adjustments to the SMA wire diameter and/or reset spring design if necessary. The 
performance of the ratcheting mechanism and data acquisition and control subsystems were 
successfully validated as separate subsystems on the benchtop, and as an integrated full system in 
a two-week submersion experiment developed to mimic basic aspects of the operating 
environment with a living pig. 
3.4.1. Ratchet Model Validation 
The success of the SMA wire and reset spring design hinges on the accuracy of the predicted 
system loads on the SMA wire during the operation of the ratcheting mechanism. Thus, the system 
load curves of the Instrumented SMA Driven Ratchet prototype were experimentally measured by 
mimicking the action of the SMA wires with steel cables attached to a load transducer and 
measuring the displacement of the front housing relative to the rear housing with a displacement 
sensor. To validate the ratcheting force model, the experimental data are compared with the 
predicative model that incorporates the axial components of the load caused by the interaction of 
the rack and pawl, the friction of the front and rear housing, and the reset spring. 
3.4.1.1. Ratcheting Force Model Validation Setup 
The forces acting on the SMA wire within the mechanism were measured using the 
experimental setup shown in Figure 3.14. In this setup, the SMA wires in the Instrumented SMA 
Driven Ratchet device (with the seal removed) were replaced with steel cables attached to a linear 
motion stage through a load cell to induce motion, emulating the action of the SMA wires, while 
measuring the corresponding force. The displacement of the front housing relative to the rear 
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housing was simultaneously measured with a laser displacement probe. The force-displacement 
cycle were recorded from the load cell and laser displacement probe by a National Instruments 
data acquisition board (NI USB-6009) and LabVIEW. 
3.4.1.2. Ratcheting Force Model Validation Procedure 
Starting with the mechanism in the initial state with the reset spring forcing the front housing 
against the hard stop and the rear pawls fully engaged, the linear stage was slowly advanced, 
pulling the front housing back a total distance of 0.055 inches (slightly more than the 0.05 in rack 
pitch) emulating heating of the SMA wires. The linear stage was then slowly returned to its initial 
position, emulating cooling of the SMA wires. 
3.4.1.3.  Ratcheting Force Model Validation Results 
The collected data are plotted in Figure 3.15 against the combined predicted forces from the 
spring, 𝐹      , given its 5.1 lbf/in spring constant, the measured sliding friction in the device, 
𝐹      𝑜 , and the ratcheting force, 𝐹     𝑒 , as computed in Equation 30 from the ratchet force 
model. In Figure 3.15, the transitions of the ratcheting mechanism are labeled, corresponding with 
the labels in Figure 3.16, which shows the path of the tip of the front pawls during disengagement. 
 
Figure 3.14. Experimental Setup. 
To measure the load experienced by the SMA during normal operation, 
the SMA wire was replaced by two steel wires connected to a load cell 
fixed to a linear stage. As the linear stage was translated back and forth, 
the action of the SMA was mimicked by the steel wires. The motion of the 
mechanism was captured by a laser displacement probe. 
Load Cell
Laser Displacement Probe Linear XY Stage
Flag (darkened for visibility)Measured Displacement
Bowel Extender
Bowel Extender Mount Steel Cables (darkened for visibility)
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From  to , the steel cables begin pulling the front housing toward the rear housing, 
mimicking the action of the SMA. In this interval, the front pawls have not yet engaged the rack 
due to a 0.01 inch backlash present between the two pawl sets. In this condition, there is no ratchet 
force and the wires act against the superposition of the spring and frictional loads only, as shown 
by the sloped line connecting points  and  in both the force deflection plot (Figure 3.15) and 
the pawl tip path (Figure 3.16). Since the value of the sliding friction, 𝐹      𝑜 , in the device was 
 
Figure 3.15. Experimental Force-Displacement Results. 
The experimental data are plotted against the predictive model of the ratchet 
rack/pawl force interaction. The force displacement curve follows a sequence 
through the labeled points 1-5 as the SMA heats (red curves), and a similar 
sequence 6-9 as the SMA cools (blue curves).  Overall, the agreement is strong, 
validating of the ratchet force model. 
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Figure 3.16. Path Followed by Tip of Pawl. 
The path followed by the tip of the pawls is shown, for clarity, with numbered 
labels that correspond with those in Figure 3.15. The path is drawn for a 
stationary pushrod while the pawl is pulled to the right by the SMA actuator as 
it heats. 
1 2
3
5
4
Path followed by tip of front pawl as SMA wire 
recovers strain
Pawl
Pushrod
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conservatively estimated at 100 gf, the shift of the measured force-displacement data from the 
spring line was used to adjust this estimate where the actual friction in the device was 75 gf. The 
over estimation of 𝐹      𝑜  provides the ratcheting mechanism with an additional 25gf of actuation 
capacity against external loads, and simultaneously reduces the maximum operating load subjected 
to the SMA wires by 25 gf. With this adjustment, the measured data exactly follow the spring and 
friction prediction (within measurement noise), demonstrating the accuracy of these predictions. 
At point , the front pawls make contact with the face of the pushrod tooth, and from  to 
, the front pawls rotate outward against the pawl bias springs. In this interval, the spring and 
friction forces combine with the ratchet force, 𝐹     𝑒 , as predicted by Equation 30 as a function 
of the rack displacement, 𝑦   𝑘. Within this interval, the forces increase with decreasing slope as 
the pawl bias springs are bent and the pawl rises up the face of the tooth, with a small discontinuity 
when the pawl first contacts the rack to overcome the preload in the bias spring. Both the model 
and the experimental data exhibit this general qualitative trend, although the discontinuity is not 
pronounced in the experimental data due to compliance in the components that was not modeled. 
The total magnitude of the rise in force over the friction and spring load was measured to be 90 gf, 
which is only 22% lower than the model prediction even though many of the components and 
resulting motions were fabricated near the 0.004 inch precision limit of the rapid prototyping 
machine. The accuracy of this prediction is critical as it provides the peak ratchet force, 𝐹     𝑒 , 
used in the Reset View methodology. 
From point  to , the pawl tooth slides along the flattened tooth tip of the rack (not 
represented in the analytical model), as shown in Figure 3.16. In this interval, the ratchet force is 
no longer active since the pawl does not disengage further against the bias spring but rather 
maintains a constant angle. Instead, in addition to the device friction and spring forces, a friction 
force is generated between the pawl tip and the flat of the rack tooth due to the inward force, 𝐹 , 
produced by the pawl bias spring. A Coulomb model is used for this additional friction force, ?̃? , 
such that 
 𝐹 ̃ = 𝜇𝐹 , (31) 
where 𝜇 is the coefficient of friction experimentally measured for the Accura 60 material as 0.17. 
This friction force is constant over the flat of the rack tooth which adds to the constant device 
friction and the slope of the spring line in Figure 3.15. In this region, the experimental data does 
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not follow this shifted sloped line from  to , but rather follows a downward slope back towards 
the spring plus friction line due to compliance in the mechanism and due to the fact that the corners 
of the ratchet components are slightly rounded. 
At point , the pawl tip skips from the flat, and engages the next tooth of the pushrod as 
specified by the design of the tooth and pawl geometry. From  to , the continued motion of the 
linear stage causes the pawl to rise up the face of the next rack tooth, producing a force-
displacement curve similar to that from point  to , with further compression (and increased 
force) on the reset spring. At , the direction of motion, and thus the sliding device friction, is 
reversed, subtracting rather than adding to the spring force, and the process repeats as the rear 
pawls rather than the front pawls rotate away from the pushrod and the devices extends one tooth 
width (3/64 inch). As the mechanism resets to the initial state (emulating cooling of the SMA), the 
force due to the interaction of the rear pawls and pushrod reduces the load on the SMA, as shown 
in Figure 3.15 and predicated by Equation 2. 
The values of 𝐹      , 𝐹     𝑒 , and 𝐹      𝑜  were predicted very near or slightly over the 
actual measured forces, validating the ability of the ratchet force model to provide a useful 
prediction for the actuation system design using the Reset View methodology. With the model and 
the methodology, a wide variety of compact SMA driven ratcheting devices can be designed. The 
design was conservative because the designed strain was 4%, although less than 2% was necessary. 
The external load against which the device must actuate was doubled in the design, and the 
predictions of 𝐹     𝑒  and 𝐹      𝑜  were slightly over predicted. These conservative design 
measures suggested using a reset spring with a spring constant equal to or less than 7.5 lbf/in, 
although a spring with a constant of 5.1 lbf/in was selected, adding yet another layer of safety to 
the design. Such a conservative design was pursued because the targeted operating environment 
of the Instrumented SMA Driven Ratchet is within the bowel of a living pig, where it must be 
robust against difficult to estimate external loading conditions and the possibility of biological 
fluids leaking onto the mechanism. 
3.4.2. Ratcheting Mechanism Performance Demonstration 
The validated model provides a means for predicting the internal forces of the mechanism that 
the actuation system must overcome, providing the basis for the Reset View methodology. The 
performance of the entire device, including the designed actuation system, was experimentally 
114 
validated for its ability to actuate against a load and to demonstrate the functionality of the entire 
device. 
The prototype was designed to successfully lengthen against at least the maximum force 
expected to the applied to the small bowel tissue, 𝐹𝑏𝑜𝑤𝑒𝑙, of 90 gf. In addition to this required load, 
additional capacity was designed into the device in the form of an extra 90 gf external load 
specification, a lower spring constant, providing an additional 160 gf (0.35 lbf), an over predicted 
friction force of 25 gf, and a 25 gf over prediction of the ratcheting force model, for a total of 320 
gf of additional load capacity. Furthermore, a lubricant was added to the seal, which was not used 
in the model validation, that significantly reduced the seal force, 𝐹 𝑒 𝑙, from its measured 150 gf 
value. Moreover, the desired stroke was also extremely conservative, exceeding the required stroke 
by a factor of approximately three. Since the SMA wire need not be fully heated to austenite to 
take a step, this allows additional pre-compression on the reset spring without over-stressing the 
austenitic wire such that the spring line in the Reset View plot (Figure 9b) could be raised if needed 
to provide additional force capacity along the hard stop, and consequently against an external load. 
To demonstrate the ability of the device to extend against loads well beyond the design 
requirement, the device was positioned vertically with the pushrod pointing upward. Successive 
loads in increments of 100 gf were applied to the device by placing weights on the end of the 
pushrod. The mechanism was actuated under control of the LabVIEW interface in communication 
with the device over the wireless communication link to evaluate if the entire operation cycle could 
complete under the load. The Instrumented SMA Driven Ratchet successfully took steps under 
wireless control against all loads up to and including 800 gf, which is well beyond the design 
bowel load specification of 90 gf, and also well beyond the additional 320 gf load available from 
the specifically quantifiable extra load capacity designed into the actuation system. At 900 gf, the 
extender could not complete the entire operation because the reset spring was unable to expand 
against the combination of the system load, 𝐹 𝑦 
 , and the martensitic wire reset force, 𝐹   
 . 
The weight was reduced to 850 gf, against which the mechanism could reliably actuate. 
Although the force the mechanism can produce is much higher than the safe loading limit on 
the bowel of 90 gf, the additional load capacity may be needed to overcome difficult to predict 
forces acting on the Instrumented SMA Driven Ratchet while implanted that depend on the pig’s 
activity, position and size. The additional force capability of the device does not present a risk to 
115 
the health of the pig, because the load applied directly to the bowel is measured at the point of 
attachment, allowing medical personnel to stop lengthening the device if the bowel tension nears 
the 90 gf limit. Furthermore, because the extension of the device per actuation is small (1.2 mm), 
reliable, and controlled, the risk of applying excessive bowel tension is minimal. Thus, this full 
system demonstration validates the ability of the device to safely actuate against the bowel tissue 
loads and against much larger additional loads acting through the body of the pig. 
3.4.3. Data Acquisition and Control System Performance Demonstration 
The load sensor was calibrated to determine its range and resolution, and the displacement 
sensor output corresponding to a successful actuation was determined. To calibrate the load sensor, 
the Instrumented SMA Driven Ratchet was mounted vertically within a saline bath held at pig 
temperature, 39°C, by an environmental chamber. After allowing the temperature of the 
Instrumented SMA Driven Ratchet to equilibrate, 20gf dead weights were sequentially added up 
to 180 gf and then subsequently removed. The output of the load sensor was linear within the range 
of weights used for the calibration, with a resolution of approximately 2.25 gf and a measurement 
range of 0 to 1.75 kgf, assuming linearity of the output beyond 180 gf. The displacement sensor 
output associated with a successful step was measured by manually actuating the ratcheting 
mechanism with the minimum distance required while recording the output of the Hall Effect 
sensor. 
Using a logic analyzer and a current sensor, the operation of the data acquisition and control 
system was validated and the communication content and timing were fine tuned to reduce the 
power consumption of the system when the Pack Circuit and Base Station Circuit are both out of 
and in the range of the wireless communication link. Because of the expected signal attenuation of 
the tissue, the range of the wireless communication link was experimentally measured with a 
cadaveric pig model by placing the Pack Circuit within its abdominal cavity, closing the midline 
incision, and slowing distancing the Base Station Circuit until the flow of communication became 
unreliable. The experimentally determined range was approximately 5 meters, which is more than 
necessary considering the size of the animal model’s cage. 
3.4.4. Benchtop Environmental Validation 
To check the Instrumented SMA Driven Ratchet seals and validate its performance when 
submerged in a reasonable approximation of the fluidic environment of the small bowel, the 
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Instrumented SMA Driven Ratchet was placed in a 39°C saline bath for 2 weeks, the maximum 
expected length of an in vivo experimental study. The submersion experiment was also used to 
verify the sufficient lifetime of the battery by actuating the device following a typical expansion 
protocol. After two weeks of submersion, no leakage into the device was observed, the battery 
capacity remained high, and no corrosion or other material change was evident. 
Although the benchtop experiments were successful, many aspects of the in vivo environment 
could not be well replicated without significant effort. These factors include the loading 
environment, the pressure and composition of fluids surrounding the Instrumented SMA Driven 
Ratchet, and the biological reaction of the porcine model to the Instrumented SMA Driven Ratchet. 
The benchtop results were encouraging, but ultimately, the conclusive performance validation of 
the Instrumented SMA Driven Ratchet was achieved through in vivo experimentation. 
3.5. In Vivo Experimental Studies 
To demonstrate the versatility of the integrated prototype, evaluate its in vivo performance, 
induce functional and healthy longitudinal porcine bowel growth, and observe the response of the 
bowel tissue to displacement-based and load-based expansion approaches, three in vivo 
experiments utilizing the Instrumented SMA Driven Ratchet were conducted. During the three 
implantations, displacement and load data were recorded, and on the eighth post-operative day, 
the Instrumented SMA Driven Ratchet was removed and tissue samples were taken to evaluate the 
health and functionality of the growth tissue segments. To demonstrate the versatility of the 
Instrumented SMA Driven Ratchet and its potential for enabling new medical studies, three 
expansion approaches were explored: constant rate impulsive displacement control, displacement 
rate limited load control, and constant load control. 
3.5.1. Experimental Procedure 
The experimental procedure consists of three distinct phases: surgical implantation, ratcheting 
mechanism expansion, and tissue evaluation. The experiments described herein were approved by 
the University Committee on Use and Care of Animals at the University of Michigan (Protocol 
#09026). 
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3.5.1.1. Surgical Implantation and Tissue Analyses 
A surgical implantation procedure was developed to implant the Instrumented SMA Driven 
Ratchet intraluminally, but not within the continuous GI tract. Rather, the device was implanted 
within a Roux limb connecting the continuous GI tract to a stoma located on the underside of the 
porcine model. The surgery began with a 15 cm midline incision to open the abdominal cavity of 
the porcine model. The small bowel was manipulated to determine the flow direction of enteral 
contents, and to locate the Ligament of Treitz, which marks the start of the small intestine. 
Approximately 90 cm along the length of small bowel from the Ligament of Treitz the small bowel 
was cut, creating two open ends of bowel labeled (a) and (b), as shown in Figure 3.16. 
Approximately 90 cm along the length of bowel from (b), an end-to-side anastomosis was created, 
connecting (a) to (c) and restoring the continuity of the GI tract. The segment of small bowel from 
(b) to (c), or Roux limb, was no longer in the continuity of the GI tract and would not pass ingested 
contents, however, the health of the Roux limb was maintained by the blood supply from the intact 
mesentery. During the creation of the Roux limb, the Instrumented SMA Driven Ratchet was 
sterilized by soaking it in a liquid sterilant (Metrix, Metricide®) for the manufacturer recommend 
time of 40 minutes. After sterilization, the device was thoroughly rinsed with sterile saline to 
prevent any sterilant from getting into the surgical field. The Instrumented SMA Driven Ratchet 
was inserted, pushrod end first, into the open end of the Roux limb, and was sutured in place with 
the device-to-tissue attachments. A stoma, or surgically created opening, was made in the skin and 
 
Figure 3.17. Surgical Implantation Schematic. 
The Instrumented SMA Driven Ratchet was implanted in a Roux Limb created by cutting the small 
bowel and creating two open ends, (a) and (b), creating an anastomosis at (a) and (c), and connecting 
(b) to a stoma on the abdomen of the porcine model. 
a
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Move (a) to (c)
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Cut
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fascia of the abdomen, and the Roux limb was secured to the stoma at the fascia and skin. The 
final steps of the surgery were to route and secure the electrical wires from the Bowel Extender 
Circuit to the Pack Circuit through the stoma, complete the connection of the Bowel Extender 
Circuit with the Pack Circuit, and to secure the Pack Circuit to the center of the pig’s back.  
3.5.1.2. Expansion Approaches 
The most effective approach to growing small bowel in a clinical setting is yet unknown, and 
a variety of approaches may be taken such as expanding the tissue at a constant rate, increasing 
the displacement rate with a non-linear or linear ramping profile, applying constant bowel tension, 
ramping tension, etc. The expansion approach used in prior studies of growing bowel tissue was 
constant rate impulsive displacement control, which may not be the most effective strategy in terms 
of the growth rate and/or resulting tissue health. Thus, enabling versatile studies of bowel growth 
in porcine models is a key feature of the Instrumented SMA Driven Ratchet. Three separate trials 
were completed with the following fundamentally different and potentially useful expansions 
approaches: constant rate impulsive displacement control, displacement rate limited load control, 
and constant load control. For the constant rate impulsive displacement control trial, the average 
daily displacement rate was constant, but the extension of the device was increased impulsively. 
In the displacement rate limited load control trial, the Instrumented SMA Driven Ratchet was 
manually commanded to actuate when the load dropped below 60 gf, but was also displacement 
rate limited to not step more than once per hour. The displacement rate constraint was included as 
a safety measure. In the constant load control experiment, the actuation threshold was lowered to 
45 gf, but the displacement rate constraint was essentially removed. For each trial, a 36 hour no-
expansion period following each implantation was observed to allow enough time for the porcine 
models to heal and recover. 
3.5.1.3. Tissue Evaluation Plan 
At the device removal and tissue harvest surgery, tissue samples are taken from the non-
distracted Roux Limb as the control samples, from the distracted Roux limb, and from normal 
small bowel for comparison. During the distraction period, the Roux limb is not exposed to what 
the animal models ingest, except for cases of reflux into the Roux limb. The lack of nutrient rich 
contents flowing though the lumen of the Roux limb has an effect on its physiology, making the 
non-distracted Roux limb tissue sample the most appropriate control for evaluating the distracted 
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tissue segment. The analyses for evaluating the tissue health and function included evaluating the 
barrier function by measuring the tissue’s transepithelial electrical resistance, evaluating growth 
by counting the percentage of proliferating cells stained by BrdU, and examining the general health 
by observing the tissue morphology from histologic slides. 
3.5.2. In Vivo Results 
Overall, the experiments were successful; the Instrumented SMA Driven Ratchet functioned 
well in the harsh in vivo environment, and a significant increase in the length of the bowel growth 
segment was achieved in each trial without negatively impacting its functionality or health. 
3.5.2.1. Constant Rate Impulsive Displacement Control Trial 
For the constant rate impulsive displacement control trial, the ratcheting mechanism was 
actuated at a constant daily rate of approximately 7 to 8 actuations (8.4 - 9.6 mm) with impulsive 
increases in displacement ranging from 3 to 4 actuations (3.6 - 4.8 mm) commanded twice daily. 
The load and displacement data are shown in Figure 3.17. The first expansion set of 3 actuations 
 
Figure 3.18. Load and Displacement Data Captured During Distraction Period of Displacement-
Based Expansion Trial. 
Despite the twice-daily expansion of the implanted device, the tensile load applied to the porcine small 
bowel continued to decrease during the distraction period. During the second half of the distraction 
period, the load fluctuated between 0 and 50 gf, suggesting that a greater rate of expansion could have 
been safety commanded, potentially resulting in a higher rate of tissue growth. *Region of 
communication loss due to removal of equipment from animal room. 
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was commanded 32 hours post operation. As a result of this expansion, the measured load 
increased dramatically from 23 gf to 135 gf. Although the safety limit of 90 gf on the applied load 
was exceeded by the final actuation of the three actuation set, the measured load reduced to 92 gf 
within the first minute after the expansion set and continued to decrease thereafter. After the first 
expansion set, the applied tension continued to decrease throughout the experiment despite the 
expansion of the ratcheting mechanism. While the rate used in this experiment was based off of 
the rate safely used in prior porcine studies with an un-instrumented bowel extender [2], these 
results suggested that a higher rate of expansion is possible, because as the load decreases the 
expansion rate can be increased while maintaining safe load levels. 
The small intestine is a highly dynamic load environment due to peristaltic action, the 
involuntary periodic longitudinal and radial contraction of the smooth muscular layers of the small 
bowel. At the timescale of the entire duration of the experiment, peristaltic action, which is 
measured by the load sensor, looks like noise in the load measurement and obscures the increases 
in load due to expansions. To illustrate what is measured during a typical expansion set, Figure 
3.18 shows a zoomed in portion of the experiment wherein a series of four actuations was taken. 
As shown in Figure 3.18, the tensile load following each actuation is increased as a result of the 
 
Figure 3.19. Effect of Actuation Close Up and the Measurement of Peristalsis. 
By zooming into a subset of data acquired over the course of a couple of minutes, the effect of actuating 
the ratcheting mechanism can be seen. For each actuation, the applied tensile load increased by 
approximately 20 gf. These data also show effect of peristaltic action on the small bowel, which 
fluctuated the load at approximately 0.15 to 0.2 Hz. 
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Instrumented SMA Driven Ratchet straining the tissue. Also shown in Figure 3.18 is the 
measurement of approximately 0.15 to 0.2 Hz fluctuations in load due to peristalsis as captured by 
the load sensor. Capturing peristalsis successfully indicated that the load sampling frequency was 
appropriate, because peristalsis contributes the highest frequency content of the measured data. 
The measurement of peristaltic loads throughout the experiment was also an indicator of the small 
bowel health and motility. 
3.5.2.2. Displacement Rate Limited Load Control Trial 
To explore the potential for higher rates of growth, a load-based trial was conducted where 
the goal was to maintain a load of 60 gf on the bowel segment or higher. However, the rate of 
actuation was limited to one step (1.2 mm) per hour as a safety precaution, except for the initial 
impulsive displacement increase to raise the applied tension quickly. The load and displacement 
data for the distraction period of this trial are shown in Figure 3.19. For most of the distraction 
 
Figure 3.20. Load and Displacement Data Captured During Distraction Period of Displacement 
Rate Limited Load Control Trial. 
During the Displacement Rate Limited Load Control Trial, the device was commanded to actuate if the 
measured bowel tension was below 60 gf. However, the device was also limited to actuate no more than 
once per hour regardless of the measured load. Thus, two regions of operation formed: the constant load 
control region, and the displacement rate limited region. Because the displacement rate limited region 
was action for 64% of the distraction period, these data suggest that a higher rate of safe bowel growth 
is achievable by relaxing the displacement rate constraint. 
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period, the load consistently dropped below 60 gf following an actuation, or remained below 60 
gf, because the displacement rate limit was constraining the expansion. Thus, when the load was 
below 60gf, the expansion of the device was essentially displacement rate controlled. However, 
there was also a window, from approximately 8 to 22 hours, where the displacement rate limit was 
not constraining the device expansion. This window began at approximately 8 hours into the 
distraction period, when a second impulsive increase of the displacement was commanded to raise 
the load about 60 gf. For the following 14 hours, approximately, the displacement rate limit did 
not constrain the motion. Thus, in this window of the experiment, the expansion of the device was 
load-based. The resulting average daily extension rate was 2.1 cm per day. Compared to the 
constant rate impulsive displacement control trial, the total averaged extension rate for the 
displacement rate limited load control trial was approximately 2.3 times more rapid. However, 
because the displacement-rate constraint was active for most of the distraction period, the potential 
for an even higher rate of safe tissue growth was suggested. 
3.5.2.3. Constant Load Control Trial 
To further explore the potential for higher rates of growth, a constant load trial was conducted. 
For the constant load trial, the Instrumented SMA Driven Ratchet was set in an automatic load-
based actuation mode, wherein the Instrumented SMA Driven Ratchet actuated when the average 
measured load dropped below 45 gf. The data for the constant load control trial are shown in Figure 
3.20. The automatic expansion mode was enabled approximately 74 hours following the 
implantation. After enabling the automatic actuation mode, the Instrumented SMA Driven Ratchet 
actuated 23 times in the first 1.5 hours, bringing the applied bowel tension above 45 gf and 
extending the tissue by 27.6mm. During the 44 hour distraction period the Instrumented SMA 
Driven Ratchet expanded by 6.0 cm, giving an average rate of extension of 3.3 cm per day while 
maintaining a load on the bowel tissue in excess of 45 gf force. Compared to the constant rate 
impulsive displacement control trial, the constant load trial had an average extension rate 
approximately 3.5 times more rapid while maintaining safe magnitudes of applied small bowel 
tension. 
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3.5.2.4. Medical Results 
At the end of each of the trials, the net lengthening of the small bowel tissue was measured 
before and after detaching the Instrumented SMA Driven Ratchet from the tissue. Across all trials, 
the length of the small bowel tissue did not decrease after device removal. Thus, the net 
lengthening of the device equaled the amount of small bowel tissue grown. For the Constant Rate 
Impulsive Displacement Control Trial, Displacement Rate Limited Load Control Trial, and the 
Constant Load Control Trial, the net lengthening of the small bowel tissue was 5.5, 3.5, and 6.0 
cm, respectively.  
Tissue samples were taken during the explants of each trial to examine the health and 
functionality of the tissue. All grown tissue samples across trials did not show any gross evidence 
of damage such as tearing, necrosis, or ischemia. The health of the tissue samples were further 
evaluated through high powered microscopy for cell density and proliferation, as well as for signs 
 
Figure 3.21. Load and Displacement Data Captured During Distraction Period of Load-Based 
Expansion Trial. 
During the load based control trial in which the device was still extending, the applied tensile load was 
held between approximately 50 to 100 gf by the automatic actuation of the Instrumented SMA Driven 
Ratchet. The resulting rate of tissue expansion was 3.5 times faster than the constant rate impulsive 
displacement trial, suggesting that using the measured tensile load of the tissue to inform when to 
actuation can greatly and safely improve the tissue growth rate. *Regions of communication loss due to 
removal of equipment from animal room. 
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of microscopic damage such as tears, inflammation and edema. For all trials, samples from the 
distracted segments were compared to control samples taken from the Roux limb rather than 
normal bowel. This is because both the Roux limb control segments and the distracted segments 
were not exposed to enteral contents, potentially causing disuse atrophy, unlike the normal bowel 
segments which were exposed to enteral contents. Additionally, the normal bowel segments were 
not surgically manipulated during the implantation surgery, like the Roux limb and distraction 
segment. 
Histologic slides of the distracted bowel segments from the three experiments were developed 
to look for signs of damage on a microscopic scale such as tearing, edema, inflammation, and 
general disruption of the tissue’s structures. Across all trials, the only evidence of damage were 
the microscopic tears observed in the smooth circular muscle layer in the displacement rate limited 
load control experiment, shown in Figure 3.21b. However, it is not clear that the smooth muscle 
tearing is necessarily bad, because although different than smooth muscle, skeletal muscle requires 
tearing to promote growth and increase strength. Also, close inspection of the microscopic tears 
indicted that the tears were likely to be caused by slide preparation because of the absence of 
inflamed cell at the edges of the tears. Across trials, minor inflammation was observed in the 
distracted segments across trials, but the inflammation would be expected to decrease over time 
with the removal of the Instrumented SMA Driven Ratchet. 
 
Figure 3.22. Circular Muscle Layer of Distracted Tissue Segments. 
The only histological indication of tissue damage was seen in the circular muscle layer of the 
displacement rate limited load control trial. However, the tears seen in the figure were determined 
to be caused by slide preparation, because of the lack of inflamed cells seen at the edges of the 
tears. This result suggested that the tissue sampled during the explant was not mechanical damaged 
at a microscopic scale during the trials. Each square is approximately 350 by 350 µm. 
a). Constant Rate Impulsive 
Displacement Control Trial
b). Displacement Rate Limited 
Load Control Trial
c). Constant Load Trial
Slide preparation artifacts
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The percentage of proliferating cells within the crypt/villus complex of the distracted tissue 
segments is shown in Figure 3.22 for each trial. For this analysis, segments of distracted bowel 
tissue were collected from the middle of the distracted segments and at the ends of the distracted 
segments, the location of load application by the sutures affixing the tissue to the Instrumented 
SMA Driven Ratchet. Healthy small bowel has a high turnover rate of cells that form in the 
crypt/villus complex and subsequently slough off into the bowel lumen. For the samples collected, 
the only statistically significant difference in the percentage of proliferating cells between the Roux 
limb control and distracted segment was in the constant rate impulsive rate control trial (Fig 3.22, 
a) with the samples taken from the end of the distracted segment. However, the overall 
maintenance of the cell proliferation rates across trials was a positive indicator of the tissue health. 
For the constant rate impulsive displacement control trial, the transepithelial electrical 
resistance (TER) of the tissue was measured to evaluate the barrier function of the tissue. The data 
are shown in Figure 3.23, and no statistical significance was found in the TER between samples. 
The maintenance of the barrier function is a positive indication of tissue health and functionality, 
because microscopic tears, holes, and tissue thinning would lead to decreased barrier function. 
 
Figure 3.23. Percentage of Cell Proliferation in Crypt/Villus Complexes of Distracted Tissue 
Segments. 
Across all trials, the only statistically significant result was the difference between the Roux Y 
Control and End Device for the constant rate impulsive displacement trial. However, the medical 
significance of this result is minimal, as the overall maintenance of cell proliferation was observed 
across trials. Pairwise t-Tests were taken only for End Device against Roux Y Control, and Mid 
Device against the Roux Y Control. * indicates statistical significance (p < 0.5). 
a) Constant Rate Impulsive 
Displacement Control Trial
b). Displacement Rate 
Limited Load Control Trial
c). Constant Load 
Control Trial
0
5
10
15
20
25
30
35
40
45
50
*
P
C
N
A
 D
at
a,
 P
ro
li
fe
ra
ti
n
g
 C
el
ls
 (
%
)
0
5
10
15
20
25
30
35
40
45
50
P
C
N
A
 D
at
a,
 P
ro
li
fe
ra
ti
n
g
 C
el
ls
 (
%
)
0
5
10
15
20
25
30
35
40
45
50
P
C
N
A
 D
at
a,
 P
ro
li
fe
ra
ti
n
g
 C
el
ls
 (
%
)
126 
Although not statistically significant, the increased TER of the samples from the middle and end 
of the distracted bowel segment suggests increased barrier function. 
As a whole, the medical results across the trials have shown that there is little difference in 
the distracted bowel segments and their appropriate controls from the Roux Y Limb. The 
maintenance of cell proliferation, barrier function, and the morphology of the distracted samples 
indicates that the distracted small bowel tissue segments were actually grown, rather than simply 
stretched and/or permanently deformed. 
3.6. Conclusion 
To evaluate the best methods for exploiting the process of mechanotransduction in large 
clinically relevant animals, a fully implantable and instrumented bowel extending device was 
developed that is displacement controlled and instrumented to measure force and displacement. A 
novel graphical design methodology, the Reset View Design Methodology, was developed to 
design the device and can be used to design general SMA driven mechanisms reset by a spring or 
bias element. To predict the forces within the ratchet for the methodology, an analytical model of 
the kinematics and kinetics of the ratchet mechanism was developed which relied on the selection 
of tooth and pawl geometry based on packaging, stepping, and load-bearing constraints. To 
 
Figure 3.24. Transepithelial Electrical Resistance of Sample Bowel Tissue from Constant 
Rate Impulsive Displacement Control Trial. 
The transepithelial electrical resistance of the grown tissue segment was not statistically significantly 
different from the Roux Y Control or the Normal Bowel. This result suggests that the grown bowel 
tissue was not perforated on a microscopic level and that the barrier function of the grown tissue 
segment was maintained. 
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determine the maximum safe bowel loads, a series of ex vivo and in vivo experiments were 
conducted. Using the Reset View Design Methodology, a prototype device was designed and used 
to experimentally validate the ratchet force model, which successfully predicted both the form of 
the internal forces and the peak magnitude that was used in the design methodology within 22%. 
The data acquisition and control system functionality was characterized and validated by 
calibrating the load and displacement sensors, observing the circuit to circuit communications with 
a logic analyzer, and measuring the range of the wireless communication system with the 
Instrumented SMA Driven Ratchet implanted in a porcine model. The device was successfully 
operated against static external loads up to 850 gf, far exceeding the minimum desired force output. 
The results of this research demonstrated the ability of the model-based design process to 
successfully produce a design capable of meeting and exceeding application specifications where 
the selection of the reset spring was greatly aided by the Reset View Design Methodology, which 
allowed the impact of the selected reset spring to be visually understood. 
The Instrumented SMA Driven Ratchet was used to explore three different expansion 
approaches: constant rate impulsive displacement control, displacement rate limited load control, 
and constant load control. In the constant rate impulsive displacement control expansion, the 
average daily extension rate of the Instrumented SMA Driven Ratchet was set to a rate used safely 
in prior enterogenesis studies with porcine models [2,3]. The resulting applied tensile load on the 
tissue in the second half of the experiment did not exceed approximately 45 gf and continued to 
decrease despite the continued expansion of the device. This result suggested that greater rates of 
expansion than previously demonstrated were possible and prompted two further experiments 
utilizing the load sensor of the device to inform the expansion approach and increase the rate of 
tissue growth beyond what was previously possible. In the displacement rate limited load control 
trial, the Instrumented SMA Driven Ratchet was manually commanded to actuate when the load 
dropped below 60 gf, but a displacement rate constraint of one actuation (1.2mm) per hour was 
imposed for safety. Compared to the constant rate impulsive displacement control trial, the 
displacement rate limited load trial expanded the bowel tissue 2.3 times more rapidly. However, 
at the conclusion of the displacement rate limited constant load control experiment, the 
displacement rate constraint was active for 64% percent of the distraction period, during which the 
load fluctuated between 0 to 50 gf. Thus, an even greater possible safe rate of tissue distraction 
was suggested. In the constant load trial, the displacement rate limitation was eliminated and the 
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load threshold was reduced to 45 gf. Compared to the constant rate impulsive displacement control 
trial, the average daily expansion rate increased again, this time by approximately 3.5 times. These 
increases in the rate of tissue expansion were achieved at low magnitudes of load that did not 
approach safe limits. Furthermore, the across all trials, the health and functionality of the tissue 
was maintained when compared to controls. 
The technology’s ability to safely increase the rate of tissue growth has a large impact on the 
treatment approach for correcting SBS and the design of enterogenesis devices. In a clinical 
setting, if the planned implantation period of the enterogenesis device does not exceed 30 days, 
restrictions from the FDA lesson because the device is not considered a permanent implant 
(Investigational Device Exemptions, 21CFR812.3). More importantly, increasing the rate of small 
bowel growth will lead to lowered costs of care, reduced complication risks, reduced patient 
discomfort, and a more rapid transition from parenteral nutrition to a normal enteral diet. 
These results have proven the reliability of the Instrumented SMA Driven Ratchet in the 
difficult in vivo environment and have shown the importance of enabling studies to explore 
different approaches to exploiting mechanotransductive small bowel growth by demonstrating that 
much greater rates of small bowel growth are possible. Further studies enabled by the Instrumented 
SMA Driven Ratchet will be important for informing the expansion rate of clinical devices for 
treating Short Bowel Syndrome. With the ability to provide reliable and repeatable displacement 
control, the measurement of net displacement and applied tensile load, the flexibility to change the 
expansion approach in real-time during implantations, and the system’s full implantability, the 
Instrumented SMA Driven Ratchet represents a leap forward in device technologies for studying 
enterogenesis and the development of a clinical device. 
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CHAPTER FOUR. EXPERIMENTAL 
STUDY OF SOFT TISSUE ATTACHMENT 
METHODS 
Tissue-to-tissue and tissue-to-device attachment methods are of great importance to a broad 
range of surgical applications including tissue approximation, wound closure, anastomoses, joint 
repair and replacement, osteo-distraction, long-gap esophageal repair, the prevention of stent 
migration, and many more. With respect to the tension-induced correction of short bowel 
syndrome, the ability to reliably and safely transfer load from an extending mechanism to the 
bowel lumen is critical for success. While the mechanotransduction approach to treating SBS is 
promising, the safe transfer of load from the extending mechanism to the bowel lumen remains a 
challenge. In prior research studies on mechanotransductive enterogenesis, two primary 
attachment approaches have been used: end abutting attachments, and attaching through the lumen 
with sutures. Although these attachment methods were suitable for research, even though they 
were not reliable, there are significant disadvantages that limit their extension to clinical 
applications.  
The end abutment approach for applying tensile small bowel load is the most common 
attachment approach previously used in studies of enterogenesis. Two embodiments of the 
approach have been used: double blind-ended, and single blind-ended with a stoma. In double 
blind-ended (sealed on both sides) end abutment, the segment of small bowel to be tensioned must 
be completely removed from the continuity of the gastrointestinal (GI) tract. The extending device 
is placed within the isolated segment, the ends of the isolated segment are sutured or stapled, and 
the continuity of the remaining GI tract is restored with an end-to-end anastomosis. As the 
implanted extending device expands, its ends abut the suture/staple lines, applying tension to the 
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isolated segment and inducing small bowel tension growth. The single blind-ended approach with 
a stoma is similar to the double blind-ended approach, but with the single blind-ended approach, 
only one end of the isolated bowel segment abuts the extending device. The other end of the 
isolated bowel segment is used to create a stoma through which an external extending device can 
apply bowel tension. Experiments with rats have used the single blind-ended with a stoma 
attachment approach to extend the ratio of isolated rat small bowel segments by a factor of 2 [1]–
[3], and the double blind-ended approach was used to extend the small bowel tissue by factors 
ranging from 3.3 to 3.9 [4]–[6]. Additionally, experiments with pigs that used the double blind-
ended approach have grown the isolated small bowel segment by a factor of 2 [7]. These research 
studies successfully applied the end abutment approach to small bowel attachment, as 
demonstrated by the significant lengthening of small bowel with both small and large animal 
models. However, important disadvantages greatly limit the clinical applicability of this approach. 
The greatest clinical disadvantage of the method is that it reduces the potential available length of 
small bowel, because after removing the device from the isolated tissue segment, any portion of 
bowel with sutures or staples must be discarded before the isolated tissue segment can be placed 
back into continuity with the GI tract. With each anastomosis required to isolate and restore the 
grown tissue segment, the discarded length of tissue accumulates and significantly reduces the 
gains in length made during the distraction period. Worse, the creation of bowel anastomoses 
requires invasive laparotomies, leading to the formation of adhesions which can lead to further 
bowel damage and resection when lysed during the surgery to place the grown small bowel back 
into continuity. To attach by end-abutment, at least three anastomoses must be created to isolate 
the tissue segment and then place the tissue segment back into the GI tract, leading to greater 
surgical cost, complexity, and an increased risk of enteral content leakage. Furthermore, by 
isolating the tissue segment during the distraction period, the tissue’s contact with enteral contents 
is halted, potentially resulting in disuse atrophy.  
The use of sutures to transmit force from the extending device to the small bowel wall was 
used in a prior study with rabbits [8], with the Curved Hydraulic Device, and with the Instrumented 
SMA Driven Ratchet. In the study with rabbits, the extending device was extraluminal and had 
two perforated semicircular tissue couplers that attached to the antimesenteric side of the small 
bowel with sutures. The extraluminal suture-based tissue couplers successfully transmitted force 
to the rabbit small bowel, inducing tissue growth and extending the tissue by a factor of 2. 
132 
However, the authors reported that the sutures cut through the bowel wall. Compared to the end 
abutment approach, sutured attachments have several advantages. Most importantly, the segment 
of small bowel tissue under tension does not need to be isolated from the continuous small bowel. 
Therefore, the need for several anastomoses and corresponding loss of small bowel length is 
eliminated. Additionally, suture-based attachments have the potential to enable the minimally 
invasive implantation of the extending device through the upper GI tract. However, suture based 
attachments require the small bowel to be perforated, the perforations create stress concentrations, 
and there is a significant risk of bowel tearing because load from the device is transferred to the 
tissue through the sutures. In the previous in vivo studies using the Curved Hydraulic Device 
(Chapter 2) and the Instrumented SMA Driven Ratchet (Chapter 3), one of the greatest challenges 
has been securing the devices to the bowel lumen with sutures. Essentially, the transfer of load to 
the small bowel through sutures elicits a process by which the sutures slip through the thickness 
of the tissue gradually. Interestingly, this has not led to bowel leakage, because the tissue heals 
during the process. Although successful experiments were completed with both the Curved 
Hydraulic Device and the Instrumented SMA Driven Ratchet, many experiments with both devices 
were not successful specifically because the devices became detached from the bowel wall. In the 
experiments where the attachments held, they did so barely – the sutures were close to slipping 
through the full thickness of the bowel wall. In an attempt to address this challenge with the Curved 
Hydraulic Device and the Instrumented SMA Driven Ratchet, pieces of Alloderm (denatured 
human skin) or Strattice (denatured pig skin) material were used to reinforce the area on the outside 
of the small bowel where the sutures were secured. This process has been moderately successful 
in lengthening the amount of time that tension can be applied through sutures, but it is not a 
permanent fix because the reinforcements also slip through the bowel wall. The challenge of 
transferring load with sutures is not limited to the application applying load to correct SBS. In 
patients with long-gap esophageal atresia, a condition where a large portion of the esophagus is 
absent, traction sutures are used in the Foker method [9] to apply tension on the esophagus and 
induce longitudinal growth. Similar to what was observed with the Curved Hydraulic Device and 
the Instrumented SMA Driven Ratchet, the traction sutures exhibit a tendency to cut or slip through 
the esophagus [10].  
The mechanotransductive approach to correcting SBS has shown great promise in research 
studies where the attachments used were suitable in the research setting. However, to realize the 
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promise of the load-induced treatment approach in a clinical setting, there is a need for a tissue 
attachment approach that attaches more reliably and safely. The ideal attachment approach for this 
application would have the following characteristics: 
1. Reliably transfer load from the extending device to the bowel wall without tissue slipping 
2. Move freely through the bowel lumen without attaching during implantation, removal, and 
other purposeful repositioning 
3. Allow enteral contents to flow through or around attachment (not cause obstruction), 
enabling the implantation of device in a continuous bowel segment 
4. Not cause ischemia (reduction of blood flood) on attached tissue 
5. Not cause or require microscopic or macroscopic tearing, perforation, and/or other 
mechanical damage to tissue 
6. Enable minimally invasive surgical procedures. Minimize the surgical manipulation of 
remnant small bowel. 
Unfortunately, the end abutment and suture-based attachment do not meet many of these criteria, 
limiting their clinical applicability. 
This chapter presents an experimental design process to develop new approaches for small 
bowel tissue attachment and the identification of which attachment approaches have the greatest 
promise for meeting the above criteria with ex vivo and in vivo experiments. A broad range of 
conceptual attachment approaches are identified, and their fundamental architecture and operation 
are described. Ex vivo experiments with porcine small bowel are described for feasible conceptual 
approaches to characterize their ability to transfer load and slide through the bowel lumen freely 
for implantation/removal. Acute and long-term in vivo experiments are described for the 
attachments that performed well in the ex vivo experiments to evaluate the above six criteria, 
especially those concerning the safety of the attachment method (3, 4, and 5). Lastly, the wide 
range of attachment approaches are compared and a recommendation of the most promising 
attachment approach is made. 
134 
4.1. Attachment Approaches 
As shown in Figure 4.1, seven main categorizations of approaches were identified: end-
abutment, dilation, impingement, binding/kinking, adhesion, clamping, and tissue-piercing. 
Concepts that have not been evaluated in this study have the symbol of a circle crossed by a 
diagonal line, and each concept has been additionally categorized by location (intraluminal, 
transluminal, and extraluminal) with corresponding symbols. 
Intraluminal attachment approaches are composed of components and features that are 
completely within the bowel lumen. Completely intraluminal attachment approaches are appealing 
because they have the potential to be implanted endoscopically through natural orifices and require 
little to no surgical manipulation of the bowel compared to transluminal attachment approaches. 
Compared to minimally invasive laparoscopic and open surgery, Natural Orifice Transluminal 
Endoscopic Surgery (NOTES) provides significant advantages such as reducing the risk for 
 
Figure 4.1. Small Bowel Attachment Approaches 
Seven unique approaches to soft tissue attachment have been identified. Within each approach, the concepts 
are further categorized by whether the attachment is intraluminal, transluminal, or extraluminal. Most 
concepts were experimentally evaluated in this chapter. The symbol of a circle with a slash identifies the 
concepts that were not evaluated. 
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infection, because no device enters the peritoneal cavity, not requiring incisions, and reducing the 
recovery time. Additionally, using a NOTES approach to implanting the attachments will eliminate 
post-surgical adhesions, which make it difficult to isolate the applied tension on the bowel tissue 
segment. Despite these advantages, intraluminal attachments often rely on the application of 
pressure on the bowel lumen, such as end abutment, dilation, and impingement, and may thus lead 
to surgical complications such as ischemia and/or the creation of diverticula. 
Transluminal attachment approaches are composed of components and features that interact 
through the thickness of the tissue or pierce it. Transluminal attachments that pierce the tissue, 
such as sutures, are able to apply high loads to small bowel tissue because the slipperiness of the 
tissue is not a factor. However, this approach requires bowel perforations that can lead to 
complications such as enteral content leakage, and does not enable NOTES device implantation. 
Additionally, extraluminal components are subject to greater design constraints (material choice, 
surface finish, etc) with respect to biocompatibility, because of their direct contact and potential 
interaction with tissues and organs within the peritoneal cavity. Transluminal attachments that do 
not pierce the tissue have intraluminal and extraluminal components that interact through the 
thickness of the tissue to achieve fixation. Like the intraluminal class of approaches, these 
approaches rely on applying pressure to the bowel lumen and may lead to ischemia and subsequent 
complications.  
Extraluminal attachment approaches are composed of components and features that are 
complementally outside the bowel lumen and do not pierce the serosa. This class of attachment 
approaches does not enable NOTES device implantation, and like transluminal attachments, 
approaches is this class are subject to greater design constraints with respect to biocompatibility. 
The branches of the concept tree (Figure 4.1) include end abutment, dilation, impingement, 
binding/kinking, adhesion, clamping, and tissue piercing. Each conceptual branch is defined and 
described below. 
4.1.1. End Abutment 
The most commonly used, simple, and successful approach to transferring load to the bowel 
in a research setting is end abutment. In this approach, a segment of small bowel is isolated from 
the GI tract and both ends of the segment are closed with a staple line or sutures. Within this 
isolated segment, the enterogenesis device expands, abuts the staple lines, and applies tension. 
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This attachment approach has been successfully used in enterogenesis studies with porcine models 
[7], [11], [12], and rat models [4]–[6]. In another surgical model, only one end of the isolated 
segment is closed with a staple line while the opposite end is fixed to a stoma, creating an ostomy. 
In this variant, one end of the enterogenesis device abuts the bowel tissue while the other is 
externally fixed relative to the skin of the animal model. This particular attachment approach was 
used successfully in enterogenesis studies with rats [1]–[3]. 
The end abutment approach has been a successful attachment method for conducting small 
bowel mechanotransductive tissue growth research, but the approach is limited in a clinical setting 
for several reasons. The main limitation of the end abutment approach is that it requires several 
anastomoses at the implant and explant surgeries. The requirement for anastomoses implies 
lengthier, more invasive surgical procedures, but more importantly, using multiple anastomoses 
significantly reduces the length of viable small bowel tissue. Additionally, the end abutment 
approach requires the growth segment to be isolated from the continuity of the GI tract, which can 
lead to disuse atrophy. These limitations have prompted the current study of alternative small 
bowel tissue attachments for use in a clinical setting. 
4.1.2. Dilation 
The dilation approach radially dilates the bowel to transfer longitudinal loads. Although not 
used in prior enterogenesis studies, this approach has been used in double-balloon endoscopy 
procedures to promote endoscope mobility and with stents that resist migration. In a double-
balloon endoscopy procedure, an endoscope equipped with two balloons transverses the bowel in 
a ratcheting fashion, where the balloons alternate between gripping (inflated) and releasing 
(deflated) the bowel. This approach to endoscopy has allowed surgeons much greater access to 
previously difficult to reach sections of the small intestine, improving the management and 
treatment of GI bleeding, chronic diarrhea, abdominal pain, and other intestinal pathologies. Stents 
are used to reestablish or improve the patency of obstructed small bowel and esophageal segments, 
and treat GI perforations and fistula. However, the migration of stents is a potentially life-threating 
complication. To prevent stent migration, the stents must radially grip the lumen of the tissue in 
which it was deployed. Both esophageal and intestinal stents are often designed with wider 
diameter ends and features like barbs and petals to further prevent migration. 
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Although balloons and stents are currently clinically used within the small intestine, neither 
has been used specifically to apply longitudinal small bowel tension. However, because of the 
prohibitive cost of medical stents, only balloons were evaluated in vivo to determine their ability 
to transfer load and address potential surgical complications. 
4.1.3. Impingement 
The impingement approach aims to grip the bowel tissue by using features that impinge and/or 
partially pierce the bowel lumen with minimal radial tissue dilation. Two impingement approaches 
were developed in this study: bristles and petals. The bristles and petals, shown in Figure 4.2, are 
designed of a compliant material such that the application of increasing load causes the 
bristles/petals to bend away from each other, increasing the effective diameter of the attachment. 
The compliance of the bristles and petals can be designed such that at near injurious applied loads, 
they bend all the way backward – allowing the tissue to slip and reducing the tension. 
Prior to the current study, this approach to soft tissue attachment has not been evaluated in 
studies with living biological tissue, and there were safety concerns related to both the bristle and 
petal concepts. For bristles, the main safety concern is that they tear and or pierce through the full 
thickness of the bowel wall because they have pointed tips, causing enteral content leakage, 
 
Figure 4.2. Bristle and Petal Based Impingement Approaches 
The bristle and petal based attachments were designed to provide direction dependent attachment 
performance. In the direction in which the bristles or petals are pointed, the attachment force should be 
greater because the bristles or petals bend backward and increase the effective diameter of the 
attachment as the attachment is displaced relative to the bowel lumen. As the attachment moves in the 
opposite direction, the attachment force is decreased because the bristles and petals do not impinge the 
bowel lumen.  
Petal ConceptBristle Concept
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inflammation, sepsis, and possibly piercing other loops of small bowel and or other tissues within 
the peritoneum. For petals, there is also a safety concern that they will pierce through the bowel 
wall, but by a different mechanism. The main concern is that the petals will cause localized 
ischemia in the tissue that contacts the rounded ends of the petals, leading to tissue necrosis, 
weakening, and eventually perforation. Embodiments of these two attachment approaches were 
fabricated and evaluated in a series of ex vivo experiments, to evaluate their ability to transfer 
force, and in acute in vivo experiments, to evaluate the safety risks of using these attachments. 
4.1.4. Binding / Kinking 
The binding/kinking approach is to route the tissue around one or more sharp (small radius) 
bends. This approach can be implemented intraluminally or extraluminally by attachments that 
guide the tissue around sharp bends, and this approach can also be implemented surgically, by 
creating looped portions of small bowel with sutures. This approach was developed based on the 
observation that sharp bends and kinks in small or large bowel tissue often impede the motion of 
surgical instruments like endoscopes. 
Like the impingement approach, this approach to soft tissue attachment has not been evaluated 
in prior studies with living biological tissue. To address concerns related to the functionality and 
safety of this approach, an in-vivo experiment was completed with the surgically enforced 
embodiment of this approach.  
4.1.5. Adhesion 
The adhesion approach to gripping is to bond or adhere to either the innermost layers, the 
mucosa and submucosa, or outermost layer, the serosa, of the small bowel. Several approaches in 
this class of attachments include suction, the use of a “tissue” bonding glue, and by 
burning/cauterizing the bowel such that it sticks to the heating element. Although both concepts 
are included here for completeness, a tissue glue appropriate for this application was not identified 
in this study and the burning/cauterizing approach was considered unreasonably dangerous. 
Furthermore, although tissue glue could potentially attach to the epithelium, the turnover rate of 
epithelial cells is on the order of 2 days. Thus, the effectiveness of attaching with tissue glue is 
potentially limited to just a few days. To evaluate the functionality and safety of the suction 
approach, an acute in vivo study was performed. 
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4.1.6. Clamping 
The clamping approach uses an external clamp which narrows the bowel lumen or presses the 
bowel lumen onto an intraluminal component of the attachment. A currently practiced procedure 
using a Lap-Band®, which is essentially an adjustable diameter clamp, is a treatment alternate to 
sleeve gastrectomy and gastric bypass. The Lap-Band® was designed to reduce the diameter of the 
esophagus above the stomach rather than to attach or grip the tissue. Thus, two embodiments of 
the clamping approach were evaluated in in vivo experiments to address concerns related to the 
attachment performance and safety of this approach. 
4.1.7. Tissue Piercing 
The tissue piercing approach uses transluminal components, like sutures, to secure 
intraluminal or extraluminal components to the bowel wall. This approach is currently used 
clinically in the Foker [9] method to treat Long-Gap Esophageal Atresia (LGEA). The Foker 
method induces esophageal growth by the application of force through traction sutures. However, 
one common complication of this approach is that the sutures cut through the thickness of the 
esophagus. 
In the earliest reported study of tension-induced small bowel growth [8], in which healthy 
rabbit models were used, the extending mechanism of the device attached to the tissue with 
extraluminal semicircular tissue couplers that were sutured to the bowel. The study reported 
complications related to the sutures cutting through the rabbit small bowel, which was also a 
common complication in this dissertation, even when the sutures were reinforced with pledgets, 
strips of Alloderm, or strips of Strattice. To better understand this phenomenon, many in vivo 
experiments were completed with both the SMA Ratcheting Device and the Curved Hydraulic 
Device. 
4.2. Experimental Evaluation of Attachments 
To evaluate the attachment approaches, a series of ex vivo, acute in vivo (short term, on the 
order in minutes), and longer term in vivo experiments (up to and exceeding one week) were 
conducted. The goal of the ex vivo and acute in vivo experiments was to determine if the attachment 
approaches satisfied the following requirements: 
1. enable the application of high tensile force without slipping, 
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2. facilitate surgical implantation and removal by sliding easily though the tissue lumen, 
3. not cause acute tissue ischemia, and 
4. not cause tissue injury such as perforation and/or tears. 
Attachments that could not meet these requirements were not evaluated further in longer term in 
vivo experiments. The goal of the longer term in vivo experiments was to determine if the 
remaining attachment approaches could meet the aforementioned requirements in addition to the 
following: 
1. not block the flow of enteral contents, 
2. enable high net growth, 
3. cause tissue ischemia, 
4. cause tissue injury such as perforation and/or tears, and 
5. attach reliably for implantation periods exceeding one week. 
The following sections describe the range of experiments applied to evaluate these criteria for each 
attachment approach. 
4.2.1. Ex Vivo and Acute In Vivo Experiments 
Acute in vivo experiments were conducted on a range of the attachment concepts to determine 
how well they attach/detach and if they pose the risk of health complications like ischemia and 
bowel perforations and/or tears. Because ex vivo experiments cannot be used to determine the risk 
of ischemia, most attachments were evaluated in acute (less than 1-2 hour) in vivo experiments. 
The following approaches were not evaluated in either ex vivo or acute in vivo experiments: end 
abutment, binding/kinking, clamping, and tissue piercing. From prior research using the end 
abutment approach, it capabilities, advantages, and disadvantages are well understood. Therefore, 
the end abutment approach was not further examined in this study. Similarly, the acute behavior 
of sutures for attaching to bowel is understood, but how the small bowel tissue reacts to the sutures 
placed under tension over the course of weeks is not. Because of this, the examination of sutures 
centers on in vivo experiments lasting one to two weeks. The binding/kinking and the clamping 
approach were evaluated in only longer term in vivo tests because the interaction of the extending 
device and the tissue were similar to the end abutment approach. These similarities were enough 
to consider the concept safe and to not require prior ex vivo or acute in vivo testing. The attachment 
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approaches presented here include the dilation approach (smooth and textured balloons), the 
adhesion approach (suction), and the impingement approach (bristles and petals). 
4.2.1.1. Dilation Approach – Smooth and Textured Balloons 
A range of balloons, with and without texture, were evaluated in acute in vivo experiments to 
determine their ability to apply traction on the small bowel without slipping and without causing 
ischemia. The dilation approach to intraluminal attachment has been used in double balloon 
endoscopy procedures, where two balloons are inflated and deflated to attach and release the tissue 
in a ratcheting fashion to maneuver the endoscope along the bowel. The success of balloons for 
attachment in double balloon endoscopy supported their further study with the goal of measuring 
their gripping force and evaluating their risk of causing ischemia. 
4.2.1.1.1. Dilation Prototypes 
Many concepts were fabricated based on the various permutations of balloon type, the 
presence of a texturing material, and the type of texturing material. The balloons were taken from 
endotracheal (ET) tubes (Kimberly-Clark: Microcuff, 7mm ID tube, and Sheridan/HVT 9mm ID 
tube), and Foley urinary catheters (Bard Medical: BARDEX 5cc Balloon, 30FR catheter). In some 
trials, the balloons were textured by the application of loose mesh bagging material (Figure 4.3c) 
or abrasive material taken from scrubbing sponges (Figures 4.3d and 4.3e). Of these prototypes, 
several were eliminated early in the experiments. For example, the Foley urinary catheters did not 
inflate symmetrically about the axis of the catheter (Figure 4.3g), like the ET tubes (Figures 4.3a 
and 4.3b). Additionally, the loose mesh bagging material (Figure 4.3c) did not make any 
significant impact on the gripping performance of the balloon attachments. Because of this, only 
the ET tube balloons were evaluated with (Figures 4.3d and 4.3e) and without (Figures 4.3a and 
4.3b) the abrasive material from scrubbing sponges as a texturing agent. 
4.2.1.1.2. Dilation Approach Experimental Procedure 
To evaluate the dilation approach, the initially deflated balloons were inserted into the small 
bowel lumen of live porcine models, inflated to a measured pressure from 0 to 60 mmHg, and then 
manually pulled on with a tension measuring probe with increasing tension until the balloon 
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slipped. The condition of the balloon slipping was evaluated visually during each trial, using the 
vasculature of the small bowel as reference points, and was defined as any longitudinal motion of 
the attachment relative to the bowel wall. The health of the small bowel tissue was grossly 
determined by visually checking the tissue for any signs of macroscopic mechanical disruption 
and acute ischemia, which was indicated by tissue blanching. 
4.2.1.1.3. Dilation Approach Results 
Results from these experiments are plotted in Figure 4.4. Four different prototypes were 
evaluated: a large ET tube balloon with and without texture, and a small ET tube with and without 
texture. The basic trends of this experiment were intuitive: the application of greater pressure, the 
greater size of the balloon, and the presence of the gripping material all increased the slipping force 
of the attachments. Interestingly, the abrasive scrubbing material made a very large impact on the 
performance of the attachments without significantly scraping the delicate mucosal layer of the 
bowel segments. This result was determined by the lack of mucosal scrapings embedded in the 
material when its balloon was removed from the bowel segment. Furthermore, because the addition 
 
Figure 4.3. Dilation Prototypes. 
Several embodiments of the dilation approach were fabricated from endotracheal tubes (a and b) 
and Foley catheters (f and g). The use of texturing materials was also explored with the 
endotracheal tubes (c, d, and e). 
a) Small ET tube 
inflated
b) Large ET tube 
inflated
c) Large ET tube 
inflated with coarse 
texturing material
e) Large ET tube 
inflated with abrasive 
texturing material
d) Small ET tube 
inflated with abrasive 
texturing material
g) Foley catheter 
balloon inflated
f) Foley catheter 
balloon deflated
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of the scrubbing material greatly reduced the need for the balloons to apply high pressure in order 
to attach, the pressure applied to the small bowel and therefore the risk of acute ischemia was 
significantly reduced. Unfortunately however, the application of the scrubbing material also made 
both balloon sizes have a significant gripping load even when the balloons were completely 
deflated. In fact, the large balloon could not be inserted without using a plastic sheath between the 
material and the bowel wall. This is a disadvantage because these attachments would be difficult 
to surgically implant and remove because they do not slide though the tissue. 
4.2.1.2. Adhesion Approach – Suction 
The potential of suction as an attachment approach was evaluated in an acute in vivo test with 
a single prototype. This concept required an experiment with living tissue because there was a 
concern that creating suction on the bowel wall would cause ischemia. 
4.2.1.2.1. Suction Prototype 
The prototype (shown in Figure 4.5) was constructed from two 10 cc syringes (0.63 inch outer 
diameter) connected by silicone tubing, with the suction syringe modified by having its plunger 
 
Figure 4.4. Slipping Force of Dilation-Based Attachments. 
The slipping force as a function of balloon pressure of several dilation-based attachments was measured 
with in vivo porcine small bowel tissue. The slipping force recorded corresponds to the measured force at 
which the onset of attachment movement relative to the bowel was observed. The square data represent 
the small ET tubes and the circle data represent the large ET tubes. The outlined data are the balloons 
modified to have texture, while the data without the outlines are smooth. The data show that increasing 
pressure increases the slipping force, and the addition of texture greatly increases the slipping force, even 
for balloons that were not inflated.   
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affixed to the syringe housing and the addition of 4 evenly spaced 0.25 inch diameter holes that 
were staggered lengthwise by approximately 0.5 inches. 
4.2.1.2.2. Suction Approach Experimental Procedure 
To evaluate this embodiment of the suction approach, the suction syringe was intraluminally 
placed in a segment of living porcine small bowel, and three levels of vacuum were applied with 
the unmodified syringe and a pressure sensor: 0, approximately 50, and approximately 70 mm Hg 
of vacuum pressure. For each vacuum pressure level, the corresponding longitudinal force required 
for the suction-syringe to slip was measured. 
4.2.1.2.3. Suction Approach Results 
The results of this experiment are shown in Figure 4.6, which shows that increasing the 
vacuum pressure increases the slipping force of the attachment. Compared to all other attachment 
approaches, this embodiment of the suction approach had the capability to switch from a very low 
insertion and removal force to a very high gripping force. This is advantageous, because a low 
insertion and removal force would greatly facilitate the surgically implantation and removal of the 
attachment and potentially enable minimally invasive surgical techniques to be used. However, 
 
Figure 4.5. Prototype of Suction Attachment. 
The suction attachment prototype was made by drilling four holes into a standard 10 cc medical grade 
syringe and fixing the syringe seal relative to the syringe body to create a plug. The suction syringe 
was then connected to a 30 cc syringe with silicone tubing. When tissue prevents the flow of air through 
the holes of the suction syringe, vacuum pressure can be made within the suction syringe by pulling 
the plunger of the 30 cc syringe, holding the tissue to the attachment. 
Drilled 0.25in holes
Suction Syringe Plug
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there are concerns about how this approach would perform in a longer-term experiment, because 
the suction holes are likely to become clogged with enteral contents. To completely overcome the 
clogging issue, each suction hole would need to have its own pneumatic line, allowing each suction 
hole to be flushed independently. Additionally, there were concerns that the suction approach 
would lead to bowel ischemia because there was significant tissue blanching observed where the 
tissue overlapped the holes. Therefore, this approach was not further considered for longer term in 
vivo experimentation. 
4.2.1.3. Impingement Approach – Bristles and Petals 
A range of bristle and petal based concepts were created with superelastic nickel-titanium wire 
segments of varying lengths, diameters, circular densities, and angles. The choice of bristle 
material was made because nickel-titanium is biocompatible and because of its superelasticity, it 
can significantly bend to aid in its surgical insertion and removal without plastically deforming the 
attachment. The bristle and petal prototypes were evaluated in ex vivo segments of porcine small 
bowel tissue as well as in acute in vivo experiments. The goal of the ex vivo experiments was to 
 
Figure 4.6. Slipping Force of Suction Approach. 
The suction approach results show that when desired, the 
attachment force can be made as low as zero and as high as 500 
gf acutely. The longer term effectiveness of the approach was not 
evaluated however, because the apparent risk of tissue ischemia 
at the hole locations indicated by the tissue blanching. 
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measure the gripping performance of the attachments, while that of the in vivo experiments was to 
evaluate the risk of mechanical damage and ischemia on the bowel. 
4.2.1.3.1. Impingement Approach Ex Vivo Experimental Procedure 
For the ex vivo experiments, a custom experimental setup was created with the capability to 
simultaneously measure the displacement of the attachment and the force applied by the 
attachment to the tissue segment. The ex vivo experiments were conducted with porcine small 
bowel segments that were originally stored at below freezing and then thawed in a warm saline 
bath. The bowel segments were further prepared by rinsing out their contents and removing the 
mesentery with surgical snips. 
The experimental procedure was to first mount the attachment within the bowel lumen on a 
monofilament line pulled through a set of pulleys by a displacement-controlled stepper motor. A 
tissue tension measuring force sensor was mounted in series with the monofilament line to measure 
the magnitude of force transmitted from the attachment prototype to the bowel lumen. The free 
ends of the ex vivo bowel tissue sample were then secured relative to the housing of the custom 
experimental setup with sutures. The final step was to use the stepper motor to pull on the 
attachment prototype while recording the attachment displacement and tissue force. The return of 
the attachment to its original location was achieved by a near constant load spring affixed to the 
attachment opposite the monofilament line. Based on an experimental characterization of the 
spring’s constitutive behavior, the spring’s contribution to the load measurement was removed in 
the post-processing of the collected data. 
4.2.1.3.2. Impingement Approach Ex Vivo Experimental Results 
The characteristic behavior of these attachments is shown in Figure 4.7, which plots the force 
transmitted to the bowel segment by the attachment against the displacement of the attachment 
relative to ground, not relative to the tissue. The blue data (upper curve) were taken as the 
attachment displacement increased, showing that the bristle attachment was able to apply 
increasing loads until leveling between 350 and 425 gf. Minimal attachment slipping, if any, was 
observed prior to the plateau region. In the plateau region, the attachment alternated between 
gripping the tissue and slipping, which is indicated by the rise and fall of the applied load. The 
slipping of the bristle attachment occurred when the applied bowel tension was enough to buckle 
the attachment bristles backward, stopping the bristle points from impinging in the tissue. The red 
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data (lower curve) were taken as the attachment displacement decreased, which shows the applied 
bowel tension rapidly dropping to zero force. The hysteretic behavior resulted predominately 
because the attachment slipped several inches along the tissue lengthwise as the attachment 
displacement was increased. Although the data shown in Figure 4.7 are for an embodiment of the 
bristle concept, the characteristic behavior illustrated by the plot was the same for other bristle and 
petal embodiments. However, the bristle attachments were able to apply higher loads than the petal 
attachments. 
4.2.1.3.3. Impingement Approach Acute In Vivo Experimental Procedure 
The risk of mechanical tissue damage and ischemia were evaluated for the bristle and petal 
attachments in segments of live porcine bowel tissue. The experiments were conducted by 
intraluminally placing the attachments and visually observing for tissue perforation, macroscopic 
tearing, mucosal layer scrapping, and ischemia. 
 
Figure 4.7. Ex Vivo Gripping Performance of the Bristle Approach. 
The characteristic ex vivo load-displacement performance of the bristle approach is shown. As the 
bristle-based attachment was pulled through the bowel lumen (upper curve), it attached to tissue 
without slipping as the tensile load on the tissue increased to above 350 gf. At this stage, the bristles 
began to buckle backward (due to the force of the bowel lumen) and then snap back into place, 
causing the attachment to alternately slip and grip as the force fluctuated between 350 and 425 gf 
until the attachment displacement was 3 inches (relative to ground). As the attachment displacement 
was decreased from 3 inches back to zero (lower curve), the attachment stopped slipping relative to 
the bowel lumen and the applied bowel tensile rapidly decreased to zero. These data were typical for 
both the bristle and petal based attachments, however the bristle based attachments were able to apply 
greater tensile load before plateauing than the petal based attachments.  
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4.2.1.3.4. Impingement Approach Acute In Vivo Experimental Results 
Typical results from several experiments are illustrated by Figure 4.8, which shows the state 
of the tissue after the intraluminal placement a bristle attachment (Figure 4.8a), a petal attachment 
(Figure 4.8b), a petal attachment modified to be a sharper by bending the petals (Figure 4.8c), and 
a petal attachment modified to reduce the risk of ischemia by lining the petals with silicone 
(Figure 4.8d). Although they can reliably apply high load to the small bowel, the complication of 
the bristle approach perforating the tissue is almost certain to occur within days of implanting such 
an attachment for a longer-term experiment. The risk of puncture is increased not just because the 
bristles are thin and sharp, but because they create a highly localized area of weakened ischemic 
tissue at their tip. This risk is serious because if the bristles perforate the bowel lumen, it will cause 
enteral content leakage that can lead to severe infection, sepsis, and potentially death. Additionally, 
bristles that have perforated the bowel lumen may also puncture adjacent segments of small bowel 
and other organs. Although to a lesser extent, the petal and sharp petal attachments also caused 
localized areas of tissue ischemia where they contacted the bowel lumen, which can be seen as the 
white areas where blood was not properly perfusing the tissue. Therefore, for implantation periods 
 
Figure 4.8. Bristle and Petal Based Attachment Implanted in Live Porcine Tissue. 
The bristles and petals were evaluated with in vivo porcine small bowel tissue to evaluate their risk of 
bowel ischemia and perforation. The attachments that most effectively attached to the bowel lumen, 
the bristles, petals, and sharp petals, were also the most likely to caused bowel perforation. While the 
silicone-lined petals did not present the risk of bowel perforation secondary to ischemia, the attachment 
easily slid through the bowel lumen without gripping.   
a) Bristles b) Petals
c) Sharp Petals d) Silicone-Lined Petals
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greater than approximately one week, the risk of tissue ischemia leading to necrosis and subsequent 
bowel perforation is high. Lining the petals with thin silicone tubing greatly reduced the risk of 
ischemia and the subsequent cascading complications. However, the lined petals slipped along the 
bowel lumen readily, applying less than 50 gf.  
For the bristle and petal approaches, the acute in vivo experiments revealed an important 
tradeoff between the gripping performance and the risk of bowel perforation and/or ischemia. The 
approaches seemingly rely on the application of areas of localized pressure to create points of 
fixation along the bowel wall. The more localized the area of pressure is, the greater the risk of 
ischemia and the better gripping performance there is. To overcome this tradeoff, active petal-
based attachments that are pneumatically actuated with balloons were developed (Figure 4.9). In 
 
Figure 4.9. Balloon-Actuated Petal Approach. 
To enable the petal-based attachment to operate in engaged and disengaged attachment modes, the 
concept of spreading the petals with a balloon was explored with in vivo segments of porcine small 
bowel. In addition to being able to disengage from the small bowel lumen for implantation, removal, 
and purposeful repositioning, the disengaged mode better allowed blood to perfuse the bowel tissue 
surrounding the attachment. However, even with the balloon deflated, the tissue drapes around the ends 
of the petals, prohibiting the attachment from sliding freely along the bowel lumen.  
b) Inflateda) Deflated
d) Inflated, Implantedc) Deflated, Implanted
150 
an acute in vivo experiment, the balloon-actuated petals provided high tensile loads similar to 
passive petal-based attachments while the balloon was inflated. With the balloon was deflated, the 
gripping force was significantly reduced, but so was the risk of ischemia. Figures 4.9c and 4.9d 
show that when the balloon is inflated, areas of blanched (whitened) tissue appear along the petals 
and on the face of the balloon, whereas the tissue surrounding the deflated attachment is well-
perfused by blood. The balloon-actuated petal concept can be used to safely apply tensile bowel 
load intermittently, where the duration of time that the load is applied would be set to reduce the 
risk of ischemia. Following periods of applied bowel tension, the attachments would be deflated 
to allow blood to reperfuse the tissue. Unfortunately, the attachments did not slide easily along the 
bowel lumen in the deflated state, due to the manner with which the bowel tissue draped around 
the petals. This cycle of load application and tissue reperfusion could be repeated to safety apply 
intermittent bowel tension. 
4.2.2. One to Two Week In Vivo Experiments 
Longer in vivo experiments were conducted to evaluate the attachment performance and 
potential surgical complications associated with a series of attachment approaches that 
demonstrated promise in the ex vivo and/or acute in vivo experiments. These approaches included 
the binding/kinking approach, the clamping approach, the tissue piercing approach, and the 
dilation approach with textured balloons. The challenge of attaching safely and reliably for longer 
implantations was much greater than that for acute experiments, because over time, the small 
bowel adapted and dramatically remodeled itself in the presence of the attachments. To apply loads 
with attachments in these longer term experiments, extending devices were required to drive the 
motion of the tissue attachments. The extending devices included the Curved Hydraulic Device, 
the Instrumented SMA Driven Ratchet, and a reciprocating single-stage linear hydraulic device 
with a 3.4 cm stroke. 
4.2.2.1. Binding / Kinking Approach – Surgically Enforced 
During routine colonoscopies, the colonoscope can often become stuck within the large 
intestine due to sharp bends along the tissue. Although problematic during a colonoscopy, this 
phenomenon was evaluated as a beneficial attachment approach for small bowel in a live porcine 
animal model. To evaluate if bends in the small bowel could be used as attachments in a fashion 
similar to end-abutment, an experiment was conducted by placing the Curved Hydraulic Device 
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into a Roux limb of small bowel and then surgically enforcing sharp bends around the device using 
sutures, as shown in Figure 4.10. In addition to the sutures used to enforce a sharp bend on both 
ends of the Curved Hydraulic Device, marking sutures were also placed to track the growth of the 
tissue. During a two-week implantation period, the Curved Hydraulic Device was extended by 
approximately 9.5 cm. However, at the explant, the measurement from the marking sutures 
indicated that the tissue lengthened by only approximately 0.5 cm. Therefore, it was not an 
effective attachment approach for the application of tension-induced small bowel tissue 
lengthening and it is not recommended for similar applications. 
4.2.2.2. Clamping Approach – Extraluminal Ring 
The use of extraluminal rings was explored in two in vivo experiments to evaluate their 
potential, using two different extension devices: a reciprocating single-stage linear hydraulic 
device, and the Curved Hydraulic Device. The reciprocating single-stage linear hydraulic device 
is shown prior to implant (Figure 4.11a), at implant (Figure 4.11b), and at the conclusion of a one-
week long implantation period (Figure 4.11c). For this approach, the intended operation was that 
 
Figure 4.10. Surgically Enforced Tissue Kinking Approach. 
Tight bends in the small bowel tissue on both sides of the Curved Hydraulic Device were enforced 
by sutures as a means of evaluating the tissue kinking approach. In addition, marking sutures were 
placed along the length of the small bowel to determine the amount of tissue growth at the explant. 
At the explant. At explant, the measured tissue growth was only 0.5 cm, despite the 9.5 cm expansion 
of the Curved Hydraulic Device. 
a) Kinking Attachment Approach as Implanted
Marking Sutures
Tissue Kinking Sutures
b) Kinking Attachment Approach at Explant
Marking Sutures
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the inflated intraluminal balloons would push on the extraluminal rings, which were placed though 
surgically created mesenteric defects. The intended points of fixation were the areas of tissue with 
heightened pressure due to the interaction of the balloons (when inflated) with the rings. 
To evaluate the intraluminal balloon with an extraluminal ring attachment approach, the linear 
hydraulic device was placed through the stoma of a Roux limb of porcine small bowel with its 
balloons deflated. After device placement, an external syringe was used to inflate both balloons 
through a shared pneumatic line. The proximal and distal rings were then placed through surgically 
created mesenteric defects, which are small holes in the mesentery, such that there was minimal 
slack in the tissue between the attachments. Secondary rings were also placed to provide 
attachment points of fixation. Additionally, marking sutures were placed along the tissue to create 
 
Figure 4.11. Clamping Approach with Single Stage Linear Hydraulic. 
Using a single-stage hydraulic device as the extension mechanism, an 
embodiment of the clamping approach using internal balloons and external 
rings was evaluated in vivo in an experiment lasting one week. At explant, the 
tissue segment length was increased by 10-15% out of a possible 40% (limited 
by device stroke). 
a) Linear Hydraulic Extending Device with Balloons
Balloons
Hydraulic Stage
Pneumatic Line (For Balloons)
b) Linear Hydraulic Device with Balloons At Implant
Proximal Ring
Distal Ring 
(Hidden by 
tissue)
Secondary Rings
Balloons (inflated)
c) Linear Hydraulic Device with Balloons At Explant
Balloons (deflated)
Secondary Rings
Distal RingProximal Ring
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reference points for measuring the change in tissue length. Ideally, after growing the length of 
bowel between the outermost rings, the balloons could be deflated, repositioned, and reinflated 
(under fluoroscopy) such that the distal balloon engages one of the secondary rings, allowing for 
greater tissue growth. However, the main goal of this experiment was to grow the tissue between 
the attachment rings by 3.4 cm, the maximum stroke of the linear hydraulic device, for an increase 
in the tissue length of 40%. 
During the implantation period, an attempt to reposition the distal balloon attachment under 
fluoroscopy was not successful because the separation of the proximal and secondary rings was 
not sufficient to fit the collapsed device. At the explant surgery (Figure 4.11c), the marking sutures 
placed during the implant surgery were located and they indicated that the tissue grew by 
approximately 10% to 15% out of a potential 40%. Thus, the attachments were able to transfer 
enough tension such that the small bowel grew, but more than half of the potential tissue growth 
did not occur due to attachment slipping. Clinically, this extent of slipping is not acceptable 
because the amount of small bowel growth is already greatly limited by the space within the 
peritoneal cavity, especially for neonates, and this amount of slipping essentially reduces the 
potential tissue growth further by than a factor of more than 2. At the attachment sites, the health 
of tissue was maintained during the implantation as was demonstrated by a lack of inflammation, 
tissue necrosis, tears, or perforations. The extraluminal rings, which were made of silicone tubes, 
were not embedded in the tissue and were easy to remove. Although there was concern that the 
rings could cause tears in the mesentery because they were placed through mesenteric defects, this 
complication was also not observed. 
The complete lack of observed surgical complications and the increase of tissue length, albeit 
small, prompted a further study of this attachment approach using the Curved Hydraulic Device, 
which is capable of much greater net expansion (15 cm) but does not reciprocate. The idea of the 
attachment is the same as with the linear hydraulic device, but instead of using balloons to push 
on the extraluminal rings, intraluminal rings were used. All of the rings were made from cut 
segments of 18 Fr latex tubing. The surgical implantation procedure and the use of marking sutures 
to track tissue growth was identical with the experiment using the linear hydraulic device. The 
goal of this experiment was to double a length of bowel tissue from approximately 4.5 cm to 9 cm 
over the course of 2 weeks. Several radiographs were taken during the implantation period to 
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validate that the actual expansion of the Curved Hydraulic Device was matching the expected 
expansion, which it did successfully. 
At the explant surgery of this experiment, the expansion of the Curved Hydraulic Device was 
more than sufficient to achieve the tissue growth goal. However, the initially extraluminal rings 
were found within the lumen of the small bowel, as shown by Figures 4.12b and 4.12c. The 
proximal extraluminal ring (Figure 4.12b) was completely detached from the mesentery and bowel 
tissue, while the distal extraluminal ring (Figure 4.12c) was barely attached to the bowel at one 
site. The envelopment of the extraluminal rings into the bowel lumen was not expected, and did 
not occur during the experiment using the linear hydraulic device. This is perhaps because the 
experiment with the linear hydraulic device lasted for one week instead of two weeks. In the 
process of the extraluminal rings becoming intraluminal rings, there were no health related surgical 
complications such as enteral content leakage or bowel tears, as evidenced by the lack of an 
inflammatory response within the peritoneal cavity seen at the explant. The growth of the segment 
 
Figure 4.12. Curved Hydraulic Device with Ring Attachments. 
Using the Curved Hydraulic Device as the extension mechanism, the clamping approach was 
further evaluated using internal rings (mounted on the device) and extraluminal rings made of 
latex 18 Fr Foley catheters. After the one-week experiment, the originally extraluminal rings were 
located within the bowel lumen, leaving the device mostly detached. The distal end of the device 
was barely attached on a small part of the extraluminal ring at the explant. 
Distal Ring
Proximal Ring
Intraluminal rings 
(fixed to device)
a) Curved Hydraulic Device with Rings At Implant
b) Proximal Ring at Explant
Proximal Ring 
Intraluminal Ring
c) Distal Ring at Explant
Distal Ring 
Intraluminal Ring
Still attached here
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could not be measured at the explant, because the marking sutures placed during the implantation 
could not be found. Although the tissue probably did grow a little prior to the complete detachment 
of the proximal ring, this approach did not demonstrate reliable attachment performance and is not 
recommended for this or similar surgical applications. 
4.2.2.3. Tissue Piercing Approach – Sutures and Reinforced Sutures 
The use of sutured attachments was a focus of this study because sutures are used extensively 
by surgeons and they are able to transfer high loads to tissue acutely. To evaluate their potential 
for transferring load from a bowel lengthening device to the bowel wall, experiments (n = 12) were 
conducted with bare sutures (n = 2) and sutures reinforced by pledgets (n = 2), Alloderm (denatured 
human dermis, n = 2), and Strattice (denatured porcine dermis, n = 6). The experiments used both 
the Instrumented SMA Driven Ratchet and the Curved Hydraulic Device as the bowel lengthening 
device in experiments with implantation periods ranging from 1 to 4 weeks, distraction periods 
ranging from 2 to 27 days, and targeted amounts of small bowel longitudinal tissue growth of 50% 
and greater. 
The condition of the sutured attachments were photographed at the end of each experiment, 
and a determination of whether the attachments held or slipped was made. If the attachments held, 
the sutures were still visible on the outside of the bowel wall and the bowel tisse was not separable 
 
Figure 4.13. Schematic of Suture Attachment Outcomes. 
Three outcomes of using the sutures with and without reinforcement were observed at explant. If the 
attachments held, the sutures were still visible on the outside of the bowel at explant. The attachments 
slipped through the tissue leaving the reinforcing material on the outside of the bowel (b), and in some 
experiments, both the reinforcing material and sutures slipped through the tissue (c). 
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from the device without cutting the sutures. The reinforced suture attachments slipped in two ways, 
as shown by Figure 4.13. When the sutured attachments slipped, it was either because just the 
sutures pulled through the reinforcing material and the layers of small bowel (Figure 4.13b), or the 
sutures and the reinforcing material pulled through the bowel (Figure 4.13c). The lack of observed 
peritonitis in the experiments where the attachments slipped (n = 5) strongly suggests that when 
the sutures slip through the bowel, it does not lead to bowel perforation and subsequent enteral 
content leakage. Furthermore, these results suggest that the event of the sutures slipping is not 
abrupt, because it takes place on a timescale that allows the tissue to heal around the sutures. When 
the attachments did hold, as shown by Figure 4.14, the reinforcing component, whether it was 
pledgets, Alloderm, or Strattice, was observed to be in the process of slipping through the bowel 
wall. The slow and safe detachment of this class of attachments may be potentially advantageous 
clinically, because it facilitates the removal of the bowel lengthening device by minimally invasive 
surgery. However, it is difficult to determine how long the attachments will hold and they are 
unlikely to perform reliably from patient-to-patient.  
 
Figure 4.14. Outcomes of the Sutured Attachment Approach. 
Photographs of the reinforced sutures show the transformation of the attachment during the 
distraction period. Even when the attachments held, the reinforcing material is in the process of 
integrating into the bowel and slipping. In experiments where the attachments slipped, the 
reinforcing material was left on the outside of the bowel lumen in some experiments. In some 
experiments, both the sutures and the reinforcing material slipped through the full thickness of the 
bowel wall. 
Thick Stratus Reinforced 
Sutures at Implant
Attachment Held
Both the sutures and the thick
Strattice reinforcement have not
been pulled into the bowel
lumen.
Attachment Slipped
Although the Strattice did not
get pulled through the bowel
lumen, the sutures were pulled
through both the thick Strattice
and the layers of the bowel.
Attachment Slipped
Surprisingly, the thick Strattice
and the sutures both pulled
through the layers of the bowel
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Several key factors have been identified in the success of the suture-based attachment 
approach: length of distraction period, normalized rate of attachment separation (device 
expansion), and the magnitude of the applied force on the tissue from the sutures. The magnitude 
of the applied force was measured in only the experiments using the SMA Ratcheting Device (n = 
3), because the Curved Hydraulic Device does not have force instrumentation. As a result, the data 
were analyzed based on the rate of normalized attachment separation and the length of the 
distraction period, which is defined by the window of time during which the bowel tissue was 
actively strained. Figure 4.15 shows the relationship between these two factors and the success of 
the attachment, where the blue data indicate success and the red data indicate experiments where 
the attachment slipped. The data suggest that high rates of normalized device expansion may be 
achieved if the distraction period is less than approximately 2 to 3 days, and that even very low 
rates of normalized device expansion (less than 0.025 %/day) are not feasible for distraction period 
exceeding 2 weeks. In fact, the suture-based attachments did not hold in any of the experiments in 
which the distraction period exceeded two weeks. Additionally, the grouping of data near (13 days, 
 
Figure 4.15. Tissue Piercing Approach Results – Normalized Expansion Vs. Distraction Period. 
The attachment holding and slipping results for bare sutures, and sutures reinforced with thin Alloderm 
(denatured human skin), thick Alloderm, and thick Strattice (denatured pig skin) are shown as a function 
of the distraction period and the normalized device expansion rate (device expansion rate divided by the 
initial attachment-to-attachment length). These results show that the sutures, even when reinforced, did 
not stay attached for experiments exceeding two weeks. No dependence on the normalized device 
expansion rate was suggested by these data. 
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0.05 %/day) suggested that reinforcing the sutures with either Alloderm or Stratus improves the 
reliability of the attachment compared to just using sutures. 
4.2.2.4. Dilation Approach – Dilating Fenestrated Mesh 
In the acute in vivo experiment with textured balloons, the approach was very promising with 
respect to their ability to grip the bowel lumen when inflated. When inflated and attached, the 
tissue with which the balloons made contact remained well perfused with blood. Thus, the risk of 
ischemia with the approach is minimized. Unfortunately however, the abrasive material used to 
texture the balloons made the attachments grip well even when the balloons were deflated. This is 
an important disadvantage because an extending device using these attachments would be difficult 
and potential unsafe to implant, reposition, and remove. Thus, a method to cover the 
balloons/texture when deflated and uncover the balloons/texture when inflated was developed to 
improve the detachment ability of the attachment without reducing its attachment ability. 
The attachment prototypes, shown in Figure 4.16, were modified by the addition of elastic 
cords suspended over the texture of balloon by machined Delrin end caps. The Delrin end caps 
 
Figure 4.16. Dilating Fenestrated Mesh Attachment, Prior to Implant. 
To improve the implantation, removal, and ability to reposition the attachment, the textured balloon 
was partially covered with strands of monofilament. When the balloon is deflated, the monofilament 
strands prevent the attachment from gripping the bowel lumen. When the balloon is inflated, the 
monofilament strands are forced to spread out, exposing the texture material and enabling the 
attachment to grip the bowel wall. 
a) Deflated Textured Balloon with Covering 
Material
b) Inflated Textured Balloon with Covering 
Material
Delrin end 
caps (2X)
Monofilament 
line
Abrasive 
texturing 
material
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have a circular array of holes through which the elastic cord is placed. When the balloon is deflated 
(Figure 4.16a), the function of the cords is to prevent the bowel lumen from making contact – thus 
enabling the attachments to be implanted, repositioned, and removed safely with ease. When the 
balloon is inflated (Figure 4.16b), the spacing of the elastic cords becomes less dense, allowing 
the tissue to make contact with the textured balloons and enabling the attachments to transfer load 
effectively. 
To validate this functionality and evaluate the reliability and safety of using these attachments, 
a one week in vivo experiment was conducted where the attachments were cycled between their 
inflated and deflated states. While inflated, the balloons were separated by a reciprocating linear 
hydraulic device to apply tension on the small bowel. After several hours of applying tension, the 
balloons were deflated and the reciprocating hydraulic device was retracted for several hours to 
allow the bowel to relax and to reduce the risk of the attachments perforating the tissue. This cycle 
of tensioning and relaxing the small bowel segment was repeated for 8 hours a day over the course 
of one week. 
Results from the one-week in vivo study indicated that the attachments were a success based 
on the health of the tissue and the attachment performance observed at the explant. One major 
concern with their use was that the texturing material would become saturated with debris over 
time, greatly reducing their attachment performance. To evaluate this failure mode, the attachment 
and detachment forces were evaluated at the explant with a load sensor. With the balloons of each 
attachment deflated, the device could move though the bowel lumen with ease, with the force 
required to initiate motion being measured at approximately 120 gf (value is for both attachments). 
With a single attachment engaged, the measure force exceeded 450 gf, saturating the measurement 
system. Although the texturing material appeared to be potentially clogged, the attachment 
performance was no less than that at the start of the implantation period. The other concern 
associated with the longer term use of these attachments was their effect on the health of the bowel 
wall, given the abrasive nature of the texturing material. Figure 4.17 shows the portion of bowel 
tissue that the attachment was in contact with for the duration of the implantation. Although 
parallel line imprints from the monofilament strands were observed and there was mild tissue 
inflammation, the tissue was in good health and had an intact mucosal lining.  
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4.3. Comparison of Attachment Approaches 
The broad range of experimentally evaluated attachment concepts are shown in a chart for 
comparison in Figure 4.18, which categorizes the attachments based on their health and safety risk, 
and shows the attachment and purposeful detachment abilities of each attachment simultaneously. 
The health risks are qualitatively described as 1, the attachments are unlikely to cause a surgical 
complication, 2, there is some potential for surgical complication, and 3, there are expected serious 
surgical complications such as bowel perforation or ischemia. The dilation approaches are 
categorized as having the least health risk because there usage does not require any surgical 
manipulation of the bowel, and because they distribute their applied pressure evenly, the risks of 
bowel perforation and/or ischemia are low. The binding/kinking, clamping, and the suture 
approaches all require surgical manipulation of the small bowel. Therefore, they present a greater 
potential for surgical complications than the dilation approaches. Both the impingement and 
adhesion approaches pose likely surgical complications related to bowel ischemia and subsequent 
perforation. The starting and ending positions of the vertical bars labeled with the attachment 
concepts indicate how well each approach attaches and purposefully detaches for implantation and 
removal. For example, the “dilation (smooth)” approach failed (indicated by the “X”) to work 
“acutely well (doesn’t slip at loads exceeding 200 gf)” while inflated, but “slips freely” when 
deflated. This approach was not tested beyond an acute in vivo study, so its ability to attach “well 
 
Figure 4.17. Effect of Attachment on Tissue Health. 
At the explant surgery, the portion of the bowel tissue where the attachments made contact 
had markings from the monofilament strands and mild inflammation. Despite this, the 
health of the tissue appeared good because the mucosa was grossly intact and there were 
no perforations or tears. 
Markings from 
monofilament strands
Portion of bowel in 
contact with attachment
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for up to one week” was not tested. All other attachment approaches can be read similarly from 
this chart. 
 
Figure 4.18. Comparison of Evaluated Attachment Approaches. 
The attachment and detachment performance of the attachments, grouped by health and safety risk, is 
shown. Ideally, the attachments demonstrated strong attachment performance to induce tissue growth, 
and strong detachment performance to facilitate implantation, removal, and purposeful reposting. The 
total height of the bar for each attachment illustrates the sum of attachment and detachment 
performances. The health and safety risk ratings were given on a scale from 1 to 3, where 1 is the safest 
rating. Qualitatively, a rating of 1 indicates that the attachment approach is unlikely to cause bowel 
ischemia or perforation, and the attachment does not require any components to pierce through the 
tissue. A rating of 2 indicates that there is a moderate concern of bowel ischemia or perforation, or the 
attachment requires components to pierce through the tissue. Lastly, a rating of 3 indicates that the risk 
of ischemia or perforation or likely to occur if the attachment is implanted for more than one day. Xs 
indicate where the attachments were evaluated but did not achieve the attachment or detachment 
performance. Based on its safety, detachment performance, and attachment performance, the Dilating 
Fenestrated Mesh showed the most promise, although more experiments are required to evaluate its 
performance in trials exceeding one week. 
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Given the desired performance of being able to both attach and detach from the bowel lumen 
safely, the best candidate attachment approach is the Dilating Fenestrated Mesh. This is because 
the attachment was able to apply more the 200 gf reliably in experiments lasting up to one week, 
easily slid along the bowel lumen when detached, and posed little risk of bowel ischemia and/or 
perforation. However, their performance has not yet been evaluated in experiments exceeding one 
week, like the suture-based approaches. Despite this, the further experimental evaluation (beyond 
one week) of this approach is strongly supported by these initial results. 
4.4. Conclusion 
To investigate clinically relevant attachment approaches for supporting the development of 
enterogenesis devices to correct short bowel syndrome, a broad range of attachment approaches 
were conceptualized, fabricated, and evaluated in a series of ex vivo, acute in vivo, and longer term 
in vivo experiments with porcine animal models. The series of experimental studies confirmed the 
reliability issues of suture-based attachment approaches for small bowel tissue and identified the 
failure modes and health risks associated with each attachment approach. 
Compared to other tissue attachment approaches in this study, the Dilating Fenestrated Mesh 
demonstrated the greatest promise. The approach demonstrated its ability to apply high tensile load 
on the small bowel without causing ischemia at the attachment/tissue interface in an experiment 
lasting one week. The approach also demonstrated its ability to traverse the small bowel freely. 
These performance capabilities have the potential to enable minimally invasive surgical methods 
that reduce the risk of surgical complications, lower the cost of treatment, minimize scarring, and 
shorten the recovery time. 
The safe attachment and detachment of soft tissue to a foreign body is a challenging but 
important problem with broad medical applicability. Possible applications for intraluminal 
attachments beyond the treatment of SBS include the treatment of long-gap esophageal atresia, 
suture-less or low suture tension end-to-end anastomoses, improved mobility of endoscopic 
devices, and improved stent migration prevention. A currently practiced method for treating long-
gap esophageal atresia, a condition where a segment of the esophagus is absent, is to apply tension 
to the two ends of the esophagus with traction sutures that are manually tensioned to induce 
esophageal growth and close the gap [13], [14]. Although the method is promising, a reported 
complication is that the sutures sometimes cut through the tissue. Therefore, the use of an 
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intraluminal attachment may be able to overcome this complication. Another possible use of 
intraluminal attachments is to provide traction for creating suture-less or low suture tension end-
to-end anastomoses, which could help prevent leakage, tearing, and maintain the patency of the 
connection. The mobility and robustness of endoscopic devices may also be improved with the use 
of non-permanent intraluminal attachments. In a manner identical to double balloon endoscopy, 
endoscopes equipped with actuated non-permanent attachments may be guided along the GI tract 
more easily than with a traditional endoscope. Furthermore, the results of the attachment studies 
may be used to develop stents with improved resistance to migration. 
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CHAPTER FIVE. DEVELOPMENT OF A 
CLINICAL DEVICE FOR TREATING 
SHORT BOWEL SYNDROME 
Short bowel syndrome is an often lethal medical condition characterized by the malabsorptive 
state of a patient who was born with intestinal atresia or has undergone massive small bowel 
resection to treat intestinal pathologies. The condition is challenging to manage and treat because 
of complications associated with parenteral nutrition, surgical bowel restructuring techniques, and 
transplants. As a result, mortality rates associated with SBS are as high as 38% [1,2]. To provide 
an alternative to long-term parenteral nutrition reliance and surgical bowel lengthening, this 
dissertation explored technological approaches for a promising and novel treatment method of 
short bowel syndrome based on mechanotransductive enterogenesis. 
Chapter Two established the feasibility of the mechanotransduction-based approach in 
clinically relevant animal models. To achieve this, the Curved Hydraulic Device was developed 
and used to induce large net growth of porcine small bowel. In a series of four in vivo studies, 
tissue expansion factors (final segment length divided by initial segment length) ranged from 1.6 
to 2.2X, which is comparable to the lengthening factors achieved by the Bianchi and STEP bowel 
lengthening procedures. The grown tissue health was compared to control segments of tissue by 
evaluating tissue histology, morphology, barrier function, and epithelial cell proliferation, 
suggesting the true growth of healthy functioning bowel. Additionally, these studies have produced 
the first reported evidence of an increase in mesenteric vascularity to support the lengthened small 
bowel [3], further establishing the potential of the treatment approach. Chapter Three built upon 
this result and developed the treatment method with the Instrumented SMA Driven Ratchet by 
comparing different tissue expansion strategies, exploring the upper limit on how quickly small 
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bowel can be safely grown, and determining the safe range of tensile loading that can be applied 
to the tissue. 
For clinically relevant devices, greater design constraints are present compared to devices for 
research. The most important differences are the need to be able to implant the device in a 
continuous portion of the small bowel (by non-invasive surgical techniques) rather than within an 
isolated segment, the greater constraints on the form of the device, greater lengthening capabilities 
to enable the treatment of severe cases of SBS, and an enhanced emphasis on device safety features 
including applied tensile load measurement, displacement control, and displacement measurement. 
While the Curved Hydraulic Device and the Instrumented SMA Driven Ratchet were critical for 
laying the foundational knowledge necessary for the development of a clinically relevant device, 
they do not fulfill the aforementioned clinical design constraints and considerations. The Curved 
Hydraulic Device was useful for inducing large net and high expansion factor growth, but the 
device is not implantable in continuous small bowel because its large outer diameter would likely 
cause bowel obstruction. Furthermore, the length and rigidity of the extended device would be too 
great to fit into the peritoneal cavity of some patients. The tissue expansion capability of the device 
is approximately 2 fold, which may serve a large percentage of SBS patients. However, if the 
outcomes of patients receiving the Bianchi and STEP procedures can be extended to bowel 
lengthening by mechanotransduction, approximately 60% of patients would not be able to wean 
from TPN following treatment with the Curved Hydraulic Device. Lastly, the Curved Hydraulic 
Device was not instrumented and there was little control of the device displacement, possibly 
leading to complications such as bowel tearing from overextension. Like the Curved Hydraulic 
Device, the implantation of the Instrumented SMA Driven Ratchet into a continuous bowel 
segment would also likely lead to bowel obstruction because of its outer diameter, and the length 
and rigidity of the extended device would not fit in some patients. The linear form of the device 
would cause extraneous tension on the mesentery during the distraction period, possibly causing 
mesenteric defects. Also, the tissue expansion capability of the ratcheting mechanism is 50%, 
which would thus serve a much smaller patient population than the Curved Hydraulic Device. Both 
the Curved Hydraulic Device and the Instrumented SMA Driven Ratchet are examples of extension 
devices, an approach category (among six others identified in this chapter) which is fundamentally 
not as well-suited to induce high net growth compared to other approaches. The enterogenesis 
devices used in prior research by other groups do not fulfill the clinical design constraints and 
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considerations either. The Internal Screw Device [4] is an extraluminal device designed to attach 
to the outside of a continuous bowel segment with sutured tissue couplers. Although the ability to 
grow a continuous segment of small bowel is clinically advantageous, the implantation of the 
device requires an invasive laparotomy, and the suture-based attachment approach is not reliable 
and requires piercing the remnant bowel. The External Screw Device [5] and Intraluminal Spring 
[6] are intraluminal devices that are designed to attach by end abutment, an unfavorable attachment 
approach that precludes non-invasive implantation methods, requires isolating the grown bowel 
segment, and requires bowel anastomoses that result in discarded small bowel tissue. 
This chapter presents the development of a bowel extension device whose design focuses on 
clinical relevance rather than the enablement of research studies. Changing focus from research to 
clinical application required a full design cycle, starting with reassessing medical needs, producing 
a wide range of conceptual approaches, and downselecting to a single approach and embodiment. 
The selected embodiment was the Reciprocating Linear Hydraulic Device from the payout branch 
of the conceptualization tree, which was designed to be compatible with the Fenestrated Dilating 
Mesh attachment approach (most promising attachment from Chapter 4). The remainder of the 
chapter describes the design, prototype, fabrication, and in vivo validation of the Reciprocating 
Linear Hydraulic Device. The device presented in this chapter represents a large step forward in 
the development of a clinically relevant devices for correcting SBS for two key reasons. One, the 
device architecture has the potential to enable minimally invasive implantation and removal 
surgeries, greatly reducing the cost, recovery time, chance of surgical complications, and 
improving the overall quality of patient care. And two, the device can induce high net bowel 
growth within the limited space of the peritoneal cavity, potentially enabling the treatment of very 
severe cases of SBS in infants and children.  
5.1. Design of Expansion Approach 
To take the next step from research relevant devices to clinical, a traditional design process 
was used to identify the best expansion approach with the assumption that the Dilating Fenestrated 
Attachment approach from the previous chapter would be used. The design process steps were to 
develop selection criteria based on medical needs, organize and develop new expansion 
mechanism classes into a conceptualization tree, systematically compare the potential of each class 
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of mechanisms using a Pugh Chart, downselect to a single class of mechanisms, and design a 
detailed embodiment of the mechanism within the down-selected class. 
5.1.1. Development of Selection Criteria 
The development of selection criteria was driven by the additional design considerations and 
constraints for clinical relevant enterogenesis devices compared to research enabling devices, 
which include the ability to implant the device in a continuous portion of the small bowel (by non-
invasive surgical techniques), greater constraints on the form of the device, greater lengthening 
capabilities to enable the treatment of severe cases of SBS, and an enhanced emphasis on device 
safety features including applied tensile load measurement, displacement control, and 
displacement measurement. 
In a clinical setting, there are many benefits to implanting in continuous bowel by non-
invasive surgical techniques. The key benefit of implanting in continuous bowel is that no 
anastomoses are required at the implant or explant surgery. Small bowel anastomoses should be 
eliminated because they present a risk of bowel obstruction and enteral content leakage, reduce the 
sterility of the implant and explant surgeries by exposing the bowel lumen to the surgical field, 
and most importantly, require significant lengths of small bowel to be discarded at the explant 
surgery in order to place the grown tissue segment back into the continuous GI tract. In contrast, 
implanting and removing the enterogenesis device by non-invasive techniques hastens the 
recovery period, and reduces scarring, medical complications, and costs. To achieve this, the 
device-to-tissue attachments should traverse the small bowel readily during the device 
implantation and removal, but must also be able to reliably transfer load to the bowel during the 
distraction period. 
To implant in a continuous segment of the GI tract by non-invasive surgical techniques, reduce 
extraneous loads on the mesentery, and prevent bowel injury during device implantation/removal 
and expansion, many design parameters need to be considered that are related to the device form. 
These parameters are: 
1. Length, rigidity, and curvature 
The length, rigidity, and curvature of an enterogenesis device are coupled parameters 
in the context of device maneuverability through the GI tract. For example, if the 
device length is very short, it may still be implantable through the upper GI tract even 
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if it is rigid and straight. Likewise, long devices must have some flexibility to be 
maneuvered through the upper GI tract. The maximum length of a device, regardless 
of implantation and removal procedure, is also limited by the size of the patient’s 
peritoneal cavity and by the extent that the device induces stress in the mesentery 
supporting the bowel. Because the mesentery radially pulls on the bowel, giving it its 
curvature, long and straight devices place significant stress on the mesentery. To 
reduce mesenteric stress, long devices can be curved to mimic the natural curvature of 
the bowel, or simply shortened. In an unpublished study at the University of Michigan, 
the peritoneal cavity size of a characteristic one year old child was estimated by 
creating a three-dimensional reconstruction of the cavity from CT scans. The result of 
this study showed that approximate width and height of the cavity was 15 cm and 17 
cm, respectively. 
2. Diameter 
In general, the outer diameter of an enterogenesis device must be limited such that the 
device fits within the diameter of the relaxed bowel lumen. However, a more 
restrictive requirement exists for enterogenesis devices designed to be implanted in 
continuous bowel because the flow of enteral contents must not be obstructed by the 
device. To eliminate the risk of device-related bowel obstruction, which can lead to 
bacterial overgrowth and a cascade of further medical complications, both the device 
length and outer diameter should be limited in order to reduce the resistance of enteral 
content flow. 
3. Proximal and Distal Bowel Tissue Interface 
The proximal and distal bowel tissue interfaces of enterogenesis devices need to be 
carefully designed to reduce the potential risk of bowel ischemia on either end of the 
device. This is because the manner in which the tissue drapes around the device can 
lead to sharp bends in the tissue that lead to ischemia and perforation.  
4. Local Feature Contours 
Local enterogenesis device features that interface with the bowel wall must be 
contoured such that they do not induce bowel ischemia. The ischemia risk of 
uncontoured features is coupled to the device outer diameter, because as the outer 
diameter increases, the device must become more contoured to prevent ischemia. This 
consideration is particularly pertinent at the tissue attachment locations of the device, 
which often have the greatest outer diameter. 
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To design a clinically relevant enterogenesis device, the most important functionality of the 
device is to induce small bowel growth by an amount that is sufficient to wean the patient from 
parenteral nutrition. While critical for designing the device, setting the target net and/or expansion 
factor of the expansion mechanism is complicated by the fact that there is no one solution that fits 
all. While one patient may respond to a 20% increase in bowel length, another may require much 
more bowel lengthening to wean from TPN. To estimate a reasonable target net and factor 
expansion for the design, the outcomes of lengthening small bowel by surgical techniques were 
reviewed. Both procedures are discussed in Chapter One. In a 20-year single institution (Children’s 
Hospital of Pittsburgh) retrospective study on the outcomes of patients receiving the Bianchi 
procedure [7], a surgical technique that doubles a length of small bowel, 10 out of 19 patients did 
not undergo any further surgical lengthening or bowel transplant. While 7 of those 10 patients 
weaned from parenteral nutrition (with 5 to 26 cm of remnant bowel), 3 died (with 9 to 15 cm of 
remnant bowel). Overall, despite doubling the length of their remnant small bowel, 12 (63%) 
patients did not wean from the procedure (9 patients required rescue by small bowel transplant and 
3 patients died). Outcomes for STEP procedure patients are similar. In a study at the Children’s 
Hospital of Boston [8], only 6 out of 16 patients who received the STEP procedure, resulting in a 
mean small bowel lengthening of 91 ± 38%, weaned from parenteral nutrition (62% did not wean). 
With either procedure, doubling or nearly doubling the length of remnant small bowel was not 
sufficient to wean more than half of the patient population. Thus, to improve patient outcomes 
with a clinically relevant device, at least 2 fold expansion capacity is needed to produce results 
similar the surgical lengthening procedures. However, because more than 60% of patients were 
not able to wean from parenteral nutrition in either study, greater than 2 fold expansion is the goal. 
The control and measurement of the tissue expansion and applied tensile load are important 
safety features of a clinically relevant enterogenesis device for preventing tissue overextension 
and/or exceeding safe limits of the applied tensile load. The application of small bowel tension is 
limited by the risk of ischemia [9], a complication which can lead to bowel necrosis and 
perforation. This is a serious issue for SBS patients, because necrosed bowel tissue is no longer 
viable and must be surgically removed, worsening the severity of their condition. Additionally, 
bowel perforation leads to sepsis, a life-threatening complication caused by severe infection. To 
reduce the risk of overextending or applying too much load to small bowel tissue with 
enterogenesis devices lacking force instrumentation, the treatment regimen can be set to expand 
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the tissue at a very slow and conservative pace. However, this will not prevent bowel overextension 
with certainty, and leads to a longer than necessary treatment duration, increasing the risk of 
complications, the length of hospitalization, and the cost of care. 
With these aspects of the design considered, selection criteria for the expansion mechanism 
of the clinically relevant device were identified in collaboration with pediatric surgeons 
specializing in the care of SBS patients at the University of Michigan and by extensive experience 
with in vivo experimental studies using the Curved Hydraulic Device and the Instrumented SMA 
Driven Ratchet. Ultimately, eleven criteria were identified and are defined below. 
1. Does Not Injure Bowel While Implanted 
This criterion concerns the propensity of the device to cause bowel ischemia or 
perforation during the distraction period. The risk of bowel injury relates to the device 
form, and device force/displacement instrumentation and control. 
2. Safety of Implantation and Removal 
This criterion relates the risk of mechanically injuring the bowel during the 
implantation and removal of the device by causing bowel perforations and/or tears. 
This risk is related to the device form and attachment approach. 
3. Accurate Expansion of Tissue Control 
This criterion relates the ability of medical personal to accurately expand the bowel 
tissue by a predetermined amount. 
4. Environmentally Robust 
This criterion relates to the robustness of the device performance to the time-varying 
loading environment, the device sealing to keep enteral contents out, and the device 
robustness to a time-varying anatomical environment. 
5. Implantable in Continuous Bowel 
This criterion relates to whether a device is implantable in continuous bowel or must 
be implanted in an isolated segment.  
6. Secure Attachments 
Many attachments work well acutely. This criterion relates the ability of an attachment 
to have reliable performance on the timescale of weeks. 
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7. Bowel Tension Monitored in Real-Time 
This criterion relates to the ability of medical personal to have a real-time 
measurement of the applied bowel tension available during treatment, an important 
diagnostic for preventing bowel injury and informing the tissue expansion protocol. 
8. Compact Size 
This criterion relates to the overall size of the enterogenesis device. 
9. High Growth Factor 
This criterion relates to the ability of the enterogenesis device to induce high fold 
growth, which is related to the net expansion capacity of the device as well as its 
unextended length. 
10. Net Bowel Growth Monitored in Real-Time 
This criterion relates to the ability of medical personal to have a real-time 
measurement of the net bowel growth. 
11. Extraneous Loads on the Mesentery Avoided 
This criterion relates to the interaction of the device form with the mesentery. Long, 
rigid, and straight devices cause extraneous loads on the mesentery at implant, while 
short, flexibility, and/or curved devices allow the mesentery to relax. 
5.1.2. Conceptualization of Expansion Mechanisms 
To meet the demanding criteria, a full conceptualization study was conducted resulting in 
seven distinct approaches depicted in the concept tree (Figure 5.1). The seven major approaches 
differ fundamentally in their architecture, operation, and/or implantation location, and have 
important advantages and disadvantages relative to each other. The approaches include Extension, 
Payout, Track, Feed-In, Motility, Secondary Growth, and Field-Induced. Although the feasibility 
of Motility, Secondary Growth, and Field Induced approaches was questionable, they are included 
in the concept tree for completeness. A brief explanation of each approach is given. 
173 
 
5.1.2.1. Extension 
Extension devices are those where the device is designed to lengthen one time within a 
segment of small bowel to apply tension to the bowel through attachments on the opposing ends 
of the device. By definition, Extension devices can only extend and cannot be retracted or reset 
during their implantation. The Intraluminal Spring [6,11,14], Linear Hydraulic Device [10], 
Curved Hydraulic Device, and Instrumented SMA Driven Ratchet are all examples of this 
approach, because they expand once while implanted and the body of the device remains within 
the segment of small bowel during the extension. Thus, the percent expansion and net expansion 
of the grown tissue segment closely matches that of the device. Compared to other expansion 
approaches, Extension devices are readily implemented, which is why many prior enterogenesis 
devices have taken this approach. However, the approach is not well-suited for inducing high net 
small bowel lengthening because their expansion capability is limited by the peritoneal cavity of 
the patient and their remnant small bowel length. Because Extension based mechanisms 
 
Figure 5.1. Conceptualization Tree. 
Seven unique enterogenesis device conceptual approaches were identified in the design process. Six of the 
concepts have been previously used in enterogenesis studies. The extension concept branch includes the 
Linear [10] and Curved Hydraulic Devices, the Instrumented SMA Driven Ratchet, and the Superelastic 
Spring [11]; The track approach includes the External Screw used in the rabbit study [4]; the feed-in branch 
includes the externally mounted screw used in studies with rats [5,12,13]; and the secondary growth 
approach includes dilation by fluid injection [10]. 
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monotonically expand during their implantation, both end-abutting and non-end-abutting 
attachments may be integrated into devices of this class. 
5.1.2.2. Payout 
Payout devices, which have been subcategorized into incremental and continuous approaches, 
have the potential to grow very large lengths of bowel because the net growth of the small bowel 
is not limited by the peritoneal cavity of the patient or their remnant bowel length. This is because 
Payout devices are able to selectively attach and detach from the bowel wall and do not expand 
monotonically throughout the implantation period. Rather, incremental payout devices cycle 
between expanded and contracted states while continuous payout devices do not increase in size 
whatsoever. Incremental payout devices operate by repeating four stages:  
1. the device is retracted and the attachments are engaged in the tissue, 
2. while attached, the device extends to induce bowel growth, 
3. the device attachments are disengaged from the tissue, and  
4. the device returns to its retracted state, the attachments are reengaged, and the process 
is repeated.  
Ideally, as the device expands in stage two, it is tensioning a shorter length of the previously 
distracted segment of bowel, because part of the previously tensioned and grown bowel from the 
previous cycle has “paid out” in stage 4. Continuous payout devices remain attached to the small 
bowel and continuously apply tension with a rotating attachment. Unlike all prior reported 
enterogenesis devices, a key advantage of the general payout approach is that the length of bowel 
grown is not limited by the initial length of remnant small bowel, by the device size, or 
subsequently, by the size of the peritoneal cavity of the patient, because a compact device can 
continue to payout bowel until a physiological limit is reached or sufficient bowel growth has be 
induced. Because the incremental payout approach requires the use of selectively active 
attachments, it is not compatible with the end-abutting attachment approach and it is challenging 
to measure the net bowel lengthening. 
5.1.2.3. Track 
Track devices utilize two initially adjacent bowel attachments which are fixed to an 
intraluminally implanted flexible or rigid track, which is located completely within a segment of 
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the small bowel. Bowel growth is induced as one or both attachments move apart along the track, 
thereby inducing load on the tissue. This approach is advantageous for producing high expansion 
factor bowel growth, because the attachments may initially be very close, even though the total 
length of grown bowel is limited by the length of the track. An important disadvantage of this 
approach is that the applied bowel tension would be difficult to measure along a curved track, 
because the load of the tissue would include tensile and bending components. Unlike the extension 
approach, track devices are not compatible with the end-abutment tissue attachment approach 
because the track cannot pass through a segment of bowel that is surgically closed.  
5.1.2.4. Feed-In 
Feed-In devices are very similar in nature to Track devices, with the major difference being 
that the component acting as the track is not completely contained within the small bowel initially. 
The track of the Feed-In device may have components that are initially external to the patient or 
within the stomach of the patient. An example of this approach is the External Screw Device used 
in the rat studies [5,12,13], because the screw was initially external to the bowel lumen of the 
animal model. Because of this, both end-abutting and non-end-abutting attachments may be 
integrated into devices of this class. Another difference with Track devices are the kinematics of 
the attachments relative to the track component. The track component of a Feed-In device moves 
through the attachments, while for Track devices, the attachments move along the track 
component. Like the Track approach, the Feed-In approach can induce high expansion tissue 
growth because the length of the initial bowel segment may be very small. 
5.1.2.5. Motility 
Motility based devices rely on the healthy motility of the small bowel, and transmit forces on 
the tissue from either the drag generated by the flow of enteral contents on a intraluminally 
implanted object and/or by the force generated by peristalsis. This branch of the conceptualization 
tree was considered for completeness of the design approach, but Motility based approaches suffer 
from major fundamental drawbacks. The first of which is that the two subclasses, enteral content 
and partial obstruction, rely on the healthy transit of enteral contents through the bowel lumen. 
However, SBS patients have limited to no enteral nutrition in their diet. Thus, there will not likely 
be enough enteral content passage to create a drag force. The peristaltic force subclass also relies 
on the healthy function of peristalsis in SBS patients. However, because large portions of SBS 
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patient small bowel is dilated, the effect of peristalsis on intraluminal objects is likely to be 
minimal. 
5.1.2.6. Secondary Growth 
Secondary Growth devices rely on the concept that the non-longitudinal application of load 
on bowel tissue will result in growth with a longitudinal component. For example, if bowel tissue 
is dilated with a balloon, the tissue growth will occur radially and have a longitudinal component. 
One implication of this approach is that after the device is removed, the dilated segment may be 
surgically tapered and lengthened with either the Bianchi or STEP procedure to increase the length 
of bowel. However, both restructuring procedures are associated with complications and the 
requirement of additional surgical procedures to correct recurrent dilation of the bowel [15]. 
Another non-longitudinal application of load would be to develop shear in the tissue through 
twisting. The result of twisting the tissue has not been experimentally evaluated, because there is 
a large risk of tearing the bowel mesentery. 
5.1.2.7. Field Induced 
Field Induced devices are non-actuated and rely on forces developed by gravitational or 
magnetic fields to create tension on small bowel segments and induce their growth. Like Motility, 
this branch of the conceptualization tree was considered for completeness of the design approach. 
To utilize gravity, a segment of bowel could be tensioned by attaching a weight to the remnant 
small bowel segment of an SBS patient. In this approach, the bowel is tensioned between the 
Ligament of Treitz (which attaches the duodenum to the diaphragm) and the distal (downstream) 
weight. This approach requires the patient to be upright and works only if the applied weight does 
not come to rest on an organ or become stuck within the peritoneal cavity. Another concept is to 
use magnets that are attached to a bowel segment and repeal each other. However, because the 
magnetic repulsion force scales with the square of the distance between the magnets, the tension 
applied to the tissue segment would decrease rapidly as the bowel tissue grows, resulting in only 
a small amount of tissue lengthening. 
5.1.3. Downselection 
To downselect among the approaches, a Pugh Chart (Figure 5.2) was developed with ratings 
for each approach against each selection criterion. The rating values are 1, 3, 6, and 9, where 1 
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means the approach will not likely work for meeting the selection criterion, 3 means the approach 
is not-well suited for meeting the selection criterion, a rating of 6 is neutral, and 9 means the 
approach is well-suited for meeting the selection criterion. Additionally, the importance of the 
downselection criterion were rated on a 0-10 scale by a committee of pediatric surgeons 
specializing in the care of SBS patients at the University of Michigan. 
A discussion of the ratings for each differentiating criterion follows. “Does not injure bowel 
while implanted,” “Ease and Safety of Implantation and Removal,” and “Secure Attachments” 
were not considered to be differentiating criteria, because each approach can address the criteria 
similarly. 
1. Accurate expansion of tissue control 
The Extension, Track, and Feed-In approaches were assigned 9s because when 
implanted, their attachments can be permanently fixed to the tissue, and the 
displacement of each expansion mechanism can be controlled. Although the Payout 
approach mechanism can have displacement control, Payout compatible attachments 
 
Figure 5.2. Pugh Chart of Expansion Mechanisms. 
To inform the downselection of the seven conceptual approaches, a Pugh Chart was created and each of 
the conceptual approaches were rated on their ability to meet the selection criteria, where 9 indicates a 
strong ability to meet the criterion, and 1 indicates the it is unlikely for the conceptual approach to meet 
the criterion. The total score for each concept was calculated as the weighted sum of the scores, and the 
“total less mean” scores were calculated by subtracting the mean of the total scores from the total score 
for each concept. 
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Does Not Injure Bowel While Implanted 10 6 6 6 6 6 6 6
Ease and Safety of Implantation and Removal 9.5 6 6 6 6 6 6 6
Accurate Expansion of Tissue Control 9 6 9 9 9 3 3 3
Environmentally Robust 8.5 6 6 6 6 9 9 6
Implantable in Continuous Bowel 8.5 9 6 6 9 6 9 6
Secure Attachments 8 6 6 6 6 6 6 6
Bowel Tension Monitored in Real Time 7.5 9 6 6 3 6 3 1
Compact Size 7 9 6 6 3 9 9 9
High Tissue Growth Factor ( > 2 ) 5.5 9 9 6 9 3 3 3
Net Bowel Growth Monitored in Real Time 5 3 9 9 9 6 1 1
Extraneous Loads on Mesentery Avoided 5 9 6 6 6 9 6 9
3.5 587 560 543 542 519 482 431
Total Less Mean 63.3 36.3 19.79 18.3 -4.21 -41.2 -92.2
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must be able to act in attached and detach states. Thus, tissue is more likely to slip 
with attachments compatible with the Payout approach, and the approach received a 
neutral score of 6. The Field Induced, Motility, and Secondary Growth approaches are 
not well-suited for accurately controlling the expansion of tissue, because they are not 
displacement controlled architectures. They have been assigned 3s, because there is a 
possibility that they can be adapted to achieve some control of tissue expansion.  
2. Environmentally robust 
The most environmentally robust approaches are Field Induced and Motility, both 
assigned 9s, because they are simple, passive, and have embodiments with no moving 
parts. Thus, although they may not be likely to work, they are also not likely to break. 
All other approaches are equal with regard to environmental robustness and were 
assigned 6s. 
3. Implantable in continuous bowel 
By definition, Feed-In devices are not implantable in continuous bowel, because they 
feed into the bowel from outside. While they cannot by definition be implanted in 
continuous bowel, they can still be fully implantable devices that grow a segment of 
continuous bowel. Thus, the Feed-In concept was assigned a 6 with regard to 
implantability in continuous bowel. The Payout, Track, and Motility approaches were 
the best-suited approaches for this criterion and received 9s because they can be 
embodied by compact and flexible expansion mechanisms. 
4. Bowel tension monitored in real-time 
The Payout approach received the only 9 for this criterion because Payout devices can 
be compact (load less affected by mesenteric stress) and linear (making the load on the 
bowel tissue as close to pure tension as possible). The Track approach was assigned a 
3 because embodiments of the Track approach include long, curved and flexible tracks, 
making the load on the bowel tissue have non tensile components requiring complex 
instrumentation. The Motility approach was assigned a 3 because it would be difficult 
to attach a force sensor to the bowel wall and the passive drag-creating object. The 
Secondary Growth approach is unlikely to be able to be compatible with the ability to 
measure bowel tension because Secondary Growth devices do not directly apply 
tension loads. Thus, Secondary Growth was assigned a 1 for this criterion. 
5. Compact size 
The Payout Approach is well-suited to be compact because the net growth of tissue 
that payout devices can induce is not limited by the stroke of the device, which is 
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coupled to device size. Thus, the Payout approach was assigned a 9. The Field Induced, 
Motility, and Secondary Growth approaches were also assigned 9s because they are 
simple to implement approaches can have compact embodiments. 
6. High tissue growth factor ( > 2X) 
The Payout, Feed-In, and Track approaches were assigned 9s because with each 
approach, the initial segment length of bowel can be very short. Thus, even moderate 
net amounts of bowel growth can result in high growth factors. The ability of the Field 
Induced, Motility, and Secondary Growth approaches to lengthen bowel by any 
amount is questionable, as the approaches were included in this design process only 
for completeness. Thus, these approaches were assigned 3s. 
7. Net bowel growth monitored in real-time 
The Extension, Track, and Feed-In approaches are the best-suited for monitoring the 
net growth of bowel because they are compatible with permanent attachment 
approaches. Thus, they were assigned 9s. The Payout approach, which was assigned a 
3, must use attachments that are more prone to slipping due to their requirement to 
attach and detach. Therefore, monitoring the net growth of bowel in real-time with 
payout-based devices would be much more difficult. The Motility and Secondary 
Growth approaches are unlikely to enable real-time measurement of net bowel growth 
because their embodiments attach to the bowel at one location and at least two 
references points are required for a growth measurement, and thus there were assigned 
1s. 
8. Extraneous loads on mesentery avoided 
The Payout, Field Induced, and Secondary Growth approaches are least likely to apply 
extraneous loads on the mesentery because they are most likely to be embodied by 
short devices. Thus, they were assigned 9s, while the other approaches were assigned 
6s. 
A total score for each approach was found by summing the products of each criterion weight 
and approach rating pair, and the difference in each total score from the mean of all approaches is 
plotted in Figure 5.3. Based on this results, the Payout approach is the clear leader because it was 
well-suited for most of the selection criteria. The main advantage of the Payout approach is that it 
is the only concept that is well suited for achieving a high growth factor while simultaneously 
being compact. Furthermore, because the device pays out tissue, the net growth of tissue is not 
limited by the stroke of the device. Instead, the only limitations to growth will be physiological, if 
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they exist, making the device capable of producing high tissue growth factors. The main 
disadvantage of the approach is that it would be difficult to measure the net bowel growth in real-
time because the device pays out tissue, which becomes difficult to track once it is beyond the 
device. 
5.1.4. Payout Expansion Mechanism 
Two subclasses of payout devices have been conceptualized: the incremental payout device, 
and the continuous payout device. The main difference between the two approaches is that the 
incremental payout operation involves expanding and retracting the device cyclically and requires 
at least one attachment to disengage, reset, and slide easily through the bowel lumen, whereas the 
continuous payout operation continuously applies tension to the bowel with rotating attachments 
that never completely disengage. 
The incremental and continuous payout approaches are rich with numerous possible 
embodiments. However, the most promising attachment approach, the Dilating Fenestrated Mesh 
(Figure 5.9), is only compatible with incremental approaches. The architecture and operation of 
 
Figure 5.3. Concept Score Difference from Mean. 
By plotting the difference of each concept score with the mean of the concept scores, the decision 
to downselect to the Payout approach in clear. 
-100
-80
-60
-40
-20
0
20
40
60
80
D
if
fe
re
n
ce
 F
ro
m
 M
ea
n
 S
co
re
181 
 
the downselected incremental payout approach, the Reciprocating Linear Hydraulic Device, is 
described below. 
5.1.4.1. Architecture 
The architecture of the Reciprocating Linear Hydraulic Device is shown in Figure 5.4. The 
concept consists an outer housing and an inner housing that displace relative to each other when 
 
Figure 5.4. Architecture and Operation of Reciprocating Linear Hydraulic Device. 
The Reciprocating Linear Hydraulic Device is based on the Payout approach. By repeating the 
operation cycle, the length of tissue growth induced is limited by the number of times the device 
is cycled rather than the device stroke. 
Outer Housing Inner Housing
Seal and Seal Mount
Compression SpringHydraulic Line Adapter 
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Constraining Rod
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1, Implanting. Device is retracted, attachments are detached, no 
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2, Attaching. Engage tissue by inflating attachments.
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3, Tensioning. Device is extended, load is transferred to tissue through 
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4, Detaching. After sufficient time for bowel growth, attachments are 
disengaged.
5, Paying Out. Device is retracted, returning cycle to same conditions 
as the first stage. Grown bowel is “paid out” distal to the device. 
∆X
Additional Bowel 
Length
Repeat
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hydraulically driven, two attachments that are capable of gripping and releasing the bowel wall, a 
compression spring which retracts the device, a constraining rod that limits the motion of the inner 
housing relative to the outer housing, and a hydraulic line adapter. The hydraulic line connects to 
an external syringe from which water can be injected into the device. In addition to the hydraulic 
line, two pneumatic lines connect each attachment to external syringes to inflate and deflate the 
balloons. 
5.1.4.2. Operation 
The payout operation of the Reciprocating Linear Hydraulic Device with textured balloon 
attachments is described in five stages and illustrated in Figure 5.4. In the first, nominal, or 
“implanting” stage, the device is retracted and the attachments are deflated, disengaging them from 
the tissue. In the “attaching” stage, the attachments are inflated from external syringes through 
pneumatic lines, pressing the abrasive mesh material into the bowel lumen and thus gripping the 
tissue. In the “tensioning” stage, water injected from an external syringe through the hydraulic line 
enters the inner and outer housings of the sealed device, forcing the displacement of the inner 
housing relative to the outer housing. As more water is injected from the external syringe, the 
constraining rod and seal mount compress the spring until it reaches its solid length. At this point, 
further device expansion is not possible and the bowel segment between the attachments is 
tensioned. The expansion of the device and engagement of the attachments is maintained for a 
time sufficient to induce bowel growth prior to disengaging the attachments (venting the balloons 
to atmospheric pressure) in stage four, the “detaching” stage. Ideally at stage four, the bowel has 
grown and does not reduce in length when the attachments are disengaged. In the “paying out” 
stage, the pressure on the hydraulic line is reduced to atmospheric pressure and the compression 
spring retracts the device, leaving the additional length of tissue distal to the distal attachment. The 
completion of stage five returns the device to its nominal position, and the cycle is repeated 
multiple times during the distraction period of an implantation. Each time a cycle is completed, 
the amount of bowel growth induced is accumulated without the length of the device accumulating. 
Therefore, the growth of the small bowel is not limited by the constrained space of the peritoneal 
cavity or the remnant length of small bowel. This represents a very important advantage compared 
to the other conceptual expansion approaches for treating SBS. This advantage would not be 
possible without the ability of the attachments to disengage and reengage the bowel lumen. 
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5.2. Reciprocating Linear Hydraulic Device Prototype 
From engineering drawings, a prototype of the expansion mechanism was fabricated and 
integrated with the Fenestrated Dilating Mesh attachments introduced in Chapter Four to enable 
in vivo experimental studies with the goal of demonstrating the payout approach to small bowel 
lengthening in porcine animal models. Prior to implanting the Reciprocating Linear Hydraulic 
Device into pigs, the performance of the device was successfully validated and the relationship 
between the input hydraulic line pressure and the expansion of the device was experimentally 
characterized on the benchtop. 
5.2.1. Expansion Mechanism 
The expansion mechanism, shown in section views in Figure 5.5, is a reciprocating single-
stage linear hydraulic device. The prototype was fabricated by traditional milling operations with 
predominately corrosion resistant stainless steel components including the inner and outer 
housings, the compression spring, the E-style retaining rings, the 1/16 inch dowel rod, and the set 
screws. All other components were Delrin or nylon, and the O-rings were EPDM rubber. The 
motion of the inner housing relative to the outer housing is driven hydraulically with 
approximately 2 cc of water, expanding to a maximum displacement of 3.4 cm. As water is injected 
through the hydraulic line, the water flows through the luer lock adapter and the Delrin radial O-
ring mount through which the 1/16 inch dowel rod passes, filling both the outer and inner housings 
with pressurized water. As the hydraulic pressure is increased, the compression spring approaches 
its solid height (0.86 in), stopping the motion of the inner housing relative to the outer housing. 
When the pressure from the hydraulic line is lowered, the compression spring retracts the device 
to its original length. Although the mechanism could retract without the compression spring by 
creating a negative gage pressure on the hydraulic line, this approach is not robust to friction from 
the seal because the return force would limited by the vacuum pressure to approximately 200 gf. 
Whereas the return force with the compression spring varies from approximately 1500 gf (full 
compression) to 1000 gf (device fully retracted). It should be noted that these forces act internally 
to the device, as they are largely transmitted from the spring through the dowel pin, and they do 
not act on the bowel. 
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The assembled expansion mechanism is shown in Figure 5.6 with the hydraulic line attached. 
Additionally, a mount for the distal attachment, not shown in Figure 5.5, is shown in Figure 5.6. 
The distal attachment mount was made from the same 316 stainless steel tubing as the outer 
housing and is 1.85 in (4.7 cm) in length, the same length as the attachments described in the 
following section.  
 
Figure 5.5. Section Views of Expansion Mechanism Prototype. 
Section views of the Reciprocating Linear Hydraulic Device show how the device is sealed, how the device 
reciprocates, and how the stroke is limited. The O-ring seals (seen in c and d) prevent water from leaving 
the outer and inner housings of the device. Thus, as water is injected from the hydraulic line, the inner 
housing displaces, lengthening the device and compressing the spring. Once the compression spring 
reaches its solid height, further displacement of the inner housing relative to the outer housing is prevented 
by the 3 inch dowel pin in the center of the device. As the pressure of the working fluid is released, the 
compression spring returns the device to its original length. 
b). Section View: Reciprocating Linear Hydraulic Device Fully Extended
a). Section View: Reciprocating Linear Hydraulic Device (retracted)
Detailed view A Detailed view B
d). Detailed View of B
Delrin Radial O-Ring Mount
Stainless Steel Side Mount 
Retaining Ring (E style)
Nylon 6/6 
Washer
2-56 Stainless Steel 
Set Screw 1/16in 
length (2X)
EPDM O-Ring (AS568a #5)
c). Detailed View of A
Delrin Radial O-Ring Mount
EPDM O-Ring (AS568a #7)
Stainless Steel Side Mount 
Retaining Ring (E style)
3.4 cm (extension)
Stainless Steel Outer Housing 
(9/32 in OD, 0.261 in ID)
Stainless Steel 
Compression Spring 
(Century Spring # O-72)
Stainless Steel Inner Housing 
(1/4 in OD, 0.21 in ID)
Stainless Steel 1/16 in Dowel, 3 in length
Nylon Luer Lock Coupling
Delrin Luer Lock Adapter
185 
 
5.2.2. Expansion Mechanism Integration with Attachments 
The extension mechanism was integrated with a distal and proximal tissue attachment having 
the capability to both attach and detach from the bowel wall, enabling the payout operation. Figure 
5.7 shows the components of the integrated prototype prepared for in vivo experiments, which 
includes a compliant device extension made from 18 Fr latex tubing, the distal and proximal 
attachments, a thin silicone sheath held between the attachments, and 4 controls lines for the device 
extension (water), the flush (water), and the independently inflated balloons for the attachments 
(air). 
A detailed view of the inflated distal attachment is shown in Figure 5.9. Each attachment is 
composed of two machined Delrin filament guides, abrasive texturing material taken from a 
scrubbing sponge (Scotch-Brite “Dobie”), a balloon taken from a Foley catheter (Bard® BARDEX 
30 Fr 5cc), and a single length of clear elastic monofilament. To assemble, the balloon is mounted 
directly on the extending mechanism, with the monofilament guides on each end, the abrasive 
material is positioned over the balloon and held in place by the monofilament line, which is 
threaded through the guides. 
The compliant tissue guide was designed to enhance the way the bowel drapes around the 
device by preventing the tissue from kinking sharply around the distal end of the device. A silicon 
coated Delrin sphere (16 mm diameter) was placed at the end of the tissue guide to prevent bowel 
perforation by distributing the force on the tissue over a large smooth surface. The importance of 
 
Figure 5.6. Expansion Mechanism. 
The fabricated Reciprocating Linear Hydraulic Device is shown prior to its 
integration with the attachments. 
Stainless Steel Outer Housing
b). Reciprocating Linear Hydraulic Device Fully Extended
a). Reciprocating Linear Hydraulic Device Retracted
Stainless Steel Inner Housing
Hydraulic Line (Silicone)
Luer Lock Coupling
Luer Lock Adapter
Distal Attachment Mount 
3.4 cm 
(extension)
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using a compliant tissue guide is illustrated in Figure 5.8, which shows how the tissue drapes 
around an enterogenesis device without a compliant tissue guide (Figure 5.8a) and how the tissue 
drapes around the Reciprocating Linear Hydraulic Device equipped with two embodiments of the 
compliant tissue guide (Figures 5.8b and 5.8c). Without the compliant tissue guide, the 
enterogenesis device shown in Figure 5.8a abutted a small area of the small bowel tissue, which 
caused an area of localized pressure and acute ischemia. To prevent this complication with the 
Reciprocating Linear Hydraulic Device, the distal end of the device was equipped with a single 
diameter compliant tissue guide, as shown in Figures 5.7 and 5.8b. Compared to the device without 
the compliant tissue guide, the single diameter compliant tissue guide greatly improved the 
perfusion of blood within the bowel tissue by distributing mesenteric tension over a greater area 
of bowel tissue. The design of the compliant tissue guide was improved by tapering the diameter 
 
Figure 5.7. Prototype Integrated with Attachments. 
The integrated prototype is composed of the Reciprocating Linear Hydraulic Device, distal and 
proximal tissue attachments separated by a thin silicone sheath, a compliant tissue guide, and a set of 
four silicone tubes connecting the device to external syringes. When the device is retracted, the thin 
silicone sheath prevents the bowel from pleating between the attachments, promoting the 
repositioning of bowel relative to the attachments. The compliant latex tissue guide prevents the 
bowel tissue from sharply kinking around of the device and becoming ischemic. 
a). Device collapsed with deflated attachments
b). Device expanded with deflated attachments
c). Device expanded with inflated attachments
Compliant tissue guide (latex)
6 cm
9.4 cm (≈ 56% extension)
Control Lines (4x)
•Device Extension
•Attachment Balloons
• Flush
Distal Attachment (deflated) Proximal Attachment (deflated)
Thin sheath (silicone)
16 mm outer diameter
27 mm outer diameter
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of the guide such that a smooth transition from the rigid device to the compliant bowel tissue was 
achieved. The tapering compliant tissue guide was fabricated by attaching a series of catheter 
segments with decreasing diameters end-to-end. The tapering embodiment of the compliant tissue 
guide provided the best performance with respect to preventing ischemia, as no blanching was 
observed in the tissue (Figure 5.8c). 
The thin silicone sheath between the attachments was designed to prevent the tissue from 
pleating between the attachments when the device is retracted, encouraging the tissue to slide over 
the attachments in their deflated state. A flush line was included to help remove pleats from the 
tissue between the attachments. The flush is located between the attachments and under the silicone 
sheath, which has small holes in it to allow the flushed water to flow into contact with the bowel 
wall. Four silicone lines, which attach to the proximal end of the device, provide independent 
control of each attachment (two pneumatic lines), the flush line (hydraulic), and the line driving 
the displacement of the extension mechanism (hydraulic). 
The total length of the device (excluding the lines) is approximately 26 cm, although when 
retracted the attachment-to-attachment distance is 6 cm. When the attachments are deflated, the 
maximum outer diameter of the device is 16 mm (5/8 in), which is expands to 27 mm when the 
 
Figure 5.8. Compliant Tissue Guide. 
A compliant tissue guide was integrated with the Reciprocating Linear Hydraulic Device to reduce the 
risk of ischemia related to the interaction of the tissue with the distal end of the device. In 5.8a, the 
enterogenesis shown does not have a tissue guide. As a result, tension in the mesentery caused a small 
area of the bowel tissue to become acutely ischemic. By transitioning from the rigid device to a single 
diameter complaint tissue guide in 8b, the perfusion of blood within the bowel tissue was better 
maintained. Using a tapering compliant tissue guide further improved on this result. 
Blanched tissue 
indicating acute 
ischemia Better blood perfusion 
with compliant tissue 
guide
Tensioned mesentery
Best blood perfusion with 
tapered compliant tissue guide
a). Device without 
compliant tissue 
guide
b). Device with single 
diameter compliant 
tissue guide
c). Device with tapering 
compliant tissue 
guide
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attachments are inflated with 20 cc of air. The device extends by 3.4 cm when actuated by the 
hydraulic line with approximately 2 cc of water, displacing the midpoints of the attachments from 
6 to 9.4 cm (56% expansion). 
5.2.3. Benchtop Prototype Characterization 
A benchtop characterization of the Reciprocating Linear Hydraulic Device was conducted to 
experimentally measure the pressure on the input syringe required to initiate the motion of the 
device, the pressure on the input syringe required to fully extend the device, the volume of inputted 
working fluid (water) corresponding to full extension, and to visually inspect the device for leaking 
at pressures exceeding normal operation conditions. The measurements of the required input water 
volume and pressure to achieve full device extension were a potentially useful diagnostic for 
evaluating the performance of the device while implanted (if a leak was suspected).   
 
Figure 5.9. Detailed View of Attachment. 
The distal and proximal attachments are composed of a balloon from a Foley catheter 
wrapped with an abrasive texturing material. To aid in the implantation, removal, and 
repositioning of the attachments (critical for the Payout approach), the abrasive material 
is partially covered with elastic monofilament strands woven through the Delrin guides. 
When the Foley balloon is deflated, the attachment slides through the bowel lumen with 
ease because the monofilament strands prevent the interaction of the tissue with the 
abrasive material. When the Foley balloon is inflated, the monofilament strands are 
forced to separate and the abrasive material is pressed into the bowel wall, achieving 
fixation. 
Clear elastic monofilament Abrasive texture (Scotch-Brite Dobie)
Foley balloon 
(Bard® Bardex 30 Fr 5cc)
Delrin monofilament guides (2X)
189 
 
An experimental setup was created to measure the hydraulic line pressure and device 
extension simultaneously. To measure the pressure of the syringe, a “T” shaped fitting was 
introduced into the hydraulic line near the syringe and a pressure sensor (Freescale Semiconductor, 
MPX2200) was placed at one of the junctions. The other two junctions were for the syringe and 
the hydraulic line leading to the device. The extension of the device was measured with a laser 
displacement probe (Micro-Epsilon, OptoNCDT). The outputs of both sensors were read into 
LabVIEW by a DAQ (NI USB-6009) and calibrated based on each manufacturers’ given 
calibration constants.  
The experimental procedure consisted of the following steps: 
1. To remove air pockets from the hydraulic line and device, flush hydraulic line with 
water before attaching it to the device 
2. Mount the device relative to the laser displacement probe such that the full motion 
range of the device is within the measurement range and the laser is parallel to the 
extension direction. 
3. Start recording the pressure and displacement data with LabVIEW (4K samples at 
500Hz) 
4. Using the input syringe, slowly drive water into the device until it is fully extended 
5. Once fully extended, allow the compression spring within the device to fully retract 
the device  
The hydraulic line pressure and device extension data are shown in Figure 5.10. From the 
plots, the pressure to initiate motion and to fully extend the device were determined be to 
approximately 175 kPa and 285 kPa, respectively. The reason the pressure to fully extend was 
greater than the pressure to initiate motion was because as the device is extended, the spring within 
the housings becomes more compressed. Thus, as the device is extended, the required pressure 
increases. Despite exceeding the operating pressures by reaching 375 kPa, no device leaking was 
observed. These results successfully proved the performance of the device on the benchtop, 
supporting further validation in vivo. 
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5.3. In Vivo Experimental Growth Study 
To validate the operation of the Reciprocating Linear Hydraulic Device in vivo, and more 
importantly, to demonstrate that the payout approach to growing small bowel is achievable, an in 
vivo study was conducted with a porcine animal model. The ultimate goal of the experiment was 
to increase a length of bowel by an amount that is greater than the stroke of the device, because 
this would establish that the payout approach is feasible. In the following section, the experimental 
procedure and results are discussed. 
5.3.1. In Vivo Experiment Procedure 
The procedures of the in vivo experiment consist of the procedure for the surgical implantation 
of the device, the device expansion procedure, and the tissue analysis and growth measurement 
plan. Although the surgical implantation of the Reciprocating Linear Hydraulic Device is almost 
identical to that of the Curved Hydraulic Device and the Instrumented SMA Driven Ratchet, the 
compact design of the device and the controlled intraluminal attachments enable less invasive 
implantation approaches. For example, the device could potentially be placed into the continuous 
GI tract through a gastrostomy and guided into the small bowel with an endoscope placed through 
the upper GI tract. More optimally, with some refinement the device could potentially be placed 
 
Figure 5.10. Benchtop Characterization of Reciprocating Linear Hydraulic Device. 
The input syringe pressure and device displacement data are plotted against time and each other. The 
data show the pressure required to initiate the motion of the stage, 175 kPa, the pressure to fully extend 
the stage, 185 kPa, and the total expansion of the device, 3.4 cm.  
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through the upper GI tract and require little to no surgical tissue manipulation of the small bowel. 
All animal experiments were conducted at the University of Michigan with approval from the 
University Committee on the Use and Care of Animals (protocol number 09026). 
5.3.1.1. Surgical Implantation Procedure 
As shown in Figure 5.11, the Reciprocating Linear Hydraulic Device was implanted into a 
Roux limb rather than placed in the continuous GI tract. The procedure for the creation of the Roux 
limb matches that of the in vivo experiments described in Chapters Two and Three. In contrast to 
those in vivo experiments, the Reciprocating Linear Hydraulic Device was not fixed relative to the 
Roux limb by sutures and was free to slide through the bowel lumen when the attachments were 
disengaged. 
The surgery began with a 15 cm midline incision to open the abdominal cavity of the porcine 
model. The small bowel was manipulated to determine the flow direction of enteral contents and 
to locate the Ligament of Treitz, which marks the start of the small intestine. Approximately 60 
cm along the length of small bowel from the Ligament of Treitz, the small bowel was cut, creating 
two open ends of bowel labeled (a) and (b), as shown in Figure 5.11. Approximately 60 to 75 cm 
along the length of bowel from (b), an end-to-side anastomosis was created, connecting (a) to (c) 
and restoring the continuity of the GI tract. The segment of small bowel from (b) to (c), or Roux 
limb, was no longer in the continuity of the GI tract and would not pass ingested contents, however, 
the health of the Roux limb was maintained by the blood supply from the intact mesentery. During 
the creation of the Roux limb, the Reciprocating Linear Hydraulic Device was sterilized by soaking 
it in a liquid sterilant (Metrix, Metricide®) for the manufacturer recommend time of 40 minutes. 
After sterilization, the device was thoroughly rinsed with sterile saline to prevent any sterilant from 
getting into the surgical field, with special care was taken to completely remove sterilant from the 
mesh material of the attachments. The Reciprocating Linear Hydraulic Device was inserted, 
compliant tissue guide first, into the open end of the Roux limb. A stoma, or surgically created 
opening, was made in the skin and fascia of the abdomen, and the Roux limb was secured to the 
stoma at the fascia and skin. The final steps of the surgery were to route the hydraulic and 
pneumatic lines through the Roux limb, connect the external syringes to the lines, and secure the 
external syringes and control lines to the center of the porcine model’s back. At the conclusion of 
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the implantation, the Roux limb was 70 cm in length and the device was implanted approximately 
25 cm from the stoma. 
 
Figure 5.11. Surgical Implantation Procedure. 
The device was implanted in a Roux Limb, removing it from the continuity of the GI tract and preventing 
bowel obstruction. The hydraulic and pneumatic lines were placed through the stoma and bundled on the 
back of the porcine model. To measure growth, evenly spaced marking sutures are placed along the Roux 
Limb and paired with radiopaque stainless steel clips. At explant, the distance between the sutures and the 
position of the sutures relative to the device were used to evaluate the tissue growth. At the time of the 
implant, sutures 11 (numbered from the stoma) through 17 were positioned along the device as shown. In 
total, 35 marking suture were placed along a 70 cm Roux Limb at implant. 
Stoma
Roux limb
Anastomosis
Device 
implantation 
location
Roux limb lined with evenly
spaced and stainless steel clipped 
marking sutures
11
12
13
15
14
16
17
Marking sutures 11 through 17 
relative to device at implant. 2 cm 
separates each suture.
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c
Move (a) to (c)
Move (b) to 
abdominal 
wall
60 cm to 
Ligament of 
Treitz
Cut
Small bowel
a
c
b
1 2
3
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5.3.1.2. Device Expansion Procedure 
During the day of the operation, no extension of the device or inflation of the attachments was 
completed to allow the animal to rest. For the next six days post operation, the five-stage operation 
illustrated by Figure 5.4 was repeated four times per day, at 8 am, 12 pm, 4 pm, and 8 pm. At 8 
am each post-operative day, the device was already contracted and the attachments are disengaged 
from the prior day. First, both attachments were engaged by inflating the distal and proximal 
balloons with approximately 15 mL of air. Then, the device was extended 3.4 cm by the injection 
of 2 mL of water into the hydraulic line, putting the bowel segment between the attachments under 
tension. Over the following four hours, the bowel tension decreased due to some combination 
tissue growth, tissue slipping, and/or viscoelastic effects until the next device expansion at 12 pm. 
At both 12 pm and 4 pm, the payout operation was continued by disengaging both attachments 
(deflating the balloons), retracting the device (drawing 2 mL out of the hydraulic line), reengaging 
both attachments, and extending the device. Finally, at 8 pm each day, the attachments were 
disengaged and the device was retracted, allowing the bowel to rest for 12 hours. The device was 
removed on the 7th post-operative day during the explant surgery. 
5.3.1.3. Tissue Measurement Plan 
The net growth of the bowel in the Roux limb was evaluated using marking sutures onto which 
radiopaque stainless steel clips were attached. At the implant surgery, thirty five marking sutures 
were evenly placed along the entire length of the Roux Limb and three sutures (placed 2 cm apart) 
were placed on the normal fed bowel distal to the anastomosis. Initially, the markers on the Roux 
limb were also placed 2 cm apart. This marking approach was taken, because even if the implanted 
device changes position along the Roux Limb, measurements of the distance between the sutures 
at the explant can be used to estimate the net growth of the tissue. Figure 5.11 shows the 11th 
through the 17th (numbered from the stoma to the anastomosis) suture as they were aligned with 
the device at the implant. 
5.3.1.4. In Vivo Performance of Device Validation Procedure 
The performance of the Reciprocating Linear Hydraulic Device was evaluated once during 
each post-operative day to determine the presence of leaks in the hydraulic line or device housing, 
and leaks in the pneumatic lines and/or in either attachment. Because the device is inaccessible 
and not instrumented, the performance evaluation was in large part completed by comparing the 
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device usage experience to its performance in the laboratory. For example, from benchtop 
characterization, when there is not a “fast” leak, the pressure on the hydraulic line increases 
dramatically when the device was fully extended (Figure 5.10). Thus, this increase in pressure can 
be felt through the input syringe on the hydraulic line and suggests there is not a fast leak. The 
presence of a “slow” leak can be detected by a reduction of the water in the input syringe for the 
hydraulic line when the device is fully retracted. Similarly, to evaluate the presence of a fast leak 
in either attachment, the haptic feedback from the input syringe can be used. As the attachments 
are engaged, the pressure on the input syringe should increase as the syringe plunger drives more 
air into the attachments. The presence of a slow leak in either attachment can be detected by 
listening to the pneumatic lines when they are purposefully vented to atmospheric pressure, 
disengaging the attachments. If there was not a slow leak, the air held by the attachments (over 4 
hours) made an audible sound as it rushed out of the pneumatic line. 
5.3.2. In Vivo Experiment Results 
The results of the in vivo experimental study include a description of the Reciprocating Linear 
Hydraulic Device performance, the measurement of the small bowel lengthening achieved by the 
payout approach, and an evaluation of the grown tissue health compared to controls.  
5.3.2.1. Performance of Reciprocating Linear Hydraulic Device 
The successful performance of the Reciprocating Linear Hydraulic Device depended on the 
lack of hydraulic (expansion mechanism) and pneumatic (attachments) leaks. Using the 
aforementioned method for detecting slow and fast leaks while the device was implanted, no fast 
leaks were detected in either the pneumatic or hydraulic lines, and no slow leak was detected for 
either attachment. A slow leak of approximately 0.1 mL/day was found in the hydraulic line, which 
was easily remedied by removing and refilling the syringe. Despite the slow leak in the hydraulic 
line, the overall performance of the Reciprocating Linear Hydraulic Device was excellent. At the 
explant, no damage to the device or corrosion was observed, supporting the use of 316 stainless 
steel and Delrin materials for device fabrication. 
5.3.2.2. Tissue Growth Analysis 
The extent of macroscopic tissue growth can be estimated by comparing the tissue marking 
suture measurements from the explant relative to the implant. Figure 5.12 shows the placement of 
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the device relative to the sutures at the implant and the explant, and the change in marker spacing 
between the markers that were originally on the device. Initially, the sutures were placed 2 cm 
apart, making the distance from the 11th to the 17th marking suture 12 cm. At the explant, the total 
tissue length from the 11th to the 17th marking suture was 16 cm to 18.8 cm, depending on whether 
a marking suture slipped out of the tissue distal to the 15th marking suture. Unfortunately, it was 
not possibly to determine whether this particular suture slipped out of the tissue or not during the 
distraction period with any certainty. Best case scenario, the tissue grew approximately 6.8 cm, 
which is twice the stroke of the Reciprocating Linear Hydraulic Device. In this case, lengthening 
the tissue by twice the stroke of the device very strongly demonstrates that the payout approach to 
tissue lengthening is feasible. In the worst case scenario, the tissue grew 4 cm, which is 120% of 
 
Figure 5.12. Growth Measurement. 
The growth of the tissue was evaluated using marking sutures placed in the Roux Limb 
during the implantation by summing the change in the distance between adjacent markers. 
Based on the markers, the change in tissue length was 4 cm (worst case) to 6.8 cm (best 
case). The exact determination of the growth could not be made conclusively because it was 
unclear if a marker was missing at the explant distal to the 15th marker. If the marker was 
not missing, then the tissue grew 6.8 cm, which is twice the stroke of the Reciprocating 
Linear Hydraulic Device. If the marker was missing, the growth represent 120% of the 
device stroke, which still strongly suggests that the payout approach worked. 
11
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the device stroke and still suggests that the payout approach is feasible. In either case, there are 
some definitive results that can be made from tracking the known marking sutures. First, the tissue 
segment from suture 11 to suture 15 expanded from 8 cm at implant, to 12 cm at explant, growing 
by 50%. And second, the tissue marked by sutures 16 and 17 was successfully paid out from the 
device. These two definitive results strongly suggest that the attachments were able to both apply 
bowel tension and slide through the bowel lumen, and of equal importance, that the payout 
approach to bowel lengthening is feasible. 
5.3.2.3. Grown Tissue Health 
To determine if true small bowel growth occurred rather than permanent deformation, the 
tissue health of the grown small bowel segment was compared to the health of control samples 
taken from the Roux limb and to tissue samples taken from normal small bowel. To evaluate tissue 
health, the tissue histology was observed for microscopic damage, and the morphology and rate of 
cell proliferation were measured. Although there was superficial mucosal disruption observed in 
the tissue samples taken from the distal and proximal tissue attachment sites, the result of the 
evaluations suggested that true growth of the small bowel was successfully induced. 
5.3.2.3.1. Histology 
Histologic slides of tissue samples from the Roux limb control, the site of the distal 
attachment, the middle of the device, and the site of the proximal attachment are shown in Figure 
5.13. The key result from the histologic evaluation of tissue health was that the attachment sites 
showed significant epithelial sloughing and general disruption of the mucosal layer without 
damage to the underlying submucosa and muscle layers. In contrast, histology of the grown tissue 
between the attachments was atraumatic. Although not preferred, the damage to the mucosal layer 
 
Figure 5.13. Tissue Histology. 
The tissue histology from the Roux limb control, the site of the distal and proximal attachments, and the 
middle of the device show at that the attachment sites, there is significant epithelial sloughing without 
damage to the submucosa or muscles layers, while the tissue growth in between the attachments was 
atraumatic. 
a). Roux Control b). Distal Attachment c). Mid Device d). Proximal Attachment
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at the attachment sites is clinically acceptable because in the absence of the attachments, the 
mucosal layer will heal. 
5.3.2.3.2. Morphology 
Morphologic measurements of the crypt depth, villus height, and muscle layer thickness are 
shown in Figure 5.14. Compared to the Roux limb, the crypt depth of tissue samples taken from 
the distal attachment site, proximal attachment site, and the middle of the device were preserved. 
The villus height was also not statistically significant from the Roux limb for the middle of the 
device and the proximal attachment site. Villi could not be identified in the sample taken at the 
distal attachment site due to mucosal disruption. Consistent with the bowel growth achieved in 
Chapter Two, Chapter Three, and prior research [4–6,10,12], the muscle layer thickness of the 
grown tissue was much greater than that of the Roux limb control.  
5.3.2.3.3. Cell Proliferation 
Measurements of epithelial cell proliferation in tissue samples taken from the distal 
attachment, proximal attachment, the middle of the device, the Roux limb control, and normal 
bowel are shown in Figure 5.15. Compared to the Roux limb control, an increase in cell 
proliferation was measured for tissue samples taken from the middle of the device and the distal 
and proximal attachment sites. Although the increase in cell proliferation measured for the tissue 
 
Figure 5.14. Tissue Morphology. 
Morphologic measurements of the crypt depth, villus height, and muscle layer thickness show that while 
the crypt depth and villus height were preserved relative to the Roux limb control, the muscle layer 
thickness was greatly increased. Villi could not be identified at the site of the distal mesh. Pairwise t-
Tests were taken for the distal mesh against the Roux Y control, the proximal mesh against the Roux Y 
control, and the mid device against the Roux Y control. *Brackets indicate statistically significant 
differences   (p < 0.05). 
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taken from the middle of the device was not statistically significant. This results suggested that 
true bowel growth was occurring and indicated the health of the mucosa. 
5.4. Conclusion 
Short bowel syndrome remains a difficult condition to manage and treat, leading to high 
mortality rates. To research a novel treatment of SBS based on inducing the growth of remnant 
small bowel tissue with tensile loading, many enterogenesis devices have been developed to study 
mechanotransductive enterogenesis in rabbits, rats, and pigs. However, these devices were 
designed with a focus on research and were not extendable for clinical applications due to 
limitations in their implantability, device form, tissue lengthening capacity, and lack of force 
instrumentation. To improve the state of the art, this chapter developed the Reciprocating Linear 
Hydraulic Device, a compact enterogenesis device technology with the potential to enable 
minimally invasive surgical implantation and removal, and high-expansion tissue lengthening not 
limited by the stroke of the device. 
The focus of the design was on the expansion mechanism of the enterogenesis device, because 
a promising and clinically relevant attachment approach was identified in Chapter 4. To 
 
Figure 5.15. Cell Proliferation. 
The measurements of cell proliferation in the tissue samples taken at the attachment sites, the middle of 
the device, normal bowel, and the Roux limb control show that the attachment sites had statistically 
greater cell proliferation than the Roux limb control. Pairwise t-Tests were taken for the distal mesh 
against the Roux Y control, the proximal mesh against the Roux Y control, and the mid device against 
the Roux Y control. *Brackets indicate statistically significant differences   (p < 0.05). 
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comprehensively explore the design space of enterogenesis device expansion mechanisms, seven 
distinct approaches were conceptualized. Among the expansion approaches, a novel tissue 
lengthening approach based on paying out small bowel tissue was selected. The defining advantage 
of the payout approach for bowel lengthening is that the net growth of small bowel is not limited 
by the device stroke, which is constrained by the peritoneal cavity of patients, or by the length of 
the patient’s remnant bowel. 
The Reciprocating Linear Hydraulic Device was designed and fabricated to evaluate the 
feasibility of the payout approach to bowel lengthening, and to demonstrate a scalable compact 
expansion mechanism with clinical applicability. A one week in vivo experiment with a porcine 
animal model was conducted with the goal of growing a length of bowel greater than the device 
stroke of 3.4 cm while maintaining the health of the tissue, thereby demonstrating the feasibility 
of the payout approach. Difficulty recovering the marking sutures at the explant surgery made the 
measurement of net bowel growth difficult, but the tissue lengthened by 4 cm in the worst case, 
and 6.8 cm in the best. To health of the tissue was examined by observing the tissue histology, and 
measuring the tissue morphology and cell proliferation. Although the mucosal layer of the tissue 
was disrupted at the attachment sites, the mucosa would regenerate in the absence of the 
attachments and there was no damage in any other areas of the sampled tissue. The medical 
evaluation of the tissue suggested that true growth of the small bowel was achieved. Whether the 
tissue lengthened by 4 cm or 6.8 cm, the feasibility of the payout approach and performance of the 
Reciprocating Linear Hydraulic Device were successfully demonstrated. 
The viability of the payout approach has a large impact on the design of enterogenesis devices, 
because the ability to grow a segment of remnant bowel multiple times in the same implantation 
period enables the design of compact enterogenesis devices with the ability to induce large net 
bowel growth. Regardless of the linear expansion actuator architecture, there is a tradeoff between 
actuator length and actuator stroke. This fundamental tradeoff makes the design of a compact 
enterogenesis device capable of producing large net bowel growth difficult. However, the strength 
of the new payout approach is that it makes this tradeoff irrelevant. The clinical implication of 
enabling compact enterogenesis devices is that they permit non-invasive surgical techniques for 
device implantation and removal into continuous bowel, resulting in faster recovery, reduced cost 
of treatment, less (if any) scarring, reduced complication risk, shorter hospitalization, and an 
overall better quality of patient care. 
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CHAPTER SIX. CONCLUSION 
The ultimate purpose of this body of research is to hasten the realization of the 
mechanotransduction approach for correcting short bowel syndrome such that it becomes a real 
clinical alternative to bowel restructuring surgeries and transplants. This dissertation has made 
very significant contributions towards this vision, both from a medical and from a technological 
standpoint. 
This chapter presents a restatement of the research goal and objectives, summarizes the 
research, and discusses the findings and contributions of this dissertation, which are organized into 
four themes: medical treatment, device innovation, experimental methodologies, and mechanical 
device/tissue interface. The impact of these contributions are discussed, and the chapter closes 
with future research recommendations to guide the direction of this continuing research effort. 
6.1. Goal and Objectives 
The goal of this research was to explore technological approaches for a promising and novel 
treatment method of short bowel syndrome based on mechanotransduction. Four key research 
objectives have been identified and accomplished toward to the achievement of this goal: 
1. Treatment Approach Feasibility and Potential. 
Investigate the potential for inducing large net growth, large expansion factor growth, 
and inspect the mesentery for an increase in the vascularity to evaluate the feasibility 
of mechanotransduction for correcting short bowel syndrome and to support further 
research into the technologies for and the development of mechanotransduction-based 
treatment approaches.  
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2. Treatment Development 
Create technologies and perform studies to determine the upper bound of safely 
applied bowel tension, compare the effect of applying different tissue expansion 
profiles on tissue growth, and explore the limits of the maximum small bowel 
expansion rate to develop the best practices and methods for safely and effectively 
exploiting mechanotransduction. 
3. Tissue Attachment 
Develop clinically relevant tissue attachments for the safe attachment and detachment 
of an expansion mechanism to the small bowel. Identify the risk of surgical 
complications associated with a range of attachment approaches, including perforation 
and ischemia, and measure their attachment and detachment performance. 
4. Clinically Relevant Device 
Develop and demonstrate a clinically relevant enterogenesis device and treatment 
method for pediatric and adult SBS by demonstrating very high net bowel growth. The 
in vivo validation of the device with porcine models must produce medical results for 
promoting clinical trials by achieving high expansion factor growth backed by analysis 
of the tissue to demonstrate its health and functionality. 
6.2. Research Summary 
The process of developing the mechanotransduction-based treatment approach was highly 
multidisciplinary, requiring contributions from both medical and engineering research to be 
successful. Medical challenges included demonstrating the feasibility of the approach in clinically 
relevant animal models and identifying methods of efficiently and safely exploiting 
mechanotransductive growth. Addressing these medical challenges required the development of 
novel enterogenesis devices designed for clinically relevant animal models with new capabilities 
that were not available in the previously limited state of the art. 
To achieve the first objective in Chapter Two, the feasibility of growing small bowel in 
clinically relevant porcine models was established in a series of in vivo medical experiments 
supported by the design and fabrication of the Curved Hydraulic Device, an enterogenesis device 
capable of doubling the length of the small bowel segment in which it is implanted. The design 
considerations for the device were related to the device form, sealing, and the mechanical 
device/tissue interaction. The Curved Hydraulic Device was fabricated by traditional milling 
operations from biocompatible Stainless Steel and Delrin materials. To give the device its 
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curvilinear form factor, the stainless steel housing and stages were manually curved around a 
circular mandrel. A benchtop experimental characterization of the device expansion versus input 
working fluid volume was completed, allowing the displacement of the stages to be estimated 
while the device was implanted. Four in vivo experiments were conducted where the expansion of 
the small bowel tissue ranged from 1.6 to 2.2X. To support the conclusion that true growth was 
occurring rather than permanent tissue deformation, tissue samples were taken and compared with 
relevant controls to evaluate tissue morphology, cell proliferation, barrier function, and to observe 
the adaptation of the vasculature in the supporting mesentery. The results of these experiments 
have successfully established the feasibility of growing small bowel in clinically relevant animal 
models through the demonstration of significant small bowel growth, mesenteric angiogenesis, 
and the examination of tissue morphology, cell proliferation, and barrier function. 
To achieve the second objective, Chapter Three expanded on these results by exploring 
methods of efficiently exploiting the growth process through the comparison of tissue expansion 
strategies and by determining the maximum safely applied small bowel tension. These medical 
studies required an enterogenesis device with displacement control and real-time tracking of the 
applied bowel tension and displacement. To enable these studies, a force and displacement 
instrumented SMA driven ratcheting device was developed. A scalable SMA driven ratcheting 
mechanism design methodology was developed, validated, and successfully applied to the 
enterogenesis device design. In vivo experimental studies with porcine animal models using the 
Instrumented SMA Driven Ratchet suggested that small bowel growth can be induced much more 
rapidly than previously attempted by using a load-based tissue expansion strategy, the tissue 
responds to low magnitudes of force, and that bowel may grow more readily as the implantation 
and device expansion progresses. Additionally, the Instrumented SMA Driven Ratchet was used 
in acute in vivo experiments to determine the maximum safely applied small bowel tension in 
porcine models. As with the feasibility studies in Chapter Two, the health and functionality of the 
grown tissues segments were compared to relevant controls, demonstrating true growth. 
To achieve the third objective, Chapters Four explored the design of clinically applicable 
device-to-tissue attachments to overcome the challenge of safely and reliably attaching to and 
detaching (for implantation, removal, and repositioning) small bowel. Prior research attachment 
approaches included end-abutment and sutured attachments, but neither approach is clinically 
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relevant because they preclude minimally invasive device implantation and removal. Sutures are 
not reliable for tensioning soft tissue – the enterogenesis study using sutured attachments reported 
that the sutures slipped through the rabbit small bowel [1], sutures slipped through small bowel 
tissue in all of the in vivo studies with the Curved Hydraulic Device that exceeded 2 weeks, and 
this complication has been reported in the treatment of long-gap esophageal atresia [2,3], where 
esophageal tissue is tensioned by sutures. The end-abutment approach requires the grown bowel 
tissue to be isolated from the GI tract and the use of several anastomoses, which lead to the need 
to discard small bowel tissue when the grown segment is placed back into the continuity of the GI 
tract. To provide a clinically relevant attachment, many approaches for attaching to and detaching 
from the small bowel were evaluated in ex vivo and in vivo experiments. Several qualitative trade-
offs were found. Attachments that gripped the bowel well also posed the greatest tissue health 
concerns, such as bowel perforation and ischemia. Furthermore, attachments that gripped the 
bowel well did not also detach well from the tissue, making their implantation difficult and/or 
unsafe. The conclusion of the chapter compared all of the evaluated attachment approaches and 
recommended a promising and clinically relevant attachment approach, the Dilating Fenestrated 
Mesh. 
To achieve the fourth objective, Chapter Five presented the development of an enterogenesis 
device designed with a focus on clinical relevance over research applicability. Specifically, the 
chapter focused on the design of the expansion mechanism, which integrated with the attachments 
recommended in Chapter Four to create a clinically relevant enterogenesis device with significant 
advantages compared to the current state of the art. Compared to the research-focused devices of 
Chapters Two and Three, there were greater design constraints for a clinically relevant device. The 
most important differences were the need to be able to implant the device in a continuous segment 
of the small bowel (by non-invasive surgical techniques) rather than within an isolated segment, 
greater constraints on the form of the device, greater lengthening capabilities to enable the 
treatment of severe cases of SBS, and an enhanced emphasis on device safety features including 
applied tensile load measurement, displacement control, and displacement measurement. To 
develop the clinically relevant enterogenesis device, a design process was conducted from the 
earliest stage of requesting customer requirements to the later stage of evaluating the in situ 
performance of the device. Seven distinct conceptual approaches to lengthening small bowel tissue 
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were identified, from which the novel payout approach was selected. The payout approach is a 
high-fold bowel tissue growth approach based on applying tension, allowing time for the bowel to 
respond by growing, reestablishing the implanted condition of the device, and repeating. An 
embodiment of the payout approach, the Reciprocating Linear Hydraulic Device, was fabricated 
and characterized on the benchtop. Using the device, a one-week in vivo experiment with a porcine 
animal model was conducted to validate the performance of the device and demonstrate the 
viability of the payout approach. The results of the experiment supported the viability of the payout 
approach, because the net bowel lengthening exceeded the device stroke and the health of the tissue 
was largely maintained. 
6.3. Medical Treatment Contributions 
Critical contributions in the development of the mechanotransduction-based treatment for 
correcting short bowel syndrome have been made in this dissertation. Most importantly, this 
dissertation has established the feasibility of the treatment approach in clinically relevant porcine 
animal models. Additionally, studies comparing tissue expansion strategies based on tissue 
displacement rates or/and the applied tensile load were conducted with the Instrumented SMA 
Driven Ratchet. These studies showed that basing the expansion of bowel tissue on the applied 
tensile load results in much higher rates of expansion (without affecting the tissue health) than 
setting a fixed tissue displacement rate. Lastly, the medical viability of tensioning and relaxing the 
same segment of bowel tissue multiple times to induce high fold growth was demonstrated, 
supporting the design of ultra-compact enterogenesis devices that can enable non-invasive surgical 
techniques. 
6.3.1. Feasibility of Mechanotransduction Approach 
Although load induced small bowel growth was previously demonstrated in rabbit and rat 
models, the clinical relevance of these studies was limited by the use of small animal models. By 
inducing the longitudinal growth of porcine small bowel, comparing the health of the grown 
segments to appropriate controls, and measuring the vascular adaption of the mesentery supporting 
the growth segment [4], the clinical feasibility of the treatment approach was established. 
The feasibility of an alternate treatment approach is huge, because current treatments for short 
bowel syndrome are associated with potentially lethal complications, leading to high mortality 
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rates. Furthermore, the impact of this result is not limited to just patients suffering from short 
bowel syndrome, because the method has the potential to become an alternative to bowel 
transplants for a broader range of indications. In the context of this dissertation, the demonstrated 
clinical feasibility of the treatment approach has provided the motivation and the foundation from 
which to further develop technologies for treating short bowel syndrome by inducing bowel growth 
through mechanotransduction. 
6.3.2. Profile Comparison 
The expansion of an enterogenesis device can follow a number a strategies based on a 
maintaining a tissue displacement rate, a constant tensile tissue load, or a mixed piecewise 
displacement and load based approach. The effect of these three approaches on the growth rate 
and health of small bowel tissue was investigated in a series of in vivo experiments with the 
Instrumented SMA Driven Ratchet. An important conclusion of this series of experiments was that 
expanding the tissue based on real-time measurements of the applied tension enabled much higher 
rates of growth compared to displacement rate based expansion strategies without negatively 
affecting tissue health.  
Without applied tissue tension feedback, the tissue expansion rate must be conservatively set 
to prevent complications related to exceeding the maximum safe tension. In prior experiments 
using the Curved Hydraulic Device, the strain rate of the tissue was set to less than 10% (of the 
starting segment length) per day. By using the applied tissue tension feedback to inform the tissue 
expansion, the rate of bowel tissue growth achieved was approximately 3.5 fold more rapid, 
without approaching unsafe magnitudes of applied tension, than expansion rates used in prior 
experiments with un-instrumented devices. 
This result is important for several reasons. From a practical standpoint, increasing the rate of 
bowel growth such that the implantation period lasts less than 30 days will lessen restrictions from 
the FDA (Investigational Device Exemptions, 21CFR812.3). In a clinical setting, increasing the 
rate of bowel growth will lead to lowered costs of care, reduced risk of complications, reduced 
patient discomfort, and a more rapid transition from parenteral nutrition to a normal oral diet. 
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6.3.3. Payout Approach 
Most research devices for studying mechanotransductive enterogenesis, including the Curved 
Hydraulic Device and the Instrumented SMA Driven Ratchet, have used the extension approach 
to inducing tissue growth. Although these devices have been essential for research, all extension-
based devices have one disadvantage in common: the net amount of tissue lengthening is limited 
to the stroke of the expansion mechanism and thus the size of the patient’s peritoneal cavity and/or 
remnant bowel length. Devices based on the novel payout approach to tissue lengthening do not 
have this disadvantage, because payout devices, upon inducing one device stroke’s amount of 
bowel growth, can detach from the bowel wall, reset/retract, reattach, and repeat the operation ad 
infinitum to induce large net tissue growth with a compact device. 
The potential for this bowel lengthening approach to be used for correcting short bowel 
syndrome is large, because the net increase in bowel length would not be limited by the length of 
the device, the length of the patient’s remnant bowel, or the space within the peritoneal cavity. 
However, until recently, the approach had never been considered or experimentally demonstrated. 
Using an embodiment of the payout concept, the Reciprocating Linear Hydraulic Device, the 
growth of small tissue by 120% to 200% of the device stroke was induced using the payout 
operation, demonstrating its viability. 
The successful demonstration of the payout approach has a great impact on the design of 
enterogenesis devices for treating SBS. The main impact is that enterogenesis devices can be 
designed more compactly because the bowel growth will not be limited to the device stroke, which 
is strongly coupled to the device length regardless of extension mechanism architecture. A more 
compact device is less likely to cause complications such as bowel obstruction, bowel perforation, 
and mesenteric tearing. Additionally, compact devices will enable less invasive surgical 
implantation and removal surgeries, resulting in faster recovery, reduced cost of treatment, less (if 
any) scarring, reduced complications, shortened hospitalization, and an overall better quality of 
patient care. 
6.4. Device Innovation Contributions 
The medical treatment contributions were made by conducting in vivo experiments that were 
enabled for the first time by the development of a series of novel enterogenesis device technologies 
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designed for porcine animal models. In addition to supporting the clinically relevant research 
studies presented in this dissertation and facilitating future studies of mechanotransductive 
enterogenesis, these novel technologies and the design methodologies used to create them 
represent a large step forward in the development of innovative enterogenesis device technologies 
for correcting short bowel syndrome. 
6.4.1. Novel Technologies 
Three actuation architectures with unique features and functionality have been developed to 
enable studies of mechanotransductive growth with porcine animal models, the Curved Hydraulic 
Device, the Instrumented SMA Driven Ratchet, and the Reciprocating Linear Hydraulic Device. 
Each device was designed to demonstrate and give insight on a specific aspect of 
mechanotransductive enterogenesis in porcine animal models, including clinically feasibility, 
methods of efficiently and safely inducing small bowel growth, and the viability of the payout 
approach to high-fold tissue lengthening. Additionally, all devices provided robust expansion 
platforms for evaluating a broad range of small bowel tissue attachment approaches. 
6.4.1.1. Curved Hydraulic Device 
The telescoping Curved Hydraulic Device is a novel hydraulic device architecture designed 
for enterogenesis studies of treatment approach feasibility with porcine animal models. For 
enterogenesis studies, the Curved Hydraulic Device had two important advantages compared a 
linear hydraulic architecture. First, the curvilinear form factor was better suited for the naturally 
forming curves of the small bowel and eliminated extraneous mesenteric tension, preventing 
mesenteric tears and secondary complications. Second, within the space-constrained peritoneal 
cavity, the curvilinear form factor increased the capacity for net bowel growth, because a curved 
path between the two attachments is greater in length than the corresponding linear path. The 
Curved Hydraulic Device enabled studies of treatment feasibility by having the capability to 
lengthen small bowel tissue by a large net amount (15 cm) and large expansion ratio (2X and 
greater, depending on initial attachment placement). Lastly, the Curved Hydraulic Device 
architecture can be potentially scaled for a broad range of actuation needs for applications such as 
powered joint prosthetics/orthotics, automotive applications, and robotic actuators.  
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6.4.1.2. Instrumented SMA Driven Ratchet 
The ratcheting mechanism is a compact external architecture for accumulating the small 
displacements of SMA wire with important SMA actuator features such as the integrated 
adjustable martensite hard stop and the vented-screw SMA wire mounts, which enabled the SMA 
tension to be adjusted after installation. Ratcheting mechanisms are an important external 
architecture for SMA wire actuators, because they overcome one of the major disadvantages of the 
actuator, its low actuation strain, which is typically limited to 2 to 8%. Unlike other internal or 
external SMA architectures for increasing stroke, like the SMA helix [5] or web architectures [6], 
linear ratcheting mechanisms do not tradeoff force with stroke. Additionally, SMA driven 
ratcheting mechanisms are advantageous because they have repeatable displacement, zero-power 
hold, and because SMA is a lightweight, compact, and energy dense actuator, SMA driven 
ratcheting mechanisms are lighter and more compact than their traditionally actuated countertypes. 
Given its compact size and scalable design models, the SMA driven ratcheting mechanism can be 
used in a wide variety of ratcheting applications where high actuation frequency is not required. 
6.4.1.3. Reciprocating Linear Hydraulic Device 
The Reciprocating Linear Hydraulic Device is a unique compact hydraulic device due to its 
ability to retract without requiring separate extension and retraction lines. Instead, the device 
retracts from the force provided by an internal compression spring, making the design more 
compact by eliminating one seal and one hydraulic line compared to tradition hydraulic actuators. 
The compact size and retractability of the Reciprocating Linear Hydraulic Device made it an ideal 
platform for evaluating attachments and demonstrating the payout approach in live porcine animal 
models. In concert with the Dilating Fenestrated Mesh Attachment approach, the integrated 
Reciprocating Linear Hydraulic Device represents a leap forward in the capabilities of 
enterogenesis device technology for correcting SBS by enabling minimally invasive surgical 
device implantation and removal, in continuity device placement, and high-fold bowel growth not 
limited by the stroke of the device. 
6.4.2. Design Methodologies 
To design the Instrumented SMA Driven Ratchet, the Reset View Design Methodology and 
an analytical model of the ratchet rack and pawl force interaction were developed. Although 
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created for the design of a compact SMA driven ratcheting mechanism, the Reset View Design 
Methodology is a general graphical approach for designing SMA actuators biased by a reset 
element that greatly facilitates the selection of the reset element. Similarly, the analytical ratchet 
rack and pawl force interaction model is scalable, making the model useful for designing a large 
range of actuated linear ratcheting mechanisms. 
6.4.2.1. Reset View Design Methodology 
Although used to in this dissertation to design the Shape Memory Alloy (SMA) driven 
ratcheting mechanism, the Reset View Design Methodology is a general approach for designing 
any SMA actuator with a bias element to re-strain the SMA wire between actuations. SMA wire 
is linear actuator composed of nickel and titanium that contracts as it transitions from its martensite 
phase (cool) to its austenite phase (hot). Without external tension, SMA wire does not typically re-
lengthen as it transitions in the other direction, from austenite to martensite. Thus, the actuator is 
often coupled with a reset spring or bias element to serve this purpose. Compared to the traditional 
graphical design approach for SMA actuators, the Reset View Design Methodology is particularly 
useful for designing SMA actuators where a constraint on the length of the SMA wire is enforced, 
because the method readily illustrates the impact of spring selection on SMA stroke.  
The successful realization of any SMA actuated device is contingent on the coupled design of 
the SMA design parameters (diameter, length) and reset spring parameters (stiffness, maximum 
suggested load/deflection, solid height, etc). However, the design space of springs is far richer than 
that of SMA wires, which is limited to a handful of commercially available wire diameters. 
Because of this, a design method where the reset spring is specified after the selection of an SMA 
wire is more intuitive than first specifying the reset spring and then selecting an appropriate SMA 
wire diameter. The Reset View Design Methodology is powerful because it enables this approach, 
resulting in more robust SMA actuated device designs regardless of actuator scale or application 
field. 
6.4.2.2. Ratcheting Rack-Pawl Force Interaction Model 
Although SMA wire is an energy dense, lightweight, and compact actuator capable of 
providing moderate forces, the material has limited actuation strains on the order of 2-4%. External 
architectures that can accumulate the displacement provided by the SMA wire, like a ratcheting 
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mechanism, greatly expand the application space of SMA. To better design SMA actuated linear 
ratcheting mechanisms, an analytical model of the ratcheting rack-pawl force interaction was 
developed and experimentally validated. The model predicts the force and displacement required 
by any linear actuator (not just SMA wire) to advance the position of the rack by its pitch. This 
predication was key to the design of the SMA actuator for the Instrumented SMA Driven Ratchet. 
However, because the model is scalable, it can be used to predict the forces and displacements 
required by much smaller or larger devices. 
6.5. Experimental Methodology Contributions 
While novel enterogenesis device technologies were critical for enabling the in vivo studies of 
mechanotransductive enterogenesis presented in this dissertation, the development and refinement 
of experimental methods was necessary to conduct the experiments and evaluate their results. In 
Chapter Three, the second objective of developing the treatment approach was achieved by 
determining the upper bound of safely applied bowel tension, comparing the effect of applying 
different tissue expansion profiles on tissue growth, and exploring the limits of the maximum 
expansion rate of the small bowel. A key device capability to enable these studies was the real-
time measurement of bowel tension within live pigs. Thus, a method for isolating the measurement 
of the applied small bowel tension was needed. Across all trials, methodologies for evaluating the 
tissue growth and health were developed or refined to determine that the observed bowel 
lengthening was a result of growth rather than permanent tissue deformation. 
6.5.1. Bowel Tension Measurement 
The techniques for measuring the applied tensile load have significantly evolved over the 
course of this research. In the beginning, the measurement of the bowel tension was captured by 
placing a force sensor on the end of the device, which was only compatible with the end-abutting 
tissue attachment approach that is not extendable to clinical application. Additionally, this 
measurement architecture measured all external loads on the device, not just those due to the bowel 
tension. The sources of these loads were due to the position and activity level of the animal model, 
and were an order of magnitude higher than the bowel tension. Some measurement of the bowel 
tension is better than nothing, but the captured data was noisy, often saturated the data acquisition 
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electronics, and placed time-varying offsets on the measured load that could not be distinguished 
from the bowel tension. 
Initially, to isolate the measurement on the contribution from the bowel tension, experiments 
were conducted where the segment of bowel with an early version of the Instrumented SMA 
Driven Ratchet was placed inside of an isolation tube. Although the measurement of load was 
considerably cleaner, this approach was not surgically favorable because of the large size of the 
isolation tube and the reaction of the adjacent tissues during the implantation period. The design 
of the isolation tube was challenging because it had to have a lengthwise slot for the mesentery. If 
the slot was too narrow, external loads on the isolation tube could cause the slot to pinch the 
mesentery. If the slot was too wide, loops of bowel could slide into the isolation tube during the 
experiments and become necrotic and/or obstructed. Also, to prevent the isolation tube from 
twisting and/or moving into an unfavorable position, it was sewn into the fascia of the peritoneal 
cavity through a series of holes opposite the slot. At explant surgeries, several surgical issues were 
observed where the isolation tube was used. The bowel tissue within tube grew into the holes, 
essentially anchoring itself and resisting lengthening. Worse, loops of bowel were observed inside 
of the isolation tube that were packed tightly enough to cause ischemia and necrosis. These surgical 
issues made it clear that the isolation tube approach should be abandoned, but the accurate 
measurement of the applied bowel load was still critical to enable important medical studies. 
Thus, a key contribution of the Instrumented SMA Driven Ratchet was the force 
instrumentation system, whose mechanical architecture made the accurate measurement of the 
applied tensile load possible by greatly attenuating external loads on the device due to the activity 
and/or position of the porcine animal model. The external load attenuation was achieved by 
creating a rigid external load path around the force sensor. The real-time measurement of the 
applied bowel tension was critical for conducting the enterogenesis studies where the bowel 
tension was used to inform the tissue expansion procedure and for maintaining a safe range of 
loads on the small bowel during the distraction period. Additionally, the data acquisition rate and 
measurement sensitivity was able to capture peristaltic action, an important health indicator of 
bowel motility. 
The clinical impact of this contribution is important, because the safe application of the 
mechanotransductive treatment approach will rely on not overstressing the remnant small bowel, 
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which could lead to ischemia and a cascade of worsening complications. Although a low bowel 
tension could be achieved by very conservatively expanding the remnant bowel, this approach is 
not in the best interest of patients because it lengthens the duration of the treatment, increases the 
risk of general complications related to the presence of a foreign body, and increases the cost of 
care. The measurement system can also be extended for research and clinical applications in other 
tubular tissues such as large blood vessels, the esophagus, and the colon. 
6.5.2. Tissue Health and Growth Analyses 
To support experimental studies, techniques for measuring the net growth of small bowel and 
quantifying the neovascularization of the mesentery supporting the bowel were developed. 
Additionally, an important finding regarding cell proliferation measurement techniques was made. 
6.5.2.1. Tissue Length Measurement 
To measure the net growth of small bowel in enterogenesis studies, a method based on the use 
of marking sutures was developed. For the method, evenly spaced sutures are placed along the 
Roux limb and along a segment of normal bowel to act as a control, and stainless steel clips are 
placed on every other, or every, suture. By remeasuring the marker spacing at explant, the small 
bowel growth can be recorded and compared to the control. This approach to measuring the change 
in bowel length is particularly advantageous for enterogenesis devices with non-permanent 
attachments (designed to actively attach and detach), because they may displace relative to the 
bowel. In contrast, for devices using permanent attachments (not designed to actively attach and 
detach) like sutures, the tissue length change was simply determined by measuring the 
displacement between the proximal and distal device-to-tissue attachments.  
6.5.2.2. Measurement of Neovascularization 
One important and previously overlooked aspect of healthy small bowel growth is the 
adaptation of the mesentery supporting the lengthened tissue. Compared to controls, the mesentery 
supporting the growth segments had increased neovascularization to support a greater demand for 
blood from the lengthened tissue. This result was important to establishing the feasibility of the 
mechanotransductive approach to correcting short bowel syndrome. To quantify this increase in 
neovascularization, several approaches were explored including immunofluorescence staining, 
using a laser Doppler system to measure blood perfusion, and the use of micro-CT scanning 
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technology to create 3D reconstructions of the blood vessels [4]. Among these methods, the use of 
micro-CT scanning technology was the most successful approach because it could be used for 
large (representative) areas of the mesentery. 
6.5.2.3. Measurement of Cell Proliferation 
Both bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) staining 
techniques were used to identify proliferating cells in the mucosa of tissue samples taken from 
normal bowel, the unfed Roux limb, and from the distracted bowel segment. In studies where both 
approaches were taken, the results were in strong agreement. BrdU, however, is difficult to 
administer because it is designed for use with living tissue, and must be timed carefully to capture 
the proliferation of cells at a moment of interest. Furthermore, because it must be used with living 
tissue, its injection into the peritoneum must occur hours to days before the explant. To achieve 
this, a catheter placed during implant surgeries (which was flushed daily to prevent clogging) was 
used to inject BrdU. One important finding is that the use BrdU seemed to correlate with more 
severe adhesions at explant surgeries, one of the main reasons its use was discontinued during this 
research. In contrast, PCNA staining for cell proliferation is a routine lab procedure that provides 
results in strong agreement with BrdU without causing problems like strengthened intraperitoneal 
adhesions. Thus, PCNA was a more advantageous approach to measuring cell proliferation than 
BrdU. 
6.6. Mechanical Device/Tissue Interaction Contributions 
Across all in vivo experimental studies, regardless of the enterogenesis device, important 
contributions and findings were made regarding the mechanical device/tissue interaction. These 
findings and contributions include the determination of the maximum safely applied bowel tension, 
methods for attaching to bowel tissue, and important considerations for designing the form of 
enterogenesis devices. 
6.6.1. Safe Load Determination 
To safely use enterogenesis devices for research and clinical applications, the range of safely 
applied tensile loads was determined, and the dominant failure mode of the bowel tissue was 
identified. Based on ex vivo and in vivo experimental studies using segments of porcine small 
bowel, the risk of tissue ischemia limits the maximum safely applied tension far more than the risk 
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of mechanical damage such as bowel perforation, mesenteric tearing, and/or bowel tearing. Using 
laser Doppler perfusion imaging technology, the onset of ischemia was observed for applied tensile 
loads exceeding 90 gf.  
This result guided the experimental procedures of the in vivo experiments using the 
Instrumented SMA Driven Ratchet by providing an upper bound of the applied tensile load and 
has been critical for preventing complications with the porcine animal models. By following the 
procedure developed for porcine animal models, the tensile load associated with the onset of 
ischemia can be extended to human patients and used to guide enterogenesis device design, refine 
treatment on a patient-to-patient basis, and most importantly, prevent the complications related to 
applying excessive small bowel tension in a clinical setting. 
6.6.2. Tissue Attachment 
Although originally considered trivial (“just use sutures”), the challenge of reliably and safely 
transferring load from the enterogenesis device to the bowel wall persisted throughout this 
research. In addition to describing the successful Dilating Fenestrated Mesh approach, this section 
will discuss the important reasons why the unsuccessful attachment approaches were unreliable 
and/or unsafe.  
6.6.2.1. Dilating Fenestrated Mesh 
Reliably and safely attaching to the wall of the small bowel has been a constant challenge 
throughout this research. In a series of experimental studies evaluating a range of tissue attachment 
approaches, the Dilating Fenestrated Mesh concept has demonstrated robust attachment 
performance and the ability to operate in a detached state to facilitate implantation, removal, and 
purposeful repositioning of the attachment. 
The biggest clinical implications of this attachment approach is the enablement of Natural 
Orifice Transluminal Endoscopic Surgery (NOTES) and other minimally invasive surgical 
techniques. With the attachments in their detached state, it will be possible to place an 
enterogenesis device into the remnant small bowel through the upper GI tract or through an ostomy 
without requiring any surgical manipulation of the small bowel. These surgical approaches can 
greatly improve the acceptance of the mechanotransductive treatment approach, eliminate the risk 
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of many surgical complications, prevent the development of intraperitoneal adhesions, prevent the 
creation of scars, and reduce the cost of treatment. 
Additionally, the attachment approach is a significant contribution because its use can be 
extended to a number of other medical applications such as improving endoscopic 
maneuverability, anchoring an instrument within large blood vessels to accurately place stents or 
perform endovascular coiling, and applying tensile load to the esophagus for the treatment of long-
gap esophageal atresia. 
6.6.2.2. Unreliable and/or Unsafe Tissue Attachment Approaches 
Very few attachment approaches in the intraluminal attachment study were considered both 
safe to use and able to transfer load without slipping. The shortcomings of the permanent (not 
designed to actively attach and detach) approaches and non-permanent (designed to actively attach 
and detach) approaches are described below. 
6.6.2.2.1. Ill-Suited Permanent Attachment Approaches 
Although the goal of the attachment study (Chapter 4) was to develop a safe tissue attachment 
approach with the ability to operate in attached and detached states, several permanent attachment 
approaches were considered in the study. Permanent approaches included sutures (with and 
without reinforcement), surgically enforced binding/kinking, and tissue clamping. The surgically 
enforced tissue binding/kinking approach was not effective because the enterogenesis device was 
able to slide despite the bends in the bowel. Even if effective, this approach is prone to creating 
diverticulum (pouches of bowel tissue growth not-aligned with the bowel). The tissue clamping 
and suture approaches were not reliable because of adaptations undergone by the bowel during the 
distraction period. For both approaches, the attachments displayed a tendency to slip through the 
full thickness of the bowel tissue, rendering the attachments completely ineffective during latter 
portions of the distraction period. 
6.6.2.2.2. Ill-Suited Non-Permanent Attachment Approaches 
Attachment approaches with the ability to apply high loads without slipping, such as 
impingement and suction approaches, were also considered the most likely to cause bowel 
ischemia and subsequent perforation. The dilation approach using smooth balloons was considered 
the safest approach, but unless the balloons were inflated enough to cause acute ischemia, they 
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easily slid along the bowel lumen at low loads. Texturing balloons with an abrasive mesh made it 
possible to attach without causing acute ischemia. However, the detachment performance of these 
attachments was so poor that it was nearly impossible to implant and remove the prototypes during 
acute in vivo experiments. This challenge led to the development of the Fenestrated Dilating Mesh 
approach, which demonstrated strong attachment and detachment performance without risking 
tissue ischemia and subsequent perforation. 
6.6.3. Device Form 
Many of the findings of this dissertation relate to the importance of the device form. The 
considerations for and relationships between length, rigidity, curvature, diameter, tissue interfaces, 
the local feature contours are important to understand in order to design enterogenesis devices that 
are safe to implant, operate, and remove. The findings here were developed over the course of this 
dissertation through many experiences in the operating room with porcine animal models. 
6.6.3.1. Length, Rigidity and Curvature 
The length, rigidity, and curvature of an enterogenesis device are coupled parameters in the 
context of device maneuverability through the GI tract, the fit of the device within the peritoneal 
cavity, and the stress the implanted device places on the mesentery. For example, if the device 
length is very short, it may still be implantable through the upper GI tract even if it is rigid and 
straight. Likewise, long devices must have some flexibility to be maneuvered through the upper 
GI tract. The maximum length of a device, regardless of implantation and removal procedure, is 
also limited by the size of the patient’s peritoneal cavity and by the extent that the device induces 
stress in the mesentery supporting the bowel. Because the mesentery radially pulls on the bowel, 
giving the bowel curvature, long and straight devices place significant stress on the mesentery. To 
reduce mesenteric stress, long devices can be curved to mimic the natural curvature of the bowel, 
as was done with the Curved Hydraulic Device, or shortened like the Reciprocating Linear 
Hydraulic Device. 
6.6.3.2. Diameter 
In general, the outer diameter of an enterogenesis device must be limited such that the device 
fits within the diameter of the relaxed bowel lumen. However, a more restrictive requirement exists 
for enterogenesis devices designed to be implanted in continuous bowel because the flow of enteral 
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contents must not be obstructed by the device. To eliminate the risk of device-related bowel 
obstruction, which can lead to bacterial overgrowth and a cascade of further medical 
complications, both the device length and outer diameter should be decreased in order to reduce 
the resistance of enteral content flow. 
6.6.3.3. Proximal and Distal Bowel Tissue Interface 
The proximal and distal bowel tissue interface an of enterogenesis device needs to be carefully 
designed to reduce the potential risk of bowel ischemia on either end of the device. This is because 
the manner in which the tissue drapes around the device can lead to sharp bends in the tissue that 
lead to ischemia and perforation. Methods to prevent this include designing flexibility and or 
curvature into the devices. For rigid devices, tissue guides can be incorporated that transition from 
the rigidity of the device to the compliance of the tissue. 
6.6.3.4. Local Feature Contours 
Local enterogenesis device features that interface with the bowel lumen must be contoured 
such that they do not induce bowel ischemia. The ischemia risk of uncontoured features is coupled 
to the device outer diameter, because as the outer diameter increases, the features on the device 
must become more contoured to prevent bowel ischemia. This consideration is particularly 
pertinent at the tissue attachment locations of the device, which often have the greatest outer 
diameter. 
6.7. Impact 
This dissertation has laid the complete engineering and medical foundation for the design and 
usage of enterogenesis devices for correcting short bowel syndrome. The medical foundation was 
set by the establishment of the treatment feasibility, and strengthened by identifying the maximum 
safely applied tensile load and evaluating the effect of different load and displacement-based tissue 
expansion strategies. In addition, the demonstrated medical viability of the payout approach has 
huge ramifications on the design of enterogenesis devices, enabling their compact design by 
breaking the tradeoff between device size and tissue expansion capability. The engineering 
foundation was set by the development of specifications for clinical device design, the design of 
and validation of three unique expansion architectures, the force instrumentation system, and the 
Dilating Fenestrated Mesh attachment approach. This foundation will guide the refinement of the 
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Reciprocating Linear Hydraulic Device designed in Chapter 5, eventually leading to clinical 
studies with the potential to provide an essential and life-saving alternative treatment approach for 
patients with short bowel syndrome. 
The focus of this dissertation was on the mechanotransductive correction of short bowel 
syndrome, but the impact is far-reaching. The most direct extension of the engineering foundation 
provided by this dissertation regards the treatment of long-gap esophageal atresia (LGEA), a 
serious condition where a large portion of the patient’s esophagus is missing at birth. While the 
mechanotransductive treatment of this condition has already been achieved by the application of 
distractive forces on the esophagus (known as the Foker method [7,2,8]), the transfer of load to 
the esophagus is currently achieved with sutures manually tensioned from outside the patient. As 
with porcine small bowel in this research, the sutures tend to slip through the esophagus of these 
patients, requiring additional thoracotomies to replace them and continue treatment. This is 
potentially an ideal application of the Dilating Fenestrated Mesh attachment approach, because the 
requirements for attachment, detachment, and safety overlap significantly. Additionally, the force 
instrumentation system developed in Chapter Three could be extended for treating LGEA to give 
medical personal a real-time measurement of the esophageal tension, allowing them to avoid the 
application of injurious loads and/or maintain the consistent application of tension. The Dilating 
Fenestrated Mesh could also be extended to other medical applications. To provide improved 
endoscope maneuverability, the Dilating Fenestrated Mesh could replace the smooth balloons used 
in double-balloon endoscopy procedures; the approach could be used for anchoring instruments 
within large blood vessels to accurately place stents or perform endovascular coiling; and the 
approach could also be potentially used to perform mucosal biopsy of the GI tract. 
6.8. Future Research 
The future direction of this research should address important surgical and engineering 
challenges related to researching mechanotransductive enterogenesis, which include further 
developing the clinical approach and refining the design of the Reciprocating Linear Hydraulic 
Device. 
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6.8.1. Medical and Surgical Challenges 
The current main challenges to conducting mechanotransduction-based enterogenesis studies 
is the formation of intraperitoneal adhesions following the implantation surgery, and the accurate 
measurement of the macroscopic net bowel growth with non-permanent attachments. 
6.8.1.1. Improving the Measurement of Small Bowel Growth 
The method used to measure net bowel growth in the in vivo experiments of this dissertation 
has been to place marking sutures in the Roux limb during the implantation surgery, measure the 
distance between adjacent sutures with a ruler, and remeasure the distance between adjacent 
sutures at the explant surgery for comparison. This method is complicated by two issues. First, 
bowel tissue exhibits high elongation for small changes in the applied tension, so manipulating the 
tissue in order to physically take the length measurement between sutures is prone to error. To 
mitigate this source of error, measurements were made with the bowel resting in the surgical field 
where possible. The second and more important problem related to this approach to measurement 
is that the marking sutures tend to slip out of the tissue, particularly for experiments exceeding one 
week. In experiments where the number of counted marking sutures does not change between the 
implant and explant surgeries, measurements of net bowel lengthening were made with 
confidence. However, such experiments were not the norm. When a mismatch in the number of 
marking sutures is discovered at explant, it can be difficult if not impossible to make conclusive 
statements about the net lengthening of the bowel tissue. For example, in the in vivo experiment 
to demonstrate the viability of the Payout Approach with the Reciprocating Linear Hydraulic 
Device, it was not possible to conclude whether the tissue grew by 120% or 200% of the device 
stroke. In the short term, the problem of the sutures slipping through the tissue may be solved by: 
1. exploring the reliability of different thread diameter and suturing materials (silk, 
prolene, nylon, polyester, etc.), 
2. placing multiple (redundant) sutures circumferentially around the tissue, and 
3. alternating suture colors in a pattern to identify which sutures have slipped at explant. 
A more fundamental issue with the current approach to measuring small bowel growth is that 
placing the marking sutures is an invasive open-cavity procedure. When the ability to implant an 
enterogenesis device with minimally invasive surgical techniques is achieved, an alternative 
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measurement approach will be required. One possibility is that the device could be modified to 
place radiopaque (for radiographs) or high density (for fluoroscopy) tissue markers during the 
implant. However, they too would be likely to slip through the bowel thickness and become 
unrecoverable for experiments exceeding one week. 
6.8.1.2. Addressing the Formation of Adhesions 
Post-surgical tissue adhesions form in the peritoneum, connecting loops of bowel to adjacent 
loops, the peritoneum, and to organs such as the liver and spleen. At explant surgeries, the 
adhesions must be carefully broken down to locate the Roux limb and implanted device. In severe 
cases, removing adhesions can require damaging tissue, which can make it difficult to determine 
if damaged tissue is the result of the enterogenesis device or from the separation of adhesed tissues. 
Furthermore, during the distraction period, adhesions on the growth segment with neighboring 
tissues can create non-optimal load paths away from the growth segment. Thus, the load applied 
by the enterogenesis device to the growth segment may be significantly less than expected or 
measured. In a clinical setting, adhesions can lead to serious consequences such as chronic pain, 
bowel obstruction, bowel necrosis, and others. To address the formation of adhesions for both 
research and clinical applications, the use of adhesion preventing film, delaying the distraction 
period, and minimally invasive surgical techniques are discussed. 
6.8.1.2.1. Adhesion Preventing Film and Gels 
The use of an adhesion preventing film (Seprafilm®) may reduce adhesions and has been tried 
in a number of the in vivo experiments of this dissertation, but there were no significant changes 
in the adhesions encountered during the explants. Additionally, Seprafilm® and other adhesion 
preventing films and gels may prevent tissue healing and should thus be placed very carefully. 
Nonetheless, adhesion preventing films and gels should be considered in clinical trials if adhesions 
are an issue, despite their insignificant impact during the in vivo experiments of this dissertation. 
6.8.1.2.2. Delaying the Distraction Period 
In porcine models, adhesions begin to form in the days following the implantation surgery, 
worsen (strengthen) for two to three weeks, and then begin to dissipate naturally. Thus, delaying 
the distraction period following the creation of the Roux limb may be a method to prevent 
adhesions from creating non-optimal loading paths away from the growth segment. Additionally, 
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locating the growth segment would be much easier at explant, because less effort would be required 
to separate the adhesions. Disadvantages to this approach would be the increased cost of each 
experiment, because of the daily costs associated with housing and caring for the animals; the 
increased time to run each experiment; and difficulty using the current tissue measurement 
technique, because the marking sutures would not be recoverable at the explant. 
6.8.1.2.3. Minimally Invasive Surgical Techniques 
To prevent adhesions from forming in the first place, the use of device implantation techniques 
that do not expose the peritoneum to open air should be a goal. Challenges to this endeavor are 
strongly coupled to the size, curvature, rigidity, and attachment approaches used in current 
enterogenesis devices. Additionally, a non-invasive method for measuring net bowel lengthening 
would be required to validate the success of the enterogenesis device. 
To place an enterogenesis device into the small bowel without surgically manipulating the 
tissue, the device could potentially be placed through the upper GI tract or through a preexisting 
gastrostomy/jejunostomy. In either scenario, the attachments of the enterogenesis device would 
need to operate in attached (to apply tensile loading) and detached (to implant/remove) states. 
Additionally, the enterogenesis device would need to be compact and potentially flexible to enable 
its placement through the upper GI tract. 
6.8.2. Engineering Challenges 
Future engineering research will focus on enterogenesis device improvements that enable the 
Reciprocating Linear Hydraulic Device to be implanted in the continuous GI tract rather than in 
an isolated segment, enable the device to be implanted by non-invasive or less invasive surgical 
techniques, instrumenting the device, and automating its control. 
6.8.2.1. Expansion Mechanism Improvements 
The expansion mechanism of the Reciprocating Linear Hydraulic Device is composed 
primarily of stainless steel tubing, making the device rigid and straight. As a result, stress on the 
mesentery was observed during the implant because the bowel is naturally curved by the 
mesentery. By bending the housings to give the device a curvilinear form factor, the stress on the 
mesentery could be reduced. However, the device would still be rigid, and thus difficult or 
impossible to implant though the upper GI tract or through a preexisting gastrostomy/jejunostomy. 
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Thus, the development of a flexible expansion mechanism is critical to enabling minimally 
invasive surgical techniques. Ideally, the device could be placed through the upper GI tract and 
into the remnant bowel without leading to device-related bowel obstruction. To achieve this, 
enteral contents must be able to flow through or around the expansion mechanism and attachments. 
6.8.2.1.1. Flexible Expansion Mechanism 
Designing a reciprocating flexible expansion mechanism will greatly improve the surgical 
options for implanting and removing the enterogenesis device. To achieve this, many feasible 
architectures will be considered from the soft robotics community that can be scaled and modified 
for studying bowel growth in porcine models and correcting SBS in both infants and adults. 
Examples of applicable expansion mechanisms include pneumatic bellows [9], fiber-reinforced 
elastomeric enclosures [10], and miniature McKibben actuators [11]. To evaluate a range of 
flexible expansion mechanism quickly, recent advances in thermoplastic elastomers (TPEs) for 
additive manufacturing can be used to print flexible models. Once a flexible expansion mechanism 
architecture is downselected, more traditional manufacturing processes such as TPE injection 
molding can be used to fabricate functional and high quality prototypes. 
6.8.2.1.2. Allowing Flow Through or Around the Device 
In addition to developing an expansion mechanism that is flexible, the expansion mechanism 
must allow the flow of enteral contents either through a channel of the device or around the outside 
of the device to enable its implantation in the continuous GI tract. The benefit of implanting in the 
continuous GI tract is that non-invasive surgical techniques may be used. Furthermore, isolating a 
segment of the small bowel from the GI tract can lead to disuse atrophy, because the isolated 
segment is not exposed to enteral contents. For patients that are receiving fully parenteral nutrition, 
the requirement for the device to allow for flow-through is still relevant to allow the passage of 
proximally secreted fluids.  
A pilot study of flow-through with simulated enteral contents (SEC), ex vivo segments of 
porcine bowel, and a small set of prototype attachments was conducted to correlate the percent 
area of small bowel blocked with the flow-through rate [12]. The study concluded that even with 
a 75% decrease in flow-through area, the rate of SEC was not significantly altered. Although this 
study was promising, it did not account for an overall resistance to flow, which would include both 
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the decrease in the cross-sectional area of flow and the length of bowel over which it acts. 
Additionally, conducting a flow-through study with a living animal model is important, because 
ex vivo studies cannot account for peristaltic action. 
6.8.2.2. Instrumentation and Control 
The current Reciprocating Linear Hydraulic Device is not instrumented to measure the applied 
bowel force or device expansion, nor is its control automated. Studies with the Instrumented SMA 
Driven Ratchet demonstrated the value of measuring the applied load. Force instrumentation made 
it possible to keep the applied tensile load within a safe range and also allowed the expansion of 
the tissue to proceed at unprecedented rates without affecting tissue health. For the Reciprocating 
Linear Hydraulic Device, measuring the applied tensile bowel force would increase the rate of 
small bowel growth by informing the timing of the payout approach operation. In the in vivo study 
using the Reciprocating Linear Hydraulic Device, four hours were given for the bowel to respond 
to the applied tensile load before resetting the device and repeating the operation. The four hour 
time span may have been too long, resulting in slower than necessary growth, or too short, resulting 
in the bowel not growing sufficiently between payout operation cycles. Ideally, with force 
instrumentation, the time given for the bowel to grow could be based on when the measured load 
reaches a low force threshold, which may vary greatly from cycle to cycle and from animal model 
to animal model. To provide this flexibility, automating the control of the hydraulic line that drives 
the device expansion and the pneumatic lines that drive the inflation of the attachments is key, 
especially if the cycle period is short. To design the data acquisition and control system of the 
Reciprocating Linear Hydraulic Device for porcine animal models, it will be critical to miniaturize 
the pumps, electronics, and power sources, because porcine animal models do not tolerate large 
and/or heavy devices on their back. For clinical applications, external equipment will not be an 
issue. 
6.9. Closing 
Prior to this research, little was known about how to develop the load-based approach to 
growing small bowel tissue for correcting short bowel syndrome, both in a surgical and in an 
engineering context, although numerous promising studies with small animal models hinted at the 
clinical feasibility of the approach. This dissertation has transitioned the technological state of the 
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art for enterogenesis devices tremendously through the development of novel enterogenesis 
devices, actuation architectures, the force instrumentation system, and tissue attachment 
approaches. These technological advances have enabled medical studies establishing the clinical 
feasibility of the treatment method, set guidelines for the safe application of load on bowel tissue, 
provided insight on how to effectively expand small bowel tissue to induce growth rapidly, and 
demonstrated the viability of the advantageous payout approach for inducing small bowel growth. 
Although much progress has been made, a continued research effort to refine enterogenesis 
device technologies and medical research techniques will be needed to achieve the ultimate goal 
of saving the lives of SBS patients by inducing the growth of their remnant bowel. From an 
engineering perspective, the future work will focus on providing a compact, instrumented, and 
flexible expansion mechanism that allows enteral content flow through, thus enabling the 
placement of an enterogenesis device into the non-isolated remnant bowel segment by non-
invasive surgical techniques. Future surgical and medical research will focus on accurately 
measuring the growth of small bowel, addressing the problem of intraperitoneal adhesion 
formation, and developing minimally invasive surgical device implantation and removal 
techniques. There is great confidence that the interdisciplinary team of engineers and surgeons 
conducting this research will overcome these difficult challenges, as we have done successfully in 
the past, and make the mechanotransductive approach to correcting short bowel syndrome a 
clinical reality, improving the quality of care for those afflicted with short bowel syndrome and 
ultimately saving lives. 
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